<?xml version="1.0" encoding="UTF-8"?>
<database>
	<database_properties>
		<name>MFIB - Mutual Folding Induced by Binding</name>
		<version>26-06-2017</version>
		<source>http://mfib.enzim.ttk.mta.hu/</source>
	</database_properties>
	<entry>
		<accession>MF2120001</accession>
		<general>
			<name>Bacterial antidote ParD</name>
			<pdb_id>2an7</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>17656583</pmid>
				<authors>Oberer M, Zangger K, Gruber K, Keller W</authors>
				<title>The solution structure of ParD, the antidote of the ParDE toxin antitoxin module, provides the structural basis for DNA and toxin binding.</title>
				<journal>Protein Sci.</journal>
				<year>2007</year>
				<issue>8</issue>
				<volume>16</volume>
				<pages>1676-88</pages>
				<abstract>ParD is the antidote of the plasmid-encoded toxin-antitoxin (TA) system ParD-ParE. These modules rely on differential stabilities of a highly expressed but labile antidote and a stable toxin expressed from one operon. Consequently, loss of the coding plasmid results in loss of the protective antidote and poisoning of the cell. The antidote protein usually also exhibits an autoregulatory function of the operon. In this paper, we present the solution structure of ParD. The repressor activity of ParD is mediated by the N-terminal half of the protein, which adopts a ribbon-helix-helix (RHH) fold. The C-terminal half of the protein is unstructured in the absence of its cognate binding partner ParE. Based on homology with other RHH proteins, we present a model of the ParD-DNA interaction, with the antiparallel beta-strand being inserted into the major groove of DNA. The fusion of the N-terminal DNA-binding RHH motif to the toxin-binding unstructured C-terminal domain is discussed in its evolutionary context.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0051290</accession>
					<name>protein heterotetramerization</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0030541</accession>
					<name>plasmid partitioning</name>
				</go>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin ParD</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MSRLTIDMTDQQHQSLKALAALQGKTIKQYALERLFPGDADADQAWQELKTMLGNRINDGLAGKVSTKSVGEILDEELSGDRA</sequence>
				<length>83</length>
				<uniprot>
					<id>P22995</id>
					<start>1</start>
					<end>83</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22995</id>
					<start>1</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09386.7</region_id>
						<region_name>ParD</region_name>
						<region_start>1</region_start>
						<region_end>79</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Antitoxin ParD</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MSRLTIDMTDQQHQSLKALAALQGKTIKQYALERLFPGDADADQAWQELKTMLGNRINDGLAGKVSTKSVGEILDEELSGDRA</sequence>
				<length>83</length>
				<uniprot>
					<id>P22995</id>
					<start>1</start>
					<end>83</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22995</id>
					<start>1</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09386.7</region_id>
						<region_name>ParD</region_name>
						<region_start>1</region_start>
						<region_end>79</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:17656583). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120002</accession>
		<general>
			<name>Helicobacter pylori HP0222</name>
			<pdb_id>1x93</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Helicobacter pylori</source_organism>
			<publication>
				<pmid>15723352</pmid>
				<authors>Popescu A, Karpay A, Israel DA, Peek RM, Krezel AM</authors>
				<title>Helicobacter pylori protein HP0222 belongs to Arc/MetJ family of transcriptional regulators.</title>
				<journal>Proteins</journal>
				<year>2005</year>
				<issue>2</issue>
				<volume>59</volume>
				<pages>303-11</pages>
				<abstract>Helicobacter pylori is a widespread human bacterial pathogen responsible for inducing gastric and duodenal ulcers and gastric cancers. To date, only 16 protein structures from this organism have been determined, and more than 30% of its 1500 protein functions remain unknown. We report the biochemical characterization, the tertiary structure determined by solution nuclear magnetic resonance (NMR) methods and the putative function of the previously uncharacterized protein HP0222 (JHP0208) from H. pylori. Recombinant HP0222 behaves as a dimer in crosslinking and size exclusion chromatography experiments. The structure consists of a ribbon-helix-helix fold characteristic of transcription factors of the Arc/MetJ family, which all bind DNA as higher order oligomers. Electrophoretic mobility shift assays reveal that HP0222 binds to double-stranded DNA. Previous studies have shown significant increases in transcription levels of HP0222 in response to acid shock and adherence to gastric epithelial cells. To assess possible involvement of HP0222 in acid resistance, we constructed and assayed an H. pylori HP0222 null mutant. We propose that HP0222 is a novel transcriptional regulator in H. pylori.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein</name>
				<source_organism>Helicobacter pylori</source_organism>
				<sequence>TRAVSLYFSDEQYQKLEKMANEEEESVGSYIKRYILKALRKIEMRGSHHHHHHGS</sequence>
				<length>55</length>
				<uniprot>
					<id>O25010</id>
					<start>31</start>
					<end>73</end>
					<coverage>58.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A0A060Q0Z2</id>
					<start>31</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16777.2</region_id>
						<region_name>RHH_7</region_name>
						<region_start>1</region_start>
						<region_end>73</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Uncharacterized protein</name>
				<source_organism>Helicobacter pylori</source_organism>
				<sequence>TRAVSLYFSDEQYQKLEKMANEEEESVGSYIKRYILKALRKIEMRGSHHHHHHGS</sequence>
				<length>55</length>
				<uniprot>
					<id>O25010</id>
					<start>31</start>
					<end>73</end>
					<coverage>58.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A0A060Q0Z2</id>
					<start>31</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16777.2</region_id>
						<region_name>RHH_7</region_name>
						<region_start>1</region_start>
						<region_end>73</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:15723352). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120003</accession>
		<general>
			<name>Helicobacter pylori JHP0511 (HP0564)</name>
			<pdb_id>2k1o</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Helicobacter pylori</source_organism>
			<publication>
				<pmid>18623065</pmid>
				<authors>Borin BN, Krezel AM</authors>
				<title>Structure of HP0564 from Helicobacter pylori identifies it as a new transcriptional regulator.</title>
				<journal>Proteins</journal>
				<year>2008</year>
				<issue>1</issue>
				<volume>73</volume>
				<pages>265-8</pages>
				<abstract>No abstract available.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Putative</name>
				<source_organism>Helicobacter pylori</source_organism>
				<sequence>MRGSHHHHHHGSKRNFSVTFYLSKEEHDVLRRLADEEVESVNSFVKRHILKTIIYKKGTNQDSSIN</sequence>
				<length>66</length>
				<uniprot>
					<id>Q9ZLR7</id>
					<start>21</start>
					<end>74</end>
					<coverage>66.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_B5Z6T5</id>
					<start>21</start>
					<end>74</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>24</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16777.2</region_id>
						<region_name>RHH_7</region_name>
						<region_start>2</region_start>
						<region_end>66</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Putative</name>
				<source_organism>Helicobacter pylori</source_organism>
				<sequence>MRGSHHHHHHGSKRNFSVTFYLSKEEHDVLRRLADEEVESVNSFVKRHILKTIIYKKGTNQDSSIN</sequence>
				<length>66</length>
				<uniprot>
					<id>Q9ZLR7</id>
					<start>21</start>
					<end>74</end>
					<coverage>66.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_B5Z6T5</id>
					<start>21</start>
					<end>74</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>23</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16777.2</region_id>
						<region_name>RHH_7</region_name>
						<region_start>2</region_start>
						<region_end>66</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:18623065). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120004</accession>
		<general>
			<name>ParG</name>
			<pdb_id>1p94</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Salmonella newport</source_organism>
			<publication>
				<pmid>14622405</pmid>
				<authors>Golovanov AP, Barillà D, Golovanova M, Hayes F, Lian LY</authors>
				<title>ParG, a protein required for active partition of bacterial plasmids, has a dimeric ribbon-helix-helix structure.</title>
				<journal>Mol. Microbiol.</journal>
				<year>2003</year>
				<issue>4</issue>
				<volume>50</volume>
				<pages>1141-53</pages>
				<abstract>The ParG protein (8.6 kDa) is an essential component of the DNA partition complex of multidrug resistance plasmid TP228. ParG is a dimer in solution, interacts with DNA sequences upstream of the parFG genes and also with the ParF partition protein both in the absence and presence of target DNA. Here, the solution nuclear magnetic resonance structure of ParG is reported. The ParG dimer is composed of a folded domain formed by two closely intertwined C-terminal parts (residues 33-76), and two highly mobile tails consisting of N-terminal regions (residues 1-32). The folded part of ParG has the ribbon-helix-helix (RHH) architecture similar to that of the Arc/MetJ superfamily of DNA-binding transcriptional repressors, although the primary sequence similarity is very low. ParG interacts with DNA predominantly via its folded domain; this interaction is coupled with ParG oligomerization. The dimeric RHH structure of ParG suggests that it binds to DNA by inserting the double-stranded beta-sheet into the major groove of DNA, in a manner similar to transcriptional repressors from the Arc/MetJ superfamily, and that ParG can function as a transcriptional repressor itself. A new classification of proteins belonging to the Arc/MetJ superfamily and ParG homologues is proposed, based on the location of a conserved positively charged residue at either the beginning or at the end of the beta-strand which forms part of the DNA recognition motif.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Plasmid partition protein ParG</name>
				<source_organism>Salmonella newport</source_organism>
				<sequence>MSLEKAHTSVKKMTFGENRDLERVVTAPVSSGKIKRVNVNFDEEKHTRFKAACARKGTSITDVVNQLVDNWLKENE</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9KJ82</id>
					<start>1</start>
					<end>76</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_K3K332</id>
					<start>1</start>
					<end>76</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>43</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09274.7</region_id>
						<region_name>ParG</region_name>
						<region_start>1</region_start>
						<region_end>76</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Plasmid partition protein ParG</name>
				<source_organism>Salmonella newport</source_organism>
				<sequence>MSLEKAHTSVKKMTFGENRDLERVVTAPVSSGKIKRVNVNFDEEKHTRFKAACARKGTSITDVVNQLVDNWLKENE</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9KJ82</id>
					<start>1</start>
					<end>76</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_K3K332</id>
					<start>1</start>
					<end>76</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>19</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>43</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09274.7</region_id>
						<region_name>ParG</region_name>
						<region_start>1</region_start>
						<region_end>76</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:14622405). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100001</accession>
		<general>
			<name>Human parathyroid hormone</name>
			<pdb_id>1et1</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>0.90</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>10837469</pmid>
				<authors>Jin L, Briggs SL, Chandrasekhar S, Chirgadze NY, Clawson DK, Schevitz RW, Smiley DL, Tashjian AH, Zhang F</authors>
				<title>Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2000</year>
				<issue>35</issue>
				<volume>275</volume>
				<pages>27238-44</pages>
				<abstract>The N-terminal fragment 1-34 of parathyroid hormone (PTH), administered intermittently, results in increased bone formation in patients with osteoporosis. PTH and a related molecule, parathyroid hormone-related peptide (PTHrP), act on cells via a common PTH/PTHrP receptor. To define more precisely the ligand-receptor interactions, we have crystallized human PTH (hPTH)-(1-34) and determined the structure to 0.9-A resolution. hPTH-(1-34) crystallizes as a slightly bent, long helical dimer. Analysis reveals that the extended helical conformation of hPTH-(1-34) is the likely bioactive conformation. We have developed molecular models for the interaction of hPTH-(1-34) and hPTHrP-(1-34) with the PTH/PTHrP receptor. A receptor binding pocket for the N terminus of hPTH-(1-34) and a hydrophobic interface with the receptor for the C terminus of hPTH-(1-34) are proposed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003705</accession>
					<name>transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0031857</accession>
					<name>type 1 parathyroid hormone receptor binding</name>
				</go>
				<go>
					<accession>GO:0005179</accession>
					<name>hormone activity</name>
				</go>
				<go>
					<accession>GO:0051428</accession>
					<name>peptide hormone receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0048873</accession>
					<name>homeostasis of number of cells within a tissue</name>
				</go>
				<go>
					<accession>GO:0045725</accession>
					<name>positive regulation of glycogen biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0046326</accession>
					<name>positive regulation of glucose import</name>
				</go>
				<go>
					<accession>GO:0030819</accession>
					<name>positive regulation of cAMP biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0034645</accession>
					<name>cellular macromolecule biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0090290</accession>
					<name>positive regulation of osteoclast proliferation</name>
				</go>
				<go>
					<accession>GO:0045453</accession>
					<name>bone resorption</name>
				</go>
				<go>
					<accession>GO:0010288</accession>
					<name>response to lead ion</name>
				</go>
				<go>
					<accession>GO:0030501</accession>
					<name>positive regulation of bone mineralization</name>
				</go>
				<go>
					<accession>GO:0045471</accession>
					<name>response to ethanol</name>
				</go>
				<go>
					<accession>GO:0009967</accession>
					<name>positive regulation of signal transduction</name>
				</go>
				<go>
					<accession>GO:0042493</accession>
					<name>response to drug</name>
				</go>
				<go>
					<accession>GO:0071864</accession>
					<name>positive regulation of cell proliferation in bone marrow</name>
				</go>
				<go>
					<accession>GO:0071107</accession>
					<name>response to parathyroid hormone</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0046686</accession>
					<name>response to cadmium ion</name>
				</go>
				<go>
					<accession>GO:0071774</accession>
					<name>response to fibroblast growth factor</name>
				</go>
				<go>
					<accession>GO:0006874</accession>
					<name>cellular calcium ion homeostasis</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0046058</accession>
					<name>cAMP metabolic process</name>
				</go>
				<go>
					<accession>GO:0008628</accession>
					<name>hormone-mediated apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0001501</accession>
					<name>skeletal system development</name>
				</go>
				<go>
					<accession>GO:0007266</accession>
					<name>Rho protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0033280</accession>
					<name>response to vitamin D</name>
				</go>
				<go>
					<accession>GO:0071866</accession>
					<name>negative regulation of apoptotic process in bone marrow</name>
				</go>
				<go>
					<accession>GO:0007267</accession>
					<name>cell-cell signaling</name>
				</go>
				<go>
					<accession>GO:0007189</accession>
					<name>adenylate cyclase-activating G-protein coupled receptor signaling pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0005622</accession>
					<name>intracellular</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Parathyroid hormone</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF</sequence>
				<length>34</length>
				<uniprot>
					<id>P01270</id>
					<start>32</start>
					<end>65</end>
					<coverage>29.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01270</id>
					<start>32</start>
					<end>65</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>34</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01279.14</region_id>
						<region_name>Parathyroid</region_name>
						<region_start>29</region_start>
						<region_end>112</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Parathyroid hormone</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF</sequence>
				<length>34</length>
				<uniprot>
					<id>P01270</id>
					<start>32</start>
					<end>65</end>
					<coverage>29.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01270</id>
					<start>32</start>
					<end>65</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>34</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01279.14</region_id>
						<region_name>Parathyroid</region_name>
						<region_start>29</region_start>
						<region_end>112</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 32-65 region described in DisProt entry DP00637 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 32-65 region described in DisProt entry DP00637 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200001</accession>
		<general>
			<name>Human ribosomal protein P1-P2 heterodimer</name>
			<pdb_id>4beh</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>23892290</pmid>
				<authors>Lee KM, Yusa K, Chu LO, Wing-Heng Yu C, Oono M, Miyoshi T, Ito K, Shaw PC, Wong KB, Uchiumi T</authors>
				<title>Solution structure of human P1*P2 heterodimer provides insights into the role of eukaryotic stalk in recruiting the ribosome-inactivating protein trichosanthin to the ribosome.</title>
				<journal>Nucleic Acids Res.</journal>
				<year>2013</year>
				<abstract>Lateral ribosomal stalk is responsible for binding and recruiting translation factors during protein synthesis. The eukaryotic stalk consists of one P0 protein with two copies of P1•P2 heterodimers to form a P0(P1•P2)2 pentameric P-complex. Here, we have solved the structure of full-length P1•P2 by nuclear magnetic resonance spectroscopy. P1 and P2 dimerize via their helical N-terminal domains, whereas the C-terminal tails of P1•P2 are unstructured and can extend up to ∼125 Å away from the dimerization domains. (15)N relaxation study reveals that the C-terminal tails are flexible, having a much faster internal mobility than the N-terminal domains. Replacement of prokaryotic L10(L7/L12)4/L11 by eukaryotic P0(P1•P2)2/eL12 rendered Escherichia coli ribosome, which is insensitive to trichosanthin (TCS), susceptible to depurination by TCS and the C-terminal tail was found to be responsible for this depurination. Truncation and insertion studies showed that depurination of hybrid ribosome is dependent on the length of the proline-alanine rich hinge region within the C-terminal tail. All together, we propose a model that recruitment of TCS to the sarcin-ricin loop required the flexible C-terminal tail, and the proline-alanine rich hinge region lengthens this C-terminal tail, allowing the tail to sweep around the ribosome to recruit TCS.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0070180</accession>
					<name>large ribosomal subunit rRNA binding</name>
				</go>
				<go>
					<accession>GO:0003735</accession>
					<name>structural constituent of ribosome</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0019083</accession>
					<name>viral transcription</name>
				</go>
				<go>
					<accession>GO:0000184</accession>
					<name>nuclear-transcribed mRNA catabolic process, nonsense-mediated decay</name>
				</go>
				<go>
					<accession>GO:0006413</accession>
					<name>translational initiation</name>
				</go>
				<go>
					<accession>GO:0002181</accession>
					<name>cytoplasmic translation</name>
				</go>
				<go>
					<accession>GO:0006364</accession>
					<name>rRNA processing</name>
				</go>
				<go>
					<accession>GO:0006614</accession>
					<name>SRP-dependent cotranslational protein targeting to membrane</name>
				</go>
				<go>
					<accession>GO:0006414</accession>
					<name>translational elongation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030687</accession>
					<name>preribosome, large subunit precursor</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005925</accession>
					<name>focal adhesion</name>
				</go>
				<go>
					<accession>GO:0022625</accession>
					<name>cytosolic large ribosomal subunit</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>60S acidic ribosomal protein P1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MASVSELACIYSALILHDDEVTVTEDKINALIKAAGVNVEPFWPGLFAKALANVNIGSLICNVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAKKEESEESDDDMGFGLFD</sequence>
				<length>114</length>
				<uniprot>
					<id>P05386</id>
					<start>1</start>
					<end>114</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05386</id>
					<start>1</start>
					<end>114</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00428.16</region_id>
						<region_name>Ribosomal_60s</region_name>
						<region_start>22</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>60S acidic ribosomal protein P2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AMRYVASYLLAALGGNSSPSAKDIKKILDSVGIEADDDRLNKVISELNGKNIEDVIAQGIGKLASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEKKEESEESDDDMGFGLFD</sequence>
				<length>116</length>
				<uniprot>
					<id>P05387</id>
					<start>1</start>
					<end>115</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05387</id>
					<start>1</start>
					<end>115</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>1</region_start>
						<region_end>3</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00428.16</region_id>
						<region_name>Ribosomal_60s</region_name>
						<region_start>17</region_start>
						<region_end>114</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00428.16) has been experimentally characterized as disordered in DisProt entry DP00001.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00428.16) has been experimentally characterized as disordered in DisProt entry DP00002.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2lbf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100002</accession>
		<general>
			<name>Dimerization domain of ribosomal protein P2</name>
			<pdb_id>2w1o</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>20385603</pmid>
				<authors>Lee KM, Yu CW, Chan DS, Chiu TY, Zhu G, Sze KH, Shaw PC, Wong KB</authors>
				<title>Solution structure of the dimerization domain of ribosomal protein P2 provides insights for the structural organization of eukaryotic stalk.</title>
				<journal>Nucleic Acids Res.</journal>
				<year>2010</year>
				<issue>15</issue>
				<volume>38</volume>
				<pages>5206-16</pages>
				<abstract>The lateral stalk of ribosome is responsible for kingdom-specific binding of translation factors and activation of GTP hydrolysis that drives protein synthesis. In eukaryotes, the stalk is composed of acidic ribosomal proteins P0, P1 and P2 that constitute a pentameric P-complex in 1: 2: 2 ratio. We have determined the solution structure of the N-terminal dimerization domain of human P2 (NTD-P2), which provides insights into the structural organization of the eukaryotic stalk. Our structure revealed that eukaryotic stalk protein P2 forms a symmetric homodimer in solution, and is structurally distinct from the bacterial counterpart L12 homodimer. The two subunits of NTD-P2 form extensive hydrophobic interactions in the dimeric interface that buries 2400 A(2) of solvent accessible surface area. We have showed that P1 can dissociate P2 homodimer spontaneously to form a more stable P1/P2 1 : 1 heterodimer. By homology modelling, we identified three exposed polar residues on helix-3 of P2 are substituted by conserved hydrophobic residues in P1. Confirmed by mutagenesis, we showed that these residues on helix-3 of P1 are not involved in the dimerization of P1/P2, but instead play a vital role in anchoring P1/P2 heterodimer to P0. Based on our results, models of the eukaryotic stalk complex were proposed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003735</accession>
					<name>structural constituent of ribosome</name>
				</go>
				<go>
					<accession>GO:0070180</accession>
					<name>large ribosomal subunit rRNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006414</accession>
					<name>translational elongation</name>
				</go>
				<go>
					<accession>GO:0006364</accession>
					<name>rRNA processing</name>
				</go>
				<go>
					<accession>GO:0006614</accession>
					<name>SRP-dependent cotranslational protein targeting to membrane</name>
				</go>
				<go>
					<accession>GO:0006413</accession>
					<name>translational initiation</name>
				</go>
				<go>
					<accession>GO:0002181</accession>
					<name>cytoplasmic translation</name>
				</go>
				<go>
					<accession>GO:0000184</accession>
					<name>nuclear-transcribed mRNA catabolic process, nonsense-mediated decay</name>
				</go>
				<go>
					<accession>GO:0019083</accession>
					<name>viral transcription</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005925</accession>
					<name>focal adhesion</name>
				</go>
				<go>
					<accession>GO:0022625</accession>
					<name>cytosolic large ribosomal subunit</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0016020</accession>
					<name>membrane</name>
				</go>
				<go>
					<accession>GO:0030687</accession>
					<name>preribosome, large subunit precursor</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>60S acidic ribosomal protein P2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AMRYVASYLLAALGGNSSPSAKDIKKILDSVGIEADDDRLNKVISELNGKNIEDVIAQGIGKLASVPAGG</sequence>
				<length>70</length>
				<uniprot>
					<id>P05387</id>
					<start>1</start>
					<end>69</end>
					<coverage>60%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05387</id>
					<start>1</start>
					<end>66</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00428.16</region_id>
						<region_name>Ribosomal_60s</region_name>
						<region_start>17</region_start>
						<region_end>114</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>60S acidic ribosomal protein P2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AMRYVASYLLAALGGNSSPSAKDIKKILDSVGIEADDDRLNKVISELNGKNIEDVIAQGIGKLASVPAGG</sequence>
				<length>70</length>
				<uniprot>
					<id>P05387</id>
					<start>1</start>
					<end>69</end>
					<coverage>60%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05387</id>
					<start>1</start>
					<end>66</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00428.16</region_id>
						<region_name>Ribosomal_60s</region_name>
						<region_start>17</region_start>
						<region_end>114</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00428.16) has been experimentally characterized as disordered in DisProt entry DP00002.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00428.16) has been experimentally characterized as disordered in DisProt entry DP00002.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201001</accession>
		<general>
			<name>Nuclear receptor coactivators CBP and ACTR</name>
			<pdb_id>1kbh</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Mus musculus</source_organism>
			<publication>
				<pmid>11823864</pmid>
				<authors>Demarest SJ, Martinez-Yamout M, Chung J, Chen H, Xu W, Dyson HJ, Evans RM, Wright PE</authors>
				<title>Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators.</title>
				<journal>Nature</journal>
				<year>2002</year>
				<issue>6871</issue>
				<volume>415</volume>
				<pages>549-53</pages>
				<abstract>Nuclear hormone receptors are ligand-activated transcription factors that regulate the expression of genes that are essential for development, reproduction and homeostasis. The hormone response is mediated through recruitment of p160 receptor coactivators and the general transcriptional coactivator CBP/p300, which function synergistically to activate transcription. These coactivators exhibit intrinsic histone acetyltransferase activity, function in the remodelling of chromatin, and facilitate the recruitment of RNA polymerase II and the basal transcription machinery. The activities of the p160 coactivators are dependent on CBP. Both coactivators are essential for proper cell-cycle control, differentiation and apoptosis, and are implicated in cancer and other diseases. To elucidate the molecular basis of assembling the multiprotein activation complex, we undertook a structural and thermodynamic analysis of the interaction domains of CBP and the activator for thyroid hormone and retinoid receptors. Here we show that although the isolated domains are intrinsically disordered, they combine with high affinity to form a cooperatively folded helical heterodimer. Our study uncovers a unique mechanism, called &apos;synergistic folding', through which p160 coactivators recruit CBP/p300 to allow transmission of the hormonal signal to the transcriptional machinery.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003713</accession>
					<name>transcription coactivator activity</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0004402</accession>
					<name>histone acetyltransferase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0016573</accession>
					<name>histone acetylation</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Nuclear receptor coactivator 3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EGQSDERALLDQLHTLLSNTDATGLEEIDRALGIPELVNQGQALEPK</sequence>
				<length>47</length>
				<uniprot>
					<id>Q9Y6Q9</id>
					<start>1045</start>
					<end>1091</end>
					<coverage>3.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9Y6Q9</id>
					<start>1045</start>
					<end>1091</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1049</region_start>
						<region_end>1060</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1069</region_start>
						<region_end>1075</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1078</region_start>
						<region_end>1084</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1086</region_start>
						<region_end>1088</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08815.7</region_id>
						<region_name>Nuc_rec_co-act</region_name>
						<region_start>1045</region_start>
						<region_end>1093</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>CREB-binding protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>PNRSISPSALQDLLRTLKSPSSPQQQQQVLNILKSNPQLMAAFIKQRTAKYVANQPGMQ</sequence>
				<length>59</length>
				<uniprot>
					<id>P45481</id>
					<start>2059</start>
					<end>2117</end>
					<coverage>2.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q92793</id>
					<start>2058</start>
					<end>2116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2067</region_start>
						<region_end>2076</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2086</region_start>
						<region_end>2091</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2095</region_start>
						<region_end>2110</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09030.7</region_id>
						<region_name>Creb_binding</region_name>
						<region_start>2019</region_start>
						<region_end>2115</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting monomers have been described to undergo mutual synergistic folding upon binding (PMID:11823864).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1018-1088 region described in DisProt entry DP00343 and the 1018-1088 region described in IDEAL entry IID00110 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 2059-2152 region described in DisProt entry DP00348 and the 2057-2117 region described in IDEAL entry IID50008 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4210001</accession>
		<general>
			<name>L27 (Lin-2, Lin-7) domain complex (rat)</name>
			<pdb_id>1rso</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterotetramer (dimer of dimers)</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>15048107</pmid>
				<authors>Feng W, Long JF, Fan JS, Suetake T, Zhang M</authors>
				<title>The tetrameric L27 domain complex as an organization platform for supramolecular assemblies.</title>
				<journal>Nat. Struct. Mol. Biol.</journal>
				<year>2004</year>
				<issue>5</issue>
				<volume>11</volume>
				<pages>475-80</pages>
				<abstract>L27 domain, initially identified in the Caenorhabditis elegans Lin-2 and Lin-7 proteins, is a protein interaction module that exists in a large family of scaffold proteins. The domain can function as an organization center of large protein assemblies required for establishment and maintenance of cell polarity. We have solved the high-resolution NMR structure of a tetrameric complex of L27 domains containing two SAP97-mLin-2 L27 domain heterodimers. Each L27 domain contains three a-helices. The first two helices of each domain are packed together to form a four-helical bundle in the heterodimer. The third helix of each L27 domain forms another four-helical bundle that assembles the two heterodimers into a tetramer. The structure of the complex provides a mechanistic explanation for L27 domain-mediated polymerization of scaffold proteins, a process that is crucial for the assembly of supramolecular complexes in asymmetric cells.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008022</accession>
					<name>protein C-terminus binding</name>
				</go>
				<go>
					<accession>GO:0030165</accession>
					<name>PDZ domain binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0042734</accession>
					<name>presynaptic membrane</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_1 type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Disks large homolog 1</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>RKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVISIFQSNLFQALIDIQEFYEVTLLDN</sequence>
				<length>60</length>
				<uniprot>
					<id>Q62696</id>
					<start>4</start>
					<end>63</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q12959</id>
					<start>4</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09058.7</region_id>
						<region_name>L27_1</region_name>
						<region_start>4</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Peripheral plasma membrane protein CASK</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GLLAAERAVSQVLDSLEEIHALTDSSEKDLDFLHSVFQDQHLHTLLDLYDKINTKS</sequence>
				<length>56</length>
				<uniprot>
					<id>Q62915</id>
					<start>339</start>
					<end>394</end>
					<coverage>6.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14936</id>
					<start>339</start>
					<end>394</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>345</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>376</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>378</region_start>
						<region_end>391</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>347</region_start>
						<region_end>400</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Disks large homolog 1</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>RKQDTQRALHLLEEYRSKLSQTEDRQLRSSIERVISIFQSNLFQALIDIQEFYEVTLLDN</sequence>
				<length>60</length>
				<uniprot>
					<id>Q62696</id>
					<start>4</start>
					<end>63</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q12959</id>
					<start>4</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09058.7</region_id>
						<region_name>L27_1</region_name>
						<region_start>4</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Peripheral plasma membrane protein CASK</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GLLAAERAVSQVLDSLEEIHALTDSSEKDLDFLHSVFQDQHLHTLLDLYDKINTKS</sequence>
				<length>56</length>
				<uniprot>
					<id>Q62915</id>
					<start>339</start>
					<end>394</end>
					<coverage>6.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14936</id>
					<start>339</start>
					<end>394</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>342</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>376</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>378</region_start>
						<region_end>393</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>347</region_start>
						<region_end>400</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a heterotetrameric L27 complex (PMID:15048107). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201002</accession>
		<general>
			<name>CBP nuclear coactivator binding domain in complex with p53 TAD</name>
			<pdb_id>2l14</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Mus musculus / Homo sapiens</source_organism>
			<publication>
				<pmid>20961098</pmid>
				<authors>Lee CW, Martinez-Yamout MA, Dyson HJ, Wright PE</authors>
				<title>Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.</title>
				<journal>Biochemistry</journal>
				<year>2010</year>
				<issue>46</issue>
				<volume>49</volume>
				<pages>9964-71</pages>
				<abstract>The activity and stability of the tumor suppressor p53 are regulated by interactions with key cellular proteins such as MDM2 and CBP/p300. The transactivation domain (TAD) of p53 contains two subdomains (AD1 and AD2) and interacts directly with the N-terminal domain of MDM2 and with several domains of CBP/p300. Here we report the NMR structure of the full-length p53 TAD in complex with the nuclear coactivator binding domain (NCBD) of CBP. Both the p53 TAD and NCBD are intrinsically disordered and fold synergistically upon binding, as evidenced by the observed increase in helicity and increased level of dispersion of the amide proton resonances. The p53 TAD folds to form a pair of helices (denoted Pα1 and Pα2), which extend from Phe19 to Leu25 and from Pro47 to Trp53, respectively. In the complex, the NCBD forms a bundle of three helices (Cα1, residues 2066-2075; Cα2, residues 2081-2092; and Cα3, residues 2095-2105) with a hydrophobic groove into which p53 helices Pα1 and Pα2 dock. The polypeptide chain between the p53 helices remains flexible and makes no detectable intermolecular contacts with the NCBD. Complex formation is driven largely by hydrophobic contacts that form a stable intermolecular hydrophobic core. A salt bridge between D49 of p53 and R2105 of NCBD may contribute to the binding specificity. The structure provides the first insights into simultaneous binding of the AD1 and AD2 motifs to a target protein.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0002039</accession>
					<name>p53 binding</name>
				</go>
				<go>
					<accession>GO:0001228</accession>
					<name>transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0003684</accession>
					<name>damaged DNA binding</name>
				</go>
				<go>
					<accession>GO:0001085</accession>
					<name>RNA polymerase II transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0048511</accession>
					<name>rhythmic process</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0034644</accession>
					<name>cellular response to UV</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
				<go>
					<accession>GO:0016605</accession>
					<name>PML body</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>CREB-binding protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>PNRSISPSALQDLLRTLKSPSSPQQQQQVLNILKSNPQLMAAFIKQRTAKYVANQPGMQ</sequence>
				<length>59</length>
				<uniprot>
					<id>P45481</id>
					<start>2059</start>
					<end>2117</end>
					<coverage>2.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q92793</id>
					<start>2058</start>
					<end>2116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2066</region_start>
						<region_end>2075</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2081</region_start>
						<region_end>2092</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2095</region_start>
						<region_end>2106</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09030.7</region_id>
						<region_name>Creb_binding</region_name>
						<region_start>2019</region_start>
						<region_end>2115</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPD</sequence>
				<length>49</length>
				<uniprot>
					<id>P04637</id>
					<start>13</start>
					<end>61</end>
					<coverage>12.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04637</id>
					<start>13</start>
					<end>61</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>19</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08563.8</region_id>
						<region_name>P53_TAD</region_name>
						<region_start>5</region_start>
						<region_end>29</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 2059-2152 region described in DisProt entry DP00348 and the 2057-2117 region described in IDEAL entry IID50008 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-73 region described in DisProt entry DP00086 and the 1-96 region described in IDEAL entry IID00015 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201003</accession>
		<general>
			<name>P160/CREB-binding protein coactivator complex</name>
			<pdb_id>2c52</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Mus musculus / Homo sapiens</source_organism>
			<publication>
				<pmid>16540468</pmid>
				<authors>Waters L, Yue B, Veverka V, Renshaw P, Bramham J, Matsuda S, Frenkiel T, Kelly G, Muskett F, Carr M, Heery DM</authors>
				<title>Structural diversity in p160/CREB-binding protein coactivator complexes.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2006</year>
				<issue>21</issue>
				<volume>281</volume>
				<pages>14787-95</pages>
				<abstract>Ligand-induced transcription by nuclear receptors involves the recruitment of p160 coactivators such as steroid receptor coactivator 1 (SRC1), in complex with histone acetyltransferases such as CREB-binding protein (CBP) and p300. Here we describe the solution structure of a complex formed by the SRC1 interaction domain (SID) of CBP and the activation domain (AD1) of SRC1, both of which contain four helical regions (Calpha1, Calpha2, Calpha3, and Calpha3&apos; in CBP and Salpha1, Salpha2', Salpha2, and Salpha3 in SRC1). A tight four-helix bundle is formed between Salpha1, Calpha1, Calpha2, and Calpha3 that is capped by Salpha3. In contrast to the structure of the AD1 domain of the related p160 protein ACTR in complex with CBP SID, the sequences forming Salpha2' and Salpha2 in SRC1 AD1 are not involved in the interface between the two domains but rather serve to position Salpha3. Thus, although the CBP SID domain adopts a similar fold in complex with different p160 proteins, the topologies of the AD1 domains are strikingly different, a feature that is likely to contribute to functional specificity of these coactivator complexes.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0004402</accession>
					<name>histone acetyltransferase activity</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0001105</accession>
					<name>RNA polymerase II transcription coactivator activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>CREB-binding protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>PNRSISPSALQDLLRTLKSPSSPQQQQQVLNILKSNPQLMAAFIKQRTAKYVANQPGMQ</sequence>
				<length>59</length>
				<uniprot>
					<id>P45481</id>
					<start>2059</start>
					<end>2117</end>
					<coverage>2.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q92793</id>
					<start>2058</start>
					<end>2116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2067</region_start>
						<region_end>2075</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2082</region_start>
						<region_end>2093</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2095</region_start>
						<region_end>2106</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09030.7</region_id>
						<region_name>Creb_binding</region_name>
						<region_start>2019</region_start>
						<region_end>2115</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Nuclear receptor coactivator 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PTTVEGRNDEKALLEQLVSFLSGKDETELAELDRALGIDKLVQGGGLDVLSKLVPRGSL</sequence>
				<length>59</length>
				<uniprot>
					<id>Q15788</id>
					<start>920</start>
					<end>974</end>
					<coverage>3.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q15788</id>
					<start>920</start>
					<end>974</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>929</region_start>
						<region_end>941</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>945</region_start>
						<region_end>947</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>952</region_start>
						<region_end>954</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08815.7</region_id>
						<region_name>Nuc_rec_co-act</region_name>
						<region_start>924</region_start>
						<region_end>971</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 2059-2152 region described in DisProt entry DP00348 and the 2057-2117 region described in IDEAL entry IID50008 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF08815.7) has been experimentally characterized as disordered in DisProt entry DP00343 and IDEAL entry IID00110.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4120001</accession>
		<general>
			<name>YefM antitoxin (Mycobacterium tuberculosis)</name>
			<pdb_id>3cto</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Mycobacterium tuberculosis</source_organism>
			<publication>
				<pmid>18793646</pmid>
				<authors>Kumar P, Issac B, Dodson EJ, Turkenburg JP, Mande SC</authors>
				<title>Crystal structure of Mycobacterium tuberculosis YefM antitoxin reveals that it is not an intrinsically unstructured protein.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2008</year>
				<issue>3</issue>
				<volume>383</volume>
				<pages>482-93</pages>
				<abstract>Toxin-antitoxin modules are present on chromosomes of almost all free-living prokaryotes. Some are implicated to act as stress-responsive elements, among their many functional roles. The YefM-YoeB toxin-antitoxin system is present in many bacterial species, where YefM belongs to the Phd family antidote of phage P1, whereas YoeB is a homolog of the RelE toxin of the RelBE system, rather than the Doc system of phage P1. YoeB, a ribonuclease, is believed to be conformationally stable, whereas YefM has been proposed to be a member of intrinsically disordered proteins. The ribonucleolytic activity of YoeB is neutralized by YefM upon formation of the YefM-YoeB complex. We report here the crystal structure of Mycobacterium tuberculosis YefM from two crystal isoforms. Our crystallographic and biophysical studies reveal that YefM is not an intrinsically unfolded protein and instead forms a well-defined structure with significant secondary and tertiary structure conformations. The residues involved in core formation of the folded structure are evolutionarily conserved among many bacterial species, supporting our observation. The C-terminal end of its polypeptide is highly pliable, which adopts different conformations in different monomers. Since at the physiological level YefM controls the activity of YoeB through intricate protein-protein interactions, the conformational heterogeneity in YefM revealed by our structure suggests that these might act a master switch in controlling YoeB activity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain E has been removed, as it is possibly a fragment of one of the chains forming the tetramer and is not involved in molecular interactions stabilizing the complex</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Phd antitoxin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin RelJ</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MSISASEARQRLFPLIEQVNTDHQPVRITSRAGDAVLMSADDYDAWQETVYLLRSPENARRLMEAVARDKAGHSAFTKSVDELREMAGGEE</sequence>
				<length>91</length>
				<uniprot>
					<id>P9WF24</id>
					<start>1</start>
					<end>91</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P9WF24</id>
					<start>1</start>
					<end>91</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Antitoxin RelJ</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MSISASEARQRLFPLIEQVNTDHQPVRITSRAGDAVLMSADDYDAWQETVYLLRSPENARRLMEAVARDKAGHSAFTKSVDELREMAGGEE</sequence>
				<length>91</length>
				<uniprot>
					<id>P9WF24</id>
					<start>1</start>
					<end>91</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P9WF24</id>
					<start>1</start>
					<end>91</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>73</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Antitoxin RelJ</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MSISASEARQRLFPLIEQVNTDHQPVRITSRAGDAVLMSADDYDAWQETVYLLRSPENARRLMEAVARDKAGHSAFTKSVDELREMAGGEE</sequence>
				<length>91</length>
				<uniprot>
					<id>P9WF24</id>
					<start>1</start>
					<end>91</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P9WF24</id>
					<start>1</start>
					<end>91</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Antitoxin RelJ</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MSISASEARQRLFPLIEQVNTDHQPVRITSRAGDAVLMSADDYDAWQETVYLLRSPENARRLMEAVARDKAGHSAFTKSVDELREMAGGEE</sequence>
				<length>91</length>
				<uniprot>
					<id>P9WF24</id>
					<start>1</start>
					<end>91</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P9WF24</id>
					<start>1</start>
					<end>91</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The dimerization of the prevents host death (phd) antitoxin from Escherichia virus P1 has been shown with differential scanning calorimetry to fit well to a two-state model consisting of a dimer unfolding into monomer species (PMID:20603017).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>D</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3d55</pdb_id>
			<pdb_id>3oei</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140001</accession>
		<general>
			<name>Arc repressor</name>
			<pdb_id>1arq</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Enterobacteria phage P22</source_organism>
			<publication>
				<pmid>8107113</pmid>
				<authors>Bonvin AM, Vis H, Breg JN, Burgering MJ, Boelens R, Kaptein R</authors>
				<title>Nuclear magnetic resonance solution structure of the Arc repressor using relaxation matrix calculations.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1994</year>
				<issue>1</issue>
				<volume>236</volume>
				<pages>328-41</pages>
				<abstract>The Arc repressor of Salmonella bacteriophage P22 is a dimeric sequence-specific DNA-binding protein. The solution structure of Arc has been determined from 2D NMR data using an &amp;quot;ensemble" iterative relaxation matrix approach (IRMA) followed by direct NOE refinement with DINOSAUR. A set of 51 structures was generated with distance geometry and further refined with a combination of restrained energy minimization and restrained molecular dynamics in a parallel refinement protocol. Distance constraints were obtained from an extensive set of NOE build-ups in H2O and 2H2O via relaxation matrix calculations from the ensemble of structures. Methyl group rotation, aromatic ring flaps and internal mobility effects (via order parameters obtained from a free molecular dynamics run in water) were included in these calculations. The best structures were finally refined with direct NOE constraints following a slow-cooling simulated annealing protocol. In this final refinement stage, theoretical NOE intensities were directly compared with the experimental data and forces were derived using a simple two-spin approximation for the gradient of the NOE function. Dynamic assignment was applied to the peaks involving unassigned diastereotopic groups. The structure is determined to a precision (r.m.s.d. from the average excluding the ill defined C and N-terminal region) of 0.55 and 1.10 A for backbone and all atoms, respectively. The final structures, with R factor values around 0.35, have good stereochemical qualities, contain an extensive network of hydrogen bonds consistent with the secondary structure elements and structural features in concordance with genetic data. The overall folding of the solution and crystal structures is the same.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcriptional repressor arc</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>MKGMSKMPQFNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA</sequence>
				<length>53</length>
				<uniprot>
					<id>P03050</id>
					<start>1</start>
					<end>53</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03050</id>
					<start>1</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>33</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03869.11</region_id>
						<region_name>Arc</region_name>
						<region_start>4</region_start>
						<region_end>53</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcriptional repressor arc</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>MKGMSKMPQFNLRWPREVLDLVRKVAEENGRSVNSEIYQRVMESFKKEGRIGA</sequence>
				<length>53</length>
				<uniprot>
					<id>P03050</id>
					<start>1</start>
					<end>53</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03050</id>
					<start>1</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>34</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03869.11</region_id>
						<region_name>Arc</region_name>
						<region_start>4</region_start>
						<region_end>53</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The Arc repressor protein has been experimentally shown to be a molten globule in monomeric form (PMID:8446590, PMID:7696567). Adopting the proper three dimensional structure is linked to dimerization (PMID:8110744, PMID:10889040).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1arr</pdb_id>
			<pdb_id>1b28</pdb_id>
			<pdb_id>1baz</pdb_id>
			<pdb_id>1bdt</pdb_id>
			<pdb_id>1bdv</pdb_id>
			<pdb_id>1myk</pdb_id>
			<pdb_id>1myl</pdb_id>
			<pdb_id>1nla</pdb_id>
			<pdb_id>1par</pdb_id>
			<pdb_id>1qtg</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120005</accession>
		<general>
			<name>Trp repressor protein (Ruminococcus obeum)</name>
			<pdb_id>3frw</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.05</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Blautia obeum ATCC 29174</source_organism>
			<publication>
				<authors>Osipiuk, J., Keigher, L., Jedrzejczak, R., Babnigg, G., Joachimiak, A.</authors>
				<title>X-ray crystal structure of putative TrpR protein from Ruminococcus obeum.</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005622</accession>
					<name>intracellular</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C,D,E,F,G and H were removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Trp repressor-like</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>TrpR family protein YerC/YecD</name>
				<source_organism>Blautia obeum ATCC 29174</source_organism>
				<sequence>SNAMGKKIRTEEVDHLFEAILCLKNKEECYTFFEDVCTINELLSLSQRFEVAKMLTDKRTYLDISEKTGASTATISRVNRSLNYGNDGYEMVFSRMKEKETAGKTEE</sequence>
				<length>107</length>
				<uniprot>
					<id>A5ZMD8</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_D4LQW8</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>54</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>86</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>89</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>8</region_start>
						<region_end>94</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>TrpR family protein YerC/YecD</name>
				<source_organism>Blautia obeum ATCC 29174</source_organism>
				<sequence>SNAMGKKIRTEEVDHLFEAILCLKNKEECYTFFEDVCTINELLSLSQRFEVAKMLTDKRTYLDISEKTGASTATISRVNRSLNYGNDGYEMVFSRMKEKETAGKTEE</sequence>
				<length>107</length>
				<uniprot>
					<id>A5ZMD8</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_D4LQW8</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>54</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>86</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>89</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>8</region_start>
						<region_end>94</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The folding and dimerization of the Trp repressor were shown to be linked by both experimental (PMID:10329154, PMID:2223756, PMID:7578063) and computational studies (PMID:10465773).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120006</accession>
		<general>
			<name>Transcriptional repressor CopG</name>
			<pdb_id>2cpg</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Streptococcus agalactiae</source_organism>
			<publication>
				<pmid>9857196</pmid>
				<authors>Gomis-Rüth FX, Solá M, Acebo P, Párraga A, Guasch A, Eritja R, González A, Espinosa M, del Solar G, Coll M</authors>
				<title>The structure of plasmid-encoded transcriptional repressor CopG unliganded and bound to its operator.</title>
				<journal>EMBO J.</journal>
				<year>1998</year>
				<issue>24</issue>
				<volume>17</volume>
				<pages>7404-15</pages>
				<abstract>The structure of the 45 amino acid transcriptional repressor, CopG, has been solved unliganded and bound to its target operator DNA. The protein, encoded by the promiscuous streptococcal plasmid pMV158, is involved in the control of plasmid copy number. The structure of this protein repressor, which is the shortest reported to date and the first isolated from a plasmid, has a homodimeric ribbon-helix-helix arrangement. It is the prototype for a family of homologous plasmid repressors. CopG cooperatively associates, completely protecting several turns on one face of the double helix in both directions from a 13-bp pseudosymmetric primary DNA recognition element. In the complex structure, one protein tetramer binds at one face of a 19-bp oligonucleotide, containing the pseudosymmetric element, with two beta-ribbons inserted into the major groove. The DNA is bent 60 degrees by compression of both major and minor grooves. The protein dimer displays topological similarity to Arc and MetJ repressors. Nevertheless, the functional tetramer has a unique structure with the two vicinal recognition ribbon elements at a short distance, thus inducing strong DNA bend. Further structural resemblance is found with helix-turn-helix regions of unrelated DNA-binding proteins. In contrast to these, however, the bihelical region of CopG has a role in oligomerization instead of DNA recognition. This observation unveils an evolutionary link between ribbon-helix-helix and helix-turn-helix proteins.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006276</accession>
					<name>plasmid maintenance</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain C has been removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein CopG</name>
				<source_organism>Streptococcus agalactiae</source_organism>
				<sequence>MKKRLTITLSESVLENLEKMAREMGLSKSAMISVALENYKKGQER</sequence>
				<length>45</length>
				<uniprot>
					<id>P13920</id>
					<start>1</start>
					<end>45</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13920</id>
					<start>1</start>
					<end>45</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>11</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01402.18</region_id>
						<region_name>RHH_1</region_name>
						<region_start>4</region_start>
						<region_end>41</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein CopG</name>
				<source_organism>Streptococcus agalactiae</source_organism>
				<sequence>MKKRLTITLSESVLENLEKMAREMGLSKSAMISVALENYKKGQER</sequence>
				<length>45</length>
				<uniprot>
					<id>P13920</id>
					<start>1</start>
					<end>45</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13920</id>
					<start>1</start>
					<end>45</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>11</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01402.18</region_id>
						<region_name>RHH_1</region_name>
						<region_start>4</region_start>
						<region_end>41</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:17656583). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:9857196). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077). Furthermore, CopG was directly shown to associate and fold cooperatively via a two state folding and binding process (PMID:9857196, PMID:15169951).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1b01</pdb_id>
			<pdb_id>1ea4</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120007</accession>
		<general>
			<name>UmuD' protein filament</name>
			<pdb_id>1ay9</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli O157:H7</source_organism>
			<publication>
				<pmid>8994967</pmid>
				<authors>Peat TS, Frank EG, McDonald JP, Levine AS, Woodgate R, Hendrickson WA</authors>
				<title>The UmuD' protein filament and its potential role in damage induced mutagenesis.</title>
				<journal>Structure</journal>
				<year>1996</year>
				<issue>12</issue>
				<volume>4</volume>
				<pages>1401-12</pages>
				<abstract> CONCLUSIONS: The activation of UmuD to UmuD&apos; appears to cause a large conformational change in the protein which allows it to form oligomers in solution at physiologically relevant concentrations. Properties of these oligomers are consistent with the filament structures seen in crystals of UmuD'. RESULTS: Recent X-ray crystallographic analysis shows that in addition to forming molecular dimers, the N- and C-terminal tails of UmuD&apos; extend from a globular beta structure to associate and produce crystallized filaments. We have investigated this phenomenon and find that these filaments appear to relate to biological activity. Higher order oligomers are found in solution with UmuD', but not with UmuD nor with a mutant of UmuD' lacking the extended N terminus. Deletion of the N terminus of UmuD' does not affect its ability to form molecular dimers but does severely compromise its ability to interact with a RecA-DNA filament and to participate in mutagenesis. Mutations in the C terminus of UmuD' result in both gain and loss of function for mutagenesis. BACKGROUND: Damage induced &apos;SOS mutagenesis' may occur transiently as part of the global SOS response to DNA damage in bacteria. A key participant in this process is the UmuD protein, which is produced in an inactive from but converted to the active form, UmuD', by a RecA-mediated self-cleavage reaction. UmuD', together with UmuC and activated RecA (RecA*), enables the DNA polymerase III holoenzyme to replicate across chemical and UV induced lesions. The efficiency of this reaction depends on several intricate protein-protein interactions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008236</accession>
					<name>serine-type peptidase activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006281</accession>
					<name>DNA repair</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0009432</accession>
					<name>SOS response</name>
				</go>
				<go>
					<accession>GO:0006508</accession>
					<name>proteolysis</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein UmuD</name>
				<source_organism>Escherichia coli O157:H7</source_organism>
				<sequence>DYVEQRIDLNQLLIQHPSATYFVKASGDSMIDGGISDGDLLIVDSAITASHGDIVIAAVDGEFTVKKLQLRPTVQLIPMNSAYSPITISSEDTLDVFGVVIHVVKAMR</sequence>
				<length>108</length>
				<uniprot>
					<id>P0AG12</id>
					<start>32</start>
					<end>139</end>
					<coverage>77.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0AG12</id>
					<start>32</start>
					<end>139</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>62</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00717.20</region_id>
						<region_name>Peptidase_S24</region_name>
						<region_start>55</region_start>
						<region_end>122</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein UmuD</name>
				<source_organism>Escherichia coli O157:H7</source_organism>
				<sequence>DYVEQRIDLNQLLIQHPSATYFVKASGDSMIDGGISDGDLLIVDSAITASHGDIVIAAVDGEFTVKKLQLRPTVQLIPMNSAYSPITISSEDTLDVFGVVIHVVKAMR</sequence>
				<length>108</length>
				<uniprot>
					<id>P0AG12</id>
					<start>32</start>
					<end>139</end>
					<coverage>77.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0AG12</id>
					<start>32</start>
					<end>139</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>62</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00717.20</region_id>
						<region_name>Peptidase_S24</region_name>
						<region_start>55</region_start>
						<region_end>122</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-139 region described in DisProt entry DP00626 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-139 region described in DisProt entry DP00626 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1i4v</pdb_id>
			<pdb_id>1umu</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4100001</accession>
		<general>
			<name>Transthyretin (human)</name>
			<pdb_id>3a4d</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>19950966</pmid>
				<authors>Miyata M, Sato T, Mizuguchi M, Nakamura T, Ikemizu S, Nabeshima Y, Susuki S, Suwa Y, Morioka H, Ando Y, Suico MA, Shuto T, Koga T, Yamagata Y, Kai H</authors>
				<title>Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.</title>
				<journal>Biochemistry</journal>
				<year>2010</year>
				<issue>1</issue>
				<volume>49</volume>
				<pages>114-23</pages>
				<abstract>Transthyretin (TTR) is a tetrameric protein associated with amyloidosis caused by tetramer dissociation and monomer misfolding. The structure of two TTR variants (E54G and E54K) with Glu54 point mutation that cause clinically aggressive amyloidosis remains unclear, although amyloidogenicity of artificial triple mutations (residues 53-55) in beta-strand D had been investigated. Here we first analyzed the crystal structures and biochemical and biophysical properties of E54G and E54K TTRs. The direction of the Lys15 side chain in E54K TTR and the surface electrostatic potential in the edge region in both variants were different from those of wild-type TTR. The presence of Lys54 leads to destabilization of tetramer structure due to enhanced electrostatic repulsion between Lys15 of two monomers. Consistent with structural data, the biochemical analyses demonstrated that E54G and E54K TTRs were more unstable than wild-type TTR. Furthermore, the entrance of the thyroxine (T(4)) binding pocket in TTR was markedly narrower in E54K TTR and wider in E54G TTR compared with wild-type TTR. The tetramer stabilization and amyloid fibril formation assays in the presence of T(4) showed lower tetramer stability and more fibril formation in E54K and E54G TTRs than in wild-type TTR, suggesting decreased T(4) binding to the TTR variants. These findings indicate that structural modification by Glu54 point mutation may sufficiently alter tetramer stability and T(4) binding.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0005179</accession>
					<name>hormone activity</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0070324</accession>
					<name>thyroid hormone binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042572</accession>
					<name>retinol metabolic process</name>
				</go>
				<go>
					<accession>GO:0030198</accession>
					<name>extracellular matrix organization</name>
				</go>
				<go>
					<accession>GO:0044267</accession>
					<name>cellular protein metabolic process</name>
				</go>
				<go>
					<accession>GO:0006810</accession>
					<name>transport</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were generated from chains A and B respectively, using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>Transthyretin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transthyretin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE</sequence>
				<length>127</length>
				<uniprot>
					<id>P02766</id>
					<start>21</start>
					<end>147</end>
					<coverage>86.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02766</id>
					<start>21</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transthyretin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE</sequence>
				<length>127</length>
				<uniprot>
					<id>P02766</id>
					<start>21</start>
					<end>147</end>
					<coverage>86.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02766</id>
					<start>21</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transthyretin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE</sequence>
				<length>127</length>
				<uniprot>
					<id>P02766</id>
					<start>21</start>
					<end>147</end>
					<coverage>86.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02766</id>
					<start>21</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Transthyretin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE</sequence>
				<length>127</length>
				<uniprot>
					<id>P02766</id>
					<start>21</start>
					<end>147</end>
					<coverage>86.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02766</id>
					<start>21</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1bm7</pdb_id>
			<pdb_id>1bmz</pdb_id>
			<pdb_id>1bz8</pdb_id>
			<pdb_id>1bzd</pdb_id>
			<pdb_id>1bze</pdb_id>
			<pdb_id>1dvq</pdb_id>
			<pdb_id>1dvs</pdb_id>
			<pdb_id>1dvt</pdb_id>
			<pdb_id>1dvu</pdb_id>
			<pdb_id>1dvx</pdb_id>
			<pdb_id>1dvy</pdb_id>
			<pdb_id>1dvz</pdb_id>
			<pdb_id>1e3f</pdb_id>
			<pdb_id>1e4h</pdb_id>
			<pdb_id>1e5a</pdb_id>
			<pdb_id>1eta</pdb_id>
			<pdb_id>1etb</pdb_id>
			<pdb_id>1f41</pdb_id>
			<pdb_id>1f86</pdb_id>
			<pdb_id>1fh2</pdb_id>
			<pdb_id>1fhn</pdb_id>
			<pdb_id>1g1o</pdb_id>
			<pdb_id>1gko</pdb_id>
			<pdb_id>1ict</pdb_id>
			<pdb_id>1iii</pdb_id>
			<pdb_id>1iik</pdb_id>
			<pdb_id>1ijn</pdb_id>
			<pdb_id>1qab</pdb_id>
			<pdb_id>1qwh</pdb_id>
			<pdb_id>1rlb</pdb_id>
			<pdb_id>1sok</pdb_id>
			<pdb_id>1soq</pdb_id>
			<pdb_id>1tha</pdb_id>
			<pdb_id>1thc</pdb_id>
			<pdb_id>1tlm</pdb_id>
			<pdb_id>1tsh</pdb_id>
			<pdb_id>1tt6</pdb_id>
			<pdb_id>1tta</pdb_id>
			<pdb_id>1ttb</pdb_id>
			<pdb_id>1ttc</pdb_id>
			<pdb_id>1ttr</pdb_id>
			<pdb_id>1tyr</pdb_id>
			<pdb_id>1tz8</pdb_id>
			<pdb_id>1u21</pdb_id>
			<pdb_id>1x7s</pdb_id>
			<pdb_id>1x7t</pdb_id>
			<pdb_id>1y1d</pdb_id>
			<pdb_id>1z7j</pdb_id>
			<pdb_id>1zcr</pdb_id>
			<pdb_id>1zd6</pdb_id>
			<pdb_id>2b14</pdb_id>
			<pdb_id>2b15</pdb_id>
			<pdb_id>2b16</pdb_id>
			<pdb_id>2b77</pdb_id>
			<pdb_id>2b9a</pdb_id>
			<pdb_id>2f7i</pdb_id>
			<pdb_id>2f8i</pdb_id>
			<pdb_id>2fbr</pdb_id>
			<pdb_id>2flm</pdb_id>
			<pdb_id>2g3x</pdb_id>
			<pdb_id>2g3z</pdb_id>
			<pdb_id>2g4e</pdb_id>
			<pdb_id>2g4g</pdb_id>
			<pdb_id>2g5u</pdb_id>
			<pdb_id>2g9k</pdb_id>
			<pdb_id>2gab</pdb_id>
			<pdb_id>2h4e</pdb_id>
			<pdb_id>2nbo</pdb_id>
			<pdb_id>2nbp</pdb_id>
			<pdb_id>2noy</pdb_id>
			<pdb_id>2pab</pdb_id>
			<pdb_id>2qel</pdb_id>
			<pdb_id>2qgb</pdb_id>
			<pdb_id>2qgc</pdb_id>
			<pdb_id>2qgd</pdb_id>
			<pdb_id>2qge</pdb_id>
			<pdb_id>2rox</pdb_id>
			<pdb_id>2roy</pdb_id>
			<pdb_id>2trh</pdb_id>
			<pdb_id>2try</pdb_id>
			<pdb_id>2wqa</pdb_id>
			<pdb_id>3a4e</pdb_id>
			<pdb_id>3a4f</pdb_id>
			<pdb_id>3b56</pdb_id>
			<pdb_id>3bsz</pdb_id>
			<pdb_id>3bt0</pdb_id>
			<pdb_id>3cbr</pdb_id>
			<pdb_id>3cfm</pdb_id>
			<pdb_id>3cfn</pdb_id>
			<pdb_id>3cfq</pdb_id>
			<pdb_id>3cft</pdb_id>
			<pdb_id>3cn0</pdb_id>
			<pdb_id>3cn1</pdb_id>
			<pdb_id>3cn2</pdb_id>
			<pdb_id>3cn3</pdb_id>
			<pdb_id>3cn4</pdb_id>
			<pdb_id>3cxf</pdb_id>
			<pdb_id>3d2t</pdb_id>
			<pdb_id>3d7p</pdb_id>
			<pdb_id>3dgd</pdb_id>
			<pdb_id>3did</pdb_id>
			<pdb_id>3djr</pdb_id>
			<pdb_id>3djs</pdb_id>
			<pdb_id>3djt</pdb_id>
			<pdb_id>3djz</pdb_id>
			<pdb_id>3dk0</pdb_id>
			<pdb_id>3dk2</pdb_id>
			<pdb_id>3do4</pdb_id>
			<pdb_id>3esn</pdb_id>
			<pdb_id>3eso</pdb_id>
			<pdb_id>3esp</pdb_id>
			<pdb_id>3fc8</pdb_id>
			<pdb_id>3fcb</pdb_id>
			<pdb_id>3glz</pdb_id>
			<pdb_id>3gps</pdb_id>
			<pdb_id>3grb</pdb_id>
			<pdb_id>3grg</pdb_id>
			<pdb_id>3gs0</pdb_id>
			<pdb_id>3gs4</pdb_id>
			<pdb_id>3gs7</pdb_id>
			<pdb_id>3hj0</pdb_id>
			<pdb_id>3i9a</pdb_id>
			<pdb_id>3i9i</pdb_id>
			<pdb_id>3i9p</pdb_id>
			<pdb_id>3imr</pdb_id>
			<pdb_id>3ims</pdb_id>
			<pdb_id>3imt</pdb_id>
			<pdb_id>3imu</pdb_id>
			<pdb_id>3imv</pdb_id>
			<pdb_id>3imw</pdb_id>
			<pdb_id>3ipb</pdb_id>
			<pdb_id>3ipe</pdb_id>
			<pdb_id>3kgs</pdb_id>
			<pdb_id>3kgt</pdb_id>
			<pdb_id>3kgu</pdb_id>
			<pdb_id>3m1o</pdb_id>
			<pdb_id>3nee</pdb_id>
			<pdb_id>3neo</pdb_id>
			<pdb_id>3nes</pdb_id>
			<pdb_id>3nex</pdb_id>
			<pdb_id>3ng5</pdb_id>
			<pdb_id>3ozk</pdb_id>
			<pdb_id>3ozl</pdb_id>
			<pdb_id>3p3r</pdb_id>
			<pdb_id>3p3s</pdb_id>
			<pdb_id>3p3t</pdb_id>
			<pdb_id>3p3u</pdb_id>
			<pdb_id>3ssg</pdb_id>
			<pdb_id>3tct</pdb_id>
			<pdb_id>3tfb</pdb_id>
			<pdb_id>3u2i</pdb_id>
			<pdb_id>3u2j</pdb_id>
			<pdb_id>3w3b</pdb_id>
			<pdb_id>4abq</pdb_id>
			<pdb_id>4abu</pdb_id>
			<pdb_id>4abv</pdb_id>
			<pdb_id>4abw</pdb_id>
			<pdb_id>4ac2</pdb_id>
			<pdb_id>4ac4</pdb_id>
			<pdb_id>4act</pdb_id>
			<pdb_id>4ank</pdb_id>
			<pdb_id>4d7b</pdb_id>
			<pdb_id>4der</pdb_id>
			<pdb_id>4des</pdb_id>
			<pdb_id>4det</pdb_id>
			<pdb_id>4deu</pdb_id>
			<pdb_id>4dew</pdb_id>
			<pdb_id>4fi6</pdb_id>
			<pdb_id>4fi7</pdb_id>
			<pdb_id>4fi8</pdb_id>
			<pdb_id>4hiq</pdb_id>
			<pdb_id>4his</pdb_id>
			<pdb_id>4hjs</pdb_id>
			<pdb_id>4hjt</pdb_id>
			<pdb_id>4hju</pdb_id>
			<pdb_id>4i85</pdb_id>
			<pdb_id>4i87</pdb_id>
			<pdb_id>4i89</pdb_id>
			<pdb_id>4iiz</pdb_id>
			<pdb_id>4ik6</pdb_id>
			<pdb_id>4ik7</pdb_id>
			<pdb_id>4iki</pdb_id>
			<pdb_id>4ikj</pdb_id>
			<pdb_id>4ikk</pdb_id>
			<pdb_id>4ikl</pdb_id>
			<pdb_id>4ky2</pdb_id>
			<pdb_id>4l1s</pdb_id>
			<pdb_id>4l1t</pdb_id>
			<pdb_id>4mas</pdb_id>
			<pdb_id>4mrb</pdb_id>
			<pdb_id>4mrc</pdb_id>
			<pdb_id>4n85</pdb_id>
			<pdb_id>4n86</pdb_id>
			<pdb_id>4n87</pdb_id>
			<pdb_id>4pm1</pdb_id>
			<pdb_id>4pme</pdb_id>
			<pdb_id>4pmf</pdb_id>
			<pdb_id>4pvl</pdb_id>
			<pdb_id>4pvm</pdb_id>
			<pdb_id>4pvn</pdb_id>
			<pdb_id>4pwe</pdb_id>
			<pdb_id>4pwf</pdb_id>
			<pdb_id>4pwg</pdb_id>
			<pdb_id>4pwh</pdb_id>
			<pdb_id>4pwi</pdb_id>
			<pdb_id>4pwj</pdb_id>
			<pdb_id>4pwk</pdb_id>
			<pdb_id>4qrf</pdb_id>
			<pdb_id>4qxv</pdb_id>
			<pdb_id>4qya</pdb_id>
			<pdb_id>4tkw</pdb_id>
			<pdb_id>4tl4</pdb_id>
			<pdb_id>4tl5</pdb_id>
			<pdb_id>4tlk</pdb_id>
			<pdb_id>4tls</pdb_id>
			<pdb_id>4tlt</pdb_id>
			<pdb_id>4tlu</pdb_id>
			<pdb_id>4tm9</pdb_id>
			<pdb_id>4tne</pdb_id>
			<pdb_id>4tnf</pdb_id>
			<pdb_id>4tng</pdb_id>
			<pdb_id>4tq8</pdb_id>
			<pdb_id>4tqh</pdb_id>
			<pdb_id>4tqi</pdb_id>
			<pdb_id>4tqp</pdb_id>
			<pdb_id>4wnj</pdb_id>
			<pdb_id>4wns</pdb_id>
			<pdb_id>4wo0</pdb_id>
			<pdb_id>4y9b</pdb_id>
			<pdb_id>4y9c</pdb_id>
			<pdb_id>4y9e</pdb_id>
			<pdb_id>4y9f</pdb_id>
			<pdb_id>4y9g</pdb_id>
			<pdb_id>4ydm</pdb_id>
			<pdb_id>4ydn</pdb_id>
			<pdb_id>5a6i</pdb_id>
			<pdb_id>5aks</pdb_id>
			<pdb_id>5akt</pdb_id>
			<pdb_id>5akv</pdb_id>
			<pdb_id>5al0</pdb_id>
			<pdb_id>5al8</pdb_id>
			<pdb_id>5ayt</pdb_id>
			<pdb_id>5boj</pdb_id>
			<pdb_id>5clx</pdb_id>
			<pdb_id>5cly</pdb_id>
			<pdb_id>5clz</pdb_id>
			<pdb_id>5cm1</pdb_id>
			<pdb_id>5cn3</pdb_id>
			<pdb_id>5cnh</pdb_id>
			<pdb_id>5cr1</pdb_id>
			<pdb_id>5dej</pdb_id>
			<pdb_id>5dwp</pdb_id>
			<pdb_id>5e23</pdb_id>
			<pdb_id>5e4a</pdb_id>
			<pdb_id>5e4o</pdb_id>
			<pdb_id>5en3</pdb_id>
			<pdb_id>5ezp</pdb_id>
			<pdb_id>5fo2</pdb_id>
			<pdb_id>5fw6</pdb_id>
			<pdb_id>5fw7</pdb_id>
			<pdb_id>5fw8</pdb_id>
			<pdb_id>5hjg</pdb_id>
			<pdb_id>5ihh</pdb_id>
			<pdb_id>5jid</pdb_id>
			<pdb_id>5jim</pdb_id>
			<pdb_id>5jiq</pdb_id>
			<pdb_id>5k1j</pdb_id>
			<pdb_id>5k1n</pdb_id>
			<pdb_id>5l4f</pdb_id>
			<pdb_id>5l4i</pdb_id>
			<pdb_id>5l4j</pdb_id>
			<pdb_id>5l4m</pdb_id>
			<pdb_id>5ttr</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110001</accession>
		<general>
			<name>Transthyretin (rat)</name>
			<pdb_id>1gke</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>9511961</pmid>
				<authors>Wojtczak A</authors>
				<title>Crystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structure.</title>
				<journal>Acta Biochim. Pol.</journal>
				<year>1997</year>
				<issue>3</issue>
				<volume>44</volume>
				<pages>505-17</pages>
				<abstract>The first observation of a unique tetrameric molecular structure of transthyretin from rat (rTTR, prealbumin) is reported. The structure has been determined by X-ray diffraction using molecular replacement and the structure of human transthyretin (hTTR) as a starting model. Crystals of native rat transthyretin are tetragonal, space group P4(3)2(1)2, and have four independent monomers in the asymmetric unit of the crystal lattice. Data were collected to 2.5 A resolution and the structure has been refined to R = 18.9% for 13584 data points between 8-2.5 A resolution. Like hTTR, the rat protein is also a 54000 Da tetramer with four identical polypeptide chains of 127 amino-acid residues. Of the 22 amino-acid residues which are different in the human and rat TTR sequences, none are in the thyroxine binding domain. Analysis of these data reveal that the tertiary structure of rTTR is similar to that of hTTR with only small differences in the flexible loop regions on the surface of the protein. As a result of local changes in flexible loop regions near residues 30-41, 60-65 and 102-104, the structure of rTTR monomers is more compact than that of the corresponding hTTR monomers. The loop between residues 30-41 is bound closer to the monomer core in the former as compared with the latter structure and there is a wider opening of the space formed between these loops at two adjacent monomeric subunits. These conformational changes do not affect the interfaces between the monomeric subunits and are not transmitted to the thyroxine binding site so that its topology remains not altered.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005179</accession>
					<name>hormone activity</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0070324</accession>
					<name>thyroid hormone binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042572</accession>
					<name>retinol metabolic process</name>
				</go>
				<go>
					<accession>GO:0070327</accession>
					<name>thyroid hormone transport</name>
				</go>
				<go>
					<accession>GO:0042403</accession>
					<name>thyroid hormone metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>Transthyretin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transthyretin</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>SKCPLMVKVLDAVRGSPAVDVAVKVFKKTADGSWEPFASGKTAESGELHGLTTDEKFTEGVYRVELDTKSYWKALGISPFHEYAEVVFTANDSGHRHYTIAALLSPYSYSTTAVVSNPQN</sequence>
				<length>120</length>
				<uniprot>
					<id>P02767</id>
					<start>28</start>
					<end>147</end>
					<coverage>81.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02767</id>
					<start>28</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>131</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>140</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>143</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transthyretin</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>SKCPLMVKVLDAVRGSPAVDVAVKVFKKTADGSWEPFASGKTAESGELHGLTTDEKFTEGVYRVELDTKSYWKALGISPFHEYAEVVFTANDSGHRHYTIAALLSPYSYSTTAVVSNPQN</sequence>
				<length>120</length>
				<uniprot>
					<id>P02767</id>
					<start>28</start>
					<end>147</end>
					<coverage>81.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02767</id>
					<start>28</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>139</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>142</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transthyretin</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>SKCPLMVKVLDAVRGSPAVDVAVKVFKKTADGSWEPFASGKTAESGELHGLTTDEKFTEGVYRVELDTKSYWKALGISPFHEYAEVVFTANDSGHRHYTIAALLSPYSYSTTAVVSNPQN</sequence>
				<length>120</length>
				<uniprot>
					<id>P02767</id>
					<start>28</start>
					<end>147</end>
					<coverage>81.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02767</id>
					<start>28</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>124</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Transthyretin</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>SKCPLMVKVLDAVRGSPAVDVAVKVFKKTADGSWEPFASGKTAESGELHGLTTDEKFTEGVYRVELDTKSYWKALGISPFHEYAEVVFTANDSGHRHYTIAALLSPYSYSTTAVVSNPQN</sequence>
				<length>120</length>
				<uniprot>
					<id>P02767</id>
					<start>28</start>
					<end>147</end>
					<coverage>81.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02767</id>
					<start>28</start>
					<end>147</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>32</region_start>
						<region_end>139</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ie4</pdb_id>
			<pdb_id>1kgi</pdb_id>
			<pdb_id>1kgj</pdb_id>
			<pdb_id>2qpf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110002</accession>
		<general>
			<name>Transthyretin (Sparus aurata)</name>
			<pdb_id>1oo2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.56</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Sparus aurata</source_organism>
			<publication>
				<pmid>14644428</pmid>
				<authors>Folli C, Pasquato N, Ramazzina I, Battistutta R, Zanotti G, Berni R</authors>
				<title>Distinctive binding and structural properties of piscine transthyretin.</title>
				<journal>FEBS Lett.</journal>
				<year>2003</year>
				<issue>2</issue>
				<volume>555</volume>
				<pages>279-84</pages>
				<abstract>The thyroid hormone binding protein transthyretin (TTR) forms a macromolecular complex with the retinol-specific carrier retinol binding protein (RBP) in the blood of higher vertebrates. Piscine TTR is shown here to exhibit high binding affinity for L-thyroxine and negligible affinity for RBP. The 1.56 A resolution X-ray structure of sea bream TTR, compared with that of human TTR, reveals a high degree of conservation of the thyroid hormone binding sites. In contrast, some amino acid differences in discrete regions of sea bream TTR appear to be responsible for the lack of protein-protein recognition, providing evidence for the crucial role played by a limited number of residues in the interaction between RBP and TTR. Overall, this study makes it possible to draw conclusions on evolutionary relationships for RBPs and TTRs of phylogenetically distant vertebrates.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0070324</accession>
					<name>thyroid hormone binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0070327</accession>
					<name>thyroid hormone transport</name>
				</go>
				<go>
					<accession>GO:0042572</accession>
					<name>retinol metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>Transthyretin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transthyretin (Precursor)</name>
				<source_organism>Sparus aurata</source_organism>
				<sequence>RCPLMVKILDAVKGTPAGSVALKVSQKTADGGWTQIATGVTDATGEIHNLITEQQFPAGVYRVEFDTKAYWTNQGSTPFHEVAEVVFDAHPEGHGHYTLALLLSPFSYTTTAVVSSVHE</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9PTT3</id>
					<start>33</start>
					<end>148</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O93330</id>
					<start>32</start>
					<end>149</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>47</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>99</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>146</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>36</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transthyretin (Precursor)</name>
				<source_organism>Sparus aurata</source_organism>
				<sequence>RCPLMVKILDAVKGTPAGSVALKVSQKTADGGWTQIATGVTDATGEIHNLITEQQFPAGVYRVEFDTKAYWTNQGSTPFHEVAEVVFDAHPEGHGHYTLALLLSPFSYTTTAVVSSVHE</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9PTT3</id>
					<start>33</start>
					<end>148</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O93330</id>
					<start>32</start>
					<end>149</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>47</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>99</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>147</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>36</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transthyretin (Precursor)</name>
				<source_organism>Sparus aurata</source_organism>
				<sequence>RCPLMVKILDAVKGTPAGSVALKVSQKTADGGWTQIATGVTDATGEIHNLITEQQFPAGVYRVEFDTKAYWTNQGSTPFHEVAEVVFDAHPEGHGHYTLALLLSPFSYTTTAVVSSVHE</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9PTT3</id>
					<start>33</start>
					<end>148</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O93330</id>
					<start>32</start>
					<end>149</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>47</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>99</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>147</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>36</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Transthyretin (Precursor)</name>
				<source_organism>Sparus aurata</source_organism>
				<sequence>RCPLMVKILDAVKGTPAGSVALKVSQKTADGGWTQIATGVTDATGEIHNLITEQQFPAGVYRVEFDTKAYWTNQGSTPFHEVAEVVFDAHPEGHGHYTLALLLSPFSYTTTAVVSSVHE</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9PTT3</id>
					<start>33</start>
					<end>148</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O93330</id>
					<start>32</start>
					<end>149</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>47</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>99</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>146</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>36</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1sn0</pdb_id>
			<pdb_id>1sn2</pdb_id>
			<pdb_id>1sn5</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4201001</accession>
		<general>
			<name>Patj/Pals1 L27 domain complex (human/rat)</name>
			<pdb_id>1y76</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterotetramer (dimer of dimers)</assembly>
			<source_organism>Mus musculus / Homo sapiens</source_organism>
			<publication>
				<pmid>15863617</pmid>
				<authors>Feng W, Long JF, Zhang M</authors>
				<title>A unified assembly mode revealed by the structures of tetrameric L27 domain complexes formed by mLin-2/mLin-7 and Patj/Pals1 scaffold proteins.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2005</year>
				<issue>19</issue>
				<volume>102</volume>
				<pages>6861-6</pages>
				<abstract>Initially identified in Caenorhabditis elegans Lin-2 and Lin-7, L27 domain is a protein-protein interaction domain capable of organizing scaffold proteins into supramolecular assemblies by formation of heteromeric L27 domain complexes. L27 domain-mediated protein assemblies have been shown to play essential roles in cellular processes including asymmetric cell division, establishment and maintenance of cell polarity, and clustering of receptors and ion channels. The structural basis of L27 domain heteromeric complex assembly is controversial. We determined the high-resolution solution structure of the prototype L27 domain complex formed by mLin-2 and mLin-7 as well as the solution structure of the L27 domain complex formed by Patj and Pals1. The structures suggest that a tetrameric structure composed of two units of heterodimer is a general assembly mode for cognate pairs of L27 domains. Structural analysis of the L27 domain complex structures further showed that the central four-helix bundles mediating tetramer assembly are highly distinct between different pairs of L27 domain complexes. Biochemical studies revealed that the C-terminal alpha-helix responsible for the formation of the central helix bundle is a critical specificity determinant for each L27 domain in choosing its binding partner. Our results provide a unified picture for L27 domain-mediated protein-protein interactions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
				<go>
					<accession>GO:0005923</accession>
					<name>bicellular tight junction</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_2/N type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>InaD-like protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>NPAAEKMQVLQVLDRLRGKLQEKGDTTQNEKLSAFYETLKSPLFNQILTLQQSIKQLKGQLS</sequence>
				<length>62</length>
				<uniprot>
					<id>Q63ZW7</id>
					<start>4</start>
					<end>65</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q63ZW7</id>
					<start>4</start>
					<end>65</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09045.7</region_id>
						<region_name>L27_2</region_name>
						<region_start>8</region_start>
						<region_end>65</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>MAGUK p55 subfamily member 5</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AVKILEIEDLFSSLKHIQHTLVDSQSQEDISLLLQLVQNKDFQNAFKIHNAITVHMNKAS</sequence>
				<length>60</length>
				<uniprot>
					<id>Q8N3R9</id>
					<start>118</start>
					<end>177</end>
					<coverage>8.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9JLB2</id>
					<start>118</start>
					<end>177</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>124</region_start>
						<region_end>138</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>142</region_start>
						<region_end>155</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>157</region_start>
						<region_end>175</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09060.7</region_id>
						<region_name>L27_N</region_name>
						<region_start>123</region_start>
						<region_end>170</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>InaD-like protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>NPAAEKMQVLQVLDRLRGKLQEKGDTTQNEKLSAFYETLKSPLFNQILTLQQSIKQLKGQLS</sequence>
				<length>62</length>
				<uniprot>
					<id>Q63ZW7</id>
					<start>4</start>
					<end>65</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q63ZW7</id>
					<start>4</start>
					<end>65</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09045.7</region_id>
						<region_name>L27_2</region_name>
						<region_start>8</region_start>
						<region_end>65</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>MAGUK p55 subfamily member 5</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AVKILEIEDLFSSLKHIQHTLVDSQSQEDISLLLQLVQNKDFQNAFKIHNAITVHMNKAS</sequence>
				<length>60</length>
				<uniprot>
					<id>Q8N3R9</id>
					<start>118</start>
					<end>177</end>
					<coverage>8.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9JLB2</id>
					<start>118</start>
					<end>177</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>124</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>142</region_start>
						<region_end>155</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>157</region_start>
						<region_end>175</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09060.7</region_id>
						<region_name>L27_N</region_name>
						<region_start>123</region_start>
						<region_end>170</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a heterotetrameric L27 complex (PMID:15863617). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4201002</accession>
		<general>
			<name>Patj/Pals1 L27 domain complex (human/mouse)</name>
			<pdb_id>1vf6</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>heterotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens / Mus musculus</source_organism>
			<publication>
				<pmid>15241471</pmid>
				<authors>Li Y, Karnak D, Demeler B, Margolis B, Lavie A</authors>
				<title>Structural basis for L27 domain-mediated assembly of signaling and cell polarity complexes.</title>
				<journal>EMBO J.</journal>
				<year>2004</year>
				<issue>14</issue>
				<volume>23</volume>
				<pages>2723-33</pages>
				<abstract>L27 is a protein-binding domain that can assemble essential proteins for signaling and cell polarity into complexes by interacting in a heterodimeric manner. One of these protein complexes is the PATJ/PALS1/Crumbs tripartite complex, which is crucial for the establishment and maintenance of cell polarity. To reveal the structural basis underlining the obligate heterodimerization, we have determined the crystal structure of the PALS1-L27N/PATJ-L27 heterodimer complex. Each L27 domain is composed of three helices. The two L27 domains heterodimerize by building a compact structure consisting of a four-helix bundle formed by the first two helices of each L27 domain and one coiled-coil formed by the third helix of each domain. The large hydrophobic packing interactions contributed by all the helices of both L27 domains predominantly drive the heterodimer formation, which is likely to be a general feature of L27 domains. Combined with mutational studies, we can begin to understand the structural basis for the specificity of L27 binding pairs. Our results provide unique insights into L27 domain heterodimer complex, which is critical for cell polarization.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0070830</accession>
					<name>bicellular tight junction assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
				<go>
					<accession>GO:0005923</accession>
					<name>bicellular tight junction</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_2/N type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>InaD-like protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKLQVLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKSPLFNQILTLQQSIKQLKGQLNHILESGKETAAAKFERQHMDSSTSA</sequence>
				<length>83</length>
				<uniprot>
					<id>Q8NI35</id>
					<start>9</start>
					<end>67</end>
					<coverage>3.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_UPI0006B1AC65</id>
					<start>9</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09045.7</region_id>
						<region_name>L27_2</region_name>
						<region_start>8</region_start>
						<region_end>65</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>InaD-like protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKLQVLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKSPLFNQILTLQQSIKQLKGQLNHILESGKETAAAKFERQHMDSSTSA</sequence>
				<length>83</length>
				<uniprot>
					<id>Q8NI35</id>
					<start>9</start>
					<end>67</end>
					<coverage>3.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_UPI0006B1AC65</id>
					<start>9</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>11</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09045.7</region_id>
						<region_name>L27_2</region_name>
						<region_start>8</region_start>
						<region_end>65</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>MAGUK p55 subfamily member 5</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MGSSHHHHHHSQDPDVEDLFSSLKHIQHTLVDSQSQEDISLLLQLVQNRDFQNAFKIHNAVTVHMSKASPPF</sequence>
				<length>72</length>
				<uniprot>
					<id>Q9JLB2</id>
					<start>123</start>
					<end>180</end>
					<coverage>8.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9JLB2</id>
					<start>123</start>
					<end>180</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>123</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>141</region_start>
						<region_end>155</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>157</region_start>
						<region_end>169</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09060.7</region_id>
						<region_name>L27_N</region_name>
						<region_start>123</region_start>
						<region_end>170</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>MAGUK p55 subfamily member 5</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MGSSHHHHHHSQDPDVEDLFSSLKHIQHTLVDSQSQEDISLLLQLVQNRDFQNAFKIHNAVTVHMSKASPPF</sequence>
				<length>72</length>
				<uniprot>
					<id>Q9JLB2</id>
					<start>123</start>
					<end>180</end>
					<coverage>8.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9JLB2</id>
					<start>123</start>
					<end>180</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>124</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>141</region_start>
						<region_end>155</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>157</region_start>
						<region_end>169</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09060.7</region_id>
						<region_name>L27_N</region_name>
						<region_start>123</region_start>
						<region_end>170</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a heterotetrameric L27 complex (PMID:15241471). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4210002</accession>
		<general>
			<name>L27 (Lin-2, Lin-7) domain complex (mouse)</name>
			<pdb_id>1y74</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterotetramer (dimer of dimers)</assembly>
			<source_organism>Mus musculus</source_organism>
			<publication>
				<pmid>15863617</pmid>
				<authors>Feng W, Long JF, Zhang M</authors>
				<title>A unified assembly mode revealed by the structures of tetrameric L27 domain complexes formed by mLin-2/mLin-7 and Patj/Pals1 scaffold proteins.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2005</year>
				<issue>19</issue>
				<volume>102</volume>
				<pages>6861-6</pages>
				<abstract>Initially identified in Caenorhabditis elegans Lin-2 and Lin-7, L27 domain is a protein-protein interaction domain capable of organizing scaffold proteins into supramolecular assemblies by formation of heteromeric L27 domain complexes. L27 domain-mediated protein assemblies have been shown to play essential roles in cellular processes including asymmetric cell division, establishment and maintenance of cell polarity, and clustering of receptors and ion channels. The structural basis of L27 domain heteromeric complex assembly is controversial. We determined the high-resolution solution structure of the prototype L27 domain complex formed by mLin-2 and mLin-7 as well as the solution structure of the L27 domain complex formed by Patj and Pals1. The structures suggest that a tetrameric structure composed of two units of heterodimer is a general assembly mode for cognate pairs of L27 domains. Structural analysis of the L27 domain complex structures further showed that the central four-helix bundles mediating tetramer assembly are highly distinct between different pairs of L27 domain complexes. Biochemical studies revealed that the C-terminal alpha-helix responsible for the formation of the central helix bundle is a critical specificity determinant for each L27 domain in choosing its binding partner. Our results provide a unified picture for L27 domain-mediated protein-protein interactions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0016323</accession>
					<name>basolateral plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005911</accession>
					<name>cell-cell junction</name>
				</go>
				<go>
					<accession>GO:0045202</accession>
					<name>synapse</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_1 type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein lin-7 homolog B</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>LGLERDVSRAVELLERLQRSGELPPQKLQALQRVLQSRFCSAIREVYEQLYDTLDIT</sequence>
				<length>57</length>
				<uniprot>
					<id>O88951</id>
					<start>8</start>
					<end>64</end>
					<coverage>27.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9Z252</id>
					<start>8</start>
					<end>64</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>14</region_start>
						<region_end>67</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Peripheral plasma membrane protein CASK</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>AVQRAKEVLEEISCYPENNDAKELKRILTQPHFMALLQTHDVVAHEVYSD</sequence>
				<length>50</length>
				<uniprot>
					<id>O70589</id>
					<start>405</start>
					<end>454</end>
					<coverage>5.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14936</id>
					<start>405</start>
					<end>454</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>406</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>423</region_start>
						<region_end>433</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>435</region_start>
						<region_end>452</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>406</region_start>
						<region_end>457</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Protein lin-7 homolog B</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>LGLERDVSRAVELLERLQRSGELPPQKLQALQRVLQSRFCSAIREVYEQLYDTLDIT</sequence>
				<length>57</length>
				<uniprot>
					<id>O88951</id>
					<start>8</start>
					<end>64</end>
					<coverage>27.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9Z252</id>
					<start>8</start>
					<end>64</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>14</region_start>
						<region_end>67</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Peripheral plasma membrane protein CASK</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>AVQRAKEVLEEISCYPENNDAKELKRILTQPHFMALLQTHDVVAHEVYSD</sequence>
				<length>50</length>
				<uniprot>
					<id>O70589</id>
					<start>405</start>
					<end>454</end>
					<coverage>5.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14936</id>
					<start>405</start>
					<end>454</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>406</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>423</region_start>
						<region_end>433</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>435</region_start>
						<region_end>451</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>406</region_start>
						<region_end>457</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a heterotetrameric L27 complex (PMID:15863617). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201004</accession>
		<general>
			<name>L27 (Lin-2, Lin-7) domain complex (human/C. elegans)</name>
			<pdb_id>1zl8</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Caenorhabditis elegans / Homo sapiens</source_organism>
			<publication>
				<pmid>16147993</pmid>
				<authors>Petrosky KY, Ou HD, Löhr F, Dötsch V, Lim WA</authors>
				<title>A general model for preferential hetero-oligomerization of LIN-2/7 domains: mechanism underlying directed assembly of supramolecular signaling complexes.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2005</year>
				<issue>46</issue>
				<volume>280</volume>
				<pages>38528-36</pages>
				<abstract>LIN-2/7 (L27) domains are protein interaction modules that preferentially hetero-oligomerize, a property critical for their function in directing specific assembly of supramolecular signaling complexes at synapses and other polarized cell-cell junctions. We have solved the solution structure of the heterodimer composed of the L27 domains from LIN-2 and LIN-7. Comparison of this structure with other L27 domain structures has allowed us to formulate a general model for why most L27 domains form an obligate heterodimer complex. L27 domains can be divided in two types (A and B), with each heterodimer comprising an A/B pair. We have identified two keystone positions that play a central role in discrimination. The residues at these positions are energetically acceptable in the context of an A/B heterodimer, but would lead to packing defects or electrostatic repulsion in the context of A/A and B/B homodimers. As predicted by the model, mutations of keystone residues stabilize normally strongly disfavored homodimers. Thus, L27 domains are specifically optimized to avoid homodimeric interactions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_1 type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>LIN-7 (Fragment)</name>
				<source_organism>Caenorhabditis elegans</source_organism>
				<sequence>GSLNLERDVQRILELMEHVQKTGEVNNAKLASLQQVLQSEFFGAVREVYETVY</sequence>
				<length>53</length>
				<uniprot>
					<id>P90976</id>
					<start>116</start>
					<end>165</end>
					<coverage>16.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9U245</id>
					<start>8</start>
					<end>57</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>116</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>139</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>153</region_start>
						<region_end>164</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>121</region_start>
						<region_end>174</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Peripheral plasma membrane protein CASK</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SDAVQRAKEVLEEISCYPENNDAKELKRILTQPHFMALLQTHDVVAHEVYSDEA</sequence>
				<length>54</length>
				<uniprot>
					<id>O14936</id>
					<start>403</start>
					<end>456</end>
					<coverage>5.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14936</id>
					<start>403</start>
					<end>456</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>404</region_start>
						<region_end>416</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>423</region_start>
						<region_end>431</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>437</region_start>
						<region_end>450</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02828.13</region_id>
						<region_name>L27</region_name>
						<region_start>406</region_start>
						<region_end>457</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form half of a heterotetrameric L27 complex (a dimer of dimers) (PMID:16147993). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2140002</accession>
		<general>
			<name>HPV E7 oncoprotein CR3 domain</name>
			<pdb_id>2b9d</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Human papillomavirus type 1a</source_organism>
			<publication>
				<pmid>16249186</pmid>
				<authors>Liu X, Clements A, Zhao K, Marmorstein R</authors>
				<title>Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2006</year>
				<issue>1</issue>
				<volume>281</volume>
				<pages>578-86</pages>
				<abstract>The E7 oncoprotein from human Papillomavirus (HPV) mediates cell transformation in part by binding to the human pRb tumor suppressor protein and E2F transcription factors, resulting in the dissociation of pRb from E2F transcription factors and the premature cell progression into the S-phase of the cell cycle. This activity is mediated by the LXCXE motif and the CR3 zinc binding domain of the E7 protein. In this study we report the x-ray crystal structure of the CR3 region of HPV E7 and a structure-based mutational analysis to investigate its mode of pRb and E2F binding and E2F displacement from pRb. The structure reveals a novel zinc-bound E7-CR3 obligate homodimer that contains two surface patches of sequence conservation. Mutation of residues within these patches reveals that one patch is required for pRb binding, whereas the other is required for E2F binding. We also show that both E7-mediated interactions are required to disrupt pRb.E2F complexes. Based on these studies we present a mechanistic model for how E7 displaces E2F from pRb. Because the CR3 region of HPV E7 has no detectable homology to other human proteins, the structure-function studies presented here provide an avenue for developing small molecule compounds that inhibit HPV-E7-mediated cell transformation.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0019904</accession>
					<name>protein domain specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0039502</accession>
					<name>suppression by virus of host type I interferon-mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0039645</accession>
					<name>modulation by virus of host G1/S transition checkpoint</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030430</accession>
					<name>host cell cytoplasm</name>
				</go>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was deleted. Chain C was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein E7</name>
				<source_organism>Human papillomavirus type 1a</source_organism>
				<sequence>MKQPYAVVASCAYCEKLVRLTVLADHSAIRQLEEMLLRSLNIVCPLCTLQRQ</sequence>
				<length>52</length>
				<uniprot>
					<id>P06465</id>
					<start>42</start>
					<end>93</end>
					<coverage>55.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06465</id>
					<start>43</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>44</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00527.15</region_id>
						<region_name>E7</region_name>
						<region_start>3</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Protein E7</name>
				<source_organism>Human papillomavirus type 1a</source_organism>
				<sequence>MKQPYAVVASCAYCEKLVRLTVLADHSAIRQLEEMLLRSLNIVCPLCTLQRQ</sequence>
				<length>52</length>
				<uniprot>
					<id>P06465</id>
					<start>42</start>
					<end>93</end>
					<coverage>55.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06465</id>
					<start>43</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>44</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00527.15</region_id>
						<region_name>E7</region_name>
						<region_start>3</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Evidence suggests that the E7-CR3 domain would not be able to maintain this tertiary structure in monomeric form or in the absence of zinc coordination and is, therefore, likely to be an obligate and zinc-dependent dimer (PMID:16249186). This is consistent with solution studies showing that HPV-E7 undergoes a monomer-dimer equilibrium with a dissociation constant of about 1 Î¼m (PMID:11123931).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00527.15) has been experimentally characterized as disordered in DisProt entry DP00024.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00527.15) has been experimentally characterized as disordered in DisProt entry DP00024.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110001</accession>
		<general>
			<name>RhoA-binding domain in Rho-kinase</name>
			<pdb_id>1uix</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Bos taurus</source_organism>
			<publication>
				<pmid>12954645</pmid>
				<authors>Shimizu T, Ihara K, Maesaki R, Amano M, Kaibuchi K, Hakoshima T</authors>
				<title>Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2003</year>
				<issue>46</issue>
				<volume>278</volume>
				<pages>46046-51</pages>
				<abstract>Rho-kinase is a serine/threonine protein kinase that regulates cytoskeletal events in cells. The enzyme activity of Rho-kinase is auto-inhibited in the free state but is activated through direct binding to the small GTPase Rho in the GTP-bound form. The crystal structure of the Rho-binding domain (RhoBD) of Rho-kinase has been determined at 1.8-A resolution by the multi-wavelength anomalous dispersion technique. The structure shows that RhoBD dimerizes to form a parallel coiled-coil with long consecutive alpha-helices extended to approximately 97 A and suggests that free Rho-kinase can also form a dimer through parallel self-association. At the middle region of the coiled-coil, the polypeptide chains are flexible and display loose &amp;quot;knobs-into-holes" packing of the side chains from both chains. RhoBD residues that have been shown to be critical for Rho-binding are spread in the positively charged C-terminal region. The parallel coiled-coil structure of our Rho-kinase RhoBD in the free form is different from the anti-parallel coiled-coil structure of RhoBD of protein kinase N when complexed with RhoA. Implications derived from these structural studies in relation to the mechanism of Rho-kinase activation will be addressed with previously reported experimental data.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0017048</accession>
					<name>Rho GTPase binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0004674</accession>
					<name>protein serine/threonine kinase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042752</accession>
					<name>regulation of circadian rhythm</name>
				</go>
				<go>
					<accession>GO:0048511</accession>
					<name>rhythmic process</name>
				</go>
				<go>
					<accession>GO:0006939</accession>
					<name>smooth muscle contraction</name>
				</go>
				<go>
					<accession>GO:0032956</accession>
					<name>regulation of actin cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0006468</accession>
					<name>protein phosphorylation</name>
				</go>
				<go>
					<accession>GO:0007266</accession>
					<name>Rho protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0030036</accession>
					<name>actin cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0010825</accession>
					<name>positive regulation of centrosome duplication</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005815</accession>
					<name>microtubule organizing center</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Rho-associated protein kinase 2</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>TSDVANLANEKEELNNKLKEAQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEP</sequence>
				<length>69</length>
				<uniprot>
					<id>Q28021</id>
					<start>977</start>
					<end>1047</end>
					<coverage>5.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75116</id>
					<start>979</start>
					<end>1047</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>979</region_start>
						<region_end>1041</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1043</region_start>
						<region_end>1044</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08912.8</region_id>
						<region_name>Rho_Binding</region_name>
						<region_start>978</region_start>
						<region_end>1046</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Rho-associated protein kinase 2</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>GSTSDVANLANEKEELNNKLKEAQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEP</sequence>
				<length>71</length>
				<uniprot>
					<id>Q28021</id>
					<start>977</start>
					<end>1047</end>
					<coverage>5.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75116</id>
					<start>979</start>
					<end>1047</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>979</region_start>
						<region_end>1041</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08912.8</region_id>
						<region_name>Rho_Binding</region_name>
						<region_start>978</region_start>
						<region_end>1046</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12954645). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120008</accession>
		<general>
			<name>Trp repressor protein (Escherichia coli)</name>
			<pdb_id>3wrp</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>3375234</pmid>
				<authors>Lawson CL, Zhang RG, Schevitz RW, Otwinowski Z, Joachimiak A, Sigler PB</authors>
				<title>Flexibility of the DNA-binding domains of trp repressor.</title>
				<journal>Proteins</journal>
				<year>1988</year>
				<issue>1</issue>
				<volume>3</volume>
				<pages>18-31</pages>
				<abstract>An orthorhombic crystal form of trp repressor (aporepressor plus L-tryptophan ligand) was solved by molecular replacement, refined to 1.65 A resolution, and compared to the structure of the repressor in trigonal crystals. Even though these two crystal forms of repressor were grown under identical conditions, the refined structures have distinctly different conformations of the DNA-binding domains. Unlike the repressor/aporepressor structural transition, the conformational shift is not caused by the binding or loss of the L-tryptophan ligand. We conclude that while L-tryptophan binding is essential for forming a specific complex with trp operator DNA, the corepressor ligand does not lock the repressor into a single conformation that is complementary to the operator. This flexibility may be required by the various binding modes proposed for trp repressor in its search for and adherence to its three different operator sites.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Trp repressor-like</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Trp operon repressor</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MAQQSPYSAAMAEQRHQEWLRFVDLLKNAYQNDLHLPLLNLMLTPDEREALGTRVRIVEELLRGEMSQRELKNELGAGIATITRGSNSLKAAPVELRQWLEEVLLKSD</sequence>
				<length>108</length>
				<uniprot>
					<id>P0A881</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A9MR96</id>
					<start>1</start>
					<end>106</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>35</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>79</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>17</region_start>
						<region_end>104</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Trp operon repressor</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MAQQSPYSAAMAEQRHQEWLRFVDLLKNAYQNDLHLPLLNLMLTPDEREALGTRVRIVEELLRGEMSQRELKNELGAGIATITRGSNSLKAAPVELRQWLEEVLLKSD</sequence>
				<length>108</length>
				<uniprot>
					<id>P0A881</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A9MR96</id>
					<start>1</start>
					<end>106</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>35</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>79</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>17</region_start>
						<region_end>104</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The folding and dimerization of the Trp repressor were shown to be linked by both experimental (PMID:10329154, PMID:2223756, PMID:7578063) and computational studies (PMID:10465773).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1co0</pdb_id>
			<pdb_id>1jhg</pdb_id>
			<pdb_id>1rcs</pdb_id>
			<pdb_id>1tro</pdb_id>
			<pdb_id>1trr</pdb_id>
			<pdb_id>1wrp</pdb_id>
			<pdb_id>1wrs</pdb_id>
			<pdb_id>1wrt</pdb_id>
			<pdb_id>1zt9</pdb_id>
			<pdb_id>2oz9</pdb_id>
			<pdb_id>3ssw</pdb_id>
			<pdb_id>3ssx</pdb_id>
			<pdb_id>2xdi</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100003</accession>
		<general>
			<name>Dimerization motif of Geminin</name>
			<pdb_id>1uii</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>15260975</pmid>
				<authors>Saxena S, Yuan P, Dhar SK, Senga T, Takeda D, Robinson H, Kornbluth S, Swaminathan K, Dutta A</authors>
				<title>A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition.</title>
				<journal>Mol. Cell</journal>
				<year>2004</year>
				<issue>2</issue>
				<volume>15</volume>
				<pages>245-58</pages>
				<abstract>Geminin is a cellular protein that associates with Cdt1 and inhibits Mcm2-7 loading during S phase. It prevents multiple cycles of replication per cell cycle and prevents episome replication. It also directly inhibits the HoxA11 transcription factor. Here we report that geminin forms a parallel coiled-coil homodimer with atypical residues in the dimer interface. Point mutations that disrupt the dimerization abolish interaction with Cdt1 and inhibition of replication. An array of glutamic acid residues on the coiled-coil domain surface interacts with positive charges in the middle of Cdt1. An adjoining region interacts independently with the N-terminal 100 residues of Cdt1. Both interactions are essential for replication inhibition. The negative residues on the coiled-coil domain and a different part of geminin are also required for interaction with HoxA11. Therefore a rigid cylinder with negative surface charges is a critical component of a bipartite interaction interface between geminin and its cellular targets.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042826</accession>
					<name>histone deacetylase binding</name>
				</go>
				<go>
					<accession>GO:0003714</accession>
					<name>transcription corepressor activity</name>
				</go>
				<go>
					<accession>GO:0070491</accession>
					<name>repressing transcription factor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
				<go>
					<accession>GO:0009887</accession>
					<name>organ morphogenesis</name>
				</go>
				<go>
					<accession>GO:0006461</accession>
					<name>protein complex assembly</name>
				</go>
				<go>
					<accession>GO:0045786</accession>
					<name>negative regulation of cell cycle</name>
				</go>
				<go>
					<accession>GO:0008156</accession>
					<name>negative regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Geminin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PESSENKNLGGVTQESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMA</sequence>
				<length>83</length>
				<uniprot>
					<id>O75496</id>
					<start>70</start>
					<end>152</end>
					<coverage>39.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75496</id>
					<start>70</start>
					<end>152</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07412.9</region_id>
						<region_name>Geminin</region_name>
						<region_start>1</region_start>
						<region_end>184</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Geminin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PESSENKNLGGVTQESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMA</sequence>
				<length>83</length>
				<uniprot>
					<id>O75496</id>
					<start>70</start>
					<end>152</end>
					<coverage>39.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75496</id>
					<start>70</start>
					<end>152</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07412.9</region_id>
						<region_name>Geminin</region_name>
						<region_start>1</region_start>
						<region_end>184</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:15260975). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1t6f</pdb_id>
			<pdb_id>2wvr</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110002</accession>
		<general>
			<name>GAL4 dimerization domain</name>
			<pdb_id>1hbw</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>11316794</pmid>
				<authors>Hidalgo P, Ansari AZ, Schmidt P, Hare B, Simkovich N, Farrell S, Shin EJ, Ptashne M, Wagner G</authors>
				<title>Recruitment of the transcriptional machinery through GAL11P: structure and interactions of the GAL4 dimerization domain.</title>
				<journal>Genes Dev.</journal>
				<year>2001</year>
				<issue>8</issue>
				<volume>15</volume>
				<pages>1007-20</pages>
				<abstract>The GAL4 dimerization domain (GAL4-dd) is a powerful transcriptional activator when tethered to DNA in a cell bearing a mutant of the GAL11 protein, named GAL11P. GAL11P (like GAL11) is a component of the RNA-polymerase II holoenzyme. Nuclear magnetic resonance (NMR) studies of GAL4-dd revealed an elongated dimer structure with C(2) symmetry containing three helices that mediate dimerization via coiled-coil contacts. The two loops between the three coiled coils form mobile bulges causing a variation of twist angles between the helix pairs. Chemical shift perturbation analysis mapped the GAL11P-binding site to the C-terminal helix alpha3 and the loop between alpha1 and alpha2. One GAL11P monomer binds to one GAL4-dd dimer rendering the dimer asymmetric and implying an extreme negative cooperativity mechanism. Alanine-scanning mutagenesis of GAL4-dd showed that the NMR-derived GAL11P-binding face is crucial for the novel transcriptional activating function of the GAL4-dd on GAL11P interaction. The binding of GAL4 to GAL11P, although an artificial interaction, represents a unique structural motif for an activating region capable of binding to a single target to effect gene expression.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0001133</accession>
					<name>RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
				<go>
					<accession>GO:0001085</accession>
					<name>RNA polymerase II transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006012</accession>
					<name>galactose metabolic process</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0000435</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter by galactose</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein GAL4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>TRAHLTEVESRLERLEQLFLLIFPREDLDMILKMDSLRDIEALLTGLFVQDNVNKDA</sequence>
				<length>57</length>
				<uniprot>
					<id>P04386</id>
					<start>50</start>
					<end>106</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04386</id>
					<start>50</start>
					<end>106</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>79</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03902.10</region_id>
						<region_name>Gal4_dimer</region_name>
						<region_start>50</region_start>
						<region_end>106</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein GAL4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>TRAHLTEVESRLERLEQLFLLIFPREDLDMILKMDSLRDIEALLTGLFVQDNVNKDA</sequence>
				<length>57</length>
				<uniprot>
					<id>P04386</id>
					<start>50</start>
					<end>106</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04386</id>
					<start>50</start>
					<end>106</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>79</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03902.10</region_id>
						<region_name>Gal4_dimer</region_name>
						<region_start>50</region_start>
						<region_end>106</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:11316794). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3coq</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110003</accession>
		<general>
			<name>Spindle pole body component SPC42</name>
			<pdb_id>2q6q</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.97</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>18850724</pmid>
				<authors>Zizlsperger N, Malashkevich VN, Pillay S, Keating AE</authors>
				<title>Analysis of coiled-coil interactions between core proteins of the spindle pole body.</title>
				<journal>Biochemistry</journal>
				<year>2008</year>
				<issue>45</issue>
				<volume>47</volume>
				<pages>11858-68</pages>
				<abstract>The spindle pole body (SPB) is a multiprotein complex that organizes microtubules in yeast. Due to its large size and association with the nuclear membrane, little is known about its detailed structure. In particular, although many SPB components and some of the interactions between them have been identified, the molecular details of how most of these interactions occur are not known. The prevalence of predicted coiled-coil regions in SPB proteins suggests that some interactions may occur via coiled coils. Here this hypothesis is supported by biochemical characterization of isolated coiled-coil peptides derived from SPB proteins. Formation of four strongly self-associating coiled-coil complexes from Spc29, Spc42, and Spc72 was demonstrated by circular dichroism (CD) spectroscopy and a fluorescence resonance energy transfer (FRET) assay. Many weaker self- and heteroassociations were also detected by CD, FRET, and/or cross-linking. The thermal stabilities of nine candidate homooligomers were assessed; six unfolded cooperatively with melting temperatures ranging from &amp;lt;11 to &gt;50 degrees C. Solution studies established that coiled-coil peptides derived from Spc42 and Spc72 form parallel dimers, and this was confirmed for Spc42 by a high-resolution crystal structure. These data contribute to a growing body of knowledge that will ultimately provide a detailed model of the SPB structure.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005200</accession>
					<name>structural constituent of cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007020</accession>
					<name>microtubule nucleation</name>
				</go>
				<go>
					<accession>GO:0030474</accession>
					<name>spindle pole body duplication</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005823</accession>
					<name>central plaque of spindle pole body</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0005821</accession>
					<name>intermediate layer of spindle pole body</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Spindle pole body component SPC42</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>AVQQNKELNFKLREKQNEIFELKKIAETLRSKLEKYVDITKKLEDQNLNLQIKISDLEKKLSDANSTFKEMRFP</sequence>
				<length>74</length>
				<uniprot>
					<id>P36094</id>
					<start>65</start>
					<end>138</end>
					<coverage>20.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P36094</id>
					<start>65</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11544.5</region_id>
						<region_name>Spc42p</region_name>
						<region_start>63</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Spindle pole body component SPC42</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>AVQQNKELNFKLREKQNEIFELKKIAETLRSKLEKYVDITKKLEDQNLNLQIKISDLEKKLSDANSTFKEMRFP</sequence>
				<length>74</length>
				<uniprot>
					<id>P36094</id>
					<start>65</start>
					<end>138</end>
					<coverage>20.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P36094</id>
					<start>65</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11544.5</region_id>
						<region_name>Spc42p</region_name>
						<region_start>63</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:18850724). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120009</accession>
		<general>
			<name>Basic coiled-coil protein of unknown function (Eubacterium eligens ATCC 27750)</name>
			<pdb_id>3hnw</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Eubacterium eligens</source_organism>
			<publication>
				<authors>Kim, Y., Cuff, M., Hendricks, R., Keigher, L., Joachimiak, A.</authors>
				<title>Crystal Structure of a Basic Coiled-Coil Protein of Unknown Function from Eubacterium eligens ATCC 27750</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein</name>
				<source_organism>Eubacterium eligens</source_organism>
				<sequence>SNAMSSKNTAEVILGGKVIKLGGYESEEYLQRVASYINNKITEFNKEESYRRMSAELRTDMMYLNIADDYFKAKKMADSLSLDIENKDKEIYDLKHELIAAQIKAESSAKEIKELKSEINKYQKNIVKLETELNDSKK</sequence>
				<length>138</length>
				<uniprot>
					<id>D0VWZ2</id>
					<start>1</start>
					<end>138</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_D0VWZ2</id>
					<start>1</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>14</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>11</region_start>
						<region_end>133</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Uncharacterized protein</name>
				<source_organism>Eubacterium eligens</source_organism>
				<sequence>SNAMSSKNTAEVILGGKVIKLGGYESEEYLQRVASYINNKITEFNKEESYRRMSAELRTDMMYLNIADDYFKAKKMADSLSLDIENKDKEIYDLKHELIAAQIKAESSAKEIKELKSEINKYQKNIVKLETELNDSKK</sequence>
				<length>138</length>
				<uniprot>
					<id>D0VWZ2</id>
					<start>1</start>
					<end>138</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_D0VWZ2</id>
					<start>1</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>11</region_start>
						<region_end>14</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>17</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>11</region_start>
						<region_end>133</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200002</accession>
		<general>
			<name>Geminin:Idas coiled coil dimer</name>
			<pdb_id>4bry</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.89</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>24064211</pmid>
				<authors>Caillat C, Pefani ED, Gillespie PJ, Taraviras S, Blow JJ, Lygerou Z, Perrakis A</authors>
				<title>The Geminin and Idas coiled coils preferentially form a heterodimer that inhibits Geminin function in DNA replication licensing.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2013</year>
				<abstract>Geminin is an important regulator of proliferation and differentiation in metazoans, which predominantly inhibits the DNA replication licensing factor Cdt1, preventing genome over-replication. We show that Geminin preferentially forms stable coiled-coil heterodimers with its homologue, Idas. In contrast to Idas:Geminin heterodimers, Idas homodimers are thermodynamically unstable and are unlikely to exist as a stable macromolecule under physiological conditions. The crystal structure of the homology regions of Idas in complex with Geminin showed a tight head-to-head heterodimeric coiled-coil. This Idas:Geminin heterodimer binds Cdt1 less strongly than Geminin:Geminin, still with high affinity (~30nM), but with notably different thermodynamic properties. Consistently, in Xenopus egg extracts, Idas:Geminin is less active in licensing inhibition compared to a Geminin:Geminin homodimer. In human cultured cells, ectopic expression of Idas leads to limited over-replication, which is counteracted by Geminin co-expression. The properties of the Idas:Geminin complex suggest it as the functional form of Idas, and provide a possible mechanism to modulate Geminin activity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Geminin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>QESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMAELIERLNG</sequence>
				<length>78</length>
				<uniprot>
					<id>O75496</id>
					<start>83</start>
					<end>160</end>
					<coverage>37.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75496</id>
					<start>83</start>
					<end>160</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>157</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07412.9</region_id>
						<region_name>Geminin</region_name>
						<region_start>1</region_start>
						<region_end>184</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Multicilin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PDVPPPEQYWKEVADQNQRALGDALVENNQLHVTLTQKQEEIASLKERNVQLKELASRTRHLASVLDKLMITQ</sequence>
				<length>73</length>
				<uniprot>
					<id>D6RGH6</id>
					<start>173</start>
					<end>245</end>
					<coverage>19%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_D6RGH6</id>
					<start>179</start>
					<end>245</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>179</region_start>
						<region_end>225</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>227</region_start>
						<region_end>241</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07412.9</region_id>
						<region_name>Geminin</region_name>
						<region_start>174</region_start>
						<region_end>257</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:24064211). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110004</accession>
		<general>
			<name>Coiled-coil trigger site of the rod domain of cortexillin I</name>
			<pdb_id>1d7m</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Dictyostelium discoideum</source_organism>
			<publication>
				<pmid>10745004</pmid>
				<authors>Burkhard P, Kammerer RA, Steinmetz MO, Bourenkov GP, Aebi U</authors>
				<title>The coiled-coil trigger site of the rod domain of cortexillin I unveils a distinct network of interhelical and intrahelical salt bridges.</title>
				<journal>Structure</journal>
				<year>2000</year>
				<issue>3</issue>
				<volume>8</volume>
				<pages>223-30</pages>
				<abstract> CONCLUSIONS: The knowledge gained from the structure could be used in the de novo design of alpha-helical coiled coils for applications such as two-stage drug targeting and delivery systems, and in the design of coiled coils as templates for combinatorial helical libraries in drug discovery and as synthetic carrier molecules. RESULTS: The X-ray crystal structure of the 18-heptad-repeat alpha-helical coiled-coil domain of the actin-bundling protein cortexillin I from Dictyostelium discoideum is a tightly packed parallel two-stranded alpha-helical coiled coil. It harbors a distinct 14-residue sequence motif that is essential for coiled-coil formation, and is a prerequisite for the assembly of cortexillin I. The atomic structure reveals novel types of ionic coiled-coil interactions. In particular, the structure shows that a characteristic interhelical and intrahelical salt-bridge pattern, in combination with the hydrophobic interactions occurring at the dimer interface, is the key structural feature of its coiled-coil trigger site. BACKGROUND: The parallel two-stranded alpha-helical coiled coil is the most frequently encountered subunit-oligomerization motif in proteins. The simplicity and regularity of this motif have made it an attractive system to explore some of the fundamental principles of protein folding and stability and to test the principles of de novo design.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0051015</accession>
					<name>actin filament binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0044351</accession>
					<name>macropinocytosis</name>
				</go>
				<go>
					<accession>GO:0043327</accession>
					<name>chemotaxis to cAMP</name>
				</go>
				<go>
					<accession>GO:0009617</accession>
					<name>response to bacterium</name>
				</go>
				<go>
					<accession>GO:0000916</accession>
					<name>actomyosin contractile ring contraction</name>
				</go>
				<go>
					<accession>GO:0036360</accession>
					<name>sorocarp stalk morphogenesis</name>
				</go>
				<go>
					<accession>GO:0051017</accession>
					<name>actin filament bundle assembly</name>
				</go>
				<go>
					<accession>GO:0045184</accession>
					<name>establishment of protein localization</name>
				</go>
				<go>
					<accession>GO:0036089</accession>
					<name>cleavage furrow formation</name>
				</go>
				<go>
					<accession>GO:0051495</accession>
					<name>positive regulation of cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0001934</accession>
					<name>positive regulation of protein phosphorylation</name>
				</go>
				<go>
					<accession>GO:0034613</accession>
					<name>cellular protein localization</name>
				</go>
				<go>
					<accession>GO:0031152</accession>
					<name>aggregation involved in sorocarp development</name>
				</go>
				<go>
					<accession>GO:0019953</accession>
					<name>sexual reproduction</name>
				</go>
				<go>
					<accession>GO:0010628</accession>
					<name>positive regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0030866</accession>
					<name>cortical actin cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0043520</accession>
					<name>regulation of myosin II filament assembly</name>
				</go>
				<go>
					<accession>GO:0003382</accession>
					<name>epithelial cell morphogenesis</name>
				</go>
				<go>
					<accession>GO:0043087</accession>
					<name>regulation of GTPase activity</name>
				</go>
				<go>
					<accession>GO:0051639</accession>
					<name>actin filament network formation</name>
				</go>
				<go>
					<accession>GO:0000281</accession>
					<name>mitotic cytokinesis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0045180</accession>
					<name>basal cortex</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0031255</accession>
					<name>lateral part of motile cell</name>
				</go>
				<go>
					<accession>GO:0032154</accession>
					<name>cleavage furrow</name>
				</go>
				<go>
					<accession>GO:0005826</accession>
					<name>actomyosin contractile ring</name>
				</go>
				<go>
					<accession>GO:0045335</accession>
					<name>phagocytic vesicle</name>
				</go>
				<go>
					<accession>GO:0031254</accession>
					<name>cell trailing edge</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0031252</accession>
					<name>cell leading edge</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cortexillin-1</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>EMANRLAGLENSLESEKVSREQLIKQKDQLNSLLASLESEGAEREKRLRELEAKLDETLKNLELEKLARMELEARLAKTEKDRAILELKLAEAIDEKSKLE</sequence>
				<length>101</length>
				<uniprot>
					<id>Q54HG2</id>
					<start>243</start>
					<end>343</end>
					<coverage>22.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54HG2</id>
					<start>243</start>
					<end>343</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>244</region_start>
						<region_end>342</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09304.7</region_id>
						<region_name>Cortex-I_coil</region_name>
						<region_start>231</region_start>
						<region_end>337</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cortexillin-1</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>EMANRLAGLENSLESEKVSREQLIKQKDQLNSLLASLESEGAEREKRLRELEAKLDETLKNLELEKLARMELEARLAKTEKDRAILELKLAEAIDEKSKLE</sequence>
				<length>101</length>
				<uniprot>
					<id>Q54HG2</id>
					<start>243</start>
					<end>343</end>
					<coverage>22.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54HG2</id>
					<start>243</start>
					<end>343</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>244</region_start>
						<region_end>342</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09304.7</region_id>
						<region_name>Cortex-I_coil</region_name>
						<region_start>231</region_start>
						<region_end>337</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:10745004). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120010</accession>
		<general>
			<name>Cell division factor ZapA</name>
			<pdb_id>4p1m</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.95</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Shigella sonnei</source_organism>
			<publication>
				<pmid>25002581</pmid>
				<authors>Roach EJ, Kimber MS, Khursigara CM</authors>
				<title>Crystal structure and site-directed mutational analysis reveals key residues involved in Escherichia coli ZapA function.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2014</year>
				<abstract>FtsZ is an essential cell division protein in Escherichia coli and its localization, filamentation and bundling at the mid-cell are required for Z-ring stability. Once assembled, the Z-ring recruits a series of proteins that comprise the bacterial divisome. FtsZ- associated proteins (Zaps) stabilize the Z-ring by increasing lateral interactions between individual filaments, bundling FtsZ to provide a scaffold for divisome assembly. The X-ray crystallographic structure of E. coli ZapA (EcZapA) was determined, identifying key structural differences from the existing ZapA structure from Pseudomonas aeruginosa, including a charged α-helix on the globular domains of the ZapA tetramer. Key helix residues in EcZapA were modified using site- directed mutagenesis. These ZapA variants significantly decreased FtsZ bundling in protein sedimentation assays when compared to wild-type (WT) ZapA proteins. Electron micrographs of ZapA-bundled FtsZ filaments showed the modified ZapA variants altered the number of FtsZ filaments per bundle. These in vitro results were corroborated in vivo by expressing the ZapA variants in an E. coli ∆zapA strain. In vivo, ZapA variants that altered FtsZ bundling showed an elongated phenotype, indicating improper cell division. Our findings highlight the importance of key ZapA residues that influence the extent of FtsZ bundling, and which ultimately affect Z-ring formation in dividing cells.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0090529</accession>
					<name>cell septum assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Shigella sonnei</source_organism>
				<sequence>MHHHHHHSIEGRSGMSAQPVDIQIFGRSLRVNCPPDQRDALNQAADDLNQRLQDLKERTRVTNTEQLVFIAALNISYELAQEKAKTRDYAASMEQRIRMLQQTIEQALLEQGRITEKTNQNFE</sequence>
				<length>123</length>
				<uniprot>
					<id>Q3YXW0</id>
					<start>1</start>
					<end>109</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A9MRG5</id>
					<start>1</start>
					<end>109</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>13</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>21</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>6</region_start>
						<region_end>90</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Shigella sonnei</source_organism>
				<sequence>MHHHHHHSIEGRSGMSAQPVDIQIFGRSLRVNCPPDQRDALNQAADDLNQRLQDLKERTRVTNTEQLVFIAALNISYELAQEKAKTRDYAASMEQRIRMLQQTIEQALLEQGRITEKTNQNFE</sequence>
				<length>123</length>
				<uniprot>
					<id>Q3YXW0</id>
					<start>1</start>
					<end>109</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A9MRG5</id>
					<start>1</start>
					<end>109</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>13</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>21</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>6</region_start>
						<region_end>90</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:25002581). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120011</accession>
		<general>
			<name>Cell division factor ZapB</name>
			<pdb_id>2jee</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.8</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>18394147</pmid>
				<authors>Ebersbach G, Galli E, Møller-Jensen J, Löwe J, Gerdes K</authors>
				<title>Novel coiled-coil cell division factor ZapB stimulates Z ring assembly and cell division.</title>
				<journal>Mol. Microbiol.</journal>
				<year>2008</year>
				<issue>3</issue>
				<volume>68</volume>
				<pages>720-35</pages>
				<abstract>Formation of the Z ring is the first known event in bacterial cell division. However, it is not yet known how the assembly and contraction of the Z ring are regulated. Here, we identify a novel cell division factor ZapB in Escherichia coli that simultaneously stimulates Z ring assembly and cell division. Deletion of zapB resulted in delayed cell division and the formation of ectopic Z rings and spirals, whereas overexpression of ZapB resulted in nucleoid condensation and aberrant cell divisions. Localization of ZapB to the divisome depended on FtsZ but not FtsA, ZipA or FtsI, and ZapB interacted with FtsZ in a bacterial two-hybrid analysis. The simultaneous inactivation of FtsA and ZipA prevented Z ring assembly and ZapB localization. Time lapse microscopy showed that ZapB-GFP is present at mid-cell in a pattern very similar to that of FtsZ. Cells carrying a zapB deletion and the ftsZ84(ts) allele exhibited a synthetic sick phenotype and aberrant cell divisions. The crystal structure showed that ZapB exists as a dimer that is 100% coiled-coil. In vitro, ZapB self-assembled into long filaments and bundles. These results raise the possibility that ZapB stimulates Z ring formation directly via its capacity to self-assemble into larger structures.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0043093</accession>
					<name>FtsZ-dependent cytokinesis</name>
				</go>
				<go>
					<accession>GO:0090529</accession>
					<name>cell septum assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0032153</accession>
					<name>cell division site</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cell division protein ZapB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MTMSLEVFEKLEAKVQQAIDTITLLQMEIEELKEKNNSLSQEVQNAQHQREELERENNHLKEQQNGWQERLQALLGRMEEV</sequence>
				<length>81</length>
				<uniprot>
					<id>P0AF36</id>
					<start>1</start>
					<end>81</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A7ZUE3</id>
					<start>1</start>
					<end>81</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06005.9</region_id>
						<region_name>DUF904</region_name>
						<region_start>3</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cell division protein ZapB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MTMSLEVFEKLEAKVQQAIDTITLLQMEIEELKEKNNSLSQEVQNAQHQREELERENNHLKEQQNGWQERLQALLGRMEEV</sequence>
				<length>81</length>
				<uniprot>
					<id>P0AF36</id>
					<start>1</start>
					<end>81</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A7ZUE3</id>
					<start>1</start>
					<end>81</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06005.9</region_id>
						<region_name>DUF904</region_name>
						<region_start>3</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:18394147). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110005</accession>
		<general>
			<name>Autophagy protein 16</name>
			<pdb_id>3a7o</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<authors>Fujioka, Y., Noda, N.N., Nakatogawa, H., Ohsumi, Y., Inagaki, F.</authors>
				<title>The dimeric coiled-coil structure of Atg16 and its functional significance in autophagy</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0030674</accession>
					<name>protein binding, bridging</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0034727</accession>
					<name>piecemeal microautophagy of nucleus</name>
				</go>
				<go>
					<accession>GO:0044805</accession>
					<name>late nucleophagy</name>
				</go>
				<go>
					<accession>GO:0000045</accession>
					<name>autophagosome assembly</name>
				</go>
				<go>
					<accession>GO:0006501</accession>
					<name>C-terminal protein lipidation</name>
				</go>
				<go>
					<accession>GO:0000422</accession>
					<name>mitophagy</name>
				</go>
				<go>
					<accession>GO:0032258</accession>
					<name>CVT pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000421</accession>
					<name>autophagosome membrane</name>
				</go>
				<go>
					<accession>GO:0034274</accession>
					<name>Atg12-Atg5-Atg16 complex</name>
				</go>
				<go>
					<accession>GO:0034045</accession>
					<name>pre-autophagosomal structure membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E and F were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Autophagy protein 16</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>GSGAIGGNIVSHDDALLNTLAILQKELKSKEQEIRRLKEVIALKNKNTERLNDELISGTIENNVLQQKLSDLKKE</sequence>
				<length>75</length>
				<uniprot>
					<id>Q03818</id>
					<start>49</start>
					<end>123</end>
					<coverage>50%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A6ZML8</id>
					<start>50</start>
					<end>123</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08614.8</region_id>
						<region_name>ATG16</region_name>
						<region_start>61</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Autophagy protein 16</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>GSGAIGGNIVSHDDALLNTLAILQKELKSKEQEIRRLKEVIALKNKNTERLNDELISGTIENNVLQQKLSDLKKE</sequence>
				<length>75</length>
				<uniprot>
					<id>Q03818</id>
					<start>49</start>
					<end>123</end>
					<coverage>50%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A6ZML8</id>
					<start>50</start>
					<end>123</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>62</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08614.8</region_id>
						<region_name>ATG16</region_name>
						<region_start>61</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3a7p</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF3110001</accession>
		<general>
			<name>Assembly domain of cartilage oligomeric matrix protein (chicken)</name>
			<pdb_id>1aq5</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotrimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>9699631</pmid>
				<authors>Dames SA, Kammerer RA, Wiltscheck R, Engel J, Alexandrescu AT</authors>
				<title>NMR structure of a parallel homotrimeric coiled coil.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>1998</year>
				<issue>8</issue>
				<volume>5</volume>
				<pages>687-91</pages>
				<abstract>The solution structure of the oligomerization domain of cartilage matrix protein (also known as matrilin-1) has been determined by heteronuclear NMR spectroscopy. The domain folds into a parallel, disulfide-linked, three-stranded, alpha-helical coiled coil, spanning five heptad repeats in the amino acid sequence. The sequence of the first two heptad repeats shows some deviations from the consensus of hydrophobic and hydrophilic residue preferences. While the corresponding region of the coiled coil has a higher intrinsic flexibility, backbone alpha-helix and superhelix parameters are consistent with a regular coiled coil structure.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005201</accession>
					<name>extracellular matrix structural constituent</name>
				</go>
				<go>
					<accession>GO:0005509</accession>
					<name>calcium ion binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005578</accession>
					<name>proteinaceous extracellular matrix</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cartilage matrix protein</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GSHMEEDPCECKSIVKFQTKVEELINTLQQKLEAVAKRIEALENKII</sequence>
				<length>47</length>
				<uniprot>
					<id>P05099</id>
					<start>447</start>
					<end>493</end>
					<coverage>9.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05099</id>
					<start>450</start>
					<end>493</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>459</region_start>
						<region_end>492</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF10393.6</region_id>
						<region_name>Matrilin_ccoil</region_name>
						<region_start>448</region_start>
						<region_end>492</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cartilage matrix protein</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GSHMEEDPCECKSIVKFQTKVEELINTLQQKLEAVAKRIEALENKII</sequence>
				<length>47</length>
				<uniprot>
					<id>P05099</id>
					<start>447</start>
					<end>493</end>
					<coverage>9.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05099</id>
					<start>450</start>
					<end>493</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>459</region_start>
						<region_end>492</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF10393.6</region_id>
						<region_name>Matrilin_ccoil</region_name>
						<region_start>448</region_start>
						<region_end>492</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Cartilage matrix protein</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GSHMEEDPCECKSIVKFQTKVEELINTLQQKLEAVAKRIEALENKII</sequence>
				<length>47</length>
				<uniprot>
					<id>P05099</id>
					<start>447</start>
					<end>493</end>
					<coverage>9.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P05099</id>
					<start>450</start>
					<end>493</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>459</region_start>
						<region_end>492</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF10393.6</region_id>
						<region_name>Matrilin_ccoil</region_name>
						<region_start>448</region_start>
						<region_end>492</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:9699631). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF3140001</accession>
		<general>
			<name>Bacteriophage T4 fibritin</name>
			<pdb_id>1aa0</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Enterobacteria phage T4</source_organism>
			<publication>
				<pmid>9261070</pmid>
				<authors>Tao Y, Strelkov SV, Mesyanzhinov VV, Rossmann MG</authors>
				<title>Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain.</title>
				<journal>Structure</journal>
				<year>1997</year>
				<issue>6</issue>
				<volume>5</volume>
				<pages>789-98</pages>
				<abstract> CONCLUSIONS: The residues within the C-terminal domain make extensive hydrophobic and some polar intersubunit interactions. This is consistent with the C-terminal domain being important for the correct assembly of fibritin, as shown earlier by mutational studies. Tight interactions between the C-terminal residues of adjacent subunits counteract the latent instability that is suggested by the structural properties of the coiled-coil segments. Trimerization is likely to begin with the formation of the C-terminal domain which subsequently initiates the assembly of the coiled coil. The interplay between the stabilizing effect of the C-terminal domain and the labile coiled-coil domain may be essential for the fibritin function and for the correct functioning of many other alpha-fibrous proteins. RESULTS: The three-dimensional structure of fibritin E, a deletion mutant of wild-type fibritin, was determined to 2.2 A resolution by X-ray crystallography. Three identical subunits of 119 amino acid residues form a trimeric parallel coiled-coil domain and a small globular C-terminal domain about a crystallographic threefold axis. The coiled-coil domain is divided into three segments that are separated by insertion loops. The C-terminal domain, which consists of 30 residues from each subunit, contains a beta-propeller-like structure with a hydrophobic interior. BACKGROUND: Oligomeric coiled-coil motifs are found in numerous protein structures; among them is fibritin, a structural protein of bacteriophage T4, which belongs to a class of chaperones that catalyze a specific phage-assembly process. Fibritin promotes the assembly of the long tail fibers and their subsequent attachment to the tail baseplate; it is also a sensing device that controls the retraction of the long tail fibers in adverse environments and, thus, prevents infection. The structure of fibritin had been predicted from sequence and biochemical analyses to be mainly a triple-helical coiled coil. The determination of its structure at atomic resolution was expected to give insights into the assembly process and biological function of fibritin, and the properties of modified coiled-coil structures in general.</abstract>
			</publication>
		</general>
		<function>
			<cellular_component>
				<go>
					<accession>GO:0019012</accession>
					<name>virion</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Coiled coil/foldon domain</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Fibritin</name>
				<source_organism>Enterobacteria phage T4</source_organism>
				<sequence>VSGLNNAVQNLQVEIGNNSAGIKGQVVALNTLVNGTNPNGSTVEERGLTNSIKANETNIASVTQEVNTAKGNISSLQGDVQALQEAGYIPEAPRDGQAYVRKDGEWVLLSTFL</sequence>
				<length>113</length>
				<uniprot>
					<id>P10104</id>
					<start>372</start>
					<end>484</end>
					<coverage>23.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P10104</id>
					<start>372</start>
					<end>484</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>373</region_start>
						<region_end>386</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>393</region_start>
						<region_end>405</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>414</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>419</region_start>
						<region_end>455</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>459</region_start>
						<region_end>459</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>461</region_start>
						<region_end>461</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>470</region_start>
						<region_end>473</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>476</region_start>
						<region_end>479</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>480</region_start>
						<region_end>482</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07921.9</region_id>
						<region_name>Fibritin_C</region_name>
						<region_start>372</region_start>
						<region_end>483</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Fibritin</name>
				<source_organism>Enterobacteria phage T4</source_organism>
				<sequence>VSGLNNAVQNLQVEIGNNSAGIKGQVVALNTLVNGTNPNGSTVEERGLTNSIKANETNIASVTQEVNTAKGNISSLQGDVQALQEAGYIPEAPRDGQAYVRKDGEWVLLSTFL</sequence>
				<length>113</length>
				<uniprot>
					<id>P10104</id>
					<start>372</start>
					<end>484</end>
					<coverage>23.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P10104</id>
					<start>372</start>
					<end>484</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>373</region_start>
						<region_end>386</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>393</region_start>
						<region_end>405</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>414</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>419</region_start>
						<region_end>455</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>459</region_start>
						<region_end>459</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>461</region_start>
						<region_end>461</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>470</region_start>
						<region_end>473</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>476</region_start>
						<region_end>479</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>480</region_start>
						<region_end>482</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07921.9</region_id>
						<region_name>Fibritin_C</region_name>
						<region_start>372</region_start>
						<region_end>483</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Fibritin</name>
				<source_organism>Enterobacteria phage T4</source_organism>
				<sequence>VSGLNNAVQNLQVEIGNNSAGIKGQVVALNTLVNGTNPNGSTVEERGLTNSIKANETNIASVTQEVNTAKGNISSLQGDVQALQEAGYIPEAPRDGQAYVRKDGEWVLLSTFL</sequence>
				<length>113</length>
				<uniprot>
					<id>P10104</id>
					<start>372</start>
					<end>484</end>
					<coverage>23.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P10104</id>
					<start>372</start>
					<end>484</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>373</region_start>
						<region_end>386</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>393</region_start>
						<region_end>405</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>414</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>419</region_start>
						<region_end>455</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>459</region_start>
						<region_end>459</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>461</region_start>
						<region_end>461</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>470</region_start>
						<region_end>473</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>476</region_start>
						<region_end>479</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>480</region_start>
						<region_end>482</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07921.9</region_id>
						<region_name>Fibritin_C</region_name>
						<region_start>372</region_start>
						<region_end>483</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The foldon domain folds into a trimeric beta-propeller structure and undergoes a two-state unfolding transition from folded trimer to unfolded monomers (PMID:15033360). The other subunits in the structure are bound via coiled coil interactions (PMID:9261070). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1avy</pdb_id>
			<pdb_id>2bsg</pdb_id>
			<pdb_id>3j2o</pdb_id>
			<pdb_id>2ww6</pdb_id>
			<pdb_id>2ww7</pdb_id>
			<pdb_id>4ncu</pdb_id>
			<pdb_id>4ncv</pdb_id>
			<pdb_id>4ncw</pdb_id>
			<pdb_id>1v1h</pdb_id>
			<pdb_id>1v1i</pdb_id>
			<pdb_id>2kbl</pdb_id>
			<pdb_id>3a1m</pdb_id>
			<pdb_id>1u0p</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF3100001</accession>
		<general>
			<name>Trimerization domain from lung surfactant protein D</name>
			<pdb_id>1m7l</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotrimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>12495025</pmid>
				<authors>Kovacs H, O'Ddonoghue SI, Hoppe HJ, Comfort D, Reid KB, Campbell D, Nilges M</authors>
				<title>Solution structure of the coiled-coil trimerization domain from lung surfactant protein D.</title>
				<journal>J. Biomol. NMR</journal>
				<year>2002</year>
				<issue>2</issue>
				<volume>24</volume>
				<pages>89-102</pages>
				<abstract>Surfactant protein D (SP-D) is one of four known protein components of the pulmonary surfactant lining the lung alveoli. It is involved in immune and allergic responses. SP-D occurs as a tetramer of trimers. Trimerization is thought to be initiated by a coiled coil domain. We have determined the solution structure of a 64-residue peptide encompassing the coiled coil domain of human SP-D. As predicted, the domain forms a triple-helical parallel coiled coil. As with all symmetric oligomers, the structure calculation was complicated by the symmetry degeneracy in the NMR spectra. We used the symmetry-ADR (ambiguous distance restraint) structure calculation method to solve the structure. The results demonstrate that the leucine zipper region of SP-D is an autonomously folded domain. The structure is very similar to the independently determined X-ray crystal structure, differing mainly at a single residue, Tyr248. This residue is completely symmetric in the solution structure, and markedly asymmetric in the crystalline phase. This difference may be functionally important, as it affects the orientation of the antigenic surface presented by SP-D.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0030246</accession>
					<name>carbohydrate binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0050766</accession>
					<name>positive regulation of phagocytosis</name>
				</go>
				<go>
					<accession>GO:0044267</accession>
					<name>cellular protein metabolic process</name>
				</go>
				<go>
					<accession>GO:0045087</accession>
					<name>innate immune response</name>
				</go>
				<go>
					<accession>GO:0072593</accession>
					<name>reactive oxygen species metabolic process</name>
				</go>
				<go>
					<accession>GO:0045085</accession>
					<name>negative regulation of interleukin-2 biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0050776</accession>
					<name>regulation of immune response</name>
				</go>
				<go>
					<accession>GO:0048286</accession>
					<name>lung alveolus development</name>
				</go>
				<go>
					<accession>GO:0048246</accession>
					<name>macrophage chemotaxis</name>
				</go>
				<go>
					<accession>GO:0042742</accession>
					<name>defense response to bacterium</name>
				</go>
				<go>
					<accession>GO:0042130</accession>
					<name>negative regulation of T cell proliferation</name>
				</go>
				<go>
					<accession>GO:0006898</accession>
					<name>receptor-mediated endocytosis</name>
				</go>
				<go>
					<accession>GO:0007585</accession>
					<name>respiratory gaseous exchange</name>
				</go>
				<go>
					<accession>GO:0043129</accession>
					<name>surfactant homeostasis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005581</accession>
					<name>collagen trimer</name>
				</go>
				<go>
					<accession>GO:0005764</accession>
					<name>lysosome</name>
				</go>
				<go>
					<accession>GO:0005789</accession>
					<name>endoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0045334</accession>
					<name>clathrin-coated endocytic vesicle</name>
				</go>
				<go>
					<accession>GO:0042599</accession>
					<name>lamellar body</name>
				</go>
				<go>
					<accession>GO:0005578</accession>
					<name>proteinaceous extracellular matrix</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Pulmonary surfactant-associated protein D</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GLPDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGGI</sequence>
				<length>40</length>
				<uniprot>
					<id>P35247</id>
					<start>220</start>
					<end>259</end>
					<coverage>10.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35247</id>
					<start>220</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>221</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09006.8</region_id>
						<region_name>Surfac_D-trimer</region_name>
						<region_start>224</region_start>
						<region_end>269</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Pulmonary surfactant-associated protein D</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GLPDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGGI</sequence>
				<length>40</length>
				<uniprot>
					<id>P35247</id>
					<start>220</start>
					<end>259</end>
					<coverage>10.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35247</id>
					<start>220</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>221</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09006.8</region_id>
						<region_name>Surfac_D-trimer</region_name>
						<region_start>224</region_start>
						<region_end>269</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Pulmonary surfactant-associated protein D</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GLPDVASLRQQVEALQGQVQHLQAAFSQYKKVELFPNGGI</sequence>
				<length>40</length>
				<uniprot>
					<id>P35247</id>
					<start>220</start>
					<end>259</end>
					<coverage>10.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35247</id>
					<start>220</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>221</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09006.8</region_id>
						<region_name>Surfac_D-trimer</region_name>
						<region_start>224</region_start>
						<region_end>269</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12495025). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1b08</pdb_id>
			<pdb_id>1pw9</pdb_id>
			<pdb_id>1pwb</pdb_id>
			<pdb_id>2ggu</pdb_id>
			<pdb_id>2ggx</pdb_id>
			<pdb_id>2orj</pdb_id>
			<pdb_id>2ork</pdb_id>
			<pdb_id>2os9</pdb_id>
			<pdb_id>2ria</pdb_id>
			<pdb_id>2rib</pdb_id>
			<pdb_id>2ric</pdb_id>
			<pdb_id>2rid</pdb_id>
			<pdb_id>2rie</pdb_id>
			<pdb_id>3dbz</pdb_id>
			<pdb_id>3g81</pdb_id>
			<pdb_id>3g83</pdb_id>
			<pdb_id>3g84</pdb_id>
			<pdb_id>3ikn</pdb_id>
			<pdb_id>3ikp</pdb_id>
			<pdb_id>3ikq</pdb_id>
			<pdb_id>3ikr</pdb_id>
			<pdb_id>4e52</pdb_id>
			<pdb_id>4m17</pdb_id>
			<pdb_id>4m18</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF3120001</accession>
		<general>
			<name>Major outer membrane lipoprotein</name>
			<pdb_id>1jcc</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Shigella flexneri</source_organism>
			<publication>
				<pmid>12741822</pmid>
				<authors>Liu J, Dai J, Lu M</authors>
				<title>Zinc-mediated helix capping in a triple-helical protein.</title>
				<journal>Biochemistry</journal>
				<year>2003</year>
				<issue>19</issue>
				<volume>42</volume>
				<pages>5657-64</pages>
				<abstract>Specific sequence signals at alpha-helix termini can assist protein folding by punctuating and cueing secondary structural elements in the final native conformation. Here we report the crystallization of a 56-residue alanine-containing peptide, denoted Ala-10(56), in the presence of Zn(2+). The 1.7 A crystal structure shows that Ala-10(56) forms a parallel trimeric coiled coil with three zinc ions anchoring distinct capping conformations at the amino-terminal ends of the three helices. In each polypeptide chain, the free alpha-amino nitrogen and carbonyl oxygen of the amino-terminal Ser residue coordinate to a Zn(2+) ion to form a five-membered chelate, and the syn-unidentate interaction of the Asp7 side chain with the Zn(2+) cation leads to the formation of a unique docking arrangement for helix capping. Moreover, the coordination of the zinc ion involves a neighboring trimer molecule in the crystal. Consequently, the crystal contacts are stabilized by carboxylate-Zn(2+) interactions between four Ala-10(56) trimers in the crystal lattice. The observed synergy between the protein-zinc ion recognition and the helix-packing arrangements would contribute to the conformational specificity of the Ala-10(56) trimer.</abstract>
			</publication>
		</general>
		<function>
			<cellular_component>
				<go>
					<accession>GO:0009279</accession>
					<name>cell outer membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Alanine zipper (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Major outer membrane lipoprotein</name>
				<source_organism>Shigella flexneri</source_organism>
				<sequence>SSNAKIDQLSSDAQTANAKADQASNDANAARSDAQAAKDDAARANQRLDNMATKYR</sequence>
				<length>56</length>
				<uniprot>
					<id>P69780</id>
					<start>22</start>
					<end>77</end>
					<coverage>71.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P69778</id>
					<start>22</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04728.10</region_id>
						<region_name>LPP</region_name>
						<region_start>26</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Major outer membrane lipoprotein</name>
				<source_organism>Shigella flexneri</source_organism>
				<sequence>SSNAKIDQLSSDAQTANAKADQASNDANAARSDAQAAKDDAARANQRLDNMATKYR</sequence>
				<length>56</length>
				<uniprot>
					<id>P69780</id>
					<start>22</start>
					<end>77</end>
					<coverage>71.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P69778</id>
					<start>22</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04728.10</region_id>
						<region_name>LPP</region_name>
						<region_start>26</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Major outer membrane lipoprotein</name>
				<source_organism>Shigella flexneri</source_organism>
				<sequence>SSNAKIDQLSSDAQTANAKADQASNDANAARSDAQAAKDDAARANQRLDNMATKYR</sequence>
				<length>56</length>
				<uniprot>
					<id>P69780</id>
					<start>22</start>
					<end>77</end>
					<coverage>71.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P69778</id>
					<start>22</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04728.10</region_id>
						<region_name>LPP</region_name>
						<region_start>26</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12741822). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1eq7</pdb_id>
			<pdb_id>1kfm</pdb_id>
			<pdb_id>1kfn</pdb_id>
			<pdb_id>1jcd</pdb_id>
			<pdb_id>1t8z</pdb_id>
			<pdb_id>2gus</pdb_id>
			<pdb_id>2guv</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF3120002</accession>
		<general>
			<name>DUF16 domain of MPN010 (Mycoplasma pneumoniae)</name>
			<pdb_id>2ba2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Mycoplasma pneumoniae</source_organism>
			<publication>
				<pmid>16522803</pmid>
				<authors>Shin DH, Kim JS, Yokota H, Kim R, Kim SH</authors>
				<title>Crystal structure of the DUF16 domain of MPN010 from Mycoplasma pneumoniae.</title>
				<journal>Protein Sci.</journal>
				<year>2006</year>
				<issue>4</issue>
				<volume>15</volume>
				<pages>921-8</pages>
				<abstract>We have determined the crystal structure of the DUF16 domain of unknown function encoded by the gene MPN010 of Mycoplasma pneumoniae at 1.8 A resolution. The crystal structure revealed that this domain is composed of two separated homotrimeric coiled-coils. The shorter one consists of 11 highly conserved residues. The sequence comprises noncanonical heptad repeats that induce a right-handed coiled-coil structure. The longer one is composed of approximately nine heptad repeats. In this coiled-coil structure, there are three distinguishable regions that confer unique structural properties compared with other known homotrimeric coiled-coils. The first part, containing one stutter, is an unusual phenylalanine-rich region that is not found in any other coiled-coil structures. The second part is a highly conserved glutamine-rich region, frequently found in other trimeric coiled-coil structures. The last part is composed of prototype heptad repeats. The phylogenetic analysis of the DUF16 family together with a secondary structure prediction shows that the DUF16 family can be classified into five subclasses according to N-terminal sequences. Based on the structural comparison with other coiled-coil structures, a probable molecular function of the DUF16 family is discussed.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>UPF0134 protein MPN_010</name>
				<source_organism>Mycoplasma pneumoniae</source_organism>
				<sequence>VKTPGTRYVTHKQLDEKLKNFVTKTEFKEFQTVVMESFAVQNQNIDAQGEQIKELQVEQKAQGKTLQLILEALQGINKRLDNLES</sequence>
				<length>85</length>
				<uniprot>
					<id>P75103</id>
					<start>46</start>
					<end>130</end>
					<coverage>64.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P75103</id>
					<start>46</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01519.13</region_id>
						<region_name>DUF16</region_name>
						<region_start>37</region_start>
						<region_end>130</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>UPF0134 protein MPN_010</name>
				<source_organism>Mycoplasma pneumoniae</source_organism>
				<sequence>VKTPGTRYVTHKQLDEKLKNFVTKTEFKEFQTVVMESFAVQNQNIDAQGEQIKELQVEQKAQGKTLQLILEALQGINKRLDNLES</sequence>
				<length>85</length>
				<uniprot>
					<id>P75103</id>
					<start>46</start>
					<end>130</end>
					<coverage>64.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P75103</id>
					<start>46</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>129</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01519.13</region_id>
						<region_name>DUF16</region_name>
						<region_start>37</region_start>
						<region_end>130</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>UPF0134 protein MPN_010</name>
				<source_organism>Mycoplasma pneumoniae</source_organism>
				<sequence>VKTPGTRYVTHKQLDEKLKNFVTKTEFKEFQTVVMESFAVQNQNIDAQGEQIKELQVEQKAQGKTLQLILEALQGINKRLDNLES</sequence>
				<length>85</length>
				<uniprot>
					<id>P75103</id>
					<start>46</start>
					<end>130</end>
					<coverage>64.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P75103</id>
					<start>46</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01519.13</region_id>
						<region_name>DUF16</region_name>
						<region_start>37</region_start>
						<region_end>130</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16522803). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF3100002</accession>
		<general>
			<name>Dystrophia myotonin-protein kinase coiled-coil domain</name>
			<pdb_id>1wt6</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>16770013</pmid>
				<authors>Garcia P, Ucurum Z, Bucher R, Svergun DI, Huber T, Lustig A, Konarev PV, Marino M, Mayans O</authors>
				<title>Molecular insights into the self-assembly mechanism of dystrophia myotonica kinase.</title>
				<journal>FASEB J.</journal>
				<year>2006</year>
				<issue>8</issue>
				<volume>20</volume>
				<pages>1142-51</pages>
				<abstract>Self-assembly via coiled-coil domains (CC) is crucial for the regulation of the dystrophia myotonica kinase (DMPK) -related family of kinases. These CC domains are thought to form dimeric arrangements and thus to mediate dimerization in these enzymes. Using size exclusion chromatography combined with multiangle static light scattering, we analyzed the oligomeric state of DMPK as well as that of a truncated variant lacking the CC fraction. Remarkably, both forms were found to assemble into robust dimers. In contrast, the CC domain in isolation yielded trimeric assemblies, indicating that the oligomerization properties of CC domains from this kinase family are more diversified than anticipated. The crystal structure of this CC has been elucidated to 1.6 angstroms resolution and its properties in solution established using sedimentation equilibrium and thermal denaturation. These data show that, contrary to expectations, the self-assembly of DMPK is not dictated by the association properties of its CC domain. Instead, it appears to be driven by sequence segments flanking both N and C termini of the catalytic kinase fraction, as suggested by models of head-to-head dimers based on small angle X-ray scattering data. Our findings support a shared pattern of assembly across DMPK, ROCKs, and MRCK members of this family.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0017020</accession>
					<name>myosin phosphatase regulator activity</name>
				</go>
				<go>
					<accession>GO:0004674</accession>
					<name>protein serine/threonine kinase activity</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0031072</accession>
					<name>heat shock protein binding</name>
				</go>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0051823</accession>
					<name>regulation of synapse structural plasticity</name>
				</go>
				<go>
					<accession>GO:0010657</accession>
					<name>muscle cell apoptotic process</name>
				</go>
				<go>
					<accession>GO:0006874</accession>
					<name>cellular calcium ion homeostasis</name>
				</go>
				<go>
					<accession>GO:0014722</accession>
					<name>regulation of skeletal muscle contraction by calcium ion signaling</name>
				</go>
				<go>
					<accession>GO:0014853</accession>
					<name>regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction</name>
				</go>
				<go>
					<accession>GO:0050790</accession>
					<name>regulation of catalytic activity</name>
				</go>
				<go>
					<accession>GO:0010830</accession>
					<name>regulation of myotube differentiation</name>
				</go>
				<go>
					<accession>GO:0018105</accession>
					<name>peptidyl-serine phosphorylation</name>
				</go>
				<go>
					<accession>GO:1903779</accession>
					<name>regulation of cardiac conduction</name>
				</go>
				<go>
					<accession>GO:0002028</accession>
					<name>regulation of sodium ion transport</name>
				</go>
				<go>
					<accession>GO:0006998</accession>
					<name>nuclear envelope organization</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0033017</accession>
					<name>sarcoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0031307</accession>
					<name>integral component of mitochondrial outer membrane</name>
				</go>
				<go>
					<accession>GO:0005640</accession>
					<name>nuclear outer membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Myotonin-protein kinase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GAMAEAEAEVTLRELQEALEEEVLTRQSLSREMEAIRTDNQNFASQLREAEARNRDLEAHVRQLQERMELLQAEGATAVTG</sequence>
				<length>81</length>
				<uniprot>
					<id>Q09013</id>
					<start>457</start>
					<end>537</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q09013</id>
					<start>467</start>
					<end>537</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>468</region_start>
						<region_end>528</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08826.7</region_id>
						<region_name>DMPK_coil</region_name>
						<region_start>470</region_start>
						<region_end>530</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Myotonin-protein kinase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GAMAEAEAEVTLRELQEALEEEVLTRQSLSREMEAIRTDNQNFASQLREAEARNRDLEAHVRQLQERMELLQAEGATAVTG</sequence>
				<length>81</length>
				<uniprot>
					<id>Q09013</id>
					<start>457</start>
					<end>537</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q09013</id>
					<start>467</start>
					<end>537</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>467</region_start>
						<region_end>526</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08826.7</region_id>
						<region_name>DMPK_coil</region_name>
						<region_start>470</region_start>
						<region_end>530</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Myotonin-protein kinase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GAMAEAEAEVTLRELQEALEEEVLTRQSLSREMEAIRTDNQNFASQLREAEARNRDLEAHVRQLQERMELLQAEGATAVTG</sequence>
				<length>81</length>
				<uniprot>
					<id>Q09013</id>
					<start>457</start>
					<end>537</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q09013</id>
					<start>467</start>
					<end>537</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>468</region_start>
						<region_end>526</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08826.7</region_id>
						<region_name>DMPK_coil</region_name>
						<region_start>470</region_start>
						<region_end>530</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16770013). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2140003</accession>
		<general>
			<name>Gene V protein</name>
			<pdb_id>1gvp</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Enterobacteria phage f1</source_organism>
			<publication>
				<pmid>9098886</pmid>
				<authors>Su S, Gao YG, Zhang H, Terwilliger TC, Wang AH</authors>
				<title>Analyses of the stability and function of three surface mutants (R82C, K69H, and L32R) of the gene V protein from Ff phage by X-ray crystallography.</title>
				<journal>Protein Sci.</journal>
				<year>1997</year>
				<issue>4</issue>
				<volume>6</volume>
				<pages>771-80</pages>
				<abstract>The high-resolution crystal structure of the gene V protein (GVP) from the Ff filamentous phages (M13, fl, fd) has been solved recently for the wild-type and two surface mutant (Y41F and Y41H) proteins, leading to a plausible model for the polymeric GVP-ssDNA complex (Guan Y, Zhang H, Wang AHJ, 1995, Protein Sci 4:187-197). The model of the complex shows extensive contacts between neighboring dimer GVPs involving electrostatic interactions between the K69 from one and the D79 and R82 from the next dimer. In addition, hydrophobic interactions between the amino acids L32 and L44 from one and G23 from the next dimer also contribute to the dimer-dimer interactions. Mutations at the L32, K69, and R82 amino acid sites generally destabilize the protein and many of these affect the function of the phage. We have studied the structural effects of three mutant proteins involving those sites, i.e., L32R, K69H, and R82C, by X-ray crystallographic analysis at 2.0 A resolution. In L32R GVP, the structural perturbation is localized, whereas in K69H and R82C GVPs, some long-range effects are also detected in addition to the local perturbation. We have interpreted the protein stability and the functional properties associated with those mutations in terms of the observed structural perturbations.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003697</accession>
					<name>single-stranded DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0039684</accession>
					<name>rolling circle single-stranded viral DNA replication</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>DNA-Binding protein G5P</name>
				<source_organism>Enterobacteria phage f1</source_organism>
				<sequence>MIKVEIKPSQAQFTTRSGVSRQGKPYSLNEQLCYVDLGNEYPVLVKITLDEGQPAYAPGLYTVHLSSFKVGQFGSLMIDRLRLVPAK</sequence>
				<length>87</length>
				<uniprot>
					<id>P69543</id>
					<start>1</start>
					<end>87</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P69543</id>
					<start>1</start>
					<end>87</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>59</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02303.14</region_id>
						<region_name>Phage_DNA_bind</region_name>
						<region_start>2</region_start>
						<region_end>83</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>DNA-Binding protein G5P</name>
				<source_organism>Enterobacteria phage f1</source_organism>
				<sequence>MIKVEIKPSQAQFTTRSGVSRQGKPYSLNEQLCYVDLGNEYPVLVKITLDEGQPAYAPGLYTVHLSSFKVGQFGSLMIDRLRLVPAK</sequence>
				<length>87</length>
				<uniprot>
					<id>P69543</id>
					<start>1</start>
					<end>87</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P69543</id>
					<start>1</start>
					<end>87</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>59</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02303.14</region_id>
						<region_name>Phage_DNA_bind</region_name>
						<region_start>2</region_start>
						<region_end>83</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Reversible denaturation experiments have shown that the dimeric gene V protein unfolds in a single cooperative transition from a folded dimer into two unfolded monomers (PMID:2007116).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ae2</pdb_id>
			<pdb_id>1ae3</pdb_id>
			<pdb_id>1gkh</pdb_id>
			<pdb_id>2gn5</pdb_id>
			<pdb_id>2gva</pdb_id>
			<pdb_id>2gvb</pdb_id>
			<pdb_id>1vqa</pdb_id>
			<pdb_id>1vqb</pdb_id>
			<pdb_id>1vqc</pdb_id>
			<pdb_id>1vqd</pdb_id>
			<pdb_id>1vqe</pdb_id>
			<pdb_id>1vqf</pdb_id>
			<pdb_id>1vqg</pdb_id>
			<pdb_id>1vqh</pdb_id>
			<pdb_id>1vqi</pdb_id>
			<pdb_id>1vqj</pdb_id>
			<pdb_id>1yha</pdb_id>
			<pdb_id>1yhb</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140004</accession>
		<general>
			<name>Bacteriophage f29 scaffolding protein gp7</name>
			<pdb_id>1no4</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Bacillus phage phi29</source_organism>
			<publication>
				<pmid>12778115</pmid>
				<authors>Morais MC, Kanamaru S, Badasso MO, Koti JS, Owen BA, McMurray CT, Anderson DL, Rossmann MG</authors>
				<title>Bacteriophage phi29 scaffolding protein gp7 before and after prohead assembly.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>2003</year>
				<issue>7</issue>
				<volume>10</volume>
				<pages>572-6</pages>
				<abstract>Three-dimensional structures of the double-stranded DNA bacteriophage phi29 scaffolding protein (gp7) before and after prohead assembly have been determined at resolutions of 2.2 and 2.8 A, respectively. Both structures are dimers that resemble arrows, with a four-helix bundle composing the arrowhead and a coiled coil forming the tail. The structural resemblance of gp7 to the yeast transcription factor GCN4 suggests a DNA-binding function that was confirmed by native gel electrophoresis. DNA binding to gp7 may have a role in mediating the structural transition from prohead to mature virus and scaffold release. A cryo-EM analysis indicates that gp7 is arranged inside the capsid as a series of concentric shells. The position of the higher density features in these shells correlates with the positions of hexamers in the equatorial region of the capsid, suggesting that gp7 may regulate formation of the prolate head through interactions with these hexamers.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0019076</accession>
					<name>viral release from host cell</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0046806</accession>
					<name>viral scaffold</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Head morphogenesis protein</name>
				<source_organism>Bacillus phage phi29</source_organism>
				<sequence>PLKPEEHEDILNKLLDPELAQSERTEALQQLRVNYGSFVSEYNDLTKSHEKLAAEKDDLIVSNSKLFRQIGLTEKQEEDHKKADISETITIEDLEAK</sequence>
				<length>97</length>
				<uniprot>
					<id>P13848</id>
					<start>2</start>
					<end>98</end>
					<coverage>99%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13848</id>
					<start>2</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11418.5</region_id>
						<region_name>Scaffolding_pro</region_name>
						<region_start>2</region_start>
						<region_end>98</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Head morphogenesis protein</name>
				<source_organism>Bacillus phage phi29</source_organism>
				<sequence>PLKPEEHEDILNKLLDPELAQSERTEALQQLRVNYGSFVSEYNDLTKSHEKLAAEKDDLIVSNSKLFRQIGLTEKQEEDHKKADISETITIEDLEAK</sequence>
				<length>97</length>
				<uniprot>
					<id>P13848</id>
					<start>2</start>
					<end>98</end>
					<coverage>99%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13848</id>
					<start>2</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11418.5</region_id>
						<region_name>Scaffolding_pro</region_name>
						<region_start>2</region_start>
						<region_end>98</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12778115). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1noh</pdb_id>
			<pdb_id>4iff</pdb_id>
			<pdb_id>4xa1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4130001</accession>
		<general>
			<name>Tetrabrachion tetramerization region</name>
			<pdb_id>1fe6</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Staphylothermus marinus</source_organism>
			<publication>
				<pmid>10966648</pmid>
				<authors>Stetefeld J, Jenny M, Schulthess T, Landwehr R, Engel J, Kammerer RA</authors>
				<title>Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>2000</year>
				<issue>9</issue>
				<volume>7</volume>
				<pages>772-6</pages>
				<abstract>The crystal structure of a polypeptide chain fragment from the surface layer protein tetrabrachion from Staphylothermus marinus has been determined at 1.8 A resolution. As proposed on the basis of the presence of 11-residue repeats, the polypeptide chain fragment forms a parallel right-handed coiled coil structure. Complementary hydrophobic interactions and complex networks of surface salt bridges result in an extremely thermostable tetrameric structure with remarkable properties. In marked contrast to left-handed coiled coil tetramers, the right-handed coiled coil reveals large hydrophobic cavities that are filled with water molecules. As a consequence, the packing of the hydrophobic core differs markedly from that of a right-handed parallel coiled coil tetramer that was designed on the basis of left-handed coiled coil structures.</abstract>
			</publication>
		</general>
		<function>
			<cellular_component>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tetrabrachion (Precursor)</name>
				<source_organism>Staphylothermus marinus</source_organism>
				<sequence>GSIINETADDIVYRLTVIIDDRYESLKNLITLRADRLEMIINDNVSTILASG</sequence>
				<length>52</length>
				<uniprot>
					<id>Q54436</id>
					<start>1236</start>
					<end>1287</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54436</id>
					<start>1237</start>
					<end>1286</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11401.5</region_id>
						<region_name>Tetrabrachion</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tetrabrachion (Precursor)</name>
				<source_organism>Staphylothermus marinus</source_organism>
				<sequence>GSIINETADDIVYRLTVIIDDRYESLKNLITLRADRLEMIINDNVSTILASG</sequence>
				<length>52</length>
				<uniprot>
					<id>Q54436</id>
					<start>1236</start>
					<end>1287</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54436</id>
					<start>1237</start>
					<end>1286</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11401.5</region_id>
						<region_name>Tetrabrachion</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Tetrabrachion (Precursor)</name>
				<source_organism>Staphylothermus marinus</source_organism>
				<sequence>GSIINETADDIVYRLTVIIDDRYESLKNLITLRADRLEMIINDNVSTILASG</sequence>
				<length>52</length>
				<uniprot>
					<id>Q54436</id>
					<start>1236</start>
					<end>1287</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54436</id>
					<start>1237</start>
					<end>1286</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1240</region_start>
						<region_end>1286</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11401.5</region_id>
						<region_name>Tetrabrachion</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Tetrabrachion (Precursor)</name>
				<source_organism>Staphylothermus marinus</source_organism>
				<sequence>GSIINETADDIVYRLTVIIDDRYESLKNLITLRADRLEMIINDNVSTILASG</sequence>
				<length>52</length>
				<uniprot>
					<id>Q54436</id>
					<start>1236</start>
					<end>1287</end>
					<coverage>3.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q54436</id>
					<start>1237</start>
					<end>1286</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1238</region_start>
						<region_end>1284</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11401.5</region_id>
						<region_name>Tetrabrachion</region_name>
						<region_start>1238</region_start>
						<region_end>1286</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:10966648). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ybk</pdb_id>
			<pdb_id>5jr5</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4140001</accession>
		<general>
			<name>Virion-associated protein P3</name>
			<pdb_id>3f6n</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.10</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Cauliflower mosaic virus</source_organism>
			<publication>
				<pmid>20181714</pmid>
				<authors>Hoh F, Uzest M, Drucker M, Plisson-Chastang C, Bron P, Blanc S, Dumas C</authors>
				<title>Structural insights into the molecular mechanisms of cauliflower mosaic virus transmission by its insect vector.</title>
				<journal>J. Virol.</journal>
				<year>2010</year>
				<issue>9</issue>
				<volume>84</volume>
				<pages>4706-13</pages>
				<abstract>Cauliflower mosaic virus (CaMV) is transmitted from plant to plant through a seemingly simple interaction with insect vectors. This process involves an aphid receptor and two viral proteins, P2 and P3. P2 binds to both the aphid receptor and P3, itself tightly associated with the virus particle, with the ensemble forming a transmissible viral complex. Here, we describe the conformations of both unliganded CaMV P3 protein and its virion-associated form. X-ray crystallography revealed that the N-terminal domain of unliganded P3 is a tetrameric parallel coiled coil with a unique organization showing two successive four-stranded subdomains with opposite supercoiling handedness stabilized by a ring of interchain disulfide bridges. A structural model of virus-liganded P3 proteins, folding as an antiparallel coiled-coil network coating the virus surface, was derived from molecular modeling. Our results highlight the structural and biological versatility of this coiled-coil structure and provide new insights into the molecular mechanisms involved in CaMV acquisition and transmission by the insect vector.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Virion-associated protein</name>
				<source_organism>Cauliflower mosaic virus</source_organism>
				<sequence>MANLNQIQKEVSEILSDQKSMKADIKAILELLGSQNPIKESLETVAAKIVNDLTKLINDCPCNKEILEALGTQPKEQLIEQPKEKGKGLNLGKYSYPNYGVGNEELGSSGNPKALTWPFKAPAGWPNQF</sequence>
				<length>129</length>
				<uniprot>
					<id>P03551</id>
					<start>1</start>
					<end>129</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03551</id>
					<start>1</start>
					<end>129</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03310.10</region_id>
						<region_name>Cauli_DNA-bind</region_name>
						<region_start>4</region_start>
						<region_end>124</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Virion-associated protein</name>
				<source_organism>Cauliflower mosaic virus</source_organism>
				<sequence>MANLNQIQKEVSEILSDQKSMKADIKAILELLGSQNPIKESLETVAAKIVNDLTKLINDCPCNKEILEALGTQPKEQLIEQPKEKGKGLNLGKYSYPNYGVGNEELGSSGNPKALTWPFKAPAGWPNQF</sequence>
				<length>129</length>
				<uniprot>
					<id>P03551</id>
					<start>1</start>
					<end>129</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03551</id>
					<start>1</start>
					<end>129</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03310.10</region_id>
						<region_name>Cauli_DNA-bind</region_name>
						<region_start>4</region_start>
						<region_end>124</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Virion-associated protein</name>
				<source_organism>Cauliflower mosaic virus</source_organism>
				<sequence>MANLNQIQKEVSEILSDQKSMKADIKAILELLGSQNPIKESLETVAAKIVNDLTKLINDCPCNKEILEALGTQPKEQLIEQPKEKGKGLNLGKYSYPNYGVGNEELGSSGNPKALTWPFKAPAGWPNQF</sequence>
				<length>129</length>
				<uniprot>
					<id>P03551</id>
					<start>1</start>
					<end>129</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03551</id>
					<start>1</start>
					<end>129</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03310.10</region_id>
						<region_name>Cauli_DNA-bind</region_name>
						<region_start>4</region_start>
						<region_end>124</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Virion-associated protein</name>
				<source_organism>Cauliflower mosaic virus</source_organism>
				<sequence>MANLNQIQKEVSEILSDQKSMKADIKAILELLGSQNPIKESLETVAAKIVNDLTKLINDCPCNKEILEALGTQPKEQLIEQPKEKGKGLNLGKYSYPNYGVGNEELGSSGNPKALTWPFKAPAGWPNQF</sequence>
				<length>129</length>
				<uniprot>
					<id>P03551</id>
					<start>1</start>
					<end>129</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03551</id>
					<start>1</start>
					<end>129</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03310.10</region_id>
						<region_name>Cauli_DNA-bind</region_name>
						<region_start>4</region_start>
						<region_end>124</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:20181714). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3k4t</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF5110001</accession>
		<general>
			<name>Assembly domain of cartilage oligomeric matrix protein (rat)</name>
			<pdb_id>1fbm</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.70</resolution>
			<assembly>homopentamer</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>9736606</pmid>
				<authors>Guo Y, Bozic D, Malashkevich VN, Kammerer RA, Schulthess T, Engel J</authors>
				<title>All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of cartilage oligomeric matrix protein.</title>
				<journal>EMBO J.</journal>
				<year>1998</year>
				<issue>18</issue>
				<volume>17</volume>
				<pages>5265-72</pages>
				<abstract>The potential storage and delivery function of cartilage oligomeric matrix protein (COMP) for cell signaling molecules was explored by binding hydrophobic compounds to the recombinant five-stranded coiled-coil domain of COMP. Complex formation with benzene, cyclohexane, vitamin D3 and elaidic acid was demonstrated through increases in denaturation temperatures of 2-10 degreesC. For all-trans retinol and all-trans retinoic acid, an equilibrium dissociation constant KD = 0.6 microM was evaluated by fluorescence titration. Binding of benzene and all-trans retinol into the hydrophobic axial pore of the COMP coiled-coil domain was proven by the X-ray crystal structures of the corresponding complexes at 0.25 and 0.27 nm resolution, respectively. Benzene binds with its plane perpendicular to the pore axis. The binding site is between the two internal rings formed by Leu37 and Thr40 pointing into the pore of the COMP coiled-coil domain. The retinol beta-ionone ring is positioned in a hydrophobic environment near Thr40, and the 1.1 nm long isoprene tail follows a completely hydrophobic region of the pore. Its terminal hydroxyl group complexes with a ring of the five side chains of Gln54. A mutant in which Gln54 is replaced by Ile binds all-trans retinol with affinity similar to the wild-type, demonstrating that hydrophobic interactions are predominant.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005509</accession>
					<name>calcium ion binding</name>
				</go>
				<go>
					<accession>GO:0005499</accession>
					<name>vitamin D binding</name>
				</go>
				<go>
					<accession>GO:0005201</accession>
					<name>extracellular matrix structural constituent</name>
				</go>
				<go>
					<accession>GO:0001968</accession>
					<name>fibronectin binding</name>
				</go>
				<go>
					<accession>GO:0008201</accession>
					<name>heparin binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006915</accession>
					<name>apoptotic process</name>
				</go>
				<go>
					<accession>GO:0030198</accession>
					<name>extracellular matrix organization</name>
				</go>
				<go>
					<accession>GO:0007155</accession>
					<name>cell adhesion</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005578</accession>
					<name>proteinaceous extracellular matrix</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>5</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (pentameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDACG</sequence>
				<length>46</length>
				<uniprot>
					<id>P35444</id>
					<start>27</start>
					<end>72</end>
					<coverage>6.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49747</id>
					<start>29</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDACG</sequence>
				<length>46</length>
				<uniprot>
					<id>P35444</id>
					<start>27</start>
					<end>72</end>
					<coverage>6.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49747</id>
					<start>29</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDACG</sequence>
				<length>46</length>
				<uniprot>
					<id>P35444</id>
					<start>27</start>
					<end>72</end>
					<coverage>6.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49747</id>
					<start>29</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDACG</sequence>
				<length>46</length>
				<uniprot>
					<id>P35444</id>
					<start>27</start>
					<end>72</end>
					<coverage>6.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49747</id>
					<start>29</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDACG</sequence>
				<length>46</length>
				<uniprot>
					<id>P35444</id>
					<start>27</start>
					<end>72</end>
					<coverage>6.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49747</id>
					<start>29</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:9736606). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1vdf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF5110002</accession>
		<general>
			<name>Assembly domain of cartilage oligomeric matrix protein (mouse)</name>
			<pdb_id>1mz9</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homopentamer</assembly>
			<source_organism>Mus musculus</source_organism>
			<publication>
				<pmid>12426368</pmid>
				<authors>Ozbek S, Engel J, Stetefeld J</authors>
				<title>Storage function of cartilage oligomeric matrix protein: the crystal structure of the coiled-coil domain in complex with vitamin D(3).</title>
				<journal>EMBO J.</journal>
				<year>2002</year>
				<issue>22</issue>
				<volume>21</volume>
				<pages>5960-8</pages>
				<abstract>The five-stranded coiled-coil domain of cartilage oligomeric matrix protein (COMPcc) forms a continuous axial pore with binding capacities for hydrophobic compounds, including prominent cell signalling molecules. Here, we report the X-ray structure of the COMPcc domain in complex with vitamin D(3) at 1.7 A resolution. The COMPcc pentamer harbours two molecules of the steroid hormone precursor in a planar s-trans conformation of the conjugated triene, with the aliphatic tails lying along the molecule axis. A hydrophilic ring of five Gln54 side chains divides the channel into two hydrophobic compartments in which the bound vitamin D(3) pair is fixed in a head-to-head orientation. Vitamin D(3) binding induces a volumetric increase of the cavities of approximately 30% while the main chain distances of the pentamer are retained. This adaptation to the bulky ring systems of the ligands is accomplished by a rotamer re-orientation of beta-branched side chains that form the knobs into holes of the coiled-coil structure. Compared with binding of vitamin D and retinoic acid by their classical receptors, COMP exerts a distinct mechanism of interaction mainly defined by the pattern of hydrophobic core residues.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005518</accession>
					<name>collagen binding</name>
				</go>
				<go>
					<accession>GO:0008201</accession>
					<name>heparin binding</name>
				</go>
				<go>
					<accession>GO:0005509</accession>
					<name>calcium ion binding</name>
				</go>
				<go>
					<accession>GO:0002020</accession>
					<name>protease binding</name>
				</go>
				<go>
					<accession>GO:0043395</accession>
					<name>heparan sulfate proteoglycan binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007155</accession>
					<name>cell adhesion</name>
				</go>
				<go>
					<accession>GO:0006915</accession>
					<name>apoptotic process</name>
				</go>
				<go>
					<accession>GO:0003417</accession>
					<name>growth plate cartilage development</name>
				</go>
				<go>
					<accession>GO:0043066</accession>
					<name>negative regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0060173</accession>
					<name>limb development</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005578</accession>
					<name>proteinaceous extracellular matrix</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>5</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (pentameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDAC</sequence>
				<length>45</length>
				<uniprot>
					<id>Q9R0G6</id>
					<start>27</start>
					<end>71</end>
					<coverage>6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9R0G6</id>
					<start>28</start>
					<end>71</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDAC</sequence>
				<length>45</length>
				<uniprot>
					<id>Q9R0G6</id>
					<start>27</start>
					<end>71</end>
					<coverage>6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9R0G6</id>
					<start>28</start>
					<end>71</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDAC</sequence>
				<length>45</length>
				<uniprot>
					<id>Q9R0G6</id>
					<start>27</start>
					<end>71</end>
					<coverage>6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9R0G6</id>
					<start>28</start>
					<end>71</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDAC</sequence>
				<length>45</length>
				<uniprot>
					<id>Q9R0G6</id>
					<start>27</start>
					<end>71</end>
					<coverage>6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9R0G6</id>
					<start>28</start>
					<end>71</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Cartilage oligomeric matrix protein</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MDLAPQMLRELQETNAALQDVRELLRQQVKEITFLKNTVMECDAC</sequence>
				<length>45</length>
				<uniprot>
					<id>Q9R0G6</id>
					<start>27</start>
					<end>71</end>
					<coverage>6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9R0G6</id>
					<start>28</start>
					<end>71</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11598.5</region_id>
						<region_name>COMP</region_name>
						<region_start>28</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12426368). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3v2n</pdb_id>
			<pdb_id>3v2p</pdb_id>
			<pdb_id>3v2q</pdb_id>
			<pdb_id>3v2r</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110006</accession>
		<general>
			<name>Leucine zipper domain of the c-Jun homodimer</name>
			<pdb_id>1jun</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Serinus canaria</source_organism>
			<publication>
				<pmid>8662824</pmid>
				<authors>Junius FK, O'Donoghue SI, Nilges M, Weiss AS, King GF</authors>
				<title>High resolution NMR solution structure of the leucine zipper domain of the c-Jun homodimer.</title>
				<journal>J. Biol. Chem.</journal>
				<year>1996</year>
				<issue>23</issue>
				<volume>271</volume>
				<pages>13663-7</pages>
				<abstract>The solution structure of the c-Jun leucine zipper domain has been determined to high resolution using a new calculation protocol designed to handle highly ambiguous sets of interproton distance restraints. The domain comprises a coiled coil of parallel alpha-helices in which most of the hydrophobic residues are buried at the highly symmetrical dimer interface; this interface extends over 10 helical turns and is the most elongated protein domain solved to date using NMR methods. The backbone fold is very similar to that seen in crystal structures of the GCN4 and Jun-Fos leucine zippers; however, in contrast with these crystal structures, the Jun leucine zipper dimer appears to be devoid of favorable intermolecular electrostatic interactions. A polar asparagine residue, located at the dimer interface, forms the sole point of asymmetry in the structure; furthermore, the side chain of this residue is disordered due to motional averaging. This residue, which is highly conserved in the leucine zipper family of transcription factors, provides a destabilizing influence that is likely to facilitate the rapid exchange of zipper strands in vivo.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0044212</accession>
					<name>transcription regulatory region DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007265</accession>
					<name>Ras protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcription factor AP-1</name>
				<source_organism>Serinus canaria</source_organism>
				<sequence>CGGRIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNY</sequence>
				<length>43</length>
				<uniprot>
					<id>P54864</id>
					<start>259</start>
					<end>298</end>
					<coverage>12.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P18870</id>
					<start>259</start>
					<end>298</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>259</region_start>
						<region_end>295</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00170.18</region_id>
						<region_name>bZIP_1</region_name>
						<region_start>233</region_start>
						<region_end>296</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcription factor AP-1</name>
				<source_organism>Serinus canaria</source_organism>
				<sequence>CGGRIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNY</sequence>
				<length>43</length>
				<uniprot>
					<id>P54864</id>
					<start>259</start>
					<end>298</end>
					<coverage>12.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P18870</id>
					<start>259</start>
					<end>298</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>259</region_start>
						<region_end>295</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00170.18</region_id>
						<region_name>bZIP_1</region_name>
						<region_start>233</region_start>
						<region_end>296</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:8662824). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1fos</pdb_id>
			<pdb_id>1jnm</pdb_id>
			<pdb_id>1s9k</pdb_id>
			<pdb_id>1t2k</pdb_id>
			<pdb_id>5t01</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110007</accession>
		<general>
			<name>Delta sleep-inducing peptide immunoreactive peptide A homolog</name>
			<pdb_id>1dip</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Sus scrofa</source_organism>
			<publication>
				<pmid>9388238</pmid>
				<authors>Seidel G, Adermann K, Schindler T, Ejchart A, Jaenicke R, Forssmann WG, Rösch P</authors>
				<title>Solution structure of porcine delta sleep-inducing peptide immunoreactive peptide A homolog of the shortsighted gene product.</title>
				<journal>J. Biol. Chem.</journal>
				<year>1997</year>
				<issue>49</issue>
				<volume>272</volume>
				<pages>30918-27</pages>
				<abstract>The 77-residue delta sleep-inducing peptide immunoreactive peptide (DIP) is a close homolog of the Drosophila melanogaster shortsighted gene product. Porcine DIP (pDIP) and a peptide containing a leucine zipper-related partial sequence of pDIP, pDIP(9-46), was synthesized and studied by circular dichroism and nuclear magnetic resonance spectroscopy in combination with molecular dynamics calculations. Ultracentrifugation, size exclusion chromatography, and model calculations indicated that pDIP forms a dimer. This was confirmed by the observation of concentration-dependent thermal folding-unfolding transitions. From CD spectroscopy and thermal folding-unfolding transitions of pDIP(9-46), it was concluded that the dimerization of pDIP is a result of interaction between helical structures localized in the leucine zipper motif. The three-dimensional structure of the protein was determined with a modified simulated annealing protocol using experimental data derived from nuclear magnetic resonance spectra and a modeling approach based on an established strategy for coiled coil structures. The left-handed super helical structure of the leucine zipper type sequence resulting from the modeling approach is in agreement with known leucine zipper structures. In addition to the hydrophobic interactions between the amino acids at the heptade positions a and d, the structure of pDIP is stabilized by the formation of interhelical i to i&apos; + 5 salt bridges. This result was confirmed by the pH dependence of the thermal-folding transitions. In addition to the amphipatic helix of the leucine zipper, a second helix is formed in the NH2-terminal part of pDIP. This helix exhibits more 310-helix character and is less stable than the leucine zipper helix. For the COOH-terminal region of pDIP no elements of regular secondary structure were observed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0070236</accession>
					<name>negative regulation of activation-induced cell death of T cells</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>TSC22 domain family protein 3</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>MDLVKNHLMYAVREEVEILKEQIRELVEKNSQLERENTLLKTLASPEQLEKFQSRLSPEEPAPETPEAPEAPGGSAV</sequence>
				<length>77</length>
				<uniprot>
					<id>P80220</id>
					<start>1</start>
					<end>77</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80220</id>
					<start>1</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>7</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01166.15</region_id>
						<region_name>TSC22</region_name>
						<region_start>1</region_start>
						<region_end>57</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>TSC22 domain family protein 3</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>MDLVKNHLMYAVREEVEILKEQIRELVEKNSQLERENTLLKTLASPEQLEKFQSRLSPEEPAPETPEAPEAPGGSAV</sequence>
				<length>77</length>
				<uniprot>
					<id>P80220</id>
					<start>1</start>
					<end>77</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80220</id>
					<start>1</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01166.15</region_id>
						<region_name>TSC22</region_name>
						<region_start>1</region_start>
						<region_end>57</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:9388238). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110008</accession>
		<general>
			<name>VBP leucine zipper</name>
			<pdb_id>4u5t</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>22851716</pmid>
				<authors>Zhao J, Stagno JR, Varticovski L, Nimako E, Rishi V, McKinnon K, Akee R, Shoemaker RH, Ji X, Vinson C</authors>
				<title>P6981, an arylstibonic acid, is a novel low nanomolar inhibitor of cAMP response element-binding protein binding to DNA.</title>
				<journal>Mol. Pharmacol.</journal>
				<year>2012</year>
				<issue>5</issue>
				<volume>82</volume>
				<pages>814-23</pages>
				<abstract>Several basic leucine zipper (B-ZIP) transcription factors have been implicated in cancer, substance abuse, and other pathological conditions. We previously identified arylstibonic acids that bind to B-ZIP proteins and inhibit their interaction with DNA. In this study, we used electrophoretic mobility shift assay to analyze 46 arylstibonic acids for their activity to disrupt the DNA binding of three B-ZIP [CCAAT/enhancer-binding protein α, cyclic AMP-response element-binding protein (CREB), and vitellogenin gene-binding protein (VBP)] and two basic helix-loop-helix leucine zipper (B-HLH-ZIP) [USF (upstream stimulating factor) and Mitf] proteins. Twenty-five arylstibonic acids showed activity at micromolar concentrations. The most active compound, P6981 [2-(3-stibonophenyl)malonic acid], had half-maximal inhibition at ~5 nM for CREB. Circular dichroism thermal denaturation studies indicated that P6981 binds both the B-ZIP domain and the leucine zipper. The crystal structure of an arylstibonic acid, NSC13778, bound to the VBP leucine zipper identified electrostatic interactions between both the stibonic and carboxylic acid groups of NSC13778 [(E)-3-(3-stibonophenyl)acrylic acid] and arginine side chains of VBP, which is also involved in interhelical salt bridges in the leucine zipper. P6981 induced GFP-B-ZIP chimeric proteins to partially localize to the cytoplasm, demonstrating that it is active in cells. P6981 inhibited the growth of a patient-derived clear cell sarcoma cell line whose oncogenic potential is driven by a chimeric protein EWS-ATF1 (Ewing&apos;s sarcoma protein-activating transcription factor 1), which contains the DNA binding domain of ATF1, a B-ZIP protein. NSC13778 inhibited the growth of xenografted clear cell sarcoma, and no toxicity was observed. These experiments suggest that antimony containing arylstibonic acids are promising leads for suppression of DNA binding activities of B-ZIP and B-HLH-ZIP transcription factors.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0000977</accession>
					<name>RNA polymerase II regulatory region sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007275</accession>
					<name>multicellular organism development</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcription factor VBP</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>RDPDLEIRAAFLEKENTALRTEVAELRKEVGRCKNIVSK</sequence>
				<length>39</length>
				<uniprot>
					<id>Q92172</id>
					<start>271</start>
					<end>305</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q92172</id>
					<start>271</start>
					<end>305</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>271</region_start>
						<region_end>303</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>242</region_start>
						<region_end>295</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcription factor VBP</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>RDPDLEIRAAFLEKENTALRTEVAELRKEVGRCKNIVSK</sequence>
				<length>39</length>
				<uniprot>
					<id>Q92172</id>
					<start>271</start>
					<end>305</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q92172</id>
					<start>271</start>
					<end>305</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>271</region_start>
						<region_end>303</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>242</region_start>
						<region_end>295</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:22851716). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF07716.12) has been experimentally characterized as disordered in DisProt entry DP00083.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF07716.12) has been experimentally characterized as disordered in DisProt entry DP00083.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100004</accession>
		<general>
			<name>SH2B adapter protein 2 dimerization domain</name>
			<pdb_id>1q2h</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>15378031</pmid>
				<authors>Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi YI, Shoelson SE</authors>
				<title>A phenylalanine zipper mediates APS dimerization.</title>
				<journal>Nat. Struct. Mol. Biol.</journal>
				<year>2004</year>
				<issue>10</issue>
				<volume>11</volume>
				<pages>968-74</pages>
				<abstract>The APS, SH2-B and LNK proteins are adapters that activate and modulate receptor tyrosine kinase and JAK/STAT signaling. We now show that a conserved N-terminal domain mediates APS homodimerization. We determined the crystal structure of the dimerization domain at a resolution of 1.7 A using bromide ion MAD phasing. Each molecule contributes two helices to a compact four-helix bundle having a bisecting-U topology. Its most conspicuous feature is a stack of interdigitated phenylalanine side chains at the domain core. These residues create a new motif we refer to as a &apos;phenylalanine zipper,' which is critical to dimerization. A newly developed bridging yeast tri-hybrid assay showed that APS dimerizes JAK2, insulin receptor and IGF1 receptor kinases using its SH2 and dimerization domains. Dimerization via the phenylalanine zipper domain provides a mechanism for activating and modulating tyrosine kinase activity even in the absence of extracellular ligands.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004871</accession>
					<name>signal transducer activity</name>
				</go>
				<go>
					<accession>GO:0005070</accession>
					<name>SH3/SH2 adaptor activity</name>
				</go>
				<go>
					<accession>GO:0008269</accession>
					<name>JAK pathway signal transduction adaptor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0035556</accession>
					<name>intracellular signal transduction</name>
				</go>
				<go>
					<accession>GO:0007596</accession>
					<name>blood coagulation</name>
				</go>
				<go>
					<accession>GO:0008286</accession>
					<name>insulin receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0046425</accession>
					<name>regulation of JAK-STAT cascade</name>
				</go>
				<go>
					<accession>GO:0009967</accession>
					<name>positive regulation of signal transduction</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain C was removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Phenylalanine zipper (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>SH2B adapter protein 2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMPDWRQFCELHAQAAAVDFAHKFCRFLRDNPAYDTPDAGASFSRHFAANFLDVFGEEVRRVLVAGP</sequence>
				<length>69</length>
				<uniprot>
					<id>O14492</id>
					<start>17</start>
					<end>85</end>
					<coverage>10.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14492</id>
					<start>20</start>
					<end>85</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08916.8</region_id>
						<region_name>Phe_ZIP</region_name>
						<region_start>22</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>SH2B adapter protein 2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMPDWRQFCELHAQAAAVDFAHKFCRFLRDNPAYDTPDAGASFSRHFAANFLDVFGEEVRRVLVAGP</sequence>
				<length>69</length>
				<uniprot>
					<id>O14492</id>
					<start>17</start>
					<end>85</end>
					<coverage>10.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O14492</id>
					<start>20</start>
					<end>85</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08916.8</region_id>
						<region_name>Phe_ZIP</region_name>
						<region_start>22</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:15378031). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2202001</accession>
		<general>
			<name>GTPase binding domain of neural Wiskott-Aldrich syndrome protein in complex with E. coli EspF(U)</name>
			<pdb_id>2lnh</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Escherichia coli O157:H7</source_organism>
			<publication>
				<pmid>22921828</pmid>
				<authors>Aitio O, Hellman M, Skehan B, Kesti T, Leong JM, Saksela K, Permi P</authors>
				<title>Enterohaemorrhagic Escherichia Coli Exploits a Tryptophan Switch to Hijack Host F-Actin Assembly.</title>
				<journal>Structure</journal>
				<year>2012</year>
				<abstract>Intrinsically disordered protein (IDP)-mediated interactions are often characterized by low affinity but high specificity. These traits are essential in signaling and regulation that require reversibility. Enterohaemorrhagic Escherichia coli (EHEC) exploit this situation by commandeering host cytoskeletal signaling to stimulate actin assembly beneath bound bacteria, generating &amp;quot;pedestals" that promote intestinal colonization. EHEC translocates two proteins, EspF(U) and Tir, which form a complex with the host protein IRTKS. The interaction of this complex with N-WASP triggers localized actin polymerization. We show that EspF(U) is an IDP that contains a transiently α-helical N-terminus and dynamic C-terminus. Our structure shows that single EspF(U) repeat forms a high-affinity trimolecular complex with N-WASP and IRTKS. We demonstrate that bacterial and cellular ligands interact with IRTKS SH3 in a similar fashion, but the bacterial protein has evolved to outcompete cellular targets by utilizing a tryptophan switch that offers superior binding affinity enabling EHEC-induced pedestal formation.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was removed as it is ordered and does not directly contribute to the interaction between chains A and C. Chain C was truncated to exclude the region in contact with chain B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Neural Wiskott-Aldrich syndrome protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSNFQHIGHVGWDPNTGFDLNNLDPELKNLFDMCGISEAQLKDRETSKVIYDFIEKTGGVEAVKN</sequence>
				<length>65</length>
				<uniprot>
					<id>O00401</id>
					<start>206</start>
					<end>270</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O00401</id>
					<start>207</start>
					<end>270</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>217</region_start>
						<region_end>218</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>222</region_start>
						<region_end>223</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>225</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>232</region_start>
						<region_end>239</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>243</region_start>
						<region_end>246</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>252</region_start>
						<region_end>262</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>265</region_start>
						<region_end>269</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00786.25</region_id>
						<region_name>PBD</region_name>
						<region_start>202</region_start>
						<region_end>261</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Secreted effector protein EspF(U)</name>
				<source_organism>Escherichia coli O157:H7</source_organism>
				<sequence>GLPDVAQRLMQHLAEHGIQPARNMAEHIPPAPNWPAPTPPVQNEQSRP</sequence>
				<length>48</length>
				<uniprot>
					<id>P0DJ89</id>
					<start>220</start>
					<end>267</end>
					<coverage>14.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0DJ88</id>
					<start>221</start>
					<end>267</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>222</region_start>
						<region_end>232</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04806.9</region_id>
						<region_name>EspF</region_name>
						<region_start>190</region_start>
						<region_end>236</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04806.9</region_id>
						<region_name>EspF</region_name>
						<region_start>237</region_start>
						<region_end>283</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00786.25) has been experimentally characterized as disordered in DisProt entry DP00215 and IDEAL entry IID00269.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>The 221-314 region described in IDEAL entry IID90008 covers 97.9% of the sequence present in the structure. The interacting region has also been shown to be disordered in the structure's source publication (PMID:22921828).</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2220001</accession>
		<general>
			<name>CesA-EspA complex</name>
			<pdb_id>1xou</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.80</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>15619638</pmid>
				<authors>Yip CK, Finlay BB, Strynadka NC</authors>
				<title>Structural characterization of a type III secretion system filament protein in complex with its chaperone.</title>
				<journal>Nat. Struct. Mol. Biol.</journal>
				<year>2005</year>
				<issue>1</issue>
				<volume>12</volume>
				<pages>75-81</pages>
				<abstract>The type III secretion system (TTSS) mediates the specific translocation of bacterial proteins into the cytoplasm of eukaryotic cells, a process essential for the virulence of many Gram-negative pathogens. The enteropathogenic Escherichia coli TTSS protein EspA forms a hollow extracellular filament believed to be a molecular conduit for type III protein translocation. Structural analysis of EspA has been hampered by its polymeric nature. We show that EspA alone is sufficient to form filamentous structures in the absence of other pathogenicity island-encoded proteins. CesA is the recently proposed chaperone of EspA, and we demonstrate that CesA traps EspA in a monomeric state and inhibits its polymerization. Crystallographic analysis of the heterodimeric CesA-EspA complex at a resolution of 2.8 A reveals that EspA contains two long a-helices, which are involved in extensive coiled-coil interactions with CesA.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>EspA</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MDTSTTASVASANASTSTSMAYDLGSMSKDDVIDLFNKLGVFQAAILMFAYMYQAQSDLSIAKFADMNEASKESTTAQKMANLVDAKIADVQSSSDKNAKAQLPDEVISYINDPRNDITISGIDNINAQLGAGDLQTVKAAISAKANNLTTTVNNSQLEIQQMSNTLNLLTSARSDMQSLQYRTISGISLGK</sequence>
				<length>192</length>
				<uniprot>
					<id>Q47184</id>
					<start>1</start>
					<end>192</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q47184</id>
					<start>1</start>
					<end>192</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>151</region_start>
						<region_end>162</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>164</region_start>
						<region_end>176</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>178</region_start>
						<region_end>190</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03433.10</region_id>
						<region_name>EspA</region_name>
						<region_start>2</region_start>
						<region_end>185</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>L0052</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MGIVSQTRNKELLDKKIRSEIEAIKKIIAEFDVVKESVNELSEKAKTDPQAAEKLNKLIEGYTYGEERKLYDSALSKIEKLIETLSPARSKSQST</sequence>
				<length>95</length>
				<uniprot>
					<id>O52124</id>
					<start>1</start>
					<end>95</end>
					<coverage>88.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O52124</id>
					<start>1</start>
					<end>95</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>66</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11439.5</region_id>
						<region_name>T3SchapCesA</region_name>
						<region_start>1</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:15619638). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120012</accession>
		<general>
			<name>Cell division factor ZapA (mutant)</name>
			<pdb_id>2mmv</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Geobacillus kaustophilus</source_organism>
			<publication>
				<authors>Nogueira, M.L., Sforca, M., Zeri, A.</authors>
				<title>Zapa mutant dimer from B. stearothermophilus</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0090529</accession>
					<name>cell septum assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Geobacillus kaustophilus</source_organism>
				<sequence>GSHMTEQPKTRVSVRIYGQDYTIVGAESPAHIRLVAAFVDDKMHEFSEKQPMLDVPKLAVLTAVQIASEYLKLKEEYQRLREQLKK</sequence>
				<length>86</length>
				<uniprot>
					<id>Q5KWF5</id>
					<start>1</start>
					<end>83</end>
					<coverage>91.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q5KWF5</id>
					<start>1</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>8</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>9</region_start>
						<region_end>89</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Geobacillus kaustophilus</source_organism>
				<sequence>GSHMTEQPKTRVSVRIYGQDYTIVGAESPAHIRLVAAFVDDKMHEFSEKQPMLDVPKLAVLTAVQIASEYLKLKEEYQRLREQLKK</sequence>
				<length>86</length>
				<uniprot>
					<id>Q5KWF5</id>
					<start>1</start>
					<end>83</end>
					<coverage>91.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q5KWF5</id>
					<start>1</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>8</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>9</region_start>
						<region_end>89</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120013</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Brucella melitensis)</name>
			<pdb_id>4q14</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Brucella melitensis biotype 1</source_organism>
			<publication>
				<authors>Seattle Structural Genomics Center for Infectious Disease (SSGCID), Abendroth, J., Lorimer, D., Edwards, T.E.</authors>
				<title>Crystal structure of 5-hydroxyisourate hydrolase from Brucella melitensis</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Brucella melitensis biotype 1</source_organism>
				<sequence>MAHHHHHHMGTLEAQTQGPGSMGKLSTHVLDTAHGTPAAAMRVELYRIAASGTPELLKRVVTNLDGRTDAPLLSGDEMRTGIYELQFHVAEYFEGRGAELAHEPFLDLIPIRFGIADEDGNYHVPLLVSPWSYSTYRGS</sequence>
				<length>139</length>
				<uniprot>
					<id>Q8YFU1</id>
					<start>1</start>
					<end>118</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8YFU1</id>
					<start>1</start>
					<end>118</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>117</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Brucella melitensis biotype 1</source_organism>
				<sequence>MAHHHHHHMGTLEAQTQGPGSMGKLSTHVLDTAHGTPAAAMRVELYRIAASGTPELLKRVVTNLDGRTDAPLLSGDEMRTGIYELQFHVAEYFEGRGAELAHEPFLDLIPIRFGIADEDGNYHVPLLVSPWSYSTYRGS</sequence>
				<length>139</length>
				<uniprot>
					<id>Q8YFU1</id>
					<start>1</start>
					<end>118</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8YFU1</id>
					<start>1</start>
					<end>118</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>117</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4120002</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Salmonella dublin)</name>
			<pdb_id>2gpz</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Salmonella typhi</source_organism>
			<publication>
				<pmid>16787778</pmid>
				<authors>Hennebry SC, Law RH, Richardson SJ, Buckle AM, Whisstock JC</authors>
				<title>The crystal structure of the transthyretin-like protein from Salmonella dublin, a prokaryote 5-hydroxyisourate hydrolase.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2006</year>
				<issue>5</issue>
				<volume>359</volume>
				<pages>1389-99</pages>
				<abstract>The mechanism of binding of thyroid hormones by the transport protein transthyretin (TTR) in vertebrates is structurally well characterised. However, a homologous family of transthyretin-like proteins (TLPs) present in bacteria as well as eukaryotes do not bind thyroid hormones, instead they are postulated to perform a role in the purine degradation pathway and function as 5-hydroxyisourate hydrolases. Here we describe the 2.5 Angstroms X-ray crystal structure of the TLP from the Gram-negative bacterium Salmonella dublin, and compare and contrast its structure with vertebrate TTRs. The overall architecture of the homotetramer is conserved and, despite low sequence homology with vertebrate TTRs, structural differences within the monomer are restricted to flexible loop regions. However, sequence variation at the dimer-dimer interface has profound consequences for the ligand binding site and provides a structural rationalisation for the absence of thyroid hormone binding affinity in bacterial TLPs: the deep, negatively charged thyroxine-binding pocket that characterises vertebrate TTR contrasts with a shallow and elongated, positively charged cleft in S. dublin TLP. We have demonstrated that Sdu_TLP is a 5-hydroxyisourate hydrolase. Furthermore, using site-directed mutagenesis, we have identified three conserved residues located in this cleft that are critical to the enzyme activity. Together our data reveal that the active site of Sdu_TLP corresponds to the thyroxine binding site in TTRs.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042597</accession>
					<name>periplasmic space</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were generated from chains A and B respectively, using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Salmonella typhi</source_organism>
				<sequence>MILSVHILDQQTGKPAPGVEVVLEQKKDNGWTQLNTGHTDQDGRIKALWPEKAAAPGDYRVIFKTGQYFESKKLDTFFPEIPVEFHISKTNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>111</length>
				<uniprot>
					<id>Q8Z7Q6</id>
					<start>27</start>
					<end>136</end>
					<coverage>80.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q4VYA5</id>
					<start>27</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>135</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Salmonella typhi</source_organism>
				<sequence>MILSVHILDQQTGKPAPGVEVVLEQKKDNGWTQLNTGHTDQDGRIKALWPEKAAAPGDYRVIFKTGQYFESKKLDTFFPEIPVEFHISKTNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>111</length>
				<uniprot>
					<id>Q8Z7Q6</id>
					<start>27</start>
					<end>136</end>
					<coverage>80.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q4VYA5</id>
					<start>27</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>135</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Salmonella typhi</source_organism>
				<sequence>MILSVHILDQQTGKPAPGVEVVLEQKKDNGWTQLNTGHTDQDGRIKALWPEKAAAPGDYRVIFKTGQYFESKKLDTFFPEIPVEFHISKTNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>111</length>
				<uniprot>
					<id>Q8Z7Q6</id>
					<start>27</start>
					<end>136</end>
					<coverage>80.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q4VYA5</id>
					<start>27</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>135</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Salmonella typhi</source_organism>
				<sequence>MILSVHILDQQTGKPAPGVEVVLEQKKDNGWTQLNTGHTDQDGRIKALWPEKAAAPGDYRVIFKTGQYFESKKLDTFFPEIPVEFHISKTNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>111</length>
				<uniprot>
					<id>Q8Z7Q6</id>
					<start>27</start>
					<end>136</end>
					<coverage>80.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q4VYA5</id>
					<start>27</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>135</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18 and the publication PMID:16787778). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4120003</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Bacillus subtilis)</name>
			<pdb_id>2h0e</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Bacillus subtilis</source_organism>
			<publication>
				<pmid>16782815</pmid>
				<authors>Jung DK, Lee Y, Park SG, Park BC, Kim GH, Rhee S</authors>
				<title>Structural and functional analysis of PucM, a hydrolase in the ureide pathway and a member of the transthyretin-related protein family.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2006</year>
				<issue>26</issue>
				<volume>103</volume>
				<pages>9790-5</pages>
				<abstract>The ureide pathway, which produces ureides from uric acid, is an essential purine catabolic process for storing and transporting the nitrogen fixed in leguminous plants and some bacteria. PucM from Bacillus subtilis was recently characterized and found to catalyze the second reaction of the pathway, hydrolyzing 5-hydroxyisourate (HIU), a product of uricase in the first step. PucM has 121 amino acid residues and shows high sequence similarity to the functionally unrelated protein transthyretin (TTR), a thyroid hormone-binding protein. Therefore, PucM belongs to the TTR-related proteins (TRP) family. The crystal structures of PucM at 2.0 A and its complexes with the substrate analogs 8-azaxanthine and 5,6-diaminouracil reveal that even with their overall structure similarity, homotetrameric PucM and TTR are completely different, both in their electrostatic potential and in the size of the active sites located at the dimeric interface. Nevertheless, the absolutely conserved residues across the TRP family, including His-14, Arg-49, His-105, and the C-terminal Tyr-118-Arg-119-Gly-120-Ser-121, indeed form the active site of PucM. Based on the results of site-directed mutagenesis of these residues, we propose a possible mechanism for HIU hydrolysis. The PucM structure determined for the TRP family leads to the conclusion that diverse members of the TRP family would function similarly to PucM as HIU hydrolase.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
				<go>
					<accession>GO:0019628</accession>
					<name>urate catabolic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D and E were generated from chain A using the biomatrices described in the original PDB file. Chain B was removed as chains A, C, D and E represent the biologically relevant tetramer.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>MSEPESLMGKLTTHILDLTCGKPAANVKIGLKRLGESIMKEVYTNNDGRVDVPLLAGEELMSGEYVMEFHAGDYFASKNMNAADQPFLTIVTVRFQLADPDAHYHIPLLLSPFGYQVYRGS</sequence>
				<length>121</length>
				<uniprot>
					<id>O32142</id>
					<start>1</start>
					<end>114</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O32142</id>
					<start>1</start>
					<end>114</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>105</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>MSEPESLMGKLTTHILDLTCGKPAANVKIGLKRLGESIMKEVYTNNDGRVDVPLLAGEELMSGEYVMEFHAGDYFASKNMNAADQPFLTIVTVRFQLADPDAHYHIPLLLSPFGYQVYRGS</sequence>
				<length>121</length>
				<uniprot>
					<id>O32142</id>
					<start>1</start>
					<end>114</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O32142</id>
					<start>1</start>
					<end>114</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>105</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>MSEPESLMGKLTTHILDLTCGKPAANVKIGLKRLGESIMKEVYTNNDGRVDVPLLAGEELMSGEYVMEFHAGDYFASKNMNAADQPFLTIVTVRFQLADPDAHYHIPLLLSPFGYQVYRGS</sequence>
				<length>121</length>
				<uniprot>
					<id>O32142</id>
					<start>1</start>
					<end>114</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O32142</id>
					<start>1</start>
					<end>114</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>105</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>MSEPESLMGKLTTHILDLTCGKPAANVKIGLKRLGESIMKEVYTNNDGRVDVPLLAGEELMSGEYVMEFHAGDYFASKNMNAADQPFLTIVTVRFQLADPDAHYHIPLLLSPFGYQVYRGS</sequence>
				<length>121</length>
				<uniprot>
					<id>O32142</id>
					<start>1</start>
					<end>114</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O32142</id>
					<start>1</start>
					<end>114</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>105</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>111</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18 and the publication PMID:16782815). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2h0f</pdb_id>
			<pdb_id>2h0j</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4120004</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Klebsiella pneumoniae)</name>
			<pdb_id>3qva</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.75</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Klebsiella pneumoniae subsp. pneumoniae</source_organism>
			<publication>
				<pmid>21795808</pmid>
				<authors>French JB, Ealick SE</authors>
				<title>Structural and kinetic insights into the mechanism of 5-hydroxyisourate hydrolase from Klebsiella pneumoniae.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2011</year>
				<issue>Pt 8</issue>
				<volume>67</volume>
				<pages>671-7</pages>
				<abstract>The stereospecific oxidative degradation of uric acid to (S)-allantoin has recently been demonstrated to proceed via two unstable intermediates and requires three separate enzymatic reactions. The second step of this reaction, the conversion of 5-hydroxyisourate (HIU) to 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline, is catalyzed by HIU hydrolase (HIUH). The high-resolution crystal structure of HIUH from the opportunistic pathogen Klebsiella pneumoniae (KpHIUH) has been determined. KpHIUH is a homotetrameric protein that, based on sequence and structural similarity, belongs to the transthyretin-related protein family. In addition, the steady-state kinetic parameters for this enzyme and four active-site mutants have been measured. These data provide valuable insight into the functional roles of the active-site residues. Based upon the structural and kinetic data, a mechanism is proposed for the KpHIUH-catalyzed reaction.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transthyretin-like protein</name>
				<source_organism>Klebsiella pneumoniae subsp. pneumoniae</source_organism>
				<sequence>ENLYFQGHMSTLSTHILDISTGTPAEGVTVSLSREGETLANLVTNAQGRIATFSAAPLPAGRYCLTAETGAWFARAGRESVFTRAQIDFVIGEAAEDHFHLPFLIAPGGWSTYRGS</sequence>
				<length>116</length>
				<uniprot>
					<id>A6T926</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R4YDW2</id>
					<start>1</start>
					<end>108</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>2</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transthyretin-like protein</name>
				<source_organism>Klebsiella pneumoniae subsp. pneumoniae</source_organism>
				<sequence>ENLYFQGHMSTLSTHILDISTGTPAEGVTVSLSREGETLANLVTNAQGRIATFSAAPLPAGRYCLTAETGAWFARAGRESVFTRAQIDFVIGEAAEDHFHLPFLIAPGGWSTYRGS</sequence>
				<length>116</length>
				<uniprot>
					<id>A6T926</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R4YDW2</id>
					<start>1</start>
					<end>108</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transthyretin-like protein</name>
				<source_organism>Klebsiella pneumoniae subsp. pneumoniae</source_organism>
				<sequence>ENLYFQGHMSTLSTHILDISTGTPAEGVTVSLSREGETLANLVTNAQGRIATFSAAPLPAGRYCLTAETGAWFARAGRESVFTRAQIDFVIGEAAEDHFHLPFLIAPGGWSTYRGS</sequence>
				<length>116</length>
				<uniprot>
					<id>A6T926</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R4YDW2</id>
					<start>1</start>
					<end>108</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Transthyretin-like protein</name>
				<source_organism>Klebsiella pneumoniae subsp. pneumoniae</source_organism>
				<sequence>ENLYFQGHMSTLSTHILDISTGTPAEGVTVSLSREGETLANLVTNAQGRIATFSAAPLPAGRYCLTAETGAWFARAGRESVFTRAQIDFVIGEAAEDHFHLPFLIAPGGWSTYRGS</sequence>
				<length>116</length>
				<uniprot>
					<id>A6T926</id>
					<start>1</start>
					<end>108</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R4YDW2</id>
					<start>1</start>
					<end>108</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>16</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>4</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18 and the publication PMID:21795808). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4120005</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Escherichia coli)</name>
			<pdb_id>2g2n</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.65</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>16723258</pmid>
				<authors>Lundberg E, Bäckström S, Sauer UH, Sauer-Eriksson AE</authors>
				<title>The transthyretin-related protein: structural investigation of a novel protein family.</title>
				<journal>J. Struct. Biol.</journal>
				<year>2006</year>
				<issue>3</issue>
				<volume>155</volume>
				<pages>445-57</pages>
				<abstract>The transthyretin-related protein (TRP) family comprises proteins predicted to be structurally related to the homotetrameric transport protein transthyretin (TTR). The function of TRPs is not yet fully established, but recent data suggest that they are involved in purine catabolism. We have determined the three-dimensional structure of the Escherichia coli TRP in two crystal forms; one at 1.65 A resolution in the presence of zinc, and the other at 2.1 A resolution in the presence of zinc and bromide. The structures revealed five zinc-ion-binding sites per monomer. Of these, the zinc ions bound at sites I and II are coordinated in tetrahedral geometries to the side chains of residues His9, His96, His98, Ser114, and three water molecules at the putative ligand-binding site. Of these four residues, His9, His98, and Ser114 are conserved. His9 and His98 bind the central zinc (site I) together with two water molecules. The side chain of His98 also binds to the zinc ion at site II. Bromide ions bind at site I only, replacing one of the water molecules coordinated to the zinc ion. The C-terminal four amino acid sequence motif Y-[RK]-G-[ST] constitutes the signature sequence of the TRP family. Two Tyr111 residues form direct hydrogen bonds to each other over the tetramer interface at the area, which in TTR constitutes the rear part of its thyroxine-binding channel. The putative substrate/ligand-binding channel of TRP is consequently shallower and broader than its counterpart in TTR.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042597</accession>
					<name>periplasmic space</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AQQNILSVHILNQQTGKPAADVTVTLEKKADNGWLQLNTAKTDKDGRIKALWPEQTATTGDYRVVFKTGDYFKKQNLESFFPEIPVEFHINKVNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>114</length>
				<uniprot>
					<id>P76341</id>
					<start>24</start>
					<end>137</end>
					<coverage>83.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P76341</id>
					<start>24</start>
					<end>137</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>130</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>29</region_start>
						<region_end>136</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AQQNILSVHILNQQTGKPAADVTVTLEKKADNGWLQLNTAKTDKDGRIKALWPEQTATTGDYRVVFKTGDYFKKQNLESFFPEIPVEFHINKVNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>114</length>
				<uniprot>
					<id>P76341</id>
					<start>24</start>
					<end>137</end>
					<coverage>83.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P76341</id>
					<start>24</start>
					<end>137</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>130</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>29</region_start>
						<region_end>136</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AQQNILSVHILNQQTGKPAADVTVTLEKKADNGWLQLNTAKTDKDGRIKALWPEQTATTGDYRVVFKTGDYFKKQNLESFFPEIPVEFHINKVNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>114</length>
				<uniprot>
					<id>P76341</id>
					<start>24</start>
					<end>137</end>
					<coverage>83.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P76341</id>
					<start>24</start>
					<end>137</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>130</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>29</region_start>
						<region_end>136</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AQQNILSVHILNQQTGKPAADVTVTLEKKADNGWLQLNTAKTDKDGRIKALWPEQTATTGDYRVVFKTGDYFKKQNLESFFPEIPVEFHINKVNEHYHVPLLLSQYGYSTYRGS</sequence>
				<length>114</length>
				<uniprot>
					<id>P76341</id>
					<start>24</start>
					<end>137</end>
					<coverage>83.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P76341</id>
					<start>24</start>
					<end>137</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>130</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>29</region_start>
						<region_end>136</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18 and the publication PMID:16723258). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2g2p</pdb_id>
			<pdb_id>2igl</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110003</accession>
		<general>
			<name>5-hydroxyisourate hydrolase (Danio rerio)</name>
			<pdb_id>2h1x</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.98</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Danio rerio</source_organism>
			<publication>
				<pmid>16952372</pmid>
				<authors>Zanotti G, Cendron L, Ramazzina I, Folli C, Percudani R, Berni R</authors>
				<title>Structure of zebra fish HIUase: insights into evolution of an enzyme to a hormone transporter.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2006</year>
				<issue>1</issue>
				<volume>363</volume>
				<pages>1-9</pages>
				<abstract>During early vertebrate evolution, a duplication event in the gene encoding 5-hydroxyisourate hydrolase (HIUase), a widely distributed enzyme of purine metabolism, gave rise to transthyretin (TTR), a thyroid hormone transporter. We report here on the crystal structure of zebra fish HIUase in two different crystal forms. Despite the phylogenetic distance, this structure compares well with those of newly characterized bacterial HIUases, especially with regard to catalytic regions, which are highly preserved. Comparison with TTR structure reveals a highly conserved scaffold, harbouring distinct functional sites located in the same regions of the two vertebrate proteins. Residues that are differentially conserved in HIUases compared to TTR map in putative catalytic regions occupying significant portions of the two halves of a central channel that transverses the whole TTR protein. The evolution of TTR has been accompanied by remarkable changes of the HIUase active sites that gave rise to a channel open at both ends, thus allowing free access to hormone molecules.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0033971</accession>
					<name>hydroxyisourate hydrolase activity</name>
				</go>
				<go>
					<accession>GO:0016811</accession>
					<name>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0019628</accession>
					<name>urate catabolic process</name>
				</go>
				<go>
					<accession>GO:0006144</accession>
					<name>purine nucleobase metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005777</accession>
					<name>peroxisome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>HIUase</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>MAATLLSPLSTHVLNIAQGVPGANMTIVLHRLDPVSSAWNILTTGITNDDGRCPGLITKENFIAGVYKMRFETGKYWDALGETCFYPYVEIVFTITNTSQHYHVPLLLSRFSYSTYRGS</sequence>
				<length>119</length>
				<uniprot>
					<id>Q06S87</id>
					<start>20</start>
					<end>138</end>
					<coverage>86.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06S87</id>
					<start>20</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>MAATLLSPLSTHVLNIAQGVPGANMTIVLHRLDPVSSAWNILTTGITNDDGRCPGLITKENFIAGVYKMRFETGKYWDALGETCFYPYVEIVFTITNTSQHYHVPLLLSRFSYSTYRGS</sequence>
				<length>119</length>
				<uniprot>
					<id>Q06S87</id>
					<start>20</start>
					<end>138</end>
					<coverage>86.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06S87</id>
					<start>20</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>78</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>MAATLLSPLSTHVLNIAQGVPGANMTIVLHRLDPVSSAWNILTTGITNDDGRCPGLITKENFIAGVYKMRFETGKYWDALGETCFYPYVEIVFTITNTSQHYHVPLLLSRFSYSTYRGS</sequence>
				<length>119</length>
				<uniprot>
					<id>Q06S87</id>
					<start>20</start>
					<end>138</end>
					<coverage>86.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06S87</id>
					<start>20</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>78</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>5-hydroxyisourate hydrolase</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>MAATLLSPLSTHVLNIAQGVPGANMTIVLHRLDPVSSAWNILTTGITNDDGRCPGLITKENFIAGVYKMRFETGKYWDALGETCFYPYVEIVFTITNTSQHYHVPLLLSRFSYSTYRGS</sequence>
				<length>119</length>
				<uniprot>
					<id>Q06S87</id>
					<start>20</start>
					<end>138</end>
					<coverage>86.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06S87</id>
					<start>20</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>108</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>28</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The protein belongs to the 5-hydroxyisourate hydrolase (HIUase)/transthyretin protein family. Accordingly, the complex adopts a transthyterin-like fold (based on Pfam entry PF00576.18 and the publication PMID:16952372). Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2h6u</pdb_id>
			<pdb_id>3iwu</pdb_id>
			<pdb_id>3iwv</pdb_id>
			<pdb_id>3q1e</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110004</accession>
		<general>
			<name>Oligomerization region of the general control protein GCN4 </name>
			<pdb_id>2b1f</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.50</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>16472744</pmid>
				<authors>Deng Y, Liu J, Zheng Q, Eliezer D, Kallenbach NR, Lu M</authors>
				<title>Antiparallel four-stranded coiled coil specified by a 3-3-1 hydrophobic heptad repeat.</title>
				<journal>Structure</journal>
				<year>2006</year>
				<issue>2</issue>
				<volume>14</volume>
				<pages>247-55</pages>
				<abstract>Coiled-coil sequences in proteins commonly share a seven-amino acid repeat with nonpolar side chains at the first (a) and fourth (d) positions. We investigate here the role of a 3-3-1 hydrophobic repeat containing nonpolar amino acids at the a, d, and g positions in determining the structures of coiled coils using mutants of the GCN4 leucine zipper dimerization domain. When three charged residues at the g positions in the parental sequence are replaced by nonpolar alanine or valine side chains, stable four-helix structures result. The X-ray crystal structures of the tetramers reveal antiparallel, four-stranded coiled coils in which the a, d, and g side chains interlock in a combination of knobs-into-knobs and knobs-into-holes packing. Interfacial interactions in a coiled coil can therefore be prescribed by hydrophobic-polar patterns beyond the canonical 3-4 heptad repeat. The results suggest that the conserved, charged residues at the g positions in the GCN4 leucine zipper can impart a negative design element to disfavor thermodynamically more stable, antiparallel tetramers.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0001190</accession>
					<name>transcriptional activator activity, RNA polymerase II transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0001135</accession>
					<name>transcription factor activity, RNA polymerase II transcription factor recruiting</name>
				</go>
				<go>
					<accession>GO:0001084</accession>
					<name>transcription factor activity, TFIID-class binding</name>
				</go>
				<go>
					<accession>GO:0000981</accession>
					<name>RNA polymerase II transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010691</accession>
					<name>negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter in response to nutrient levels</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:1903833</accession>
					<name>positive regulation of cellular response to amino acid starvation</name>
				</go>
				<go>
					<accession>GO:0045899</accession>
					<name>positive regulation of RNA polymerase II transcriptional preinitiation complex assembly</name>
				</go>
				<go>
					<accession>GO:0001080</accession>
					<name>nitrogen catabolite activation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0008652</accession>
					<name>cellular amino acid biosynthetic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>General control protein GCN4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MKVKQLEDAVEELLSANYHLENAVARLKKLVGER</sequence>
				<length>34</length>
				<uniprot>
					<id>P03069</id>
					<start>249</start>
					<end>281</end>
					<coverage>11.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03069</id>
					<start>249</start>
					<end>281</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>250</region_start>
						<region_end>278</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>224</region_start>
						<region_end>276</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>General control protein GCN4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MKVKQLEDAVEELLSANYHLENAVARLKKLVGER</sequence>
				<length>34</length>
				<uniprot>
					<id>P03069</id>
					<start>249</start>
					<end>281</end>
					<coverage>11.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03069</id>
					<start>249</start>
					<end>281</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>250</region_start>
						<region_end>278</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>224</region_start>
						<region_end>276</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>General control protein GCN4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MKVKQLEDAVEELLSANYHLENAVARLKKLVGER</sequence>
				<length>34</length>
				<uniprot>
					<id>P03069</id>
					<start>249</start>
					<end>281</end>
					<coverage>11.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03069</id>
					<start>249</start>
					<end>281</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>250</region_start>
						<region_end>278</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>224</region_start>
						<region_end>276</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>General control protein GCN4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MKVKQLEDAVEELLSANYHLENAVARLKKLVGER</sequence>
				<length>34</length>
				<uniprot>
					<id>P03069</id>
					<start>249</start>
					<end>281</end>
					<coverage>11.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03069</id>
					<start>249</start>
					<end>281</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>251</region_start>
						<region_end>277</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>224</region_start>
						<region_end>276</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively. In the specific case of GCN4 refolding studies have explicitly shown that structure formation and dimerization happens at the same time (PMID:7548036)</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 225-281 region described in DisProt entry DP00083 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 225-281 region described in DisProt entry DP00083 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>The 225-281 region described in DisProt entry DP00083 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>D</chain_id>
				<support>The 225-281 region described in DisProt entry DP00083 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ce9</pdb_id>
			<pdb_id>1dgc</pdb_id>
			<pdb_id>1env</pdb_id>
			<pdb_id>1fav</pdb_id>
			<pdb_id>1fmh</pdb_id>
			<pdb_id>1gcl</pdb_id>
			<pdb_id>1gcm</pdb_id>
			<pdb_id>1gk6</pdb_id>
			<pdb_id>1gzl</pdb_id>
			<pdb_id>1ihq</pdb_id>
			<pdb_id>1ij0</pdb_id>
			<pdb_id>1ij1</pdb_id>
			<pdb_id>1ij2</pdb_id>
			<pdb_id>1ij3</pdb_id>
			<pdb_id>1kql</pdb_id>
			<pdb_id>1ld4</pdb_id>
			<pdb_id>1llm</pdb_id>
			<pdb_id>1piq</pdb_id>
			<pdb_id>1rb4</pdb_id>
			<pdb_id>1rb5</pdb_id>
			<pdb_id>1rb6</pdb_id>
			<pdb_id>1swi</pdb_id>
			<pdb_id>1tmz</pdb_id>
			<pdb_id>1unt</pdb_id>
			<pdb_id>1unu</pdb_id>
			<pdb_id>1unv</pdb_id>
			<pdb_id>1unw</pdb_id>
			<pdb_id>1unx</pdb_id>
			<pdb_id>1uny</pdb_id>
			<pdb_id>1unz</pdb_id>
			<pdb_id>1uo0</pdb_id>
			<pdb_id>1uo1</pdb_id>
			<pdb_id>1uo2</pdb_id>
			<pdb_id>1uo3</pdb_id>
			<pdb_id>1uo4</pdb_id>
			<pdb_id>1uo5</pdb_id>
			<pdb_id>1w5g</pdb_id>
			<pdb_id>1w5h</pdb_id>
			<pdb_id>1w5i</pdb_id>
			<pdb_id>1w5j</pdb_id>
			<pdb_id>1w5k</pdb_id>
			<pdb_id>1w5l</pdb_id>
			<pdb_id>1ysa</pdb_id>
			<pdb_id>1zii</pdb_id>
			<pdb_id>1zij</pdb_id>
			<pdb_id>1zik</pdb_id>
			<pdb_id>1zil</pdb_id>
			<pdb_id>1zim</pdb_id>
			<pdb_id>1zta</pdb_id>
			<pdb_id>2ahp</pdb_id>
			<pdb_id>2b22</pdb_id>
			<pdb_id>2bni</pdb_id>
			<pdb_id>2cce</pdb_id>
			<pdb_id>2ccf</pdb_id>
			<pdb_id>2ccn</pdb_id>
			<pdb_id>2dgc</pdb_id>
			<pdb_id>2g9j</pdb_id>
			<pdb_id>2hy6</pdb_id>
			<pdb_id>2ipz</pdb_id>
			<pdb_id>2k8x</pdb_id>
			<pdb_id>2n9b</pdb_id>
			<pdb_id>2nrn</pdb_id>
			<pdb_id>2o7h</pdb_id>
			<pdb_id>2ovn</pdb_id>
			<pdb_id>2vky</pdb_id>
			<pdb_id>2vnl</pdb_id>
			<pdb_id>2wg5</pdb_id>
			<pdb_id>2wg6</pdb_id>
			<pdb_id>2wpy</pdb_id>
			<pdb_id>2wpz</pdb_id>
			<pdb_id>2wq0</pdb_id>
			<pdb_id>2wq1</pdb_id>
			<pdb_id>2wq2</pdb_id>
			<pdb_id>2wq3</pdb_id>
			<pdb_id>2yny</pdb_id>
			<pdb_id>2ynz</pdb_id>
			<pdb_id>2yo0</pdb_id>
			<pdb_id>2yo1</pdb_id>
			<pdb_id>2yo2</pdb_id>
			<pdb_id>2yo3</pdb_id>
			<pdb_id>2zta</pdb_id>
			<pdb_id>3azd</pdb_id>
			<pdb_id>3ck4</pdb_id>
			<pdb_id>3crp</pdb_id>
			<pdb_id>3g9r</pdb_id>
			<pdb_id>3gjp</pdb_id>
			<pdb_id>3i1g</pdb_id>
			<pdb_id>3i5c</pdb_id>
			<pdb_id>3k7z</pdb_id>
			<pdb_id>3p8m</pdb_id>
			<pdb_id>3zmf</pdb_id>
			<pdb_id>4c46</pdb_id>
			<pdb_id>4dmd</pdb_id>
			<pdb_id>4g2k</pdb_id>
			<pdb_id>4hu5</pdb_id>
			<pdb_id>4hu6</pdb_id>
			<pdb_id>4niz</pdb_id>
			<pdb_id>4nj0</pdb_id>
			<pdb_id>4nj1</pdb_id>
			<pdb_id>4nj2</pdb_id>
			<pdb_id>4owi</pdb_id>
			<pdb_id>4tl1</pdb_id>
			<pdb_id>5apq</pdb_id>
			<pdb_id>5aps</pdb_id>
			<pdb_id>5apt</pdb_id>
			<pdb_id>5apu</pdb_id>
			<pdb_id>5apv</pdb_id>
			<pdb_id>5apw</pdb_id>
			<pdb_id>5apx</pdb_id>
			<pdb_id>5apy</pdb_id>
			<pdb_id>5iew</pdb_id>
			<pdb_id>5iir</pdb_id>
			<pdb_id>5iiv</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120014</accession>
		<general>
			<name>Regulatory protein Rop</name>
			<pdb_id>2ijk</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.55</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>18260113</pmid>
				<authors>Struble EB, Ladner JE, Brabazon DM, Marino JP</authors>
				<title>New crystal structures of ColE1 Rom and variants resulting from mutation of a surface exposed residue: Implications for RNA-recognition.</title>
				<journal>Proteins</journal>
				<year>2008</year>
				<issue>2</issue>
				<volume>72</volume>
				<pages>761-8</pages>
				<abstract>In ColE1, the plasmid encoded RNA one modulator (Rom) protein, which is also referred to as Rop, specifically binds and stabilizes an intermediate RNA loop-loop kissing structure formed between the plasmid encoded transcripts RNA I and RNA II and thereby acts as an auxiliary repressor of replication. Rom folds into a homodimeric, cylindrically packed four helix bundle with an exact twofold symmetry axis (Banner et al., J Mol Biol 1987;196:657-675; Eberle et al., J Biomol 1991;1:71-83). Previous studies (Castagnoli et al., EMBO J 1989;8:621-629; Predki et al., Cell 1995;80:41-50) have localized the RNA binding surface to the H1/H1&apos; face of the helical bundle and found Phe14 to be a key determinant of the binding affinity and specificity for RNA kissing complexes. To investigate the role of Phe14 in RNA recognition, we have determined high-resolution crystal structures of two point mutants of Rom (F14Y and F14W), as well as a high-resolution structure of a crystal form of Rom in which the dimer comprises the asymmetric unit. Although the structures of F14Y and F14W share a very high degree of structural identity with that of the wild-type protein and each other, differences are observed between the three polypeptide chains found in the asymmetric unit of each crystal in the packing of the tryptophan and tyrosine side chains at position 14, as well as some of the other surface exposed side chains of key amino acids involved in RNA binding. In both the wild-type Rom and mutant structures, crystal packing forces can break the exact twofold symmetry of the dimer and influence the conformation of the side chains presented on the H1/H1' face of Rom. Since the new structures show such a high degree of structural identity, the disruption in RNA binding observed for the mutant proteins can be attributed specifically to the chemical nature of the side chain at position 14. Moreover, the fact that even subtle changes in the side chain at position 14 cannot be compensated for by the apparent flexibility of this side chain suggests a highly constrained packing of this residue in the RNA-protein complex.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein rop</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GTKQEKTALNMARFIRSQTLTLLEKLNELDADEQADICESLHDHADELYRSCLARFGDDGENL</sequence>
				<length>63</length>
				<uniprot>
					<id>P03051</id>
					<start>1</start>
					<end>63</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03051</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01815.13</region_id>
						<region_name>Rop</region_name>
						<region_start>1</region_start>
						<region_end>57</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein rop</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GTKQEKTALNMARFIRSQTLTLLEKLNELDADEQADICESLHDHADELYRSCLARFGDDGENL</sequence>
				<length>63</length>
				<uniprot>
					<id>P03051</id>
					<start>1</start>
					<end>63</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03051</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01815.13</region_id>
						<region_name>Rop</region_name>
						<region_start>1</region_start>
						<region_end>57</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Detailed thermodynamic and spectroscopic studies were carried out on the ColE1-ROP protein in order to establish a quantitative basis for the contribution of noncovalent interactions to the stability of four-helix-bundle proteins. The energetics of both heat- and GdnHCl-induced denaturation were measured by differential scanning microcalorimetry (DSC) and/or by following the change in circular dichroism in the far-UV range. No intermediate species could be detected during thermal unfolding of the dimer in the absence of GdnHCl. Under these conditions ROP unfolding exhibits a strict two-state behavior (PMID:8471599).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1b6q</pdb_id>
			<pdb_id>4do2</pdb_id>
			<pdb_id>1f4m</pdb_id>
			<pdb_id>1f4n</pdb_id>
			<pdb_id>2ghy</pdb_id>
			<pdb_id>1gto</pdb_id>
			<pdb_id>2ijh</pdb_id>
			<pdb_id>2iji</pdb_id>
			<pdb_id>2ijj</pdb_id>
			<pdb_id>1qx8</pdb_id>
			<pdb_id>1rpr</pdb_id>
			<pdb_id>1gmg</pdb_id>
			<pdb_id>3k79</pdb_id>
			<pdb_id>1nkd</pdb_id>
			<pdb_id>1rop</pdb_id>
			<pdb_id>1rpo</pdb_id>
			<pdb_id>1yo7</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4100002</accession>
		<general>
			<name>Bcr-Abl oncoprotein oligomerization domain</name>
			<pdb_id>1k1f</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>11780146</pmid>
				<authors>Zhao X, Ghaffari S, Lodish H, Malashkevich VN, Kim PS</authors>
				<title>Structure of the Bcr-Abl oncoprotein oligomerization domain.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>2002</year>
				<issue>2</issue>
				<volume>9</volume>
				<pages>117-20</pages>
				<abstract>The Bcr-Abl oncoprotein is responsible for a wide range of human leukemias, including most cases of Philadelphia chromosome-positive chronic myelogenous leukemia. Oligomerization of Bcr-Abl is essential for oncogenicity. We determined the crystal structure of the N-terminal oligomerization domain of Bcr-Abl (residues 1-72 or Bcr1-72) and found a novel mode of oligomer formation. Two N-shaped monomers dimerize by swapping N-terminal helices and by forming an antiparallel coiled coil between C-terminal helices. Two dimers then stack onto each other to form a tetramer. The Bcr1-72 structure provides a basis for the design of inhibitors of Bcr-Abl transforming activity by disrupting Bcr-Abl oligomerization.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0005089</accession>
					<name>Rho guanyl-nucleotide exchange factor activity</name>
				</go>
				<go>
					<accession>GO:0004713</accession>
					<name>protein tyrosine kinase activity</name>
				</go>
				<go>
					<accession>GO:0019899</accession>
					<name>enzyme binding</name>
				</go>
				<go>
					<accession>GO:0004674</accession>
					<name>protein serine/threonine kinase activity</name>
				</go>
				<go>
					<accession>GO:0005096</accession>
					<name>GTPase activator activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0048008</accession>
					<name>platelet-derived growth factor receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0051726</accession>
					<name>regulation of cell cycle</name>
				</go>
				<go>
					<accession>GO:0060313</accession>
					<name>negative regulation of blood vessel remodeling</name>
				</go>
				<go>
					<accession>GO:0043114</accession>
					<name>regulation of vascular permeability</name>
				</go>
				<go>
					<accession>GO:0043547</accession>
					<name>positive regulation of GTPase activity</name>
				</go>
				<go>
					<accession>GO:0050728</accession>
					<name>negative regulation of inflammatory response</name>
				</go>
				<go>
					<accession>GO:0007420</accession>
					<name>brain development</name>
				</go>
				<go>
					<accession>GO:0050885</accession>
					<name>neuromuscular process controlling balance</name>
				</go>
				<go>
					<accession>GO:0046777</accession>
					<name>protein autophosphorylation</name>
				</go>
				<go>
					<accession>GO:0002692</accession>
					<name>negative regulation of cellular extravasation</name>
				</go>
				<go>
					<accession>GO:0043314</accession>
					<name>negative regulation of neutrophil degranulation</name>
				</go>
				<go>
					<accession>GO:0030036</accession>
					<name>actin cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0042472</accession>
					<name>inner ear morphogenesis</name>
				</go>
				<go>
					<accession>GO:0032496</accession>
					<name>response to lipopolysaccharide</name>
				</go>
				<go>
					<accession>GO:0018108</accession>
					<name>peptidyl-tyrosine phosphorylation</name>
				</go>
				<go>
					<accession>GO:0050766</accession>
					<name>positive regulation of phagocytosis</name>
				</go>
				<go>
					<accession>GO:0035556</accession>
					<name>intracellular signal transduction</name>
				</go>
				<go>
					<accession>GO:0035023</accession>
					<name>regulation of Rho protein signal transduction</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
				<go>
					<accession>GO:0045211</accession>
					<name>postsynaptic membrane</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0014069</accession>
					<name>postsynaptic density</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains E, F, G and H were removed as chains A, B, C and D represent the biologically relevant tetramer.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Breakpoint cluster region protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDR</sequence>
				<length>72</length>
				<uniprot>
					<id>P11274</id>
					<start>1</start>
					<end>72</end>
					<coverage>5.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P11274</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09036.7</region_id>
						<region_name>Bcr-Abl_Oligo</region_name>
						<region_start>3</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Breakpoint cluster region protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDR</sequence>
				<length>72</length>
				<uniprot>
					<id>P11274</id>
					<start>1</start>
					<end>72</end>
					<coverage>5.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P11274</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>7</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09036.7</region_id>
						<region_name>Bcr-Abl_Oligo</region_name>
						<region_start>3</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Breakpoint cluster region protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDR</sequence>
				<length>72</length>
				<uniprot>
					<id>P11274</id>
					<start>1</start>
					<end>72</end>
					<coverage>5.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P11274</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09036.7</region_id>
						<region_name>Bcr-Abl_Oligo</region_name>
						<region_start>3</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Breakpoint cluster region protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDR</sequence>
				<length>72</length>
				<uniprot>
					<id>P11274</id>
					<start>1</start>
					<end>72</end>
					<coverage>5.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P11274</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09036.7</region_id>
						<region_name>Bcr-Abl_Oligo</region_name>
						<region_start>3</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:11780146). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120015</accession>
		<general>
			<name>Antitoxin phd dimer (Escherichia coli)</name>
			<pdb_id>3hry</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.25</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>20603017</pmid>
				<authors>Garcia-Pino A, Balasubramanian S, Wyns L, Gazit E, De Greve H, Magnuson RD, Charlier D, van Nuland NA, Loris R</authors>
				<title>Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity.</title>
				<journal>Cell</journal>
				<year>2010</year>
				<issue>1</issue>
				<volume>142</volume>
				<pages>101-11</pages>
				<abstract>Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chain C was removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Phd antitoxin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Phd protein</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MQSINFRTARGNLSEVLNNVEAGEEVEITRRGREPAVIVSKATFEAYKKAALDAEFASLFDTLDSTNKELVNR</sequence>
				<length>73</length>
				<uniprot>
					<id>Q79A04</id>
					<start>1</start>
					<end>73</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06253</id>
					<start>1</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>70</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Phd protein</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MQSINFRTARGNLSEVLNNVEAGEEVEITRRGREPAVIVSKATFEAYKKAALDAEFASLFDTLDSTNKELVNR</sequence>
				<length>73</length>
				<uniprot>
					<id>Q79A04</id>
					<start>1</start>
					<end>73</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06253</id>
					<start>1</start>
					<end>73</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>70</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The dimerization of the prevents host death (phd) antitoxin from Escherichia virus P1 has been shown with differential scanning calorimetry to fit well to a two-state model consisting of a dimer unfolding into monomer species (PMID:20603017).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-73 region described in DisProt entry DP00288 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-73 region described in DisProt entry DP00288 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4120006</accession>
		<general>
			<name>Cell division factor ZapA (Pseudomonas aeruginosa)</name>
			<pdb_id>1t3u</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Pseudomonas aeruginosa</source_organism>
			<publication>
				<authors>Rajashankar, K.R., Kneiwel, R., Solorzano, V., Lima, C.D.</authors>
				<title>Structure of a conserved hypothetical protein Pseudomonas aeruginosa PA01</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Pseudomonas aeruginosa</source_organism>
				<sequence>MSQSNTLTVQILDKEYCINCPDDERANLESAARYLDGKMREIRSSGKVIGADRVAVMAALNITHDLLHRKERLDQESSSTRERVRELLDRVDRALANPADAGEA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9HTW3</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9HTW3</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>7</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>7</region_start>
						<region_end>97</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Pseudomonas aeruginosa</source_organism>
				<sequence>MSQSNTLTVQILDKEYCINCPDDERANLESAARYLDGKMREIRSSGKVIGADRVAVMAALNITHDLLHRKERLDQESSSTRERVRELLDRVDRALANPADAGEA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9HTW3</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9HTW3</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>5</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>7</region_start>
						<region_end>97</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Pseudomonas aeruginosa</source_organism>
				<sequence>MSQSNTLTVQILDKEYCINCPDDERANLESAARYLDGKMREIRSSGKVIGADRVAVMAALNITHDLLHRKERLDQESSSTRERVRELLDRVDRALANPADAGEA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9HTW3</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9HTW3</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>7</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>7</region_start>
						<region_end>97</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Cell division protein ZapA</name>
				<source_organism>Pseudomonas aeruginosa</source_organism>
				<sequence>MSQSNTLTVQILDKEYCINCPDDERANLESAARYLDGKMREIRSSGKVIGADRVAVMAALNITHDLLHRKERLDQESSSTRERVRELLDRVDRALANPADAGEA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9HTW3</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9HTW3</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>7</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>52</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05164.10</region_id>
						<region_name>ZapA</region_name>
						<region_start>7</region_start>
						<region_end>97</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions as evidenced by the presence of a ZapA domain (Pfam PF05164.10, PMID:25002581). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1w2e</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120016</accession>
		<general>
			<name>Putative antitoxin phd dimer (Nitrosomonas europaea)</name>
			<pdb_id>2odk</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.40</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Nitrosomonas europaea</source_organism>
			<publication>
				<authors>Osipiuk, J., Skarina, T., Kagan, O., Savchenko, A., Edwards, A., Joachimiak, A.</authors>
				<title>Crsytal structure of putative prevent-host-death protein from Nitrosomonas europaea.</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Phd antitoxin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein</name>
				<source_organism>Nitrosomonas europaea</source_organism>
				<sequence>GHMHVWPVQDAKARFSEFLDACITEGPQIVSRRGAEEAVLVPIGEWRRLQAAARPSLKQLLLSDSARTEMLVPERGKARRRQVEPLRGS</sequence>
				<length>89</length>
				<uniprot>
					<id>Q82T22</id>
					<start>1</start>
					<end>85</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q82T22</id>
					<start>1</start>
					<end>85</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>7</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>74</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Uncharacterized protein</name>
				<source_organism>Nitrosomonas europaea</source_organism>
				<sequence>GHMHVWPVQDAKARFSEFLDACITEGPQIVSRRGAEEAVLVPIGEWRRLQAAARPSLKQLLLSDSARTEMLVPERGKARRRQVEPLRGS</sequence>
				<length>89</length>
				<uniprot>
					<id>Q82T22</id>
					<start>1</start>
					<end>85</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q82T22</id>
					<start>1</start>
					<end>85</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>74</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The dimerization of the prevents host death (phd) antitoxin from Escherichia virus P1 has been shown with differential scanning calorimetry to fit well to a two-state model consisting of a dimer unfolding into monomer species (PMID:20603017).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4140002</accession>
		<general>
			<name>Tetramerization domain of the Mnt repressor</name>
			<pdb_id>1qey</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotetramer</assembly>
			<source_organism>Enterobacteria phage P22</source_organism>
			<publication>
				<pmid>10426954</pmid>
				<authors>Nooren IM, Kaptein R, Sauer RT, Boelens R</authors>
				<title>The tetramerization domain of the Mnt repressor consists of two right-handed coiled coils.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>1999</year>
				<issue>8</issue>
				<volume>6</volume>
				<pages>755-9</pages>
				<abstract>The tetrameric Mnt repressor is involved in the genetic switch between the lysogenic and lytic growth of Salmonella bacteriophage P22. The solution structure of its C-terminal tetramerization domain, which holds together the two dimeric DNA-binding domains, has been determined by NMR spectroscopy. This structure reveals an assembly of four alpha-helical subunits, consisting of a dimer of two antiparallel coiled coils with a unique right-handed twist. The superhelical winding is considerably stronger and the interhelical separation closer than those found in the well-known left-handed coiled coils in fibrous proteins and leucine zippers. An unusual asymmetry arises between the two monomers that comprise one right-handed coiled coil. A difference in the packing to the adjacent monomer of the other coiled coil occurs with an offset of two helical turns. The two asymmetric monomers within each coiled coil interconvert on a time scale of seconds. Both with respect to symmetry and handedness of helical packing, the C2 symmetric four-helix bundle of Mnt differs from other oligomerization domains that assemble DNA-binding modules, such as that in the tumor suppressor p53 and the E. coli lac repressor.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>RNDAERLADEQSELVKKMVFDTLKDLYKKTT</sequence>
				<length>31</length>
				<uniprot>
					<id>P03049</id>
					<start>53</start>
					<end>83</end>
					<coverage>37.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>53</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>RNDAERLADEQSELVKKMVFDTLKDLYKKTT</sequence>
				<length>31</length>
				<uniprot>
					<id>P03049</id>
					<start>53</start>
					<end>83</end>
					<coverage>37.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>53</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>RNDAERLADEQSELVKKMVFDTLKDLYKKTT</sequence>
				<length>31</length>
				<uniprot>
					<id>P03049</id>
					<start>53</start>
					<end>83</end>
					<coverage>37.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>53</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>RNDAERLADEQSELVKKMVFDTLKDLYKKTT</sequence>
				<length>31</length>
				<uniprot>
					<id>P03049</id>
					<start>53</start>
					<end>83</end>
					<coverage>37.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>53</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>55</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:10426954). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100005</accession>
		<general>
			<name>ING4 dimerization domain</name>
			<pdb_id>4afl</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.28</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>22334692</pmid>
				<authors>Culurgioni S, Munoz IG, Moreno A, Palacios A, Villate M, Palmero I, Montoya G, Blanco FJ</authors>
				<title>The crystal structure of the inhibitor of growth 4 (ING4) dimerization domain reveals the functional organization of the ING family of chromatin binding proteins.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2012</year>
				<abstract>The protein ING4 binds to histone H3 trimethylated at Lys4 (H3K4me3) through its C-terminal PlantHomeoDomain (PHD), thus recruiting the HBO1 histone acetyltransferase complex to target promoters. The structure of the PHD finger bound to an H3K4me3 peptide has been described, as well as the disorder and flexibility in the ING4 central region. We report the crystal structure of the ING4 N-terminal domain, which shows an antiparallel coiled-coil homodimer with each protomer folded into a helix-loop-helix structure. This arrangement suggests that ING4 can bind simultaneously two histone tails, on the same or different nucleosomes. Dimerization has a direct impact on ING4 tumor suppressor activity since monomeric mutants lose the ability of inducing apoptosis after genotoxic stress. Homology modeling based on the ING4 structure suggests that other ING dimers may also exist.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0035064</accession>
					<name>methylated histone binding</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
				<go>
					<accession>GO:0003713</accession>
					<name>transcription coactivator activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0043982</accession>
					<name>histone H4-K8 acetylation</name>
				</go>
				<go>
					<accession>GO:0006978</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</name>
				</go>
				<go>
					<accession>GO:0008285</accession>
					<name>negative regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0006260</accession>
					<name>DNA replication</name>
				</go>
				<go>
					<accession>GO:0006915</accession>
					<name>apoptotic process</name>
				</go>
				<go>
					<accession>GO:0043983</accession>
					<name>histone H4-K12 acetylation</name>
				</go>
				<go>
					<accession>GO:0043065</accession>
					<name>positive regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0043981</accession>
					<name>histone H4-K5 acetylation</name>
				</go>
				<go>
					<accession>GO:0043966</accession>
					<name>histone H3 acetylation</name>
				</go>
				<go>
					<accession>GO:0007050</accession>
					<name>cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0045926</accession>
					<name>negative regulation of growth</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000123</accession>
					<name>histone acetyltransferase complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B, D, E and F were removed as chains A and C represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Inhibitor of growth protein 4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMSSARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9UNL4</id>
					<start>2</start>
					<end>105</end>
					<coverage>41.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9UNL4</id>
					<start>2</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>93</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12998.4</region_id>
						<region_name>ING</region_name>
						<region_start>6</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Inhibitor of growth protein 4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMSSARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLA</sequence>
				<length>104</length>
				<uniprot>
					<id>Q9UNL4</id>
					<start>2</start>
					<end>105</end>
					<coverage>41.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9UNL4</id>
					<start>2</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>93</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12998.4</region_id>
						<region_name>ING</region_name>
						<region_start>6</region_start>
						<region_end>107</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:22334692). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201005</accession>
		<general>
			<name>H2A-H2B histone dimer (human/mouse), containing histone variants macro-H2A.1 and H2B type 3-A</name>
			<pdb_id>1u35</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.00</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Mus musculus</source_organism>
			<publication>
				<pmid>16107708</pmid>
				<authors>Chakravarthy S, Gundimella SK, Caron C, Perche PY, Pehrson JR, Khochbin S, Luger K</authors>
				<title>Structural characterization of the histone variant macroH2A.</title>
				<journal>Mol. Cell. Biol.</journal>
				<year>2005</year>
				<issue>17</issue>
				<volume>25</volume>
				<pages>7616-24</pages>
				<abstract>macroH2A is an H2A variant with a highly unusual structural organization. It has a C-terminal domain connected to the N-terminal histone domain by a linker. Crystallographic and biochemical studies show that changes in the L1 loop in the histone fold region of macroH2A impact the structure and potentially the function of nucleosomes. The 1.6-A X-ray structure of the nonhistone region reveals an alpha/beta fold which has previously been found in a functionally diverse group of proteins. This region associates with histone deacetylases and affects the acetylation status of nucleosomes containing macroH2A. Thus, the unusual domain structure of macroH2A integrates independent functions that are instrumental in establishing a structurally and functionally unique chromatin domain.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006334</accession>
					<name>nucleosome assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Core histone macro-H2A.1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MSSRGGKKKSTKTSRSAKAGVIFPVGRMLRYIKKGHPKYRIGVGAPVYMAAVLEYLTAEILELAVNAARDNKKGRVTPRHILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAKKRGS</sequence>
				<length>120</length>
				<uniprot>
					<id>O75367</id>
					<start>1</start>
					<end>120</end>
					<coverage>32.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75367</id>
					<start>1</start>
					<end>120</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>78</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>89</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>111</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>89</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 3-A</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MPEPSRSTPAPKKGSKKAITKAQKKDGKKRKRGRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIASEASRLAHYNKRSTITSREVQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>126</length>
				<uniprot>
					<id>Q9D2U9</id>
					<start>1</start>
					<end>126</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9D2U9</id>
					<start>1</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201006</accession>
		<general>
			<name>H2A-H2B histone dimer (human/Xenopus laevis), containing histone variants macro-H2A.1 and H2B 1.1</name>
			<pdb_id>2f8n</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.90</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Xenopus laevis</source_organism>
			<publication>
				<authors>Chakravarthy, S., Luger, K.</authors>
				<title>Nucleosomes containing the histone domain of macroH2A: In vitro possibilities.</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, D, E, F, I, J and K have been removed to highlight the basic interaction that forms the histone dimer composed of chains G and H.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>G</id>
				<name>Core histone macro-H2A.1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MSSRGGKKKSTKTSRSAKAGVIFPVGRMLRYIKKGHPKYRIGVGAPVYMAAVLEYLTAEILELAVNAARDNKKGRVTPRHILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAKKRGS</sequence>
				<length>120</length>
				<uniprot>
					<id>O75367</id>
					<start>1</start>
					<end>120</end>
					<coverage>32.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75367</id>
					<start>1</start>
					<end>120</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>78</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>89</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>111</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>89</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>H</id>
				<name>Histone H2B 1.1</name>
				<source_organism>Xenopus laevis</source_organism>
				<sequence>MAKSAPAPKKGSKKAVTKTQKKDGKKRRKTRKESYAIYVYKVLKQVHPDTGISSKAMSIMNSFVNDVFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK</sequence>
				<length>123</length>
				<uniprot>
					<id>P02281</id>
					<start>4</start>
					<end>126</end>
					<coverage>97.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P57053</id>
					<start>5</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2211001</accession>
		<general>
			<name>H2A-H2B histone dimer (human/Xenopus laevis), containing histone variants H2A.Z and H2B 1.1</name>
			<pdb_id>1f66</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Mus musculus / Xenopus laevis</source_organism>
			<publication>
				<pmid>11101893</pmid>
				<authors>Suto RK, Clarkson MJ, Tremethick DJ, Luger K</authors>
				<title>Crystal structure of a nucleosome core particle containing the variant histone H2A.Z.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>2000</year>
				<issue>12</issue>
				<volume>7</volume>
				<pages>1121-4</pages>
				<abstract>Activation of transcription within chromatin has been correlated with the incorporation of the essential histone variant H2A.Z into nucleosomes. H2A.Z and other histone variants may establish structurally distinct chromosomal domains; however, the molecular mechanism by which they function is largely unknown. Here we report the 2.6 A crystal structure of a nucleosome core particle containing the histone variant H2A.Z. The overall structure is similar to that of the previously reported 2.8 A nucleosome structure containing major histone proteins. However, distinct localized changes result in the subtle destabilization of the interaction between the (H2A.Z-H2B) dimer and the (H3-H4)(2) tetramer. Moreover, H2A.Z nucleosomes have an altered surface that includes a metal ion. This altered surface may lead to changes in higher order structure, and/or could result in the association of specific nuclear proteins with H2A.Z. Finally, incorporation of H2A.Z and H2A within the same nucleosome is unlikely, due to significant changes in the interface between the two H2A.Z-H2B dimers.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A.Z</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MAGGKAGKDSGKAKTKAVSRSQRAGLQFPVGRIHRHLKSRTTSHGRVGATAAVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGKKGQQKTV</sequence>
				<length>128</length>
				<uniprot>
					<id>P0C0S6</id>
					<start>1</start>
					<end>128</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0C0S5</id>
					<start>1</start>
					<end>128</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>116</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>4</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>95</region_start>
						<region_end>127</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B 1.1</name>
				<source_organism>Xenopus laevis</source_organism>
				<sequence>MPEPAKSAPAPKKGSKKAVTKTQKKDGKKRRKTRKESYAIYVYKVLKQVHPDTGISSKAMSIMNSFVNDVFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK</sequence>
				<length>126</length>
				<uniprot>
					<id>P02281</id>
					<start>1</start>
					<end>126</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P57053</id>
					<start>1</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200003</accession>
		<general>
			<name>H2A-H2B histone dimer (human), containing histone variants H2A.Z and H2B type 1-J</name>
			<pdb_id>3wa9</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.07</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>24311584</pmid>
				<authors>Horikoshi N, Sato K, Shimada K, Arimura Y, Osakabe A, Tachiwana H, Hayashi-Takanaka Y, Iwasaki W, Kagawa W, Harata M, Kimura H, Kurumizaka H</authors>
				<title>Structural polymorphism in the L1 loop regions of human H2A.Z.1 and H2A.Z.2.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2013</year>
				<issue>Pt 12</issue>
				<volume>69</volume>
				<pages>2431-9</pages>
				<abstract>The histone H2A.Z variant is widely conserved among eukaryotes. Two isoforms, H2A.Z.1 and H2A.Z.2, have been identified in vertebrates and may have distinct functions in cell growth and gene expression. However, no structural differences between H2A.Z.1 and H2A.Z.2 have been reported. In the present study, the crystal structures of nucleosomes containing human H2A.Z.1 and H2A.Z.2 were determined. The structures of the L1 loop regions were found to clearly differ between H2A.Z.1 and H2A.Z.2, although their amino-acid sequences in this region are identical. This structural polymorphism may have been induced by a substitution that evolutionally occurred at the position of amino acid 38 and by the flexible nature of the L1 loops of H2A.Z.1 and H2A.Z.2. It was also found that in living cells nucleosomal H2A.Z.1 exchanges more rapidly than H2A.Z.2. A mutational analysis revealed that the amino-acid difference at position 38 is at least partially responsible for the distinctive dynamics of H2A.Z.1 and H2A.Z.2. These findings provide important new information for understanding the differences in the regulation and functions of H2A.Z.1 and H2A.Z.2 in cells.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A.Z</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMAGGKAGKDSGKAKTKAVSRSQRAGLQFPVGRIHRHLKSRTTSHGRVGATAAVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGKKGQQKTV</sequence>
				<length>131</length>
				<uniprot>
					<id>P0C0S5</id>
					<start>1</start>
					<end>128</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0C0S5</id>
					<start>1</start>
					<end>128</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>116</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>4</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>95</region_start>
						<region_end>127</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 1-J</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMPEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK</sequence>
				<length>129</length>
				<uniprot>
					<id>P06899</id>
					<start>1</start>
					<end>126</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06899</id>
					<start>1</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4cay</pdb_id>
			<pdb_id>5b31</pdb_id>
			<pdb_id>5fug</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210001</accession>
		<general>
			<name>H2A-H2B histone dimer (Xenopus laevis), containing histone variants H2A type 1 and H2B 1.1</name>
			<pdb_id>1aoi</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.80</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Xenopus laevis</source_organism>
			<publication>
				<pmid>9305837</pmid>
				<authors>Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ</authors>
				<title>Crystal structure of the nucleosome core particle at 2.8 A resolution.</title>
				<journal>Nature</journal>
				<year>1997</year>
				<issue>6648</issue>
				<volume>389</volume>
				<pages>251-60</pages>
				<abstract>The X-ray crystal structure of the nucleosome core particle of chromatin shows in atomic detail how the histone protein octamer is assembled and how 146 base pairs of DNA are organized into a superhelix around it. Both histone/histone and histone/DNA interactions depend on the histone fold domains and additional, well ordered structure elements extending from this motif. Histone amino-terminal tails pass over and between the gyres of the DNA superhelix to contact neighbouring particles. The lack of uniformity between multiple histone/DNA-binding sites causes the DNA to deviate from ideal superhelix geometry.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A type 1</name>
				<source_organism>Xenopus laevis</source_organism>
				<sequence>GKQGGKTRAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGRVTIAQGGVLPNIQSVLLPKK</sequence>
				<length>116</length>
				<uniprot>
					<id>P06897</id>
					<start>5</start>
					<end>120</end>
					<coverage>89.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q00728</id>
					<start>6</start>
					<end>120</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>91</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B 1.1</name>
				<source_organism>Xenopus laevis</source_organism>
				<sequence>KKRRKTRKESYAIYVYKVLKQVHPDTGISSKAMSIMNSFVNDVFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK</sequence>
				<length>99</length>
				<uniprot>
					<id>P02281</id>
					<start>28</start>
					<end>126</end>
					<coverage>78.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P57053</id>
					<start>28</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2fj7</pdb_id>
			<pdb_id>4j8u</pdb_id>
			<pdb_id>1kx3</pdb_id>
			<pdb_id>1kx4</pdb_id>
			<pdb_id>1kx5</pdb_id>
			<pdb_id>1m18</pdb_id>
			<pdb_id>1m19</pdb_id>
			<pdb_id>1m1a</pdb_id>
			<pdb_id>3o62</pdb_id>
			<pdb_id>1p34</pdb_id>
			<pdb_id>1p3a</pdb_id>
			<pdb_id>1p3b</pdb_id>
			<pdb_id>1p3f</pdb_id>
			<pdb_id>1p3g</pdb_id>
			<pdb_id>1p3i</pdb_id>
			<pdb_id>1p3k</pdb_id>
			<pdb_id>1p3l</pdb_id>
			<pdb_id>1p3m</pdb_id>
			<pdb_id>1p3o</pdb_id>
			<pdb_id>1p3p</pdb_id>
			<pdb_id>3reh</pdb_id>
			<pdb_id>3rei</pdb_id>
			<pdb_id>3rej</pdb_id>
			<pdb_id>3rek</pdb_id>
			<pdb_id>3rel</pdb_id>
			<pdb_id>1s32</pdb_id>
			<pdb_id>4wu8</pdb_id>
			<pdb_id>4wu9</pdb_id>
			<pdb_id>3b6f</pdb_id>
			<pdb_id>3b6g</pdb_id>
			<pdb_id>4j8v</pdb_id>
			<pdb_id>4j8w</pdb_id>
			<pdb_id>4j8x</pdb_id>
			<pdb_id>4kgc</pdb_id>
			<pdb_id>3kuy</pdb_id>
			<pdb_id>3kwq</pdb_id>
			<pdb_id>3kxb</pdb_id>
			<pdb_id>3lel</pdb_id>
			<pdb_id>3lja</pdb_id>
			<pdb_id>3lz0</pdb_id>
			<pdb_id>3lz1</pdb_id>
			<pdb_id>3mgp</pdb_id>
			<pdb_id>3mgq</pdb_id>
			<pdb_id>3mgr</pdb_id>
			<pdb_id>3mgs</pdb_id>
			<pdb_id>3mnn</pdb_id>
			<pdb_id>2nzd</pdb_id>
			<pdb_id>3ut9</pdb_id>
			<pdb_id>3uta</pdb_id>
			<pdb_id>3utb</pdb_id>
			<pdb_id>4xzq</pdb_id>
			<pdb_id>4ys3</pdb_id>
			<pdb_id>4z66</pdb_id>
			<pdb_id>1zbb</pdb_id>
			<pdb_id>1zla</pdb_id>
			<pdb_id>3tu4</pdb_id>
			<pdb_id>4ld9</pdb_id>
			<pdb_id>4xuj</pdb_id>
			<pdb_id>4zux</pdb_id>
			<pdb_id>5cp6</pdb_id>
			<pdb_id>5dnm</pdb_id>
			<pdb_id>5dnn</pdb_id>
			<pdb_id>5e5a</pdb_id>
			<pdb_id>5f99</pdb_id>
			<pdb_id>5g2e</pdb_id>
			<pdb_id>5hq2</pdb_id>
			<pdb_id>5nl0</pdb_id>
			<pdb_id>5x0x</pdb_id>
			<pdb_id>5x0y</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210002</accession>
		<general>
			<name>H2A-H2B histone dimer (Gallus gallus), containing histone variants H2A-IV and H2B 5</name>
			<pdb_id>2aro</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>16920041</pmid>
				<authors>Wood CM, Sodngam S, Nicholson JM, Lambert SJ, Reynolds CD, Baldwin JP</authors>
				<title>The oxidised histone octamer does not form a H3 disulphide bond.</title>
				<journal>Biochim. Biophys. Acta</journal>
				<year>2006</year>
				<issue>8</issue>
				<volume>1764</volume>
				<pages>1356-62</pages>
				<abstract>A H3 dimer band is produced when purified native histone octamers are run on an SDS-PAGE gel in a beta-mercaptoethanol-free environment. To investigate this, native histone octamer crystals, derived from chicken erythrocytes, and of structure (H2A-H2B)-(H4-H3)-(H3&apos;-H4')-(H2B'-H2A'), were grown in 2 M KCl, 1.35 M potassium phosphates and 250-350 microM of the oxidising agent S-nitrosoglutathione, pH 6.9. X-ray diffraction data were acquired to 2.10 A resolution, yielding a structure with an Rwork value of 18.6% and an Rfree of 22.5%. The space group is P6(5), the asymmetric unit of which contains one complete octamer. Compared to the 1.90 A resolution, unoxidised native histone octamer structure, the crystals show a reduction of 2.5% in the c-axis of the unit cell, and free-energy calculations reveal that the H3-H3' dimer interface in the latter has become thermodynamically stable, in contrast to the former. Although the inter-sulphur distance of the two H3 cysteines in the oxidised native histone octamer has reduced to 6 A from the 7 A of the unoxidised form, analysis of the hydrogen bonds that constitute the (H4-H3)-(H3'-H4') tetramer indicates that the formation of a disulphide bond in the H3-H3' dimer interface is incompatible with stable tetramer formation. The biochemical and biophysical evidence, taken as a whole, is indicative of crystals that have a stable H3-H3' dimer interface, possibly extending to the interface within an isolated H3-H3' dimer, observed in SDS-PAGE gels.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G and H have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H2A-IV</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTDSHKAKAK</sequence>
				<length>129</length>
				<uniprot>
					<id>P02263</id>
					<start>1</start>
					<end>129</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02263</id>
					<start>1</start>
					<end>129</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>92</region_start>
						<region_end>126</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H2B 5</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>MPEPAKSAPAPKKGSKKAVTKTQKKGDKKRKKSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>126</length>
				<uniprot>
					<id>P0C1H4</id>
					<start>1</start>
					<end>126</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0C1H4</id>
					<start>1</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1eqz</pdb_id>
			<pdb_id>1hio</pdb_id>
			<pdb_id>2hio</pdb_id>
			<pdb_id>1hq3</pdb_id>
			<pdb_id>1tzy</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2201007</accession>
		<general>
			<name>H2A-H2B histone dimer (mouse/human), containing histone variants H2A and H2B type 1-B</name>
			<pdb_id>3x1u</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.25</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Mus musculus / Homo sapiens</source_organism>
			<publication>
				<pmid>26188507</pmid>
				<authors>Padavattan S, Shinagawa T, Hasegawa K, Kumasaka T, Ishii S, Kumarevel T</authors>
				<title>Structural and functional analyses of nucleosome complexes with mouse histone variants TH2a and TH2b, involved in reprogramming.</title>
				<journal>Biochem. Biophys. Res. Commun.</journal>
				<year>2015</year>
				<issue>3</issue>
				<volume>464</volume>
				<pages>929-35</pages>
				<abstract>Histone variants TH2a and TH2b are highly expressed in testes, oocytes and zygotes. Our recent analysis suggested that these histone variants enhance the induced generation of pluripotent stem cells (iPSCs) when co-expressed along with four transcription factors, Oct3/4, Sox2, Klf4 and c-Myc (OSKM), and are associated with an open chromatin structure [1]. In the present study, we report the crystal structures of nucleosomes (NCPs) with the mouse histone variants, TH2a and TH2b. The structures revealed two significant changes, as compared to the canonical counterparts: fewer histone-DNA contacts and changes in dimer-dimer interactions between TH2a-TH2a&apos; (L1-loop). In vivo studies with domain swapping and point mutants of the variants revealed that the residues in the histone tails and the TH2a-L1 loop are important for reprogramming. Taken together, our work indicates that the NCP variants with structural modifications and flexible tails are most likely important for enhanced reprogramming of functions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
				<go>
					<accession>GO:0000784</accession>
					<name>nuclear chromosome, telomeric region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>SGPTKRGGKARAKVKSRSSRAGLQFPVGRVHRLLRQGNYAQRIGAGAPVYLAAVLEYLTAEVLELAGNAARDNKKTRITPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKTESHKSQTK</sequence>
				<length>128</length>
				<uniprot>
					<id>Q8CGP4</id>
					<start>2</start>
					<end>129</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q93077</id>
					<start>2</start>
					<end>124</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>93</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>92</region_start>
						<region_end>126</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 1-B</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EPSKSAPAPKKGSKKAITKAQKKDGKKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>124</length>
				<uniprot>
					<id>P33778</id>
					<start>3</start>
					<end>126</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P33778</id>
					<start>3</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>119</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2210003</accession>
		<general>
			<name>H2A-H2B histone dimer (Drosophila melanogaster)</name>
			<pdb_id>2nqb</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Drosophila melanogaster</source_organism>
			<publication>
				<authors>Chakravarthy, S., Luger, K.</authors>
				<title>Comparative analysis of nucleosome structures from different species.</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006334</accession>
					<name>nucleosome assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000788</accession>
					<name>nuclear nucleosome</name>
				</go>
				<go>
					<accession>GO:0005811</accession>
					<name>lipid particle</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>SGRGKGGKVKGKAKSRSNRAGLQFPVGRIHRLLRKGNYAERVGAGAPVYLAAVMEYLAAEVLELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLSGVTIAQGGVLPNIQAVLLPKKTEKKA</sequence>
				<length>123</length>
				<uniprot>
					<id>P84051</id>
					<start>2</start>
					<end>124</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P84051</id>
					<start>2</start>
					<end>124</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>42</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>80</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>113</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>4</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>91</region_start>
						<region_end>124</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>IPPKTSGKAAKKAGKAQKNITKTDKKKKRKRKESYAIYIYTVLKQVHPDTGISSKAMSIMNSFVNDIFERIAAEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>123</length>
				<uniprot>
					<id>P02283</id>
					<start>1</start>
					<end>123</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02283</id>
					<start>1</start>
					<end>123</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>86</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>89</region_start>
						<region_end>99</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>102</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2pyo</pdb_id>
			<pdb_id>4qlc</pdb_id>
			<pdb_id>4x23</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200004</accession>
		<general>
			<name>H2A-H2B histone dimer (human), containing histone variants H2A.V and H2B type 1-J</name>
			<pdb_id>3waa</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.20</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>24311584</pmid>
				<authors>Horikoshi N, Sato K, Shimada K, Arimura Y, Osakabe A, Tachiwana H, Hayashi-Takanaka Y, Iwasaki W, Kagawa W, Harata M, Kimura H, Kurumizaka H</authors>
				<title>Structural polymorphism in the L1 loop regions of human H2A.Z.1 and H2A.Z.2.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2013</year>
				<issue>Pt 12</issue>
				<volume>69</volume>
				<pages>2431-9</pages>
				<abstract>The histone H2A.Z variant is widely conserved among eukaryotes. Two isoforms, H2A.Z.1 and H2A.Z.2, have been identified in vertebrates and may have distinct functions in cell growth and gene expression. However, no structural differences between H2A.Z.1 and H2A.Z.2 have been reported. In the present study, the crystal structures of nucleosomes containing human H2A.Z.1 and H2A.Z.2 were determined. The structures of the L1 loop regions were found to clearly differ between H2A.Z.1 and H2A.Z.2, although their amino-acid sequences in this region are identical. This structural polymorphism may have been induced by a substitution that evolutionally occurred at the position of amino acid 38 and by the flexible nature of the L1 loops of H2A.Z.1 and H2A.Z.2. It was also found that in living cells nucleosomal H2A.Z.1 exchanges more rapidly than H2A.Z.2. A mutational analysis revealed that the amino-acid difference at position 38 is at least partially responsible for the distinctive dynamics of H2A.Z.1 and H2A.Z.2. These findings provide important new information for understanding the differences in the regulation and functions of H2A.Z.1 and H2A.Z.2 in cells.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A.V</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMAGGKAGKDSGKAKAKAVSRSQRAGLQFPVGRIHRHLKTRTTSHGRVGATAAVYSAAILEYLTAEVLELAGNASKDLKVKRITPRHLQLAIRGDEELDSLIKATIAGGGVIPHIHKSLIGKKGQQKTA</sequence>
				<length>131</length>
				<uniprot>
					<id>Q71UI9</id>
					<start>1</start>
					<end>128</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q71UI9</id>
					<start>1</start>
					<end>128</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>116</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>4</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>95</region_start>
						<region_end>128</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 1-J</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMPEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK</sequence>
				<length>129</length>
				<uniprot>
					<id>P06899</id>
					<start>1</start>
					<end>126</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06899</id>
					<start>1</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200005</accession>
		<general>
			<name>H3-H4 histone dimer (human), containing histone variant H3.1</name>
			<pdb_id>3afa</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>20498094</pmid>
				<authors>Tachiwana H, Kagawa W, Osakabe A, Kawaguchi K, Shiga T, Hayashi-Takanaka Y, Kimura H, Kurumizaka H</authors>
				<title>Structural basis of instability of the nucleosome containing a testis-specific histone variant, human H3T.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2010</year>
				<issue>23</issue>
				<volume>107</volume>
				<pages>10454-9</pages>
				<abstract>A histone H3 variant, H3T, is highly expressed in the testis, suggesting that it may play an important role in the chromatin reorganization required for meiosis and/or spermatogenesis. In the present study, we found that the nucleosome containing human H3T is significantly unstable both in vitro and in vivo, as compared to the conventional nucleosome containing H3.1. The crystal structure of the H3T nucleosome revealed structural differences in the H3T regions on both ends of the central alpha2 helix, as compared to those of H3.1. The H3T-specific residues (Met71 and Val111) are the source of the structural differences observed between H3T and H3.1. A mutational analysis revealed that these residues are responsible for the reduced stability of the H3T-containing nucleosome. These physical and structural properties of the H3T-containing nucleosome may provide the basis of chromatin reorganization during spermatogenesis.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042393</accession>
					<name>histone binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0000183</accession>
					<name>chromatin silencing at rDNA</name>
				</go>
				<go>
					<accession>GO:0031047</accession>
					<name>gene silencing by RNA</name>
				</go>
				<go>
					<accession>GO:0044267</accession>
					<name>cellular protein metabolic process</name>
				</go>
				<go>
					<accession>GO:0032200</accession>
					<name>telomere organization</name>
				</go>
				<go>
					<accession>GO:0051290</accession>
					<name>protein heterotetramerization</name>
				</go>
				<go>
					<accession>GO:0045815</accession>
					<name>positive regulation of gene expression, epigenetic</name>
				</go>
				<go>
					<accession>GO:0006335</accession>
					<name>DNA replication-dependent nucleosome assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000784</accession>
					<name>nuclear chromosome, telomeric region</name>
				</go>
				<go>
					<accession>GO:0016020</accession>
					<name>membrane</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3.1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEACEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>139</length>
				<uniprot>
					<id>P68431</id>
					<start>1</start>
					<end>136</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P68431</id>
					<start>1</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>106</length>
				<uniprot>
					<id>P62805</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3ayw</pdb_id>
			<pdb_id>3aze</pdb_id>
			<pdb_id>3azf</pdb_id>
			<pdb_id>3azg</pdb_id>
			<pdb_id>3azh</pdb_id>
			<pdb_id>3azi</pdb_id>
			<pdb_id>3azj</pdb_id>
			<pdb_id>3azk</pdb_id>
			<pdb_id>3azl</pdb_id>
			<pdb_id>3azm</pdb_id>
			<pdb_id>3azn</pdb_id>
			<pdb_id>5c3i</pdb_id>
			<pdb_id>2cv5</pdb_id>
			<pdb_id>1u35</pdb_id>
			<pdb_id>3w96</pdb_id>
			<pdb_id>3w97</pdb_id>
			<pdb_id>3w98</pdb_id>
			<pdb_id>3w99</pdb_id>
			<pdb_id>3wa9</pdb_id>
			<pdb_id>3waa</pdb_id>
			<pdb_id>3wkj</pdb_id>
			<pdb_id>3x1s</pdb_id>
			<pdb_id>3x1t</pdb_id>
			<pdb_id>3x1u</pdb_id>
			<pdb_id>3x1v</pdb_id>
			<pdb_id>4ym5</pdb_id>
			<pdb_id>4ym6</pdb_id>
			<pdb_id>4z2m</pdb_id>
			<pdb_id>5av5</pdb_id>
			<pdb_id>5av6</pdb_id>
			<pdb_id>5av8</pdb_id>
			<pdb_id>5av9</pdb_id>
			<pdb_id>5avb</pdb_id>
			<pdb_id>5avc</pdb_id>
			<pdb_id>5b24</pdb_id>
			<pdb_id>5b2i</pdb_id>
			<pdb_id>5b2j</pdb_id>
			<pdb_id>5cpi</pdb_id>
			<pdb_id>5cpj</pdb_id>
			<pdb_id>5cpk</pdb_id>
			<pdb_id>5gse</pdb_id>
			<pdb_id>5gsu</pdb_id>
			<pdb_id>5jrg</pdb_id>
			<pdb_id>5b1l</pdb_id>
			<pdb_id>5b1m</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200006</accession>
		<general>
			<name>H3-H4 histone dimer (human), containing histone variant H3.2</name>
			<pdb_id>3av1</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>21636898</pmid>
				<authors>Tachiwana H, Osakabe A, Shiga T, Miya Y, Kimura H, Kagawa W, Kurumizaka H</authors>
				<title>Structures of human nucleosomes containing major histone H3 variants.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2011</year>
				<issue>Pt 6</issue>
				<volume>67</volume>
				<pages>578-83</pages>
				<abstract>The nucleosome is the fundamental repeating unit of chromatin, via which genomic DNA is packaged into the nucleus in eukaryotes. In the nucleosome, two copies of each core histone, H2A, H2B, H3 and H4, form a histone octamer which wraps 146 base pairs of DNA around itself. All of the core histones except for histone H4 have nonallelic isoforms called histone variants. In humans, eight histone H3 variants, H3.1, H3.2, H3.3, H3T, H3.5, H3.X, H3.Y and CENP-A, have been reported to date. Previous studies have suggested that histone H3 variants possess distinct functions in the formation of specific chromosome regions and/or in the regulation of transcription and replication. H3.1, H3.2 and H3.3 are the most abundant H3 variants. Here, crystal structures of human nucleosomes containing either H3.2 or H3.3 have been solved. The structures were essentially the same as that of the H3.1 nucleosome. Since the amino-acid residues specific for H3.2 and H3.3 are located on the accessible surface of the H3/H4 tetramer, they may be potential interaction sites for H3.2- and H3.3-specific chaperones.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0042393</accession>
					<name>histone binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045815</accession>
					<name>positive regulation of gene expression, epigenetic</name>
				</go>
				<go>
					<accession>GO:0006334</accession>
					<name>nucleosome assembly</name>
				</go>
				<go>
					<accession>GO:0000183</accession>
					<name>chromatin silencing at rDNA</name>
				</go>
				<go>
					<accession>GO:0031047</accession>
					<name>gene silencing by RNA</name>
				</go>
				<go>
					<accession>GO:0044267</accession>
					<name>cellular protein metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G and H have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3.2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>139</length>
				<uniprot>
					<id>Q71DI3</id>
					<start>1</start>
					<end>136</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q71DI3</id>
					<start>1</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>106</length>
				<uniprot>
					<id>P62805</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2aro</pdb_id>
			<pdb_id>5bo0</pdb_id>
			<pdb_id>4eo5</pdb_id>
			<pdb_id>1hio</pdb_id>
			<pdb_id>3b6f</pdb_id>
			<pdb_id>3b6g</pdb_id>
			<pdb_id>5bs7</pdb_id>
			<pdb_id>5bsa</pdb_id>
			<pdb_id>1eqz</pdb_id>
			<pdb_id>1f66</pdb_id>
			<pdb_id>2f8n</pdb_id>
			<pdb_id>2fj7</pdb_id>
			<pdb_id>2hio</pdb_id>
			<pdb_id>1hq3</pdb_id>
			<pdb_id>2io5</pdb_id>
			<pdb_id>4j8u</pdb_id>
			<pdb_id>4j8v</pdb_id>
			<pdb_id>4j8w</pdb_id>
			<pdb_id>4j8x</pdb_id>
			<pdb_id>4kgc</pdb_id>
			<pdb_id>3kuy</pdb_id>
			<pdb_id>3kwq</pdb_id>
			<pdb_id>1kx3</pdb_id>
			<pdb_id>1kx4</pdb_id>
			<pdb_id>1kx5</pdb_id>
			<pdb_id>3kxb</pdb_id>
			<pdb_id>3lel</pdb_id>
			<pdb_id>3lja</pdb_id>
			<pdb_id>3lz0</pdb_id>
			<pdb_id>3lz1</pdb_id>
			<pdb_id>3mgp</pdb_id>
			<pdb_id>3mgq</pdb_id>
			<pdb_id>3mgr</pdb_id>
			<pdb_id>3mgs</pdb_id>
			<pdb_id>3mnn</pdb_id>
			<pdb_id>2nzd</pdb_id>
			<pdb_id>3o62</pdb_id>
			<pdb_id>1p34</pdb_id>
			<pdb_id>1p3a</pdb_id>
			<pdb_id>1p3b</pdb_id>
			<pdb_id>1p3f</pdb_id>
			<pdb_id>1p3g</pdb_id>
			<pdb_id>1p3i</pdb_id>
			<pdb_id>1p3k</pdb_id>
			<pdb_id>1p3l</pdb_id>
			<pdb_id>1p3m</pdb_id>
			<pdb_id>1p3o</pdb_id>
			<pdb_id>1p3p</pdb_id>
			<pdb_id>3reh</pdb_id>
			<pdb_id>3rei</pdb_id>
			<pdb_id>3rej</pdb_id>
			<pdb_id>3rek</pdb_id>
			<pdb_id>3rel</pdb_id>
			<pdb_id>1s32</pdb_id>
			<pdb_id>1tzy</pdb_id>
			<pdb_id>3ut9</pdb_id>
			<pdb_id>3uta</pdb_id>
			<pdb_id>3utb</pdb_id>
			<pdb_id>4wu8</pdb_id>
			<pdb_id>4wu9</pdb_id>
			<pdb_id>4xzq</pdb_id>
			<pdb_id>4ys3</pdb_id>
			<pdb_id>4z66</pdb_id>
			<pdb_id>5b0y</pdb_id>
			<pdb_id>5b0z</pdb_id>
			<pdb_id>5b40</pdb_id>
			<pdb_id>3c9k</pdb_id>
			<pdb_id>2hue</pdb_id>
			<pdb_id>3mvd</pdb_id>
			<pdb_id>4r8p</pdb_id>
			<pdb_id>5kgf</pdb_id>
			<pdb_id>5mlu</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200007</accession>
		<general>
			<name>H3-H4 histone dimer (human), containing histone variant H3.1t</name>
			<pdb_id>3a6n</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.70</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>20498094</pmid>
				<authors>Tachiwana H, Kagawa W, Osakabe A, Kawaguchi K, Shiga T, Hayashi-Takanaka Y, Kimura H, Kurumizaka H</authors>
				<title>Structural basis of instability of the nucleosome containing a testis-specific histone variant, human H3T.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2010</year>
				<issue>23</issue>
				<volume>107</volume>
				<pages>10454-9</pages>
				<abstract>A histone H3 variant, H3T, is highly expressed in the testis, suggesting that it may play an important role in the chromatin reorganization required for meiosis and/or spermatogenesis. In the present study, we found that the nucleosome containing human H3T is significantly unstable both in vitro and in vivo, as compared to the conventional nucleosome containing H3.1. The crystal structure of the H3T nucleosome revealed structural differences in the H3T regions on both ends of the central alpha2 helix, as compared to those of H3.1. The H3T-specific residues (Met71 and Val111) are the source of the structural differences observed between H3T and H3.1. A mutational analysis revealed that these residues are responsible for the reduced stability of the H3T-containing nucleosome. These physical and structural properties of the H3T-containing nucleosome may provide the basis of chromatin reorganization during spermatogenesis.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042393</accession>
					<name>histone binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006303</accession>
					<name>double-strand break repair via nonhomologous end joining</name>
				</go>
				<go>
					<accession>GO:0051290</accession>
					<name>protein heterotetramerization</name>
				</go>
				<go>
					<accession>GO:0006334</accession>
					<name>nucleosome assembly</name>
				</go>
				<go>
					<accession>GO:0016233</accession>
					<name>telomere capping</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3.1t</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMARTKQTARKSTGGKAPRKQLATKVARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLMREIAQDFKTDLRFQSSAVMALQEACESYLVGLFEDTNLCVIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>139</length>
				<uniprot>
					<id>Q16695</id>
					<start>1</start>
					<end>136</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q16695</id>
					<start>1</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>131</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>106</length>
				<uniprot>
					<id>P62805</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1aoi</pdb_id>
			<pdb_id>3c1b</pdb_id>
			<pdb_id>3c1c</pdb_id>
			<pdb_id>1m18</pdb_id>
			<pdb_id>1m19</pdb_id>
			<pdb_id>1m1a</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200008</accession>
		<general>
			<name>H3-H4 histone dimer (human), containing histone variant H3.3</name>
			<pdb_id>3av2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.80</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>21636898</pmid>
				<authors>Tachiwana H, Osakabe A, Shiga T, Miya Y, Kimura H, Kagawa W, Kurumizaka H</authors>
				<title>Structures of human nucleosomes containing major histone H3 variants.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2011</year>
				<issue>Pt 6</issue>
				<volume>67</volume>
				<pages>578-83</pages>
				<abstract>The nucleosome is the fundamental repeating unit of chromatin, via which genomic DNA is packaged into the nucleus in eukaryotes. In the nucleosome, two copies of each core histone, H2A, H2B, H3 and H4, form a histone octamer which wraps 146 base pairs of DNA around itself. All of the core histones except for histone H4 have nonallelic isoforms called histone variants. In humans, eight histone H3 variants, H3.1, H3.2, H3.3, H3T, H3.5, H3.X, H3.Y and CENP-A, have been reported to date. Previous studies have suggested that histone H3 variants possess distinct functions in the formation of specific chromosome regions and/or in the regulation of transcription and replication. H3.1, H3.2 and H3.3 are the most abundant H3 variants. Here, crystal structures of human nucleosomes containing either H3.2 or H3.3 have been solved. The structures were essentially the same as that of the H3.1 nucleosome. Since the amino-acid residues specific for H3.2 and H3.3 are located on the accessible surface of the H3/H4 tetramer, they may be potential interaction sites for H3.2- and H3.3-specific chaperones.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042393</accession>
					<name>histone binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0000183</accession>
					<name>chromatin silencing at rDNA</name>
				</go>
				<go>
					<accession>GO:0044267</accession>
					<name>cellular protein metabolic process</name>
				</go>
				<go>
					<accession>GO:0031047</accession>
					<name>gene silencing by RNA</name>
				</go>
				<go>
					<accession>GO:0032200</accession>
					<name>telomere organization</name>
				</go>
				<go>
					<accession>GO:0006336</accession>
					<name>DNA replication-independent nucleosome assembly</name>
				</go>
				<go>
					<accession>GO:0045815</accession>
					<name>positive regulation of gene expression, epigenetic</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0000784</accession>
					<name>nuclear chromosome, telomeric region</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3.3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSAAIGALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>139</length>
				<uniprot>
					<id>P84243</id>
					<start>1</start>
					<end>136</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P84243</id>
					<start>1</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>131</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>106</length>
				<uniprot>
					<id>P62805</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4h9n</pdb_id>
			<pdb_id>4h9o</pdb_id>
			<pdb_id>4h9r</pdb_id>
			<pdb_id>4h9s</pdb_id>
			<pdb_id>4hga</pdb_id>
			<pdb_id>3wtp</pdb_id>
			<pdb_id>5b32</pdb_id>
			<pdb_id>5b33</pdb_id>
			<pdb_id>4h9p</pdb_id>
			<pdb_id>4h9q</pdb_id>
			<pdb_id>5ay8</pdb_id>
			<pdb_id>5bnv</pdb_id>
			<pdb_id>5bnx</pdb_id>
			<pdb_id>5ja4</pdb_id>
			<pdb_id>5kdm</pdb_id>
			<pdb_id>5x7x</pdb_id>
			<pdb_id>4zbj</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210004</accession>
		<general>
			<name>H3-H4 histone dimer (Drosophila melanogaster)</name>
			<pdb_id>2nqb</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Drosophila melanogaster</source_organism>
			<publication>
				<authors>Chakravarthy, S., Luger, K.</authors>
				<title>Comparative analysis of nucleosome structures from different species.</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006334</accession>
					<name>nucleosome assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0035059</accession>
					<name>RCAF complex</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>135</length>
				<uniprot>
					<id>P02299</id>
					<start>2</start>
					<end>136</end>
					<coverage>99.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q71DI3</id>
					<start>2</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>ITGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>103</length>
				<uniprot>
					<id>P84040</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P84040</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2pyo</pdb_id>
			<pdb_id>4uuz</pdb_id>
			<pdb_id>4qlc</pdb_id>
			<pdb_id>4x23</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210005</accession>
		<general>
			<name>H3-H4 histone dimer (Saccharomyces cerevisiae)</name>
			<pdb_id>1id3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.10</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>11566884</pmid>
				<authors>White CL, Suto RK, Luger K</authors>
				<title>Structure of the yeast nucleosome core particle reveals fundamental changes in internucleosome interactions.</title>
				<journal>EMBO J.</journal>
				<year>2001</year>
				<issue>18</issue>
				<volume>20</volume>
				<pages>5207-18</pages>
				<abstract>Chromatin is composed of nucleosomes, the universally repeating protein-DNA complex in eukaryotic cells. The crystal structure of the nucleosome core particle from Saccharomyces cerevisiae reveals that the structure and function of this fundamental complex is conserved between single-cell organisms and metazoans. Our results show that yeast nucleosomes are likely to be subtly destabilized as compared with nucleosomes from higher eukaryotes, consistent with the idea that much of the yeast genome remains constitutively open during much of its life cycle. Importantly, minor sequence variations lead to dramatic changes in the way in which nucleosomes pack against each other within the crystal lattice. This has important implications for our understanding of the formation of higher order chromatin structure and its modulation by post-translational modifications. Finally, the yeast nucleosome core particle provides a structural context by which to interpret genetic data obtained from yeast. Coordinates have been deposited with the Protein Data Bank under accession number 1ID3.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0043935</accession>
					<name>sexual sporulation resulting in formation of a cellular spore</name>
				</go>
				<go>
					<accession>GO:0006333</accession>
					<name>chromatin assembly or disassembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000788</accession>
					<name>nuclear nucleosome</name>
				</go>
				<go>
					<accession>GO:0031298</accession>
					<name>replication fork protection complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>ARTKQTARKSTGGKAPRKQLASKAARKSAPSTGGVKKPHRYKPGTVALREIRRFQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAIGALQESVEAYLVSLFEDTNLAAIHAKRVTIQKKEIKLARRLRGERS</sequence>
				<length>135</length>
				<uniprot>
					<id>P61830</id>
					<start>2</start>
					<end>136</end>
					<coverage>99.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q757N1</id>
					<start>2</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>122</region_start>
						<region_end>130</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>132</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>SGRGKGGKGLGKGGAKRHRKILRDNIQGITKPAIRRLARRGGVKRISGLIYEEVRAVLKSFLESVIRDSVTYTEHAKRKTVTSLDVVYALKRQGRTLYGFGG</sequence>
				<length>102</length>
				<uniprot>
					<id>P02309</id>
					<start>2</start>
					<end>103</end>
					<coverage>99%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02309</id>
					<start>2</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>19</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4jjn</pdb_id>
			<pdb_id>4kud</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110005</accession>
		<general>
			<name>Transthyretin (Gallus gallus)</name>
			<pdb_id>1tfp</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.90</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>8612621</pmid>
				<authors>Sunde M, Richardson SJ, Chang L, Pettersson TM, Schreiber G, Blake CC</authors>
				<title>The crystal structure of transthyretin from chicken.</title>
				<journal>Eur. J. Biochem.</journal>
				<year>1996</year>
				<issue>2</issue>
				<volume>236</volume>
				<pages>491-9</pages>
				<abstract>The crystal structure of chicken transthyretin has been solved at 290-pm resolution by molecular-replacement techniques. Transthyretin is the protein component of the amyloid fibrils found in patients suffering from either familial amyloidotic polyneuropathy or senile systemic amyloidosis. Familial amyloidotic polyneuropathy is an autosomal dominant hereditary type of amyloidosis which involves transthyretin with either one or two amino acid substitutions. The three-dimensional structure of chicken transthyretin was determined in order to compare a non-amyloidogenic, species-variant transthyretin with wild-type and mutant transthyretin molecules. Of the 31 chicken-to-human residue differences, 9 occur at positions which in human transthyretin give rise to amyloidogenic variants although none corresponds to the appropriate side-chain substitutions. The model of chicken transthyretin has been refined to an R-factor of 19.9%. The overall fold of the protein is that of an all-beta protein. Compared with wild-type human transthyretin the avian transthyretin shows quite large differences in the region known to be involved in binding to retinol-binding protein, it has a much shorter helical component than the human protein and some of the monomer-monomer interactions are different.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0036094</accession>
					<name>small molecule binding</name>
				</go>
				<go>
					<accession>GO:0005179</accession>
					<name>hormone activity</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0070324</accession>
					<name>thyroid hormone binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0019904</accession>
					<name>protein domain specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0001555</accession>
					<name>oocyte growth</name>
				</go>
				<go>
					<accession>GO:0042572</accession>
					<name>retinol metabolic process</name>
				</go>
				<go>
					<accession>GO:0051262</accession>
					<name>protein tetramerization</name>
				</go>
				<go>
					<accession>GO:0070327</accession>
					<name>thyroid hormone transport</name>
				</go>
				<go>
					<accession>GO:0009615</accession>
					<name>response to virus</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
				<go>
					<accession>GO:0030136</accession>
					<name>clathrin-coated vesicle</name>
				</go>
				<go>
					<accession>GO:0060417</accession>
					<name>yolk</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were generated from chains A and B respectively, using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Transthyretin-like folds</class>
				<subclass>Transthyretin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transthyretin</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>APLVSHGSVDSKCPLMVKVLDAVRGSPAANVAVKVFKKAADGTWQDFATGKTTEFGEIHELTTEEQFVEGVYRVEFDTSSYWKGLGLSPFHEYADVVFTANDSGHRHYTIAALLSPFSYSTTAVVSDPQE</sequence>
				<length>130</length>
				<uniprot>
					<id>P27731</id>
					<start>21</start>
					<end>150</end>
					<coverage>86.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P27731</id>
					<start>21</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>103</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>113</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>35</region_start>
						<region_end>142</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transthyretin</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>APLVSHGSVDSKCPLMVKVLDAVRGSPAANVAVKVFKKAADGTWQDFATGKTTEFGEIHELTTEEQFVEGVYRVEFDTSSYWKGLGLSPFHEYADVVFTANDSGHRHYTIAALLSPFSYSTTAVVSDPQE</sequence>
				<length>130</length>
				<uniprot>
					<id>P27731</id>
					<start>21</start>
					<end>150</end>
					<coverage>86.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P27731</id>
					<start>21</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>35</region_start>
						<region_end>142</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transthyretin</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>APLVSHGSVDSKCPLMVKVLDAVRGSPAANVAVKVFKKAADGTWQDFATGKTTEFGEIHELTTEEQFVEGVYRVEFDTSSYWKGLGLSPFHEYADVVFTANDSGHRHYTIAALLSPFSYSTTAVVSDPQE</sequence>
				<length>130</length>
				<uniprot>
					<id>P27731</id>
					<start>21</start>
					<end>150</end>
					<coverage>86.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P27731</id>
					<start>21</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>103</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>113</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>35</region_start>
						<region_end>142</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Transthyretin</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>APLVSHGSVDSKCPLMVKVLDAVRGSPAANVAVKVFKKAADGTWQDFATGKTTEFGEIHELTTEEQFVEGVYRVEFDTSSYWKGLGLSPFHEYADVVFTANDSGHRHYTIAALLSPFSYSTTAVVSDPQE</sequence>
				<length>130</length>
				<uniprot>
					<id>P27731</id>
					<start>21</start>
					<end>150</end>
					<coverage>86.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P27731</id>
					<start>21</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>35</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00576.18</region_id>
						<region_name>Transthyretin</region_name>
						<region_start>35</region_start>
						<region_end>142</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Transthyretin was shown in calorimetrics experiments to follow two-state folding/binding kinetics with the emergence of structure being linked to oligomerization (PMID:11152276).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2202002</accession>
		<general>
			<name>GTPase binding domain of Wiskott-Aldrich syndrome protein in complex with E. coli EspF(U)</name>
			<pdb_id>2k42</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Escherichia coli O157:H7</source_organism>
			<publication>
				<pmid>18650809</pmid>
				<authors>Cheng HC, Skehan BM, Campellone KG, Leong JM, Rosen MK</authors>
				<title>Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U).</title>
				<journal>Nature</journal>
				<year>2008</year>
				<issue>7207</issue>
				<volume>454</volume>
				<pages>1009-13</pages>
				<abstract>During infection, enterohaemorrhagic Escherichia coli (EHEC) takes over the actin cytoskeleton of eukaryotic cells by injecting the EspF(U) protein into the host cytoplasm. EspF(U) controls actin by activating members of the Wiskott-Aldrich syndrome protein (WASP) family. Here we show that EspF(U) binds to the autoinhibitory GTPase binding domain (GBD) in WASP proteins and displaces it from the activity-bearing VCA domain (for verprolin homology, central hydrophobic and acidic regions). This interaction potently activates WASP and neural (N)-WASP in vitro and induces localized actin assembly in cells. In the solution structure of the GBD-EspF(U) complex, EspF(U) forms an amphipathic helix that binds the GBD, mimicking interactions of the VCA domain in autoinhibited WASP. Thus, EspF(U) activates WASP by competing directly for the VCA binding site on the GBD. This mechanism is distinct from that used by the eukaryotic activators Cdc42 and SH2 domains, which globally destabilize the GBD fold to release the VCA. Such diversity of mechanism in WASP proteins is distinct from other multimodular systems, and may result from the intrinsically unstructured nature of the isolated GBD and VCA elements. The structural incompatibility of the GBD complexes with EspF(U) and Cdc42/SH2, plus high-affinity EspF(U) binding, enable EHEC to hijack the eukaryotic cytoskeletal machinery effectively.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Wiskott-Aldrich syndrome protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GHMSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQ</sequence>
				<length>72</length>
				<uniprot>
					<id>P42768</id>
					<start>239</start>
					<end>310</end>
					<coverage>14.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P42768</id>
					<start>239</start>
					<end>310</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>252</region_start>
						<region_end>253</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>257</region_start>
						<region_end>258</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>265</region_start>
						<region_end>274</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>278</region_start>
						<region_end>281</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>284</region_start>
						<region_end>296</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>300</region_start>
						<region_end>307</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00786.25</region_id>
						<region_name>PBD</region_name>
						<region_start>237</region_start>
						<region_end>296</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Secreted effector protein EspF(U)</name>
				<source_organism>Escherichia coli O157:H7</source_organism>
				<sequence>GHMLPDVAQRLMQHLAEHGIQPARNMAEHIPPAPNW</sequence>
				<length>36</length>
				<uniprot>
					<id>P0DJ89</id>
					<start>218</start>
					<end>253</end>
					<coverage>10.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0DJ88</id>
					<start>221</start>
					<end>253</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>224</region_start>
						<region_end>233</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04806.9</region_id>
						<region_name>EspF</region_name>
						<region_start>190</region_start>
						<region_end>236</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04806.9</region_id>
						<region_name>EspF</region_name>
						<region_start>237</region_start>
						<region_end>283</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 230-249 region described in DisProt entry DP00215 and the 230-310 region described in IDEAL entry IID00269 cover 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 221-314 region described in IDEAL entry IID90008 covers 92% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110009</accession>
		<general>
			<name>HY5 leucine zipper homodimer</name>
			<pdb_id>2oqq</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Arabidopsis thaliana</source_organism>
			<publication>
				<authors>Yoon, M.-K., Kim, H.M., Choi, G., Lee, J.-O., Choi, B.-S.</authors>
				<title>Structural basis for the conformational integrity of the Arabidopsis thaliana HY5 Ieucine zipper homodimer</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003690</accession>
					<name>double-stranded DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010218</accession>
					<name>response to far red light</name>
				</go>
				<go>
					<accession>GO:0009737</accession>
					<name>response to abscisic acid</name>
				</go>
				<go>
					<accession>GO:0031539</accession>
					<name>positive regulation of anthocyanin metabolic process</name>
				</go>
				<go>
					<accession>GO:0010114</accession>
					<name>response to red light</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0009740</accession>
					<name>gibberellic acid mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0010099</accession>
					<name>regulation of photomorphogenesis</name>
				</go>
				<go>
					<accession>GO:0010224</accession>
					<name>response to UV-B</name>
				</go>
				<go>
					<accession>GO:0080167</accession>
					<name>response to karrikin</name>
				</go>
				<go>
					<accession>GO:0009585</accession>
					<name>red, far-red light phototransduction</name>
				</go>
				<go>
					<accession>GO:0042753</accession>
					<name>positive regulation of circadian rhythm</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcription factor HY5</name>
				<source_organism>Arabidopsis thaliana</source_organism>
				<sequence>GSAYLSELENRVKDLENKNSELEERLSTLQNENQMLRHILKN</sequence>
				<length>42</length>
				<uniprot>
					<id>O24646</id>
					<start>109</start>
					<end>150</end>
					<coverage>25%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O24646</id>
					<start>111</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>111</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00170.18</region_id>
						<region_name>bZIP_1</region_name>
						<region_start>86</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcription factor HY5</name>
				<source_organism>Arabidopsis thaliana</source_organism>
				<sequence>GSAYLSELENRVKDLENKNSELEERLSTLQNENQMLRHILKN</sequence>
				<length>42</length>
				<uniprot>
					<id>O24646</id>
					<start>109</start>
					<end>150</end>
					<coverage>25%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O24646</id>
					<start>111</start>
					<end>150</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>111</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00170.18</region_id>
						<region_name>bZIP_1</region_name>
						<region_start>86</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2211002</accession>
		<general>
			<name>c-Myc-Max heterodimeric leucine zipper</name>
			<pdb_id>1a93</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Pan paniscus / Mus musculus</source_organism>
			<publication>
				<pmid>9680483</pmid>
				<authors>Lavigne P, Crump MP, Gagné SM, Hodges RS, Kay CM, Sykes BD</authors>
				<title>Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1998</year>
				<issue>1</issue>
				<volume>281</volume>
				<pages>165-81</pages>
				<abstract>The oncoprotein c-Myc (a member of the helix-loop-helix-leucine zipper (b-HLH-LZ) family of transcription factors) must heterodimerize with the b-HLH-LZ Max protein to bind DNA and activate transcription. It has been shown that the LZ domains of the c-Myc and Max proteins specifically form a heterodimeric LZ at 20 degreesC and neutral pH. This suggests that the LZ domains of the c-Myc and Max proteins are playing an important role in the heterodimerization of the corresponding gene products in vivo. Initially, to gain an insight into the energetics of heterodimerization, we studied the stability of N-terminal disulfide-linked versions of the c-Myc and Max homodimeric LZs and c-Myc-Max heterodimeric LZ by fitting the temperature-induced denaturation curves monitored by circular dichroism spectroscopy. The c-Myc LZ does not homodimerize (as previously reported) and the c-Myc-Max heterodimeric LZ is more stable than the Max homodimeric LZ at 20 degreesC and pH 7.0. In order to determine the critical interhelical interactions responsible for the molecular recognition between the c-Myc and Max LZs, the solution structure of the disulfide-linked c-Myc-Max heterodimeric LZ was solved by two-dimensional 1H-NMR techniques at 25 degreesC and pH 4.7. Both LZs are alpha-helical and the tertiary structure depicts the typical left-handed super-helical twist of a two-stranded parallel alpha-helical coiled-coil. A buried salt bridge involving a histidine on the Max LZ and two glutamate residues on the c-Myc LZ is observed at the interface of the heterodimeric LZ. A buried H-bond between an asparagine side-chain and a backbone carbonyl is also observed. Moreover, evidence for e-g interhelical salt bridges is reported. These specific interactions give insights into the preferential heterodimerization process of the two LZs. The low stabilities of the Max homodimeric LZ and the c-Myc-Max heterodimeric LZ as well as the specific interactions observed are discussed with regard to regulation of transcription in this family of transcription factors.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Myc proto-oncogene protein</name>
				<source_organism>Pan paniscus</source_organism>
				<sequence>CGGVQAEEQKLISEEDLLRKRREQLKHKLEQL</sequence>
				<length>32</length>
				<uniprot>
					<id>A1YG22</id>
					<start>406</start>
					<end>434</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01106</id>
					<start>406</start>
					<end>434</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>406</region_start>
						<region_end>433</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02344.12</region_id>
						<region_name>Myc-LZ</region_name>
						<region_start>408</region_start>
						<region_end>438</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein max</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>CGGMRRKNDTHQQDIDDLKRQNALLEQQVRAL</sequence>
				<length>32</length>
				<uniprot>
					<id>P28574</id>
					<start>74</start>
					<end>102</end>
					<coverage>18.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P61244</id>
					<start>74</start>
					<end>102</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>101</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:9680483). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 406-434 region described in DisProt entry DP00260 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-110 region described in DisProt entry DP00084 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2a93</pdb_id>
			<pdb_id>1nkp</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2201008</accession>
		<general>
			<name>Heterodimer of ATF-4 and C/EBP beta</name>
			<pdb_id>1ci6</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens / Mus musculus</source_organism>
			<publication>
				<pmid>11018027</pmid>
				<authors>Podust LM, Krezel AM, Kim Y</authors>
				<title>Crystal structure of the CCAAT box/enhancer-binding protein beta activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2001</year>
				<issue>1</issue>
				<volume>276</volume>
				<pages>505-13</pages>
				<abstract>The crystal structure of the heterodimer formed by the basic leucine zipper (bZIP) domains of activating transcription factor-4 (ATF4) and CCAAT box/enhancer-binding protein beta (C/EBP beta), from two different bZIP transcription factor families, has been determined and refined to 2.6 A. The structure shows that the heterodimer forms an asymmetric coiled-coil. Even in the absence of DNA, the basic region of ATF4 forms a continuous alpha-helix, but the basic region of C/EBP beta is disordered. Proteolysis, electrophoretic mobility shift assay, circular dichroism, and NMR analyses indicated that (i) the bZIP domain of ATF4 is a disordered monomer and forms a homodimer upon binding to the DNA target; (ii) the bZIP domain of ATF4 forms a heterodimer with the bZIP domain of C/EBP beta that binds the cAMP response element, but not CCAAT box DNA, with high affinity; and (iii) the basic region of ATF4 has a higher alpha-helical propensity than that of C/EBP beta. These results suggest that the degree of ordering of the basic region and the fork and the dimerization properties of the leucine zipper combine to distinguish the structurally similar bZIP domains of ATF4 and C/EBP beta with respect to DNA target sequence. This study provides insight into the mechanism by which dimeric bZIP transcription factors discriminate between closely related but distinct DNA targets.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:1990440</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress</name>
				</go>
				<go>
					<accession>GO:0070059</accession>
					<name>intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Leucine zipper (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cyclic AMP-dependent transcription factor ATF-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKKLKKMEQNKTAATRYRQKKRAEQEALTGECKELEKKNEALKERADSLAKEIQYLKDLIEEV</sequence>
				<length>63</length>
				<uniprot>
					<id>P18848</id>
					<start>279</start>
					<end>341</end>
					<coverage>17.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P18848</id>
					<start>280</start>
					<end>341</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>288</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00170.18</region_id>
						<region_name>bZIP_1</region_name>
						<region_start>276</region_start>
						<region_end>339</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>CCAAT/enhancer-binding protein beta</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>MEYKMRRERNNIAVRKSRDKAKMRNLETQHKVLELTAENERLQKKVEQLSRELSTLRNLFKQL</sequence>
				<length>63</length>
				<uniprot>
					<id>P28033</id>
					<start>223</start>
					<end>285</end>
					<coverage>21.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P28033</id>
					<start>224</start>
					<end>285</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>240</region_start>
						<region_end>282</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07716.12</region_id>
						<region_name>bZIP_2</region_name>
						<region_start>221</region_start>
						<region_end>274</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits of the dimer were shown to be disordered in their monomeric form with the structure arising as a result of the interaction (PMID:11018027). The subunits in the structure are bound via coiled coil interactions (PMID:11018027). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure. Leucine zippers, phenylalanine zippers and alanine zippers are subclasses of coiled coils where the hydrophobic interactions between subunits are predominantly formed by leucine, phenylalanine or alanine residues, respectively.</complex_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A homologue sharing the same Pfam domain (PF07716.12) has been experimentally characterized as disordered in DisProt entry DP00083.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4110006</accession>
		<general>
			<name>General corepressor Tup1p</name>
			<pdb_id>3vp8</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.91</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>22707714</pmid>
				<authors>Matsumura H, Kusaka N, Nakamura T, Tanaka N, Sagegami K, Uegaki K, Inoue T, Mukai Y</authors>
				<title>Crystal structure of the N-terminal domain of the yeast general corepressor Tup1p and its functional implications.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2012</year>
				<issue>32</issue>
				<volume>287</volume>
				<pages>26528-38</pages>
				<abstract>The yeast Cyc8p-Tup1p protein complex is a general transcriptional corepressor of genes involved in many different physiological processes. Herein, we present the crystal structure of the Tup1p N-terminal domain (residues 1-92), essential for Tup1p self-assembly and interaction with Cyc8p. This domain tetramerizes to form a novel antiparallel four-helix bundle. Coiled coil interactions near the helical ends hold each dimer together, whereas interdimeric association involves only two sets of two residues located toward the chain centers. A mutagenesis study confirmed that the nonpolar residues responsible for the association of the protomers as dimers are also required for transcriptional repression. An additional structural study demonstrated that the domain containing an Leu(62) → Arg mutation that had been shown not to bind Cyc8p exhibits an altered structure, distinct from the wild type. This altered structure explains why the mutant cannot bind Cyc8p. The data presented herein highlight the importance of the architecture of the Tup1p N-terminal domain for self-association.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0036033</accession>
					<name>mediator complex binding</name>
				</go>
				<go>
					<accession>GO:0042393</accession>
					<name>histone binding</name>
				</go>
				<go>
					<accession>GO:0080025</accession>
					<name>phosphatidylinositol-3,5-bisphosphate binding</name>
				</go>
				<go>
					<accession>GO:0001191</accession>
					<name>transcriptional repressor activity, RNA polymerase II transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0042826</accession>
					<name>histone deacetylase binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:2001020</accession>
					<name>regulation of response to DNA damage stimulus</name>
				</go>
				<go>
					<accession>GO:0043486</accession>
					<name>histone exchange</name>
				</go>
				<go>
					<accession>GO:0000433</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter by glucose</name>
				</go>
				<go>
					<accession>GO:0007070</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter during mitosis</name>
				</go>
				<go>
					<accession>GO:2000531</accession>
					<name>regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0001198</accession>
					<name>negative regulation of mating-type specific transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0016584</accession>
					<name>nucleosome positioning</name>
				</go>
				<go>
					<accession>GO:2000217</accession>
					<name>regulation of invasive growth in response to glucose limitation</name>
				</go>
				<go>
					<accession>GO:0035955</accession>
					<name>negative regulation of dipeptide transport by negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0008023</accession>
					<name>transcription elongation factor complex</name>
				</go>
				<go>
					<accession>GO:0033588</accession>
					<name>Elongator holoenzyme complex</name>
				</go>
				<go>
					<accession>GO:0000123</accession>
					<name>histone acetyltransferase complex</name>
				</go>
				<go>
					<accession>GO:0017053</accession>
					<name>transcriptional repressor complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>General transcriptional corepressor TUP1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MTASVSNTQNKLNELLDAIRQEFLQVSQEANTYRLQNQKDYDFKMNQQLAEMQQIRNTVYELELTHRKMKDAYEEEIKHLKLGLEQRDHQIA</sequence>
				<length>92</length>
				<uniprot>
					<id>P16649</id>
					<start>1</start>
					<end>92</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P16649</id>
					<start>1</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08581.7</region_id>
						<region_name>Tup_N</region_name>
						<region_start>11</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>General transcriptional corepressor TUP1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MTASVSNTQNKLNELLDAIRQEFLQVSQEANTYRLQNQKDYDFKMNQQLAEMQQIRNTVYELELTHRKMKDAYEEEIKHLKLGLEQRDHQIA</sequence>
				<length>92</length>
				<uniprot>
					<id>P16649</id>
					<start>1</start>
					<end>92</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P16649</id>
					<start>1</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08581.7</region_id>
						<region_name>Tup_N</region_name>
						<region_start>11</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>General transcriptional corepressor TUP1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MTASVSNTQNKLNELLDAIRQEFLQVSQEANTYRLQNQKDYDFKMNQQLAEMQQIRNTVYELELTHRKMKDAYEEEIKHLKLGLEQRDHQIA</sequence>
				<length>92</length>
				<uniprot>
					<id>P16649</id>
					<start>1</start>
					<end>92</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P16649</id>
					<start>1</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08581.7</region_id>
						<region_name>Tup_N</region_name>
						<region_start>11</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>General transcriptional corepressor TUP1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MTASVSNTQNKLNELLDAIRQEFLQVSQEANTYRLQNQKDYDFKMNQQLAEMQQIRNTVYELELTHRKMKDAYEEEIKHLKLGLEQRDHQIA</sequence>
				<length>92</length>
				<uniprot>
					<id>P16649</id>
					<start>1</start>
					<end>92</end>
					<coverage>12.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P16649</id>
					<start>1</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>4</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08581.7</region_id>
						<region_name>Tup_N</region_name>
						<region_start>11</region_start>
						<region_end>88</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:22707714). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3vp9</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120017</accession>
		<general>
			<name>TrpR-like protein (Eubacterium eligens)</name>
			<pdb_id>3g1c</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Eubacterium eligens</source_organism>
			<publication>
				<authors>Zhang, R., Hendricks, R., Freeman, L., Babnigg, G., Joachimiak, A.</authors>
				<title>The crystal structure of a TrpR like protein from Eubacterium eligens ATCC 27750</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005622</accession>
					<name>intracellular</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Trp repressor-like</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>The TrpR like protein from Eubacterium eligens ATCC 27750</name>
				<source_organism>Eubacterium eligens</source_organism>
				<sequence>MNNKLKTQAVEQLFQAILSLKDLDEAYDFFEDVCTINEILSLSQRFEVAKMLREHRTYLDIAEKTGASTATISRVNRSLNYGNDGYDRVFERLGMLEKESEDNK</sequence>
				<length>104</length>
				<uniprot>
					<id>C4Z2H9</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_C4Z2H9</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>8</region_start>
						<region_end>94</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>The TrpR like protein from Eubacterium eligens ATCC 27750</name>
				<source_organism>Eubacterium eligens</source_organism>
				<sequence>MNNKLKTQAVEQLFQAILSLKDLDEAYDFFEDVCTINEILSLSQRFEVAKMLREHRTYLDIAEKTGASTATISRVNRSLNYGNDGYDRVFERLGMLEKESEDNK</sequence>
				<length>104</length>
				<uniprot>
					<id>C4Z2H9</id>
					<start>1</start>
					<end>104</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_C4Z2H9</id>
					<start>1</start>
					<end>104</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>23</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>8</region_start>
						<region_end>94</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The folding and dimerization of the Trp repressor were shown to be linked by both experimental (PMID:10329154, PMID:2223756, PMID:7578063) and computational studies (PMID:10465773).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120018</accession>
		<general>
			<name>Putative Trp repressor (Staphylococcus aureus)</name>
			<pdb_id>3kor</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Staphylococcus aureus</source_organism>
			<publication>
				<authors>Lam, R., Vodsedalek, J., Lam, K., Romanov, V., Battaile, K.P., Beletskaya, I., Pai, E.F., Chirgadze, N.Y.</authors>
				<title>Crystal structure of a putative Trp repressor from Staphylococcus aureus</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005622</accession>
					<name>intracellular</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were removed as chains A and D represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Trp repressor-like</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein</name>
				<source_organism>Staphylococcus aureus</source_organism>
				<sequence>MGSSHHHHHHSSGLVPRGSMQIEKLRGAALDELFDAILTLENREECYQFFDDLCTVNEIQSLSQRLQVAKMIKQGYTYATIEQESGASTATISRVKRSLQWGNDAYTMILDRMNIETNE</sequence>
				<length>119</length>
				<uniprot>
					<id>A0A0H3JS52</id>
					<start>1</start>
					<end>100</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q49YV2</id>
					<start>1</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>7</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>72</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>9</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Uncharacterized protein</name>
				<source_organism>Staphylococcus aureus</source_organism>
				<sequence>MGSSHHHHHHSSGLVPRGSMQIEKLRGAALDELFDAILTLENREECYQFFDDLCTVNEIQSLSQRLQVAKMIKQGYTYATIEQESGASTATISRVKRSLQWGNDAYTMILDRMNIETNE</sequence>
				<length>119</length>
				<uniprot>
					<id>A0A0H3JS52</id>
					<start>1</start>
					<end>100</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q49YV2</id>
					<start>1</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>7</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>72</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>90</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01371.16</region_id>
						<region_name>Trp_repressor</region_name>
						<region_start>9</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The folding and dimerization of the Trp repressor were shown to be linked by both experimental (PMID:10329154, PMID:2223756, PMID:7578063) and computational studies (PMID:10465773).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF3300001</accession>
		<general>
			<name>Rb C-terminal domain bound to an E2F1-DP1 heterodimer</name>
			<pdb_id>2aze</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.55</resolution>
			<assembly>heterotrimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>16360038</pmid>
				<authors>Rubin SM, Gall AL, Zheng N, Pavletich NP</authors>
				<title>Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.</title>
				<journal>Cell</journal>
				<year>2005</year>
				<issue>6</issue>
				<volume>123</volume>
				<pages>1093-106</pages>
				<abstract>The retinoblastoma (Rb) protein negatively regulates the G1-S transition by binding to the E2F transcription factors, until cyclin-dependent kinases phosphorylate Rb, causing E2F release. The Rb pocket domain is necessary for E2F binding, but the Rb C-terminal domain (RbC) is also required for growth suppression. Here we demonstrate a high-affinity interaction between RbC and E2F-DP heterodimers shared by all Rb and E2F family members. The crystal structure of an RbC-E2F1-DP1 complex reveals an intertwined heterodimer in which the marked box domains of both E2F1 and DP1 contact RbC. We also demonstrate that phosphorylation of RbC at serines 788 and 795 destabilizes one set of RbC-E2F-DP interactions directly, while phosphorylation at threonines 821 and 826 induces an intramolecular interaction between RbC and the Rb pocket that destabilizes the remaining interactions indirectly. Our findings explain the requirement of RbC for high-affinity E2F binding and growth suppression and establish a mechanism for the regulation of Rb-E2F association by phosphorylation.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>3</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcription factor Dp-1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GEFAQECQNLEVERQRRLERIKQKQSQLQELILQQIAFKNLVQRNRHAEQQASRPPPPNSVIHLPFIIVNTSKKTVIDCSISNDKFEYLFNFDNTFEIHDDIEVLKRMGMACGLESGSCSAEDLKMARSLVPKALEPYVTEMAQGTVGGVFITTA</sequence>
				<length>155</length>
				<uniprot>
					<id>Q14186</id>
					<start>196</start>
					<end>350</end>
					<coverage>37.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q14186</id>
					<start>199</start>
					<end>350</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>199</region_start>
						<region_end>245</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>253</region_start>
						<region_end>255</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>256</region_start>
						<region_end>258</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>262</region_start>
						<region_end>267</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>272</region_start>
						<region_end>276</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>282</region_start>
						<region_end>287</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>291</region_start>
						<region_end>295</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>296</region_start>
						<region_end>302</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>311</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>316</region_start>
						<region_end>324</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>328</region_start>
						<region_end>339</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08781.7</region_id>
						<region_name>DP</region_name>
						<region_start>200</region_start>
						<region_end>338</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcription factor E2F1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMGGRLEGLTQDLRQLQESEQQLDHLMNICTTQLRLLSEDTDSQRLAYVTCQDLRSIADPAEQMVMVIKAPPETQLQAVDSSENFQISLKSKQGPIDVFLCPEE</sequence>
				<length>106</length>
				<uniprot>
					<id>Q01094</id>
					<start>196</start>
					<end>301</end>
					<coverage>24.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01094</id>
					<start>192</start>
					<end>301</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>202</region_start>
						<region_end>236</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>238</region_start>
						<region_end>243</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>245</region_start>
						<region_end>247</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>248</region_start>
						<region_end>252</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>260</region_start>
						<region_end>266</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>272</region_start>
						<region_end>277</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>282</region_start>
						<region_end>287</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>294</region_start>
						<region_end>296</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16421.2</region_id>
						<region_name>E2F_CC-MB</region_name>
						<region_start>206</region_start>
						<region_end>299</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Retinoblastoma-associated protein</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SRILVSIGESFGTSEKFQKINQMVCNSDRVLKRSAEGSNPPKPLKK</sequence>
				<length>46</length>
				<uniprot>
					<id>P06400</id>
					<start>829</start>
					<end>874</end>
					<coverage>5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06400</id>
					<start>829</start>
					<end>874</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>830</region_start>
						<region_end>834</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>841</region_start>
						<region_end>853</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08934.7</region_id>
						<region_name>Rb_C</region_name>
						<region_start>768</region_start>
						<region_end>925</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting partners have been shown to adopt a stable structure as a result of the interaction (PMID:16360038).</complex_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>The 772-874 region described in IDEAL entry IID00017 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100006</accession>
		<general>
			<name>Rab11 binding domain of Rab11 family interacting protein 2</name>
			<pdb_id>2k6s</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>19119858</pmid>
				<authors>Wei J, Liu Y, Bose K, Henry GD, Baleja JD</authors>
				<title>Disorder and structure in the Rab11 binding domain of Rab11 family interacting protein 2.</title>
				<journal>Biochemistry</journal>
				<year>2009</year>
				<issue>3</issue>
				<volume>48</volume>
				<pages>549-57</pages>
				<abstract>Rab11 plays a central role in plasma membrane recycling which returns cellular receptors for reuse at the cell surface. A recently identified family of Rab11 interacting proteins (FIP) includes FIP2. The C-terminal region of FIP2 is essential for colocalization with Rab11 on early endosomes and for enabling formation of higher-order oligomers. Rab11 binding and oligomerization of FIP2 are separable. Here we have determined the three-dimensional structure of the 40-residue coiled-coil oligomerization domain of FIP2 in the absence of Rab11 using NMR methods. The N-terminal half showed strong NOE cross-peaks and well-dispersed NMR resonances, whereas the C-terminal half had fewer NOE cross-peaks and less chemical shift dispersion. The 10 C-terminal residues were mostly disordered. The final structures of the dimer had favorable Ramachandran angles and a root-mean-square deviation of 0.59 +/- 0.13 A over superimposed backbone residues. The structure allows a comparison to a structure of FIP2 in complex with Rab11 that was determined crystallographically. In complex with Rab11, the C-terminal residues are not disordered but have a helical structure that predicts residual dipolar coupling constants that are incompatible with those measured on the unbound FIP2. In both structures, a histidine residue is found at the normally hydrophobic position of the heptad repeat of the coiled coil, and here we show its ionization destabilizes the coiled-coil structure. Together, these data allow us to build a model in which the binding of FIP family proteins to Rab11 can be described in terms of conformational changes and that suggests new modes of regulation.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0019901</accession>
					<name>protein kinase binding</name>
				</go>
				<go>
					<accession>GO:0017137</accession>
					<name>Rab GTPase binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045055</accession>
					<name>regulated exocytosis</name>
				</go>
				<go>
					<accession>GO:0030010</accession>
					<name>establishment of cell polarity</name>
				</go>
				<go>
					<accession>GO:0035773</accession>
					<name>insulin secretion involved in cellular response to glucose stimulus</name>
				</go>
				<go>
					<accession>GO:0003091</accession>
					<name>renal water homeostasis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0030659</accession>
					<name>cytoplasmic vesicle membrane</name>
				</go>
				<go>
					<accession>GO:0055038</accession>
					<name>recycling endosome membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Rab11 family-interacting protein 2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSLTYEEVLQELVKHKELLRRKDTHIRELEDYIDNLLVRVM</sequence>
				<length>41</length>
				<uniprot>
					<id>Q7L804</id>
					<start>449</start>
					<end>489</end>
					<coverage>8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q7L804</id>
					<start>450</start>
					<end>489</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>453</region_start>
						<region_end>485</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09457.7</region_id>
						<region_name>RBD-FIP</region_name>
						<region_start>452</region_start>
						<region_end>499</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Rab11 family-interacting protein 2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSLTYEEVLQELVKHKELLRRKDTHIRELEDYIDNLLVRVM</sequence>
				<length>41</length>
				<uniprot>
					<id>Q7L804</id>
					<start>449</start>
					<end>489</end>
					<coverage>8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q7L804</id>
					<start>450</start>
					<end>489</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>453</region_start>
						<region_end>485</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09457.7</region_id>
						<region_name>RBD-FIP</region_name>
						<region_start>452</region_start>
						<region_end>499</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:19119858). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3tso</pdb_id>
			<pdb_id>4c4p</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4100003</accession>
		<general>
			<name>p53 tetramerization domain (human)</name>
			<pdb_id>2j0z</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>18076077</pmid>
				<authors>Mora P, Carbajo RJ, Pineda-Lucena A, Sánchez del Pino MM, Pérez-Payá E</authors>
				<title>Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.</title>
				<journal>Proteins</journal>
				<year>2008</year>
				<issue>4</issue>
				<volume>71</volume>
				<pages>1670-85</pages>
				<abstract>The role of hydrophobic amino acids in the formation of hydrophobic cores as one of the major driving forces in protein folding has been extensively studied. However, the implication of neutral solvent-exposed amino acids is less clear and available information is scarce. We have used a combinatorial approach to study the structural relevance of three solvent-exposed residues (Tyr(327), Thr(329), and Gln(331)) located in thebeta-sheet of the tetramerization domain of the tumor suppressor p53 (p53TD). A conformationally defined peptide library was designed where these three positions were randomized. The library was screened for tetramer stability. A set of p53TD mutants containing putative stabilizing or destabilizing residue combinations was synthesized for a thermodynamic characterization. Unfolding experiments showed a wide range of stabilities, with T(m) values between 27 and 83 degrees C. Wild type p53TD and some highly destabilized and stabilized mutants were further characterized. Thermodynamic and biophysical data indicated that these proteins were folded tetramers, with the same overall structure, in equilibrium with unfolded monomers. An NMR study confirmed that the main structural features of p53TD are conserved in all the mutants analyzed. The thermodynamic stability of the different p53TD mutants showed a strong correlation with parameters that favor formation and stabilization of the beta-sheet. We propose that stabilization through hydrophobic interactions of key secondary structure elements might be the underlying mechanism for the strong influence of solvent-exposed residues in the stability of p53TD.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0002039</accession>
					<name>p53 binding</name>
				</go>
				<go>
					<accession>GO:0005507</accession>
					<name>copper ion binding</name>
				</go>
				<go>
					<accession>GO:0001228</accession>
					<name>transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0002020</accession>
					<name>protease binding</name>
				</go>
				<go>
					<accession>GO:0051721</accession>
					<name>protein phosphatase 2A binding</name>
				</go>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0043621</accession>
					<name>protein self-association</name>
				</go>
				<go>
					<accession>GO:0030971</accession>
					<name>receptor tyrosine kinase binding</name>
				</go>
				<go>
					<accession>GO:0003684</accession>
					<name>damaged DNA binding</name>
				</go>
				<go>
					<accession>GO:0035035</accession>
					<name>histone acetyltransferase binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0047485</accession>
					<name>protein N-terminus binding</name>
				</go>
				<go>
					<accession>GO:0031625</accession>
					<name>ubiquitin protein ligase binding</name>
				</go>
				<go>
					<accession>GO:0001085</accession>
					<name>RNA polymerase II transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0001046</accession>
					<name>core promoter sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0051087</accession>
					<name>chaperone binding</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0048512</accession>
					<name>circadian behavior</name>
				</go>
				<go>
					<accession>GO:0051974</accession>
					<name>negative regulation of telomerase activity</name>
				</go>
				<go>
					<accession>GO:0007265</accession>
					<name>Ras protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0030308</accession>
					<name>negative regulation of cell growth</name>
				</go>
				<go>
					<accession>GO:0043153</accession>
					<name>entrainment of circadian clock by photoperiod</name>
				</go>
				<go>
					<accession>GO:0006289</accession>
					<name>nucleotide-excision repair</name>
				</go>
				<go>
					<accession>GO:0006284</accession>
					<name>base-excision repair</name>
				</go>
				<go>
					<accession>GO:0043066</accession>
					<name>negative regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:2000379</accession>
					<name>positive regulation of reactive oxygen species metabolic process</name>
				</go>
				<go>
					<accession>GO:0031497</accession>
					<name>chromatin assembly</name>
				</go>
				<go>
					<accession>GO:1902749</accession>
					<name>regulation of cell cycle G2/M phase transition</name>
				</go>
				<go>
					<accession>GO:1901796</accession>
					<name>regulation of signal transduction by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0048147</accession>
					<name>negative regulation of fibroblast proliferation</name>
				</go>
				<go>
					<accession>GO:0090399</accession>
					<name>replicative senescence</name>
				</go>
				<go>
					<accession>GO:0000733</accession>
					<name>DNA strand renaturation</name>
				</go>
				<go>
					<accession>GO:1900740</accession>
					<name>positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0016925</accession>
					<name>protein sumoylation</name>
				</go>
				<go>
					<accession>GO:0006978</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</name>
				</go>
				<go>
					<accession>GO:0090200</accession>
					<name>positive regulation of release of cytochrome c from mitochondria</name>
				</go>
				<go>
					<accession>GO:0006977</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0035690</accession>
					<name>cellular response to drug</name>
				</go>
				<go>
					<accession>GO:0030154</accession>
					<name>cell differentiation</name>
				</go>
				<go>
					<accession>GO:1900119</accession>
					<name>positive regulation of execution phase of apoptosis</name>
				</go>
				<go>
					<accession>GO:0016032</accession>
					<name>viral process</name>
				</go>
				<go>
					<accession>GO:0008283</accession>
					<name>cell proliferation</name>
				</go>
				<go>
					<accession>GO:0010165</accession>
					<name>response to X-ray</name>
				</go>
				<go>
					<accession>GO:0071456</accession>
					<name>cellular response to hypoxia</name>
				</go>
				<go>
					<accession>GO:2001244</accession>
					<name>positive regulation of intrinsic apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0010332</accession>
					<name>response to gamma radiation</name>
				</go>
				<go>
					<accession>GO:0051262</accession>
					<name>protein tetramerization</name>
				</go>
				<go>
					<accession>GO:0071479</accession>
					<name>cellular response to ionizing radiation</name>
				</go>
				<go>
					<accession>GO:0031065</accession>
					<name>positive regulation of histone deacetylation</name>
				</go>
				<go>
					<accession>GO:0008340</accession>
					<name>determination of adult lifespan</name>
				</go>
				<go>
					<accession>GO:0034644</accession>
					<name>cellular response to UV</name>
				</go>
				<go>
					<accession>GO:0034613</accession>
					<name>cellular protein localization</name>
				</go>
				<go>
					<accession>GO:0090403</accession>
					<name>oxidative stress-induced premature senescence</name>
				</go>
				<go>
					<accession>GO:0046827</accession>
					<name>positive regulation of protein export from nucleus</name>
				</go>
				<go>
					<accession>GO:0042149</accession>
					<name>cellular response to glucose starvation</name>
				</go>
				<go>
					<accession>GO:0006983</accession>
					<name>ER overload response</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0043161</accession>
					<name>proteasome-mediated ubiquitin-dependent protein catabolic process</name>
				</go>
				<go>
					<accession>GO:0043525</accession>
					<name>positive regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0032461</accession>
					<name>positive regulation of protein oligomerization</name>
				</go>
				<go>
					<accession>GO:0097252</accession>
					<name>oligodendrocyte apoptotic process</name>
				</go>
				<go>
					<accession>GO:1990440</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress</name>
				</go>
				<go>
					<accession>GO:0042771</accession>
					<name>intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0046677</accession>
					<name>response to antibiotic</name>
				</go>
				<go>
					<accession>GO:0050731</accession>
					<name>positive regulation of peptidyl-tyrosine phosphorylation</name>
				</go>
				<go>
					<accession>GO:0051097</accession>
					<name>negative regulation of helicase activity</name>
				</go>
				<go>
					<accession>GO:0007050</accession>
					<name>cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0070245</accession>
					<name>positive regulation of thymocyte apoptotic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0016363</accession>
					<name>nuclear matrix</name>
				</go>
				<go>
					<accession>GO:0005730</accession>
					<name>nucleolus</name>
				</go>
				<go>
					<accession>GO:0005759</accession>
					<name>mitochondrial matrix</name>
				</go>
				<go>
					<accession>GO:0005783</accession>
					<name>endoplasmic reticulum</name>
				</go>
				<go>
					<accession>GO:0005657</accession>
					<name>replication fork</name>
				</go>
				<go>
					<accession>GO:0016605</accession>
					<name>PML body</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EYFTLQIRGRERFEMFRELNEALELKDAQAG</sequence>
				<length>31</length>
				<uniprot>
					<id>P04637</id>
					<start>326</start>
					<end>356</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04637</id>
					<start>326</start>
					<end>356</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>328</region_start>
						<region_end>332</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>354</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>319</region_start>
						<region_end>358</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EYFTLQIRGRERFEMFRELNEALELKDAQAG</sequence>
				<length>31</length>
				<uniprot>
					<id>P04637</id>
					<start>326</start>
					<end>356</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04637</id>
					<start>326</start>
					<end>356</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>328</region_start>
						<region_end>332</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>354</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>319</region_start>
						<region_end>358</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EYFTLQIRGRERFEMFRELNEALELKDAQAG</sequence>
				<length>31</length>
				<uniprot>
					<id>P04637</id>
					<start>326</start>
					<end>356</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04637</id>
					<start>326</start>
					<end>356</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>328</region_start>
						<region_end>332</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>353</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>319</region_start>
						<region_end>358</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>EYFTLQIRGRERFEMFRELNEALELKDAQAG</sequence>
				<length>31</length>
				<uniprot>
					<id>P04637</id>
					<start>326</start>
					<end>356</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04637</id>
					<start>326</start>
					<end>356</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>328</region_start>
						<region_end>332</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>354</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>319</region_start>
						<region_end>358</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1a1u</pdb_id>
			<pdb_id>1aie</pdb_id>
			<pdb_id>1c26</pdb_id>
			<pdb_id>1hs5</pdb_id>
			<pdb_id>2j10</pdb_id>
			<pdb_id>2j11</pdb_id>
			<pdb_id>1olg</pdb_id>
			<pdb_id>1olh</pdb_id>
			<pdb_id>1pes</pdb_id>
			<pdb_id>1pet</pdb_id>
			<pdb_id>1sae</pdb_id>
			<pdb_id>1saf</pdb_id>
			<pdb_id>1sak</pdb_id>
			<pdb_id>1sal</pdb_id>
			<pdb_id>3sak</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110007</accession>
		<general>
			<name>p53 tetramerization domain (Danio rerio)</name>
			<pdb_id>4d1l</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.97</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Danio rerio</source_organism>
			<publication>
				<pmid>25185827</pmid>
				<authors>Joerger AC, Wilcken R, Andreeva A</authors>
				<title>Tracing the Evolution of the p53 Tetramerization Domain.</title>
				<journal>Structure</journal>
				<year>2014</year>
				<issue>9</issue>
				<volume>22</volume>
				<pages>1301-10</pages>
				<abstract>The tetrameric transcription factors p53, p63, and p73 evolved from a common ancestor and play key roles in tumor suppression and development. Surprisingly, p63 and p73 require a second helix in their tetramerization domain for the formation of stable tetramers that is absent in human p53, raising questions about the evolutionary processes leading to diversification. Here we determined the crystal structure of the zebrafish p53 tetramerization domain, which contains a second helix, reminiscent of p63 and p73, combined with p53-like features. Through comprehensive phylogenetic analyses, we systematically traced the evolution of vertebrate p53 family oligomerization domains back to the beginning of multicellular life. We provide evidence that their last common ancestor also had an extended p63/p73-like domain and pinpoint evolutionary events that shaped this domain during vertebrate radiation. Domain compaction and transformation of a structured into a flexible, intrinsically disordered region may have contributed to the expansion of the human p53 interactome.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0044212</accession>
					<name>transcription regulatory region DNA binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006915</accession>
					<name>apoptotic process</name>
				</go>
				<go>
					<accession>GO:0007049</accession>
					<name>cell cycle</name>
				</go>
				<go>
					<accession>GO:0051262</accession>
					<name>protein tetramerization</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains A and B were removed as chains C, D, E and F represent the biologically relevant tetramer.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>GGSEEIFTLQVRGRERYEILKKLNDSLELSDVVPASDAEKYRQKFMTK</sequence>
				<length>48</length>
				<uniprot>
					<id>G1K2L5</id>
					<start>299</start>
					<end>346</end>
					<coverage>12.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P79734</id>
					<start>301</start>
					<end>345</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>304</region_start>
						<region_end>310</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>312</region_start>
						<region_end>330</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>333</region_start>
						<region_end>339</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>294</region_start>
						<region_end>335</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>GGSEEIFTLQVRGRERYEILKKLNDSLELSDVVPASDAEKYRQKFMTK</sequence>
				<length>48</length>
				<uniprot>
					<id>G1K2L5</id>
					<start>299</start>
					<end>346</end>
					<coverage>12.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P79734</id>
					<start>301</start>
					<end>345</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>303</region_start>
						<region_end>309</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>311</region_start>
						<region_end>327</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>332</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>294</region_start>
						<region_end>335</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>GGSEEIFTLQVRGRERYEILKKLNDSLELSDVVPASDAEKYRQKFMTK</sequence>
				<length>48</length>
				<uniprot>
					<id>G1K2L5</id>
					<start>299</start>
					<end>346</end>
					<coverage>12.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P79734</id>
					<start>301</start>
					<end>345</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>304</region_start>
						<region_end>310</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>312</region_start>
						<region_end>330</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>333</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>294</region_start>
						<region_end>335</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Cellular tumor antigen p53</name>
				<source_organism>Danio rerio</source_organism>
				<sequence>GGSEEIFTLQVRGRERYEILKKLNDSLELSDVVPASDAEKYRQKFMTK</sequence>
				<length>48</length>
				<uniprot>
					<id>G1K2L5</id>
					<start>299</start>
					<end>346</end>
					<coverage>12.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P79734</id>
					<start>301</start>
					<end>345</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>304</region_start>
						<region_end>310</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>312</region_start>
						<region_end>330</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>333</region_start>
						<region_end>335</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>294</region_start>
						<region_end>335</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4d1m</pdb_id>
			<pdb_id>4cz5</pdb_id>
			<pdb_id>4cz6</pdb_id>
			<pdb_id>4cz7</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4100004</accession>
		<general>
			<name>p63 tetramerization domain (human)</name>
			<pdb_id>3zy1</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.15</resolution>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>22100306</pmid>
				<authors>Natan E, Joerger AC</authors>
				<title>Structure and kinetic stability of the p63 tetramerization domain.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2012</year>
				<issue>3</issue>
				<volume>415</volume>
				<pages>503-13</pages>
				<abstract>The p53 family of transcription factors--comprising p53, p63 and p73--plays an important role in tumor prevention and development. Essential to their function is the formation of tetramers, allowing cooperative binding to their DNA response elements. We solved crystal structures of the human p63 tetramerization domain, showing that p63 forms a dimer of dimers with D₂ symmetry composed of highly intertwined monomers. The primary dimers are formed via an intramolecular β-sheet and hydrophobic helix packing (H1), a hallmark of all p53 family members. Like p73, but unlike p53, p63 requires a second helix (H2) to stabilize the architecture of the tetramer. In order to investigate the impact of structural differences on tetramer stability, we measured the subunit exchange reaction of p53 family homotetramers by nanoflow electrospray mass spectrometry. There were differences in both the kinetics and the pattern of the exchange reaction, with the p53 and p63 tetramers exhibiting much faster exchange kinetics than p73. The structural similarity between p63 and p73 rationalizes previous observations that p63 and p73 form mixed tetramers, and the kinetic data reveal the dissociation of the p73 homotetramers as the rate-limiting step for heterotetramer formation. Differential stability of the tetramers may play an important role in the cross talk between different isoforms and regulation of p53, p63 and p73 function in the cell cycle.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003690</accession>
					<name>double-stranded DNA binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0002039</accession>
					<name>p53 binding</name>
				</go>
				<go>
					<accession>GO:0003684</accession>
					<name>damaged DNA binding</name>
				</go>
				<go>
					<accession>GO:0050699</accession>
					<name>WW domain binding</name>
				</go>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0044212</accession>
					<name>transcription regulatory region DNA binding</name>
				</go>
				<go>
					<accession>GO:0000989</accession>
					<name>transcription factor activity, transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0043066</accession>
					<name>negative regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0060197</accession>
					<name>cloacal septation</name>
				</go>
				<go>
					<accession>GO:0061436</accession>
					<name>establishment of skin barrier</name>
				</go>
				<go>
					<accession>GO:1902808</accession>
					<name>positive regulation of cell cycle G1/S phase transition</name>
				</go>
				<go>
					<accession>GO:0031069</accession>
					<name>hair follicle morphogenesis</name>
				</go>
				<go>
					<accession>GO:2000381</accession>
					<name>negative regulation of mesoderm development</name>
				</go>
				<go>
					<accession>GO:0010482</accession>
					<name>regulation of epidermal cell division</name>
				</go>
				<go>
					<accession>GO:0002053</accession>
					<name>positive regulation of mesenchymal cell proliferation</name>
				</go>
				<go>
					<accession>GO:0060157</accession>
					<name>urinary bladder development</name>
				</go>
				<go>
					<accession>GO:0051289</accession>
					<name>protein homotetramerization</name>
				</go>
				<go>
					<accession>GO:0030859</accession>
					<name>polarized epithelial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0048807</accession>
					<name>female genitalia morphogenesis</name>
				</go>
				<go>
					<accession>GO:0043281</accession>
					<name>regulation of cysteine-type endopeptidase activity involved in apoptotic process</name>
				</go>
				<go>
					<accession>GO:0010259</accession>
					<name>multicellular organism aging</name>
				</go>
				<go>
					<accession>GO:0007219</accession>
					<name>Notch signaling pathway</name>
				</go>
				<go>
					<accession>GO:0002064</accession>
					<name>epithelial cell development</name>
				</go>
				<go>
					<accession>GO:0006978</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</name>
				</go>
				<go>
					<accession>GO:0001302</accession>
					<name>replicative cell aging</name>
				</go>
				<go>
					<accession>GO:0048485</accession>
					<name>sympathetic nervous system development</name>
				</go>
				<go>
					<accession>GO:0001501</accession>
					<name>skeletal system development</name>
				</go>
				<go>
					<accession>GO:1900740</accession>
					<name>positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0030326</accession>
					<name>embryonic limb morphogenesis</name>
				</go>
				<go>
					<accession>GO:0045669</accession>
					<name>positive regulation of osteoblast differentiation</name>
				</go>
				<go>
					<accession>GO:0051402</accession>
					<name>neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0043616</accession>
					<name>keratinocyte proliferation</name>
				</go>
				<go>
					<accession>GO:1901796</accession>
					<name>regulation of signal transduction by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0043589</accession>
					<name>skin morphogenesis</name>
				</go>
				<go>
					<accession>GO:0045617</accession>
					<name>negative regulation of keratinocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0031571</accession>
					<name>mitotic G1 DNA damage checkpoint</name>
				</go>
				<go>
					<accession>GO:0060529</accession>
					<name>squamous basal epithelial stem cell differentiation involved in prostate gland acinus development</name>
				</go>
				<go>
					<accession>GO:0010481</accession>
					<name>epidermal cell division</name>
				</go>
				<go>
					<accession>GO:0036342</accession>
					<name>post-anal tail morphogenesis</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0030216</accession>
					<name>keratinocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0010838</accession>
					<name>positive regulation of keratinocyte proliferation</name>
				</go>
				<go>
					<accession>GO:0010165</accession>
					<name>response to X-ray</name>
				</go>
				<go>
					<accession>GO:0010332</accession>
					<name>response to gamma radiation</name>
				</go>
				<go>
					<accession>GO:0007499</accession>
					<name>ectoderm and mesoderm interaction</name>
				</go>
				<go>
					<accession>GO:0006338</accession>
					<name>chromatin remodeling</name>
				</go>
				<go>
					<accession>GO:0034644</accession>
					<name>cellular response to UV</name>
				</go>
				<go>
					<accession>GO:0007283</accession>
					<name>spermatogenesis</name>
				</go>
				<go>
					<accession>GO:0048745</accession>
					<name>smooth muscle tissue development</name>
				</go>
				<go>
					<accession>GO:0043523</accession>
					<name>regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0060513</accession>
					<name>prostatic bud formation</name>
				</go>
				<go>
					<accession>GO:2000773</accession>
					<name>negative regulation of cellular senescence</name>
				</go>
				<go>
					<accession>GO:0042771</accession>
					<name>intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:2000271</accession>
					<name>positive regulation of fibroblast apoptotic process</name>
				</go>
				<go>
					<accession>GO:0042475</accession>
					<name>odontogenesis of dentin-containing tooth</name>
				</go>
				<go>
					<accession>GO:0001736</accession>
					<name>establishment of planar polarity</name>
				</go>
				<go>
					<accession>GO:0009954</accession>
					<name>proximal/distal pattern formation</name>
				</go>
				<go>
					<accession>GO:0045747</accession>
					<name>positive regulation of Notch signaling pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
				<go>
					<accession>GO:0005739</accession>
					<name>mitochondrion</name>
				</go>
				<go>
					<accession>GO:0005791</accession>
					<name>rough endoplasmic reticulum</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0030425</accession>
					<name>dendrite</name>
				</go>
				<go>
					<accession>GO:0000790</accession>
					<name>nuclear chromatin</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B, C and D were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQ</sequence>
				<length>46</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>396</start>
					<end>441</end>
					<coverage>6.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>398</start>
					<end>436</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>400</region_start>
						<region_end>406</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>429</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQ</sequence>
				<length>46</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>396</start>
					<end>441</end>
					<coverage>6.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>398</start>
					<end>436</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>400</region_start>
						<region_end>406</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>429</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQ</sequence>
				<length>46</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>396</start>
					<end>441</end>
					<coverage>6.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>398</start>
					<end>436</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>400</region_start>
						<region_end>406</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>429</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQ</sequence>
				<length>46</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>396</start>
					<end>441</end>
					<coverage>6.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>398</start>
					<end>436</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>400</region_start>
						<region_end>406</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>429</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>p63 is a member of the p53 protein family. The tetramerization region of p53, p63 and p73 are closely homologous to each other, having very similar sequences, structures and biological functions (PMID:25185827, PMID:18289041, PMID:20379196), all containing the same Pfam domain (PF07710). The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3zy0</pdb_id>
			<pdb_id>4a9z</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4100005</accession>
		<general>
			<name>p73 tetramerization domain (human)</name>
			<pdb_id>2kby</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>19763140</pmid>
				<authors>Coutandin D, Löhr F, Niesen FH, Ikeya T, Weber TA, Schäfer B, Zielonka EM, Bullock AN, Yang A, Güntert P, Knapp S, McKeon F, Ou HD, Dötsch V</authors>
				<title>Conformational stability and activity of p73 require a second helix in the tetramerization domain.</title>
				<journal>Cell Death Differ.</journal>
				<year>2009</year>
				<issue>12</issue>
				<volume>16</volume>
				<pages>1582-9</pages>
				<abstract>p73 and p63, the two ancestral members of the p53 family, are involved in neurogenesis, epithelial stem cell maintenance and quality control of female germ cells. The highly conserved oligomerization domain (OD) of tumor suppressor p53 is essential for its biological functions, and its structure was believed to be the prototype for all three proteins. However, we report that the ODs of p73 and p63 differ from the OD of p53 by containing an additional alpha-helix that is not present in the structure of the p53 OD. Deletion of this helix causes a dissociation of the OD into dimers; it also causes conformational instability and reduces the transcriptional activity of p73. Moreover, we show that ODs of p73 and p63 strongly interact and that a large number of different heterotetramers are supported by the additional helix. Detailed analysis shows that the heterotetramer consisting of two homodimers is thermodynamically more stable than the two homotetramers. No heterooligomerization between p53 and the p73/p63 subfamily was observed, supporting the notion of functional orthogonality within the p53 family.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003684</accession>
					<name>damaged DNA binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0002039</accession>
					<name>p53 binding</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0019901</accession>
					<name>protein kinase binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0060044</accession>
					<name>negative regulation of cardiac muscle cell proliferation</name>
				</go>
				<go>
					<accession>GO:0042493</accession>
					<name>response to drug</name>
				</go>
				<go>
					<accession>GO:1901796</accession>
					<name>regulation of signal transduction by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0006298</accession>
					<name>mismatch repair</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0006978</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</name>
				</go>
				<go>
					<accession>GO:0001822</accession>
					<name>kidney development</name>
				</go>
				<go>
					<accession>GO:1900740</accession>
					<name>positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0048714</accession>
					<name>positive regulation of oligodendrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0071158</accession>
					<name>positive regulation of cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0042771</accession>
					<name>intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0000187</accession>
					<name>activation of MAPK activity</name>
				</go>
				<go>
					<accession>GO:0010243</accession>
					<name>response to organonitrogen compound</name>
				</go>
				<go>
					<accession>GO:0045665</accession>
					<name>negative regulation of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0043508</accession>
					<name>negative regulation of JUN kinase activity</name>
				</go>
				<go>
					<accession>GO:0007050</accession>
					<name>cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0034644</accession>
					<name>cellular response to UV</name>
				</go>
				<go>
					<accession>GO:0051262</accession>
					<name>protein tetramerization</name>
				</go>
				<go>
					<accession>GO:0010332</accession>
					<name>response to gamma radiation</name>
				</go>
				<go>
					<accession>GO:0010165</accession>
					<name>response to X-ray</name>
				</go>
				<go>
					<accession>GO:0016032</accession>
					<name>viral process</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0031571</accession>
					<name>mitotic G1 DNA damage checkpoint</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005794</accession>
					<name>Golgi apparatus</name>
				</go>
				<go>
					<accession>GO:0005739</accession>
					<name>mitochondrion</name>
				</go>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0000785</accession>
					<name>chromatin</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>349</start>
					<end>398</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>389</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>354</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>377</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>349</start>
					<end>398</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>389</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>354</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>377</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>349</start>
					<end>398</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>389</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>354</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>377</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>349</start>
					<end>398</end>
					<coverage>7.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>389</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>354</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>377</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>p73 is a member of the p53 protein family. The tetramerization region of p53, p63 and p73 are closely homologous to each other, having very similar sequences, structures and biological functions (PMID:25185827, PMID:18289041, PMID:20379196), all containing the same Pfam domain (PF07710). The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2wqi</pdb_id>
			<pdb_id>2wtt</pdb_id>
			<pdb_id>2wqj</pdb_id>
			<pdb_id>5hob</pdb_id>
			<pdb_id>5hoc</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140005</accession>
		<general>
			<name>DNA binding domain of the E2 protein (Human papillomavirus type 16)</name>
			<pdb_id>1r8p</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Human papillomavirus type 16</source_organism>
			<publication>
				<pmid>15702528</pmid>
				<authors>Nadra AD, Eliseo T, Mok YK, Almeida CL, Bycroft M, Paci M, de Prat-Gay G, Cicero DO</authors>
				<title>Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold.</title>
				<journal>J. Biomol. NMR</journal>
				<year>2004</year>
				<issue>2</issue>
				<volume>30</volume>
				<pages>211-4</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0000166</accession>
					<name>nucleotide binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0039693</accession>
					<name>viral DNA genome replication</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0044163</accession>
					<name>host cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>E2 dimer</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 16</source_organism>
				<sequence>MTPIVHLKGDANTLKCLRYRFKKHCTLYTAVSSTWHWTGHNVKHKSAIVTLTYDSEWQRDQFLSQVKIPKTITVSTGFMSI</sequence>
				<length>81</length>
				<uniprot>
					<id>P03120</id>
					<start>285</start>
					<end>365</end>
					<coverage>22.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03120</id>
					<start>286</start>
					<end>365</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>286</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>295</region_start>
						<region_end>307</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>314</region_start>
						<region_end>315</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>319</region_start>
						<region_end>319</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>332</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>360</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>287</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 16</source_organism>
				<sequence>MTPIVHLKGDANTLKCLRYRFKKHCTLYTAVSSTWHWTGHNVKHKSAIVTLTYDSEWQRDQFLSQVKIPKTITVSTGFMSI</sequence>
				<length>81</length>
				<uniprot>
					<id>P03120</id>
					<start>285</start>
					<end>365</end>
					<coverage>22.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03120</id>
					<start>286</start>
					<end>365</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>286</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>295</region_start>
						<region_end>307</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>314</region_start>
						<region_end>315</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>319</region_start>
						<region_end>319</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>332</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>360</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>287</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The DNA binding domain of E2 was shown to exhibit a two-state concerted unfolding and dissociation in denaturation/renaturation experiments (PMID:8745409, PMID:8756330).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2q79</pdb_id>
			<pdb_id>1zzf</pdb_id>
			<pdb_id>1by9</pdb_id>
			<pdb_id>3mi7</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140006</accession>
		<general>
			<name>DNA binding domain of the E2 protein (Human papillomavirus type 18)</name>
			<pdb_id>1f9f</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.90</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Human papillomavirus type 18</source_organism>
			<publication>
				<pmid>10906136</pmid>
				<authors>Kim SS, Tam JK, Wang AF, Hegde RS</authors>
				<title>The structural basis of DNA target discrimination by papillomavirus E2 proteins.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2000</year>
				<issue>40</issue>
				<volume>275</volume>
				<pages>31245-54</pages>
				<abstract>The papillomavirus E2 proteins regulate the transcription of all papillomavirus genes and are necessary for viral DNA replication. Disruption of the E2 gene is commonly associated with malignancy in cervical carcinoma, indicating that E2 has a role in regulating tumor progression. Although the E2 proteins from all characterized papillomaviruses bind specifically to the same 12-base pair DNA sequence, the cancer-associated human papillomavirus E2 proteins display a unique ability to detect DNA flexibility and intrinsic curvature. To understand the structural basis for this phenomenon, we have determined the crystal structures of the human papillomavirus-18 E2 DNA-binding domain and its complexes with high and low affinity binding sites. The E2 protein is a dimeric beta-barrel and the E2-DNA interaction is accompanied by a large deformation of the DNA as it conforms to the E2 surface. DNA conformation and E2-DNA contacts are similar in both high and low affinity complexes. The differences in affinity correlate with the flexibility of the DNA sequence. Preferences of E2 proteins from different papillomavirus strains for flexible or prevent DNA targets correlate with the distribution of positive charge on their DNA interaction surfaces, suggesting a role for electrostatic forces in the recognition of DNA deformability.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0000166</accession>
					<name>nucleotide binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0039693</accession>
					<name>viral DNA genome replication</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
				<go>
					<accession>GO:0044163</accession>
					<name>host cytoskeleton</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>E2 dimer</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 18</source_organism>
				<sequence>GSHMTPIIHLKGDRNSLKCLRYRLRKHSDHYRDISSTWHWTGAGNEKTGILTVTYHSETQRTKFLNTVAIPDSVQILVGYMTM</sequence>
				<length>83</length>
				<uniprot>
					<id>P06790</id>
					<start>283</start>
					<end>365</end>
					<coverage>22.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06790</id>
					<start>287</start>
					<end>365</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>286</region_start>
						<region_end>295</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>296</region_start>
						<region_end>309</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>315</region_start>
						<region_end>317</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>320</region_start>
						<region_end>320</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>330</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>357</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>288</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 18</source_organism>
				<sequence>GSHMTPIIHLKGDRNSLKCLRYRLRKHSDHYRDISSTWHWTGAGNEKTGILTVTYHSETQRTKFLNTVAIPDSVQILVGYMTM</sequence>
				<length>83</length>
				<uniprot>
					<id>P06790</id>
					<start>283</start>
					<end>365</end>
					<coverage>22.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06790</id>
					<start>287</start>
					<end>365</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>286</region_start>
						<region_end>295</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>296</region_start>
						<region_end>306</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>310</region_start>
						<region_end>312</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>315</region_start>
						<region_end>316</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>320</region_start>
						<region_end>320</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>322</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>330</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>357</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>288</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The DNA binding domain of E2 was shown to exhibit a two-state concerted unfolding and dissociation in denaturation/renaturation experiments (PMID:8745409, PMID:8756330).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1jj4</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140007</accession>
		<general>
			<name>DNA binding domain of the E2 protein (Human papillomavirus type 31)</name>
			<pdb_id>1dhm</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Human papillomavirus type 31</source_organism>
			<publication>
				<pmid>8652551</pmid>
				<authors>Liang H, Petros AM, Meadows RP, Yoon HS, Egan DA, Walter K, Holzman TF, Robins T, Fesik SW</authors>
				<title>Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions.</title>
				<journal>Biochemistry</journal>
				<year>1996</year>
				<issue>7</issue>
				<volume>35</volume>
				<pages>2095-103</pages>
				<abstract>The three-dimensional structure of the DNA-binding domain of the E2 protein from human papillomavirus-31 was determined by using multidimensional heteronuclear nuclear magnetic resonance (NMR) spectroscopy. A total of 1429 NMR-derived distance and dihedral angle restraints were obtained for each of the 83-residue subunits of this symmetric dimer. The average root mean square deviations of 20 structures calculated using a distance geometry-simulated annealing protocol are 0.59 and 0.90 angstroms for the backbone and all heavy atoms, respectively, for residues 2-83. The structure of the human virus protein free in solution consists of an eight-stranded beta-barrel and two pairs of alpha-helices. Although the overall fold of the protein is similar to the crystal structure of the bovine papillomavirus-1 E2 protein when complexed to DNA, several small but interesting differences were observed between these two structures at the subunit interface. In addition, a beta-hairpin that contacts DNA in the crystal structure of the protein-DNA complex is disordered in the NMR structures, and steady-state 1H-15N heteronuclear NOE measurements indicate that this region is highly mobile in the absence of DNA. The recognition helix also appears to be flexible, as evidenced by fast amide exchange rates. This phenomenon has also been observed for a number of other DNA-binding proteins and may constitute a common theme in protein/DNA recognition.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0000166</accession>
					<name>nucleotide binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0039693</accession>
					<name>viral DNA genome replication</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>E2 dimer</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 31</source_organism>
				<sequence>MATTPIIHLKGDANILKCLRYRLSKYKQLYEQVSSTWHWTCTDGKHKNAIVTLTYISTSQRDDFLNTVKIPNTVSVSTGYMTI</sequence>
				<length>83</length>
				<uniprot>
					<id>P17383</id>
					<start>290</start>
					<end>372</end>
					<coverage>22.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P17383</id>
					<start>291</start>
					<end>372</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>294</region_start>
						<region_end>299</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>302</region_start>
						<region_end>314</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>321</region_start>
						<region_end>322</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>326</region_start>
						<region_end>326</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>339</region_start>
						<region_end>343</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>347</region_start>
						<region_end>356</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>364</region_start>
						<region_end>369</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>294</region_start>
						<region_end>370</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 31</source_organism>
				<sequence>MATTPIIHLKGDANILKCLRYRLSKYKQLYEQVSSTWHWTCTDGKHKNAIVTLTYISTSQRDDFLNTVKIPNTVSVSTGYMTI</sequence>
				<length>83</length>
				<uniprot>
					<id>P17383</id>
					<start>290</start>
					<end>372</end>
					<coverage>22.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P17383</id>
					<start>291</start>
					<end>372</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>294</region_start>
						<region_end>299</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>302</region_start>
						<region_end>314</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>321</region_start>
						<region_end>322</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>326</region_start>
						<region_end>326</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>339</region_start>
						<region_end>343</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>347</region_start>
						<region_end>356</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>364</region_start>
						<region_end>369</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>294</region_start>
						<region_end>370</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The DNA binding domain of E2 was shown to exhibit a two-state concerted unfolding and dissociation in denaturation/renaturation experiments (PMID:8745409, PMID:8756330).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1a7g</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140008</accession>
		<general>
			<name>DNA binding domain of the E2 protein (Human papillomavirus type 6a)</name>
			<pdb_id>2aye</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Human papillomavirus type 6a</source_organism>
			<publication>
				<pmid>16914454</pmid>
				<authors>Hooley E, Fairweather V, Clarke AR, Gaston K, Brady RL</authors>
				<title>The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein.</title>
				<journal>Nucleic Acids Res.</journal>
				<year>2006</year>
				<issue>14</issue>
				<volume>34</volume>
				<pages>3897-908</pages>
				<abstract>The E2 proteins are transcription/replication factors from papillomaviruses. Human papillomaviruses (HPVs) can be broadly divided in two groups; low-risk HPV subtypes cause benign warts while high-risk HPVs give rise to cervical cancer. Although a range of crystal structures of E2 DNA-binding domains (DBD) from both high- and low-risk HPV subtypes have been reported previously, structures of E2 DBD:DNA complexes have only been available for high-risk HPV18 and bovine papillomavirus (BPV1). In the present study we report the unliganded and DNA complex structures of the E2 DBD from the low-risk HPV6. As in the previous E2-DNA structures, complex formation results in considerable bending of the DNA, which is facilitated by sequences with A:T-rich spacers that adopt a pre-bent conformation. The low-risk HPV6 E2-DNA complex differs from the earlier structures in that minimal deformation of the protein accompanies complex formation. Stopped-flow kinetic studies confirm that both high- and low-risk E2 proteins adapt their structures on binding to DNA, although this is achieved more readily for HPV6 E2. It therefore appears that the higher selectivity of the HPV6 E2 protein may arise from its limited molecular adaptability, a property that might distinguish the behaviour of E2 proteins from high- and low-risk HPV subtypes.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0000166</accession>
					<name>nucleotide binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0039693</accession>
					<name>viral DNA genome replication</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E and F were removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>E2 dimer</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 6a</source_organism>
				<sequence>SSATPIVQFQGESNCLKCFRYRLNDKHRHLFDLISSTWHWASPKAPHKHAIVTVTYHSEEQRQQFLNVVKIPPTIRHKLGFMSMHLL</sequence>
				<length>87</length>
				<uniprot>
					<id>Q84294</id>
					<start>282</start>
					<end>368</end>
					<coverage>23.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q84294</id>
					<start>282</start>
					<end>368</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>284</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>294</region_start>
						<region_end>305</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>307</region_start>
						<region_end>307</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>311</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>315</region_start>
						<region_end>316</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>319</region_start>
						<region_end>319</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>321</region_start>
						<region_end>321</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>331</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>357</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>367</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>286</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein E2</name>
				<source_organism>Human papillomavirus type 6a</source_organism>
				<sequence>SSATPIVQFQGESNCLKCFRYRLNDKHRHLFDLISSTWHWASPKAPHKHAIVTVTYHSEEQRQQFLNVVKIPPTIRHKLGFMSMHLL</sequence>
				<length>87</length>
				<uniprot>
					<id>Q84294</id>
					<start>282</start>
					<end>368</end>
					<coverage>23.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q84294</id>
					<start>282</start>
					<end>368</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>284</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>294</region_start>
						<region_end>305</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>307</region_start>
						<region_end>307</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>311</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>315</region_start>
						<region_end>316</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>319</region_start>
						<region_end>319</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>321</region_start>
						<region_end>321</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>331</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>349</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>357</region_start>
						<region_end>364</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>367</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>286</region_start>
						<region_end>363</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The DNA binding domain of E2 was shown to exhibit a two-state concerted unfolding and dissociation in denaturation/renaturation experiments (PMID:8745409, PMID:8756330).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2ayb</pdb_id>
			<pdb_id>2ayg</pdb_id>
			<pdb_id>1r8h</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140009</accession>
		<general>
			<name>DNA binding domain of the E2 protein (Bovine papillomavirus type 1)</name>
			<pdb_id>1dbd</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Bovine papillomavirus type 1</source_organism>
			<publication>
				<pmid>10587434</pmid>
				<authors>Veeraraghavan S, Mello CC, Androphy EJ, Baleja JD</authors>
				<title>Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus.</title>
				<journal>Biochemistry</journal>
				<year>1999</year>
				<issue>49</issue>
				<volume>38</volume>
				<pages>16115-24</pages>
				<abstract>Papillomaviral E2 proteins participate in viral DNA replication and transcriptional regulation. We have solved the solution structure of the DNA-binding domain of the E2 protein from bovine papillomavirus (BPV-1). The structure calculation used 2222 distance and 158 dihedral angle restraints for the homodimer (202 residues in total), which were derived from homonuclear and heteronuclear multidimensional nuclear magnetic resonance (NMR) spectroscopic data. The root-mean-square deviation for structured regions of the monomer when superimposed to the average is 0.73 +/- 0.10 A for backbone atoms and 1.42 +/- 0.16 A for heavy atoms. The 101 residue construct used in this study (residues 310-410) is about 4.5 kcal/mol more stable than a minimal domain comprising the C-terminal 85 amino acid residues (residues 326-410). The structure of the core domain contained within BPV-1 E2 is similar to the corresponding regions of other papilloma viral E2 proteins. Here, however, the extra N-terminal 16 residues form a flap that covers a cavity at the dimer interface and play a role in DNA binding. Interactions between residues in the N-terminal extension and the core domain correlate with the greater stability of the longer form of the protein relative to the minimal domain.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0000166</accession>
					<name>nucleotide binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0039693</accession>
					<name>viral DNA genome replication</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>E2 dimer</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein E2</name>
				<source_organism>Bovine papillomavirus type 1</source_organism>
				<sequence>RRTTNDGFHLLKAGGSCFALISGTANQVKCYRFRVKKNHRHRYENCTTTWFTVADNGAERQGQAQILITFGSPSQRQDFLKHVPLPPGMNISGFTASLDF</sequence>
				<length>100</length>
				<uniprot>
					<id>P03122</id>
					<start>311</start>
					<end>410</end>
					<coverage>24.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03122</id>
					<start>311</start>
					<end>410</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>327</region_start>
						<region_end>333</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>352</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>355</region_start>
						<region_end>356</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>363</region_start>
						<region_end>363</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>370</region_start>
						<region_end>370</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>374</region_start>
						<region_end>380</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>387</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>389</region_start>
						<region_end>392</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>401</region_start>
						<region_end>408</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>328</region_start>
						<region_end>405</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein E2</name>
				<source_organism>Bovine papillomavirus type 1</source_organism>
				<sequence>RRTTNDGFHLLKAGGSCFALISGTANQVKCYRFRVKKNHRHRYENCTTTWFTVADNGAERQGQAQILITFGSPSQRQDFLKHVPLPPGMNISGFTASLDF</sequence>
				<length>100</length>
				<uniprot>
					<id>P03122</id>
					<start>311</start>
					<end>410</end>
					<coverage>24.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03122</id>
					<start>311</start>
					<end>410</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>327</region_start>
						<region_end>333</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>335</region_start>
						<region_end>345</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>349</region_start>
						<region_end>352</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>355</region_start>
						<region_end>356</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>360</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>363</region_start>
						<region_end>363</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>370</region_start>
						<region_end>370</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>374</region_start>
						<region_end>379</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>383</region_start>
						<region_end>392</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>401</region_start>
						<region_end>408</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00511.14</region_id>
						<region_name>PPV_E2_C</region_name>
						<region_start>328</region_start>
						<region_end>405</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The DNA binding domain of E2 was shown to exhibit a two-state concerted unfolding and dissociation in denaturation/renaturation experiments (PMID:8745409, PMID:8756330).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1jjh</pdb_id>
			<pdb_id>2bop</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF6100001</accession>
		<general>
			<name>Heat shock factor binding protein 1 (HSBP1) </name>
			<pdb_id>3ci9</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homohexamer (dimer of trimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>18767159</pmid>
				<authors>Liu X, Xu L, Liu Y, Tong X, Zhu G, Zhang XC, Li X, Rao Z</authors>
				<title>Crystal structure of the hexamer of human heat shock factor binding protein 1.</title>
				<journal>Proteins</journal>
				<year>2009</year>
				<issue>1</issue>
				<volume>75</volume>
				<pages>1-11</pages>
				<abstract>Heat shock response (HSR) is a ubiquitous cellular mechanism that copes with a variety of stresses. This response is mediated by a family of transcriptional activators, heat shock factors (HSFs), which are under tight regulation. HSF binding protein 1 (HSBP1) is a negative regulator of HSR and is reported to bind specifically with the active trimeric form of HSF1, thus inhibiting its activity. HSBP1 contains heptad-repeats in the primary sequence and was believed to stay in a trimer form in solution. We report the crystal structure of the trimerization domain of the M30I/L55P mutant of human HSBP1 at 1.8 A resolution. In this crystal form, the HSBP1 fragment of residues 6-53 forms a continuous, 11-turn long helix. The helix self-associates to form a parallel, symmetrical, triple coiled-coil helix bundle, which further assembles into a dimer of trimers in a head-to-head fashion. Solution study confirmed that the wild-type HSBP1 shares similar biophysical properties with the crystallized variant. Furthermore, we identified Ser31, which buried its polar side chain in the hydrophobic interior of the helix bundle, as a stability weak-spot. Substitution of this residue with Ile increases the melting temperature by 24 degrees C, implicating that this conserved serine residue is maintained at position 31 for functional purposes.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003714</accession>
					<name>transcription corepressor activity</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0035987</accession>
					<name>endodermal cell differentiation</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006936</accession>
					<name>muscle contraction</name>
				</go>
				<go>
					<accession>GO:1900034</accession>
					<name>regulation of cellular response to heat</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005856</accession>
					<name>cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and E were generated from chain A and chains D and F were generated from chain B using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>6</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (hexameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Heat shock factor-binding protein 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PKTVQDLTSVVQTLLQQMQDKFQTISDQIIGRIDDMSSRIDDLEKNIA</sequence>
				<length>48</length>
				<uniprot>
					<id>O75506</id>
					<start>6</start>
					<end>53</end>
					<coverage>63.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75506</id>
					<start>6</start>
					<end>53</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06825.9</region_id>
						<region_name>HSBP1</region_name>
						<region_start>10</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:18767159). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF6120001</accession>
		<general>
			<name>4-oxalocrotonate tautomerase</name>
			<pdb_id>4x19</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.94</resolution>
			<assembly>homohexamer</assembly>
			<source_organism>Pseudomonas putida</source_organism>
			<publication>
				<pmid>25728471</pmid>
				<authors>Poddar H, Rahimi M, Geertsema EM, Thunnissen AM, Poelarends GJ</authors>
				<title>Evidence for the Formation of an Enamine Species during Aldol and Michael-type Addition Reactions Promiscuously Catalyzed by 4-Oxalocrotonate Tautomerase.</title>
				<journal>Chembiochem</journal>
				<year>2015</year>
				<abstract>The enzyme 4-oxalocrotonate tautomerase (4-OT), which has a catalytic N-terminal proline residue (Pro1), can promiscuously catalyze various carbon-carbon bond-forming reactions, including aldol condensation of acetaldehyde with benzaldehyde to yield cinnamaldehyde, and Michael-type addition of acetaldehyde to a wide variety of nitroalkenes to yield valuable γ-nitroaldehydes. To gain insight into how 4-OT catalyzes these unnatural reactions, we carried out exchange studies in D2 O, and X-ray crystallography studies. The former established that H-D exchange within acetaldehyde is catalyzed by 4-OT and that the Pro1 residue is crucial for this activity. The latter showed that Pro1 of 4-OT had reacted with acetaldehyde to give an enamine species. These results provide evidence of the mechanism of the 4-OT-catalyzed aldol and Michael-type addition reactions in which acetaldehyde is activated for nucleophilic addition by Pro1-dependent formation of an enamine intermediate.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0016853</accession>
					<name>isomerase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042184</accession>
					<name>xylene catabolic process</name>
				</go>
				<go>
					<accession>GO:0042203</accession>
					<name>toluene catabolic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z, a, b, c and d were removed as chains A, B, C, D, E and F represent the biologically active hexamer.</note>
				<nr_of_chains>6</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homohexameric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>2-hydroxymuconate tautomerase</name>
				<source_organism>Pseudomonas putida</source_organism>
				<sequence>PIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASKVRR</sequence>
				<length>62</length>
				<uniprot>
					<id>Q01468</id>
					<start>2</start>
					<end>63</end>
					<coverage>98.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q01468</id>
					<start>2</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>36</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>40</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>48</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01361.18</region_id>
						<region_name>Tautomerase</region_name>
						<region_start>2</region_start>
						<region_end>60</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>4-oxalocrotonate tautomerase hexamer from Pseudomonas putida was shown by DSC to follow a two-state folding with the hexameric, dimeric and secondary structure all melting at the same temperature (PMID:20465238).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1bjp</pdb_id>
			<pdb_id>2fm7</pdb_id>
			<pdb_id>4ota</pdb_id>
			<pdb_id>4otb</pdb_id>
			<pdb_id>4otc</pdb_id>
			<pdb_id>4x1c</pdb_id>
			<pdb_id>5cln</pdb_id>
			<pdb_id>5clo</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120019</accession>
		<general>
			<name>Escherichia coli met repressor (MetJ)</name>
			<pdb_id>1cmb</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>2677753</pmid>
				<authors>Rafferty JB, Somers WS, Saint-Girons I, Phillips SE</authors>
				<title>Three-dimensional crystal structures of Escherichia coli met repressor with and without corepressor.</title>
				<journal>Nature</journal>
				<year>1989</year>
				<issue>6244</issue>
				<volume>341</volume>
				<pages>705-10</pages>
				<abstract>The three-dimensional crystal structure of met repressor, in the presence or absence of bound corepressor (S-adenosylmethionine), shows a dimer of intertwined monomers, which do not have the helix-turn-helix motif characteristic of other bacterial repressor and activator structures. We propose that the interaction of met repressor with DNA occurs through either a pair of symmetry-related alpha-helices or a pair of beta-strands, and suggest a model for binding of several dimers to met operator regions.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0009086</accession>
					<name>methionine biosynthetic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Met repressor</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AEWSGEYISPYAEHGKKSEQVKKITVSIPLKVLKILTDERTRRQVNNLRHATNSELLCEAFLHAFTGQPLPDDADLRKERSDEIPEAAKEIMREMGINPETWEY</sequence>
				<length>104</length>
				<uniprot>
					<id>P0A8U6</id>
					<start>2</start>
					<end>105</end>
					<coverage>99%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A7ZUF7</id>
					<start>2</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>18</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>31</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01340.17</region_id>
						<region_name>MetJ</region_name>
						<region_start>3</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Met repressor</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>AEWSGEYISPYAEHGKKSEQVKKITVSIPLKVLKILTDERTRRQVNNLRHATNSELLCEAFLHAFTGQPLPDDADLRKERSDEIPEAAKEIMREMGINPETWEY</sequence>
				<length>104</length>
				<uniprot>
					<id>P0A8U6</id>
					<start>2</start>
					<end>105</end>
					<coverage>99%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A7ZUF7</id>
					<start>2</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>31</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>80</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01340.17</region_id>
						<region_name>MetJ</region_name>
						<region_start>3</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>MetJ was shown by differential scanning calorimetry to follow a two-state folding and dimerization (PMID:1390748).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1cma</pdb_id>
			<pdb_id>1cmc</pdb_id>
			<pdb_id>1mj2</pdb_id>
			<pdb_id>1mjk</pdb_id>
			<pdb_id>1mjl</pdb_id>
			<pdb_id>1mjm</pdb_id>
			<pdb_id>1mjo</pdb_id>
			<pdb_id>1mjp</pdb_id>
			<pdb_id>1mjq</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110010</accession>
		<general>
			<name>Nerve growth factor (NGF)</name>
			<pdb_id>1bet</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Mus musculus</source_organism>
			<publication>
				<pmid>1956407</pmid>
				<authors>McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell TL</authors>
				<title>New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.</title>
				<journal>Nature</journal>
				<year>1991</year>
				<issue>6352</issue>
				<volume>354</volume>
				<pages>411-4</pages>
				<abstract>Nerve growth factor (NGF) is a member of an expanding family of neurotrophic factors (including brain-derived neurotrophic factor and the neurotrophins) that control the development and survival of certain neuronal populations both in the peripheral and in the central nervous systems. Its biological effects are mediated by a high-affinity ligand-receptor interaction and a tyrosine kinase signalling pathway. A potential use for NGF and its relatives in the treatment of neurological disorders such as Alzheimer&apos;s disease and Parkinson's disease requires an understanding of the structure-function relationships of NGF. NGF is a dimeric molecule, with 118 amino acids per protomer. We report the crystal structure of the murine NGF dimer at 2.3-A resolution, which reveals a novel protomer structure consisting of three antiparallel pairs of beta strands, together forming a flat surface. Two subunits associate through this surface, thus burying a total of 2,332 A. Four loop regions, which contain many of the variable residues observed between different NGF-related molecules, may determine the different receptor specificities. A clustering of positively charged side chains may provide a complementary interaction with the acidic low-affinity NGF receptor. The structure provides a model for rational design of analogues of NGF and its relatives and for testing the NGF-receptor recognition determinants critical for signal transduction.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0030297</accession>
					<name>transmembrane receptor protein tyrosine kinase activator activity</name>
				</go>
				<go>
					<accession>GO:0005057</accession>
					<name>receptor signaling protein activity</name>
				</go>
				<go>
					<accession>GO:0008191</accession>
					<name>metalloendopeptidase inhibitor activity</name>
				</go>
				<go>
					<accession>GO:0005163</accession>
					<name>nerve growth factor receptor binding</name>
				</go>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007422</accession>
					<name>peripheral nervous system development</name>
				</go>
				<go>
					<accession>GO:0010951</accession>
					<name>negative regulation of endopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0048672</accession>
					<name>positive regulation of collateral sprouting</name>
				</go>
				<go>
					<accession>GO:0048812</accession>
					<name>neuron projection morphogenesis</name>
				</go>
				<go>
					<accession>GO:0045773</accession>
					<name>positive regulation of axon extension</name>
				</go>
				<go>
					<accession>GO:0046928</accession>
					<name>regulation of neurotransmitter secretion</name>
				</go>
				<go>
					<accession>GO:0007171</accession>
					<name>activation of transmembrane receptor protein tyrosine kinase activity</name>
				</go>
				<go>
					<accession>GO:0097192</accession>
					<name>extrinsic apoptotic signaling pathway in absence of ligand</name>
				</go>
				<go>
					<accession>GO:0008625</accession>
					<name>extrinsic apoptotic signaling pathway via death domain receptors</name>
				</go>
				<go>
					<accession>GO:0046579</accession>
					<name>positive regulation of Ras protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0048015</accession>
					<name>phosphatidylinositol-mediated signaling</name>
				</go>
				<go>
					<accession>GO:0038180</accession>
					<name>nerve growth factor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0014042</accession>
					<name>positive regulation of neuron maturation</name>
				</go>
				<go>
					<accession>GO:0031954</accession>
					<name>positive regulation of protein autophosphorylation</name>
				</go>
				<go>
					<accession>GO:0019233</accession>
					<name>sensory perception of pain</name>
				</go>
				<go>
					<accession>GO:0043065</accession>
					<name>positive regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0007623</accession>
					<name>circadian rhythm</name>
				</go>
				<go>
					<accession>GO:0031398</accession>
					<name>positive regulation of protein ubiquitination</name>
				</go>
				<go>
					<accession>GO:0032455</accession>
					<name>nerve growth factor processing</name>
				</go>
				<go>
					<accession>GO:0051402</accession>
					<name>neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0051279</accession>
					<name>regulation of release of sequestered calcium ion into cytosol</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0051091</accession>
					<name>positive regulation of sequence-specific DNA binding transcription factor activity</name>
				</go>
				<go>
					<accession>GO:0051388</accession>
					<name>positive regulation of neurotrophin TRK receptor signaling pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005788</accession>
					<name>endoplasmic reticulum lumen</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
				<go>
					<accession>GO:0016023</accession>
					<name>cytoplasmic, membrane-bounded vesicle</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Homodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Beta-nerve growth factor</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GEFSVCDSVSVWVGDKTTATDIKGKEVTVLAEVNINNSVFRQYFFETKCRASNPVESGCRGIDSKHWNSYCTTTHTFVKALTTDEKQAAWRFIRIDTACVCVLSRKA</sequence>
				<length>107</length>
				<uniprot>
					<id>P01139</id>
					<start>131</start>
					<end>237</end>
					<coverage>44.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01139</id>
					<start>131</start>
					<end>237</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>133</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>156</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>162</region_start>
						<region_end>165</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>174</region_start>
						<region_end>179</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>185</region_start>
						<region_end>185</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>188</region_start>
						<region_end>188</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>192</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>197</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>218</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>128</region_start>
						<region_end>238</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Beta-nerve growth factor</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GEFSVCDSVSVWVGDKTTATDIKGKEVTVLAEVNINNSVFRQYFFETKCRASNPVESGCRGIDSKHWNSYCTTTHTFVKALTTDEKQAAWRFIRIDTACVCVLSRKA</sequence>
				<length>107</length>
				<uniprot>
					<id>P01139</id>
					<start>131</start>
					<end>237</end>
					<coverage>44.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01139</id>
					<start>131</start>
					<end>237</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>133</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>156</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>162</region_start>
						<region_end>165</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>174</region_start>
						<region_end>179</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>185</region_start>
						<region_end>185</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>188</region_start>
						<region_end>188</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>192</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>197</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>218</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>128</region_start>
						<region_end>238</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1btg</pdb_id>
			<pdb_id>4eax</pdb_id>
			<pdb_id>1sgf</pdb_id>
			<pdb_id>4xpj</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100007</accession>
		<general>
			<name>Neurotrophin 3 homodimer</name>
			<pdb_id>1b8k</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.15</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>10631974</pmid>
				<authors>Robinson RC, Radziejewski C, Spraggon G, Greenwald J, Kostura MR, Burtnick LD, Stuart DI, Choe S, Jones EY</authors>
				<title>The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site.</title>
				<journal>Protein Sci.</journal>
				<year>1999</year>
				<issue>12</issue>
				<volume>8</volume>
				<pages>2589-97</pages>
				<abstract>The neurotrophins are growth factors that are involved in the development and survival of neurons. Neurotrophin release by a target tissue results in neuron growth along the neurotrophin concentration gradient, culminating in the eventual innervation of the target tissue. These activities are mediated through trk cell surface receptors. We have determined the structures of the heterodimer formed between brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4), as well as the structure of homodimer of NT4. We also present the structure of the Neurotrophin 3 homodimer, which is refined to higher resolution than previously published. These structures provide the first views of the architecture of the NT4 protomer. Comparison of the surface of a model of the BDNF homodimer with the structures of the neurotrophin homodimers reveals common features that may be important in the binding between the neurotrophins and their receptors. In particular, there exists an analogous region on the surface of each neurotrophin that is likely to be involved in trk receptor binding. Variations in sequence on the periphery of this common region serve to confer trk receptor specificity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005166</accession>
					<name>neurotrophin p75 receptor binding</name>
				</go>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
				<go>
					<accession>GO:0042056</accession>
					<name>chemoattractant activity</name>
				</go>
				<go>
					<accession>GO:0048406</accession>
					<name>nerve growth factor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045664</accession>
					<name>regulation of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0000187</accession>
					<name>activation of MAPK activity</name>
				</go>
				<go>
					<accession>GO:0050731</accession>
					<name>positive regulation of peptidyl-tyrosine phosphorylation</name>
				</go>
				<go>
					<accession>GO:0050930</accession>
					<name>induction of positive chemotaxis</name>
				</go>
				<go>
					<accession>GO:0090630</accession>
					<name>activation of GTPase activity</name>
				</go>
				<go>
					<accession>GO:0050804</accession>
					<name>modulation of synaptic transmission</name>
				</go>
				<go>
					<accession>GO:0033138</accession>
					<name>positive regulation of peptidyl-serine phosphorylation</name>
				</go>
				<go>
					<accession>GO:0050918</accession>
					<name>positive chemotaxis</name>
				</go>
				<go>
					<accession>GO:0007169</accession>
					<name>transmembrane receptor protein tyrosine kinase signaling pathway</name>
				</go>
				<go>
					<accession>GO:0048812</accession>
					<name>neuron projection morphogenesis</name>
				</go>
				<go>
					<accession>GO:0002092</accession>
					<name>positive regulation of receptor internalization</name>
				</go>
				<go>
					<accession>GO:0008284</accession>
					<name>positive regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0045687</accession>
					<name>positive regulation of glial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0042552</accession>
					<name>myelination</name>
				</go>
				<go>
					<accession>GO:0007267</accession>
					<name>cell-cell signaling</name>
				</go>
				<go>
					<accession>GO:2000251</accession>
					<name>positive regulation of actin cytoskeleton reorganization</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0032148</accession>
					<name>activation of protein kinase B activity</name>
				</go>
				<go>
					<accession>GO:0030335</accession>
					<name>positive regulation of cell migration</name>
				</go>
				<go>
					<accession>GO:0050732</accession>
					<name>negative regulation of peptidyl-tyrosine phosphorylation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0016023</accession>
					<name>cytoplasmic, membrane-bounded vesicle</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Homodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Neurotrophin-3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>YAEHKSHRGEYSVCDSESLWVTDKSSAIDIRGHQVTVLGEIKTGNSPVKQYFYETRCKEARPVKNGCRGIDDKHWNSQCKTSQTYVRALTSENNKLVGWRWIRIDTSCVCALSRKIGRT</sequence>
				<length>119</length>
				<uniprot>
					<id>P20783</id>
					<start>139</start>
					<end>257</end>
					<coverage>46.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P20783</id>
					<start>139</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>150</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>154</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>164</region_start>
						<region_end>167</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>172</region_start>
						<region_end>175</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>178</region_start>
						<region_end>178</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>187</region_start>
						<region_end>187</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>190</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>208</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>216</region_start>
						<region_end>229</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>236</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>144</region_start>
						<region_end>255</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Neurotrophin-3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>YAEHKSHRGEYSVCDSESLWVTDKSSAIDIRGHQVTVLGEIKTGNSPVKQYFYETRCKEARPVKNGCRGIDDKHWNSQCKTSQTYVRALTSENNKLVGWRWIRIDTSCVCALSRKIGRT</sequence>
				<length>119</length>
				<uniprot>
					<id>P20783</id>
					<start>139</start>
					<end>257</end>
					<coverage>46.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P20783</id>
					<start>139</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>150</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>154</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>164</region_start>
						<region_end>167</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>172</region_start>
						<region_end>175</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>178</region_start>
						<region_end>178</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>187</region_start>
						<region_end>187</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>190</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>208</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>216</region_start>
						<region_end>229</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>236</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>144</region_start>
						<region_end>255</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1nt3</pdb_id>
			<pdb_id>3buk</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100008</accession>
		<general>
			<name>Neurotrophin 4 homodimer</name>
			<pdb_id>1b98</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.75</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>10631974</pmid>
				<authors>Robinson RC, Radziejewski C, Spraggon G, Greenwald J, Kostura MR, Burtnick LD, Stuart DI, Choe S, Jones EY</authors>
				<title>The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site.</title>
				<journal>Protein Sci.</journal>
				<year>1999</year>
				<issue>12</issue>
				<volume>8</volume>
				<pages>2589-97</pages>
				<abstract>The neurotrophins are growth factors that are involved in the development and survival of neurons. Neurotrophin release by a target tissue results in neuron growth along the neurotrophin concentration gradient, culminating in the eventual innervation of the target tissue. These activities are mediated through trk cell surface receptors. We have determined the structures of the heterodimer formed between brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4), as well as the structure of homodimer of NT4. We also present the structure of the Neurotrophin 3 homodimer, which is refined to higher resolution than previously published. These structures provide the first views of the architecture of the NT4 protomer. Comparison of the surface of a model of the BDNF homodimer with the structures of the neurotrophin homodimers reveals common features that may be important in the binding between the neurotrophins and their receptors. In particular, there exists an analogous region on the surface of each neurotrophin that is likely to be involved in trk receptor binding. Variations in sequence on the periphery of this common region serve to confer trk receptor specificity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
				<go>
					<accession>GO:0005166</accession>
					<name>neurotrophin p75 receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007267</accession>
					<name>cell-cell signaling</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0008344</accession>
					<name>adult locomotory behavior</name>
				</go>
				<go>
					<accession>GO:0042490</accession>
					<name>mechanoreceptor differentiation</name>
				</go>
				<go>
					<accession>GO:0008052</accession>
					<name>sensory organ boundary specification</name>
				</go>
				<go>
					<accession>GO:0007402</accession>
					<name>ganglion mother cell fate determination</name>
				</go>
				<go>
					<accession>GO:0007616</accession>
					<name>long-term memory</name>
				</go>
				<go>
					<accession>GO:0008544</accession>
					<name>epidermis development</name>
				</go>
				<go>
					<accession>GO:0061193</accession>
					<name>taste bud development</name>
				</go>
				<go>
					<accession>GO:0045664</accession>
					<name>regulation of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0048812</accession>
					<name>neuron projection morphogenesis</name>
				</go>
				<go>
					<accession>GO:0060384</accession>
					<name>innervation</name>
				</go>
				<go>
					<accession>GO:0007169</accession>
					<name>transmembrane receptor protein tyrosine kinase signaling pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0016023</accession>
					<name>cytoplasmic, membrane-bounded vesicle</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
				<go>
					<accession>GO:0005788</accession>
					<name>endoplasmic reticulum lumen</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Homodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Neurotrophin-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GVSETAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAEEGGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRTGRA</sequence>
				<length>130</length>
				<uniprot>
					<id>P34130</id>
					<start>81</start>
					<end>210</end>
					<coverage>61.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P34130</id>
					<start>81</start>
					<end>210</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>99</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>109</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>161</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>181</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>189</region_start>
						<region_end>203</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>89</region_start>
						<region_end>208</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>M</id>
				<name>Neurotrophin-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GVSETAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAEEGGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRTGRA</sequence>
				<length>130</length>
				<uniprot>
					<id>P34130</id>
					<start>81</start>
					<end>210</end>
					<coverage>61.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P34130</id>
					<start>81</start>
					<end>210</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>99</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>109</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>161</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>167</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>188</region_start>
						<region_end>205</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>89</region_start>
						<region_end>208</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1hcf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200009</accession>
		<general>
			<name>Brain-derived neurotrophic factor/neurotrophin 3 heterodimer</name>
			<pdb_id>1bnd</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>7703225</pmid>
				<authors>Robinson RC, Radziejewski C, Stuart DI, Jones EY</authors>
				<title>Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer.</title>
				<journal>Biochemistry</journal>
				<year>1995</year>
				<issue>13</issue>
				<volume>34</volume>
				<pages>4139-46</pages>
				<abstract>The development and sustenance of specific neuronal populations in the peripheral and central nervous systems are controlled through the binding of neurotrophic factors to high-affinity cell surface receptors. The neurotrophins (nerve growth factor, NGF; brain-derived neurotrophic factor, BDNF; neurotrophin 3, NT3; and neurotrophin 4, NT4) are dimeric molecules which share approximately 50% sequence identity. The crystal structure of the murine NGF homodimer [McDonald et al. (1991) Nature 354, 411-414] indicated that the dimer interface corresponds to regions of high sequence conservation throughout the neurotrophin family. This potential compatibility was duly exploited for the production in vitro of noncovalent heterodimers between the different neurotrophins [Radziejewski, C., &amp; Robinson, R.C. (1993) Biochemistry 32, 13350-13356; Jungbluth et al. (1994) Eur. J. Biochem. 221, 677-685]. Here, we report the X-ray structure at 2.3 A resolution of one such heterodimer, between human BDNF, and human NT3. The NGF, BDNF, and NT3 protomers share the same topology and are structurally equivalent in regions which contribute to the dimer interface in line with the propensity of the neurotrophins to form heterodimers. Analysis of the structure of regions of the BDNF/NT3 heterodimer involved in receptor specificity led us to conclude that heterodimer binding to p75 involves distant binding sites separately located on each protomer of the heterodimer. In contrast, heterodimer interactions with the trk receptors probably utilize hybrid binding sites comprised of residues contributed by both protomers in the heterodimer. The existence of such hybrid binding sites for the trk receptor provides an explanation for the lower activity of the BDNF/NT3 heterodimer in comparison to the homodimers.(ABSTRACT TRUNCATED AT 250 WORDS)</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007267</accession>
					<name>cell-cell signaling</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0007399</accession>
					<name>nervous system development</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0016023</accession>
					<name>cytoplasmic, membrane-bounded vesicle</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Heterodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Brain-derived neurotrophic factor</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>HSDPARRGQLSVCDSISEWVTAADKKTAVDMSGGTVTVLEKVPVSKGQLKQYFYETKCNPMGYTKEGCRGIDKRHWNSQCRTTQSYVRALTMDSKKRIGWRFIRIDTSCVCTLTIKRGR</sequence>
				<length>119</length>
				<uniprot>
					<id>P23560</id>
					<start>129</start>
					<end>247</end>
					<coverage>48.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P23560</id>
					<start>129</start>
					<end>247</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>139</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>143</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>150</region_start>
						<region_end>153</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>155</region_start>
						<region_end>158</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>163</region_start>
						<region_end>166</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>169</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>176</region_start>
						<region_end>178</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>180</region_start>
						<region_end>186</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>191</region_start>
						<region_end>193</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>199</region_start>
						<region_end>199</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>204</region_start>
						<region_end>220</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>226</region_start>
						<region_end>243</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>133</region_start>
						<region_end>246</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Neurotrophin-3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>YAEHKSHRGEVSVCDSESLWVTDKSSAIDIRGHQVTVLGEIKTQNSPVKQYFYETRCKEARPVKNGCRGIDDKHWNSQCKTSQTYVRALTSENNKLVGWRWIRIDTSCVCALSRKIGRT</sequence>
				<length>119</length>
				<uniprot>
					<id>P20783</id>
					<start>139</start>
					<end>257</end>
					<coverage>46.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P20783</id>
					<start>139</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>154</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>164</region_start>
						<region_end>167</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>172</region_start>
						<region_end>175</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>178</region_start>
						<region_end>179</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>186</region_start>
						<region_end>187</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>190</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>208</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>214</region_start>
						<region_end>230</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>233</region_start>
						<region_end>251</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>144</region_start>
						<region_end>255</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2201009</accession>
		<general>
			<name>Brain-derived neurotrophic factor/neurotrophin 4 heterodimer</name>
			<pdb_id>1b8m</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.75</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Sus scrofa / Homo sapiens</source_organism>
			<publication>
				<pmid>10631974</pmid>
				<authors>Robinson RC, Radziejewski C, Spraggon G, Greenwald J, Kostura MR, Burtnick LD, Stuart DI, Choe S, Jones EY</authors>
				<title>The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site.</title>
				<journal>Protein Sci.</journal>
				<year>1999</year>
				<issue>12</issue>
				<volume>8</volume>
				<pages>2589-97</pages>
				<abstract>The neurotrophins are growth factors that are involved in the development and survival of neurons. Neurotrophin release by a target tissue results in neuron growth along the neurotrophin concentration gradient, culminating in the eventual innervation of the target tissue. These activities are mediated through trk cell surface receptors. We have determined the structures of the heterodimer formed between brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4), as well as the structure of homodimer of NT4. We also present the structure of the Neurotrophin 3 homodimer, which is refined to higher resolution than previously published. These structures provide the first views of the architecture of the NT4 protomer. Comparison of the surface of a model of the BDNF homodimer with the structures of the neurotrophin homodimers reveals common features that may be important in the binding between the neurotrophins and their receptors. In particular, there exists an analogous region on the surface of each neurotrophin that is likely to be involved in trk receptor binding. Variations in sequence on the periphery of this common region serve to confer trk receptor specificity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007169</accession>
					<name>transmembrane receptor protein tyrosine kinase signaling pathway</name>
				</go>
				<go>
					<accession>GO:0048812</accession>
					<name>neuron projection morphogenesis</name>
				</go>
				<go>
					<accession>GO:0045664</accession>
					<name>regulation of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0007267</accession>
					<name>cell-cell signaling</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0016023</accession>
					<name>cytoplasmic, membrane-bounded vesicle</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Heterodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Brain-derived neurotrophic factor</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>HSDPARRGELSVCDSISEWVTAADKKTAVDMSGGTVTVLEKVPVSKGQLKQYFYETKCNPMGYTKEGCRGIDKRHWNSQCRTTQSYVRALTMDSKKRIGWRFIRIDTSCVCTLTIKRGR</sequence>
				<length>119</length>
				<uniprot>
					<id>P14082</id>
					<start>134</start>
					<end>252</end>
					<coverage>47.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P23560-3</id>
					<start>144</start>
					<end>262</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>144</region_start>
						<region_end>144</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>154</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>155</region_start>
						<region_end>158</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>160</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>174</region_start>
						<region_end>177</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>180</region_start>
						<region_end>183</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>185</region_start>
						<region_end>191</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>204</region_start>
						<region_end>204</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>210</region_start>
						<region_end>225</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>231</region_start>
						<region_end>247</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>138</region_start>
						<region_end>251</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Neurotrophin-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GVSETAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAEEGGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRTGRA</sequence>
				<length>130</length>
				<uniprot>
					<id>P34130</id>
					<start>81</start>
					<end>210</end>
					<coverage>61.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P34130</id>
					<start>81</start>
					<end>210</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>99</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>109</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>161</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>167</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>188</region_start>
						<region_end>205</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>89</region_start>
						<region_end>208</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110011</accession>
		<general>
			<name>Ovulation-inducing factor (OIF) from llama seminal plasma</name>
			<pdb_id>4efv</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.32</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Saimiri boliviensis boliviensis</source_organism>
			<publication>
				<pmid>22908303</pmid>
				<authors>Ratto MH, Leduc YA, Valderrama XP, van Straaten KE, Delbaere LT, Pierson RA, Adams GP</authors>
				<title>The nerve of ovulation-inducing factor in semen.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2012</year>
				<issue>37</issue>
				<volume>109</volume>
				<pages>15042-7</pages>
				<abstract>A component in seminal fluid elicits an ovulatory response and has been discovered in every species examined thus far. The existence of an ovulation-inducing factor (OIF) in seminal plasma has broad implications and evokes questions about identity, tissue sources, mechanism of action, role among species, and clinical relevance in infertility. Most of these questions remain unanswered. The goal of this study was to determine the identity of OIF in support of the hypothesis that it is a single distinct and widely conserved entity. Seminal plasma from llamas and bulls was used as representative of induced and spontaneous ovulators, respectively. A fraction isolated from llama seminal plasma by column chromatography was identified as OIF by eliciting luteinizing hormone (LH) release and ovulation in llamas. MALDI-TOF revealed a molecular mass of 13,221 Da, and 12-23 aa sequences of OIF had homology with human, porcine, bovine, and murine sequences of β nerve growth factor (β-NGF). X-ray diffraction data were used to solve the full sequence and structure of OIF as β-NGF. Neurite development and up-regulation of trkA in phaeochromocytoma (PC(12)) cells in vitro confirmed NGF-like properties of OIF. Western blot analysis of llama and bull seminal plasma confirmed immunorecognition of OIF using polyclonal mouse anti-NGF, and administration of β-NGF from mouse submandibular glands induced ovulation in llamas. We conclude that OIF in seminal plasma is β-NGF and that it is highly conserved. An endocrine route of action of NGF elucidates a previously unknown pathway for the direct influence of the male on the hypothalamo-pituitary-gonadal axis of the inseminated female.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
				<go>
					<accession>GO:0008191</accession>
					<name>metalloendopeptidase inhibitor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010951</accession>
					<name>negative regulation of endopeptidase activity</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Homodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Beta-nerve growth factor</name>
				<source_organism>Saimiri boliviensis boliviensis</source_organism>
				<sequence>APSHPIFHRGEFSVCDSVSVWVADKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVASGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSKKAS</sequence>
				<length>117</length>
				<uniprot>
					<id>Q5ISB0</id>
					<start>124</start>
					<end>238</end>
					<coverage>47.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13600</id>
					<start>124</start>
					<end>236</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>133</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>156</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>162</region_start>
						<region_end>164</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>169</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>174</region_start>
						<region_end>179</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>192</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>194</region_start>
						<region_end>196</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>197</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>218</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>128</region_start>
						<region_end>238</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Beta-nerve growth factor</name>
				<source_organism>Saimiri boliviensis boliviensis</source_organism>
				<sequence>APSHPIFHRGEFSVCDSVSVWVADKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVASGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSKKAS</sequence>
				<length>117</length>
				<uniprot>
					<id>Q5ISB0</id>
					<start>124</start>
					<end>238</end>
					<coverage>47.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P13600</id>
					<start>124</start>
					<end>236</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>133</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>138</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>156</region_start>
						<region_end>159</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>162</region_start>
						<region_end>165</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>171</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>174</region_start>
						<region_end>179</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>192</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>197</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>218</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>128</region_start>
						<region_end>238</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins. While OIF plays a different biological role than NGF, they share a 97% sequence identity and have virtually identical structures.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110012</accession>
		<general>
			<name>Dimerization domain of HNF-1alpha</name>
			<pdb_id>1jb6</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Mus musculus</source_organism>
			<publication>
				<pmid>11439029</pmid>
				<authors>Narayana N, Hua Q, Weiss MA</authors>
				<title>The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2001</year>
				<issue>3</issue>
				<volume>310</volume>
				<pages>635-58</pages>
				<abstract>Maturity-onset diabetes mellitus of the young (MODY) is a human genetic syndrome most commonly due to mutations in hepatocyte nuclear factor-1alpha (HNF-1alpha). Here, we describe the crystal structure of the HNF-1alpha dimerization domain at 1.7 A resolution and assess its structural plasticity. The crystal&apos;s low solvent content (23%, v/v) leads to tight packing of peptides in the lattice. Two independent dimers, similar in structure, are formed in the unit cell by a 2-fold crystallographic symmetry axis. The dimers define a novel intertwined four-helix bundle (4HB). Each protomer contains two alpha-helices separated by a sharp non-canonical turn. Dimer-related alpha-helices form anti-parallel coiled-coils, including an N-terminal &amp;quot;mini-zipper" complementary in structure, symmetry and surface characteristics to transcriptional coactivator dimerization cofactor of HNF-1 (DCoH). A confluence of ten leucine side-chains (five per protomer) forms a hydrophobic core. Isotope-assisted NMR studies demonstrate that a similar intertwined dimer exists in solution. Comparison of structures obtained in multiple independent crystal forms indicates that the mini-zipper is a stable structural element, whereas the C-terminal alpha-helix can adopt a broad range of orientations. Segmental alignment of the mini-zipper (mean pairwise root-mean-square difference (rmsd) in C(alpha) coordinates of 0.29 A) is associated with a 2.1 A mean C(alpha) rmsd displacement of the C-terminal coiled-coil. The greatest C-terminal structural variation (4.1 A C(alpha) rmsd displacement) is observed in the DCoH-bound peptide. Diabetes-associated mutations perturb distinct structural features of the HNF-1alpha domain. One mutation (L12H) destabilizes the domain but preserves structural specificity. Adjoining H12 side-chains in a native-like dimer are predicted to alter the functional surface of the mini-zipper involved in DCoH recognition. The other mutation (G20R), by contrast, leads to a dimeric molten globule, as indicated by its 1H-NMR features and fluorescent binding of 1-anilino-8-naphthalene sulfonate. We propose that a glycine-specific turn configuration enables specific interactions between the mini-zipper and the C-terminal coiled-coil.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0001221</accession>
					<name>transcription cofactor binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042593</accession>
					<name>glucose homeostasis</name>
				</go>
				<go>
					<accession>GO:0006699</accession>
					<name>bile acid biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0030073</accession>
					<name>insulin secretion</name>
				</go>
				<go>
					<accession>GO:0048341</accession>
					<name>paraxial mesoderm formation</name>
				</go>
				<go>
					<accession>GO:0060261</accession>
					<name>positive regulation of transcription initiation from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0015908</accession>
					<name>fatty acid transport</name>
				</go>
				<go>
					<accession>GO:0015721</accession>
					<name>bile acid and bile salt transport</name>
				</go>
				<go>
					<accession>GO:0035623</accession>
					<name>renal glucose absorption</name>
				</go>
				<go>
					<accession>GO:0009749</accession>
					<name>response to glucose</name>
				</go>
				<go>
					<accession>GO:0030326</accession>
					<name>embryonic limb morphogenesis</name>
				</go>
				<go>
					<accession>GO:0046323</accession>
					<name>glucose import</name>
				</go>
				<go>
					<accession>GO:0001824</accession>
					<name>blastocyst development</name>
				</go>
				<go>
					<accession>GO:0031018</accession>
					<name>endocrine pancreas development</name>
				</go>
				<go>
					<accession>GO:0006633</accession>
					<name>fatty acid biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0001889</accession>
					<name>liver development</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0008203</accession>
					<name>cholesterol metabolic process</name>
				</go>
				<go>
					<accession>GO:0006338</accession>
					<name>chromatin remodeling</name>
				</go>
				<go>
					<accession>GO:0050796</accession>
					<name>regulation of insulin secretion</name>
				</go>
				<go>
					<accession>GO:0043691</accession>
					<name>reverse cholesterol transport</name>
				</go>
				<go>
					<accession>GO:0016573</accession>
					<name>histone acetylation</name>
				</go>
				<go>
					<accession>GO:0006783</accession>
					<name>heme biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0001890</accession>
					<name>placenta development</name>
				</go>
				<go>
					<accession>GO:0006979</accession>
					<name>response to oxidative stress</name>
				</go>
				<go>
					<accession>GO:0045453</accession>
					<name>bone resorption</name>
				</go>
				<go>
					<accession>GO:0030111</accession>
					<name>regulation of Wnt signaling pathway</name>
				</go>
				<go>
					<accession>GO:0060395</accession>
					<name>SMAD protein signal transduction</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
				<go>
					<accession>GO:0001750</accession>
					<name>photoreceptor outer segment</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0045120</accession>
					<name>pronucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain C was generated from chain A using the biomatrix described in the original PDB file. Chain B was removed as chains A and C represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Hepatocyte nuclear factor 1-alpha</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>VSKLSQLQTELMAALLESGLSKEALIQALGEW</sequence>
				<length>32</length>
				<uniprot>
					<id>P22361</id>
					<start>1</start>
					<end>33</end>
					<coverage>5.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22361</id>
					<start>2</start>
					<end>32</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04814.10</region_id>
						<region_name>HNF-1_N</region_name>
						<region_start>8</region_start>
						<region_end>168</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Hepatocyte nuclear factor 1-alpha</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>VSKLSQLQTELMAALLESGLSKEALIQALGEW</sequence>
				<length>32</length>
				<uniprot>
					<id>P22361</id>
					<start>1</start>
					<end>33</end>
					<coverage>5.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22361</id>
					<start>2</start>
					<end>32</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04814.10</region_id>
						<region_name>HNF-1_N</region_name>
						<region_start>8</region_start>
						<region_end>168</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>HNF dimer The thermal and chemical equilibrium unfolding of a 32-residue alpha-helical peptide comprising the dimerization domain of HNF-1 was monitored by circular dichroism spectroscopy. The conformational stability of this peptide was shown to be concentration dependent, and the unfolding reaction is described as a two-state transition between folded dimers and unfolded monomers (PMID:1988015).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1f93</pdb_id>
			<pdb_id>1g2y</pdb_id>
			<pdb_id>1g2z</pdb_id>
			<pdb_id>1g39</pdb_id>
			<pdb_id>2gyp</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120020</accession>
		<general>
			<name>Factor for inversion stimulation (FIS)</name>
			<pdb_id>1ety</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>11183780</pmid>
				<authors>Cheng YS, Yang WZ, Johnson RC, Yuan HS</authors>
				<title>Structural analysis of the transcriptional activation region on Fis: crystal structures of six Fis mutants with different activation properties.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2000</year>
				<issue>5</issue>
				<volume>302</volume>
				<pages>1139-51</pages>
				<abstract>The Fis protein regulates gene expression in Escherichia coli by activating or repressing transcription of a variety of genes. Fis can activate transcription when bound to DNA upstream of the RNA-polymerase-binding site, such as in the rrnB P1 promoter, or when bound to a site overlapping the -35 RNA polymerase binding site, such as in the proP P2 promoter. It has been suggested that transcriptional activation in both promoters results from interactions between specific amino acids within a turn connecting the B and C helices (the BC turn) in Fis and the C-terminal domain of the alpha-subunit of RNA polymerase (alphaCTD of RNAP). Here, crystal structures of six Fis BC turn mutants with different transcriptional activation properties, Q68A, R71Y, R71L, G72A, G72D and Q74A, were determined at 1.9 to 2.8 A resolution. Two of these mutants, R71Y and R71L, crystallized in unit cells which are different from that of wild-type Fis, and the structure of R71L offers the most complete Fis model to date in that the extended structure of the N-terminal region is revealed. The BC turn in all of these mutant structures remains in a nearly identical gamma gamma beta-turn conformation as present in wild-type Fis. Analyses of the molecular surfaces of the transactivation region of the mutants suggest that several residues in or near the BC turn, including Gln68, Arg71, Gly72 and Gln74, form a ridge that could contact the alphaCTD of RNAP on one side. The structures and biochemical properties of the mutants suggest that Arg71 is the most critical residue for contacting RNAP within this ridge and that the glycine at position 72 helps to stabilize the structure.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000787</accession>
					<name>cytoplasmic nucleosome</name>
				</go>
				<go>
					<accession>GO:0009295</accession>
					<name>nucleoid</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>DNA-binding protein Fis</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MFEQRVNSDVLTVSTVNSQDQVTQKPLRDSVKQALKNYFAQLNGQDVNDLYELVLAEVEQPLLDMVMQYTRGNQTRAALMMGINRGTLRKKLKKYGMN</sequence>
				<length>98</length>
				<uniprot>
					<id>P0A6R3</id>
					<start>10</start>
					<end>98</end>
					<coverage>90.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A8AQG0</id>
					<start>10</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>23</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02954.16</region_id>
						<region_name>HTH_8</region_name>
						<region_start>54</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>DNA-binding protein Fis</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MFEQRVNSDVLTVSTVNSQDQVTQKPLRDSVKQALKNYFAQLNGQDVNDLYELVLAEVEQPLLDMVMQYTRGNQTRAALMMGINRGTLRKKLKKYGMN</sequence>
				<length>98</length>
				<uniprot>
					<id>P0A6R3</id>
					<start>6</start>
					<end>98</end>
					<coverage>94.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A8AQG0</id>
					<start>6</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>12</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>50</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>85</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02954.16</region_id>
						<region_name>HTH_8</region_name>
						<region_start>54</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>FIS forms an intertwined homodimer. Equilibrium and kinetic methods have shown that FIS follows a two-step folding reaction where the two unfolded monomers associate to a dimeric intermediate during a fast phase, which is followed by a slower, subsequent folding of the dimeric intermediate to the native dimer (PMID:14698300).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1etk</pdb_id>
			<pdb_id>1eto</pdb_id>
			<pdb_id>1etq</pdb_id>
			<pdb_id>1etv</pdb_id>
			<pdb_id>1etw</pdb_id>
			<pdb_id>1etx</pdb_id>
			<pdb_id>1f36</pdb_id>
			<pdb_id>1fia</pdb_id>
			<pdb_id>1fip</pdb_id>
			<pdb_id>3fis</pdb_id>
			<pdb_id>4fis</pdb_id>
			<pdb_id>4ihv</pdb_id>
			<pdb_id>4ihw</pdb_id>
			<pdb_id>4ihx</pdb_id>
			<pdb_id>4ihy</pdb_id>
			<pdb_id>3iv5</pdb_id>
			<pdb_id>3jr9</pdb_id>
			<pdb_id>3jra</pdb_id>
			<pdb_id>3jrb</pdb_id>
			<pdb_id>3jrc</pdb_id>
			<pdb_id>3jrd</pdb_id>
			<pdb_id>3jre</pdb_id>
			<pdb_id>3jrf</pdb_id>
			<pdb_id>3jrg</pdb_id>
			<pdb_id>3jrh</pdb_id>
			<pdb_id>3jri</pdb_id>
			<pdb_id>5ds9</pdb_id>
			<pdb_id>5dtd</pdb_id>
			<pdb_id>5e3l</pdb_id>
			<pdb_id>5e3m</pdb_id>
			<pdb_id>5e3n</pdb_id>
			<pdb_id>5e3o</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4410001</accession>
		<general>
			<name>Neuronal SNARE core complex (Vamp2 / Syntaxin-1A / SNAP25)</name>
			<pdb_id>1n7s</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.45</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>12496247</pmid>
				<authors>Ernst JA, Brunger AT</authors>
				<title>High resolution structure, stability, and synaptotagmin binding of a truncated neuronal SNARE complex.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2003</year>
				<issue>10</issue>
				<volume>278</volume>
				<pages>8630-6</pages>
				<abstract>The structure of a truncated SNARE complex has been solved to 1.4-A resolution revealing a stabilizing salt bridge, sites of hydration, and conformational variability of the ionic central layer that were not observed in a previously published structure at 2.4-A resolution (Sutton, R. B., Fasshauer, D., Jahn, R., and Brunger, A. T. (1998) Nature 395, 347-353). The truncated complex lacks residues involved in phospholipid binding and denatures at a lower temperature than longer complexes as assessed by SDS and circular dichroism thermal melts. The truncated SNARE complex is monomeric, and it retains binding to synaptotagmin I.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0048306</accession>
					<name>calcium-dependent protein binding</name>
				</go>
				<go>
					<accession>GO:0044325</accession>
					<name>ion channel binding</name>
				</go>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
				<go>
					<accession>GO:0017022</accession>
					<name>myosin binding</name>
				</go>
				<go>
					<accession>GO:0000149</accession>
					<name>SNARE binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0070044</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a complex</name>
				</go>
				<go>
					<accession>GO:0070032</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex</name>
				</go>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
				<go>
					<accession>GO:0043229</accession>
					<name>intracellular organelle</name>
				</go>
				<go>
					<accession>GO:0070033</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex</name>
				</go>
				<go>
					<accession>GO:0043005</accession>
					<name>neuron projection</name>
				</go>
				<go>
					<accession>GO:0045202</accession>
					<name>synapse</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vesicle-associated membrane protein 2</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKLKRKYW</sequence>
				<length>63</length>
				<uniprot>
					<id>P63045</id>
					<start>27</start>
					<end>89</end>
					<coverage>54.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P63044</id>
					<start>28</start>
					<end>89</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00957.18</region_id>
						<region_name>Synaptobrevin</region_name>
						<region_start>28</region_start>
						<region_end>116</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-1A</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDTKKAVK</sequence>
				<length>68</length>
				<uniprot>
					<id>P32851</id>
					<start>189</start>
					<end>256</end>
					<coverage>23.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P32851</id>
					<start>191</start>
					<end>256</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>254</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00804.22</region_id>
						<region_name>Syntaxin</region_name>
						<region_start>30</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>228</region_start>
						<region_end>280</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLDRVEEGMNHINQDMKEAEKNLKDLGK</sequence>
				<length>79</length>
				<uniprot>
					<id>P60881</id>
					<start>7</start>
					<end>83</end>
					<coverage>37.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>7</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>7</region_start>
						<region_end>82</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSARENEMDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQRATKMLG</sequence>
				<length>66</length>
				<uniprot>
					<id>P60881</id>
					<start>139</start>
					<end>204</end>
					<coverage>32%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>141</start>
					<end>204</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>142</region_start>
						<region_end>201</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:12496247). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1kil</pdb_id>
			<pdb_id>1sfc</pdb_id>
			<pdb_id>2n1t</pdb_id>
			<pdb_id>3hd7</pdb_id>
			<pdb_id>3ipd</pdb_id>
			<pdb_id>3rk2</pdb_id>
			<pdb_id>3rk3</pdb_id>
			<pdb_id>3rl0</pdb_id>
			<pdb_id>5cch</pdb_id>
			<pdb_id>5cci</pdb_id>
			<pdb_id>5ccg</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4400001</accession>
		<general>
			<name>Autophagic SNARE core complex (Vamp8 / Syntaxin-17 / SNAP29)</name>
			<pdb_id>4wy4</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.40</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>25686604</pmid>
				<authors>Diao J, Liu R, Rong Y, Zhao M, Zhang J, Lai Y, Zhou Q, Wilz LM, Li J, Vivona S, Pfuetzner RA, Brunger AT, Zhong Q</authors>
				<title>ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes.</title>
				<journal>Nature</journal>
				<year>2015</year>
				<abstract>Autophagy, an important catabolic pathway implicated in a broad spectrum of human diseases, begins by forming double membrane autophagosomes that engulf cytosolic cargo and ends by fusing autophagosomes with lysosomes for degradation. Membrane fusion activity is required for early biogenesis of autophagosomes and late degradation in lysosomes. However, the key regulatory mechanisms of autophagic membrane tethering and fusion remain largely unknown. Here we report that ATG14 (also known as beclin-1-associated autophagy-related key regulator (Barkor) or ATG14L), an essential autophagy-specific regulator of the class III phosphatidylinositol 3-kinase complex, promotes membrane tethering of protein-free liposomes, and enhances hemifusion and full fusion of proteoliposomes reconstituted with the target (t)-SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) syntaxin 17 (STX17) and SNAP29, and the vesicle (v)-SNARE VAMP8 (vesicle-associated membrane protein 8). ATG14 binds to the SNARE core domain of STX17 through its coiled-coil domain, and stabilizes the STX17-SNAP29 binary t-SNARE complex on autophagosomes. The STX17 binding, membrane tethering and fusion-enhancing activities of ATG14 require its homo-oligomerization by cysteine repeats. In ATG14 homo-oligomerization-defective cells, autophagosomes still efficiently form but their fusion with endolysosomes is blocked. Recombinant ATG14 homo-oligomerization mutants also completely lose their ability to promote membrane tethering and to enhance SNARE-mediated fusion in vitro. Taken together, our data suggest an autophagy-specific membrane fusion mechanism in which oligomeric ATG14 directly binds to STX17-SNAP29 binary t-SNARE complex on autophagosomes and primes it for VAMP8 interaction to promote autophagosome-endolysosome fusion.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006810</accession>
					<name>transport</name>
				</go>
				<go>
					<accession>GO:0097352</accession>
					<name>autophagosome maturation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0031201</accession>
					<name>SNARE complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vesicle-associated membrane protein 8</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DRVRNLQSEVEGVKNIMTQNVERILARGENLEHLRNKTEDLEATSEHFKTTSQKVARKFWWKNV</sequence>
				<length>64</length>
				<uniprot>
					<id>Q9BV40</id>
					<start>11</start>
					<end>74</end>
					<coverage>64%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9BV40</id>
					<start>11</start>
					<end>74</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00957.18</region_id>
						<region_name>Synaptobrevin</region_name>
						<region_start>9</region_start>
						<region_end>97</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-17</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>ESWETLEADLIELSQLVTDFSLLVNSQQEKIDSIADHVNSAAVNVEEGTKNLGKAAKY</sequence>
				<length>58</length>
				<uniprot>
					<id>P56962</id>
					<start>170</start>
					<end>227</end>
					<coverage>19.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P56962</id>
					<start>170</start>
					<end>227</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>173</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>197</region_start>
						<region_end>226</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Synaptosomal-associated protein 29</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>ADRQQYLRQEVLRRAEATAASTSRSLALMYESEKVGVASSEELARQRGVLERTEKMVDKMDQDLKISQKHINSIKSVF</sequence>
				<length>78</length>
				<uniprot>
					<id>O95721</id>
					<start>39</start>
					<end>116</end>
					<coverage>30.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O95721</id>
					<start>39</start>
					<end>116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12352.5</region_id>
						<region_name>V-SNARE_C</region_name>
						<region_start>52</region_start>
						<region_end>114</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Synaptosomal-associated protein 29</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>HLRAYHQKIDSNLDELSMGLGRLKDIALGMQTEIEEQDDILDRLTTKVDKLDVNIKSTERKVRQL</sequence>
				<length>65</length>
				<uniprot>
					<id>O95721</id>
					<start>194</start>
					<end>258</end>
					<coverage>25.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O95721</id>
					<start>194</start>
					<end>258</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>195</region_start>
						<region_end>251</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>254</region_start>
						<region_end>256</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:25686604). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4411001</accession>
		<general>
			<name>Endosomal SNARE core complex (Vamp4 / Vti1-rp2 / Syntaxin-6 / Syntaxin-13)</name>
			<pdb_id>2nps</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.50</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Mus musculus / Rattus norvegicus / Pongo abelii</source_organism>
			<publication>
				<pmid>17159904</pmid>
				<authors>Zwilling D, Cypionka A, Pohl WH, Fasshauer D, Walla PJ, Wahl MC, Jahn R</authors>
				<title>Early endosomal SNAREs form a structurally conserved SNARE complex and fuse liposomes with multiple topologies.</title>
				<journal>EMBO J.</journal>
				<year>2007</year>
				<issue>1</issue>
				<volume>26</volume>
				<pages>9-18</pages>
				<abstract>SNARE proteins mediate membrane fusion in eukaryotic cells. They contain conserved SNARE motifs that are usually located adjacent to a C-terminal transmembrane domain. SNARE motifs spontaneously assemble into four helix bundles, with each helix belonging to a different subfamily. Liposomes containing SNAREs spontaneously fuse with each other, but it is debated how the SNAREs are distributed between the membranes. Here, we report that the SNAREs mediating homotypic fusion of early endosomes fuse liposomes in five out of seven possible combinations, in contrast to previously studied SNAREs involved in heterotypic fusion events. The crystal structure of the early endosomal SNARE complex resembles that of the neuronal and late endosomal complexes, but differs in surface side-chain interactions. We conclude that homotypic fusion reactions may proceed with multiple SNARE topologies, suggesting that the conserved SNARE structure allows for flexibility in the initial interactions needed for fusion.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0016192</accession>
					<name>vesicle-mediated transport</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005794</accession>
					<name>Golgi apparatus</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vesicle-associated membrane protein 4</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GSMGPRNDKIKHVQNQVDEVIDVMQENITKVIERGERLDELQDKSESLSDNATAFSNRSKQLRRQMWWRGCKIK</sequence>
				<length>74</length>
				<uniprot>
					<id>O70480</id>
					<start>44</start>
					<end>117</end>
					<coverage>52.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75379</id>
					<start>46</start>
					<end>117</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>54</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>109</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00957.18</region_id>
						<region_name>Synaptobrevin</region_name>
						<region_start>49</region_start>
						<region_end>137</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-12</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSMRETAIQQLEADILDVNQIFKDLAMMIHDQGDLIDSIEANVESSEVHVERASDQLQRAAYYQKKSRKKM</sequence>
				<length>71</length>
				<uniprot>
					<id>G3V7P1</id>
					<start>181</start>
					<end>251</end>
					<coverage>25.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q86Y82</id>
					<start>184</start>
					<end>251</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>184</region_start>
						<region_end>245</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>214</region_start>
						<region_end>266</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Vesicle transport through interaction with t-SNAREs homolog 1A</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSMRAHLLDNTERLERSSRRLEAGYQIAVETEQIGQEMLENLSHDRERIQRARERLRETDANLGKSSRILTGMLRRIIQNR</sequence>
				<length>81</length>
				<uniprot>
					<id>Q9JI51</id>
					<start>119</start>
					<end>199</end>
					<coverage>36.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9JI51</id>
					<start>122</start>
					<end>199</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>124</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>138</region_start>
						<region_end>194</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12352.5</region_id>
						<region_name>V-SNARE_C</region_name>
						<region_start>130</region_start>
						<region_end>195</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Syntaxin-6</name>
				<source_organism>Pongo abelii</source_organism>
				<sequence>GSHMASMTGGNNMGRMQDEQLELVSGSIGVLKNMSQRIGGELEEQAVMLEDFSHELESTQSRLDNVMKKLAKVSHMTSDRRQ</sequence>
				<length>82</length>
				<uniprot>
					<id>Q5R6Q2</id>
					<start>169</start>
					<end>234</end>
					<coverage>25.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O43752</id>
					<start>169</start>
					<end>234</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>173</region_start>
						<region_end>229</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>199</region_start>
						<region_end>251</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:17159904). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4411002</accession>
		<general>
			<name>Endosomal SNARE core complex (Vamp8 / Vti1-rp1 / Syntaxin-7 / Syntaxin-8)</name>
			<pdb_id>1gl2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.9</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Rattus norvegicus / Mus musculus</source_organism>
			<publication>
				<pmid>11786915</pmid>
				<authors>Antonin W, Fasshauer D, Becker S, Jahn R, Schneider TR</authors>
				<title>Crystal structure of the endosomal SNARE complex reveals common structural principles of all SNAREs.</title>
				<journal>Nat. Struct. Biol.</journal>
				<year>2002</year>
				<issue>2</issue>
				<volume>9</volume>
				<pages>107-11</pages>
				<abstract>SNARE proteins are crucial for intracellular membrane fusion in all eukaryotes. These proteins assemble into tight complexes that connect membranes and may induce fusion. The crystal structure of the neuronal core complex is represented by an unusually long bundle of four alpha-helices connected by 16 layers of mostly hydrophobic amino acids. Here we report the 1.9 A resolution crystal structure of an endosomal SNARE core complex containing four SNAREs: syntaxin 7, syntaxin 8, vti1b and endobrevin/VAMP-8. Despite limited sequence homology, the helix alignment and the layer structure of the endosomal complex are remarkably similar to those of the neuronal complex. However, subtle variations are evident that characterize different SNARE subfamilies. We conclude that the structure of the SNARE core complex is an evolutionarily conserved hallmark of all SNARE complexes and is intimately associated with the general role of SNAREs in membrane fusion.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0016192</accession>
					<name>vesicle-mediated transport</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005765</accession>
					<name>lysosomal membrane</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
				<go>
					<accession>GO:0031201</accession>
					<name>SNARE complex</name>
				</go>
				<go>
					<accession>GO:0055037</accession>
					<name>recycling endosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vesicle-associated membrane protein 8</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSHMSAGNDRVRNLQSEVEGVKNIMTQNVERILARGENLDHLRNKTEDLEATSEHFKTTSQKVAR</sequence>
				<length>65</length>
				<uniprot>
					<id>Q9WUF4</id>
					<start>2</start>
					<end>66</end>
					<coverage>65%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O70404</id>
					<start>7</start>
					<end>67</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00957.18</region_id>
						<region_name>Synaptobrevin</region_name>
						<region_start>8</region_start>
						<region_end>96</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-7</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GSHMHERESSIRQLEADIMDINEIFKDLGMMIHEQGDVIDSIEANVESAEVHVQQANQQLSRAAN</sequence>
				<length>65</length>
				<uniprot>
					<id>O70439</id>
					<start>165</start>
					<end>229</end>
					<coverage>24.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15400</id>
					<start>168</start>
					<end>229</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>170</region_start>
						<region_end>226</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>201</region_start>
						<region_end>255</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Vesicle transport through interaction with t-SNAREs homolog 1B</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GSHMNRATQSIERSHRIATETDQIGTEIIEELGEQRDQLERTKSRLVNTNENLSKSRKILRSMSR</sequence>
				<length>65</length>
				<uniprot>
					<id>O88384</id>
					<start>136</start>
					<end>200</end>
					<coverage>28%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O88384</id>
					<start>139</start>
					<end>200</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>141</region_start>
						<region_end>196</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12352.5</region_id>
						<region_name>V-SNARE_C</region_name>
						<region_start>137</region_start>
						<region_end>202</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Syntaxin-8</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSHMQEQDAGLDALSSIISRQKQMGQEIGNELDEQNEIIDDLANLVENTDEKLRTEARRVTLVDR</sequence>
				<length>65</length>
				<uniprot>
					<id>Q9Z2Q7</id>
					<start>145</start>
					<end>209</end>
					<coverage>27.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9Z2Q7</id>
					<start>152</start>
					<end>209</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>153</region_start>
						<region_end>204</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>181</region_start>
						<region_end>233</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:11786915). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4411003</accession>
		<general>
			<name>Neuronal SNARE core complex (Syntaxin-binding protein 5 / Syntaxin-1A / SNAP25)</name>
			<pdb_id>1urq</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.0</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Rattus norvegicus / Macaca mulatta</source_organism>
			<publication>
				<pmid>15316007</pmid>
				<authors>Pobbati AV, Razeto A, Böddener M, Becker S, Fasshauer D</authors>
				<title>Structural basis for the inhibitory role of tomosyn in exocytosis.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2004</year>
				<issue>45</issue>
				<volume>279</volume>
				<pages>47192-200</pages>
				<abstract>Upon Ca2+ influx synaptic vesicles fuse with the plasma membrane and release their neurotransmitter cargo into the synaptic cleft. Key players during this process are the Q-SNAREs syntaxin 1a and SNAP-25 and the R-SNARE synaptobrevin 2. It is thought that these membrane proteins gradually assemble into a tight trans-SNARE complex between vesicular and plasma membrane, ultimately leading to membrane fusion. Tomosyn is a soluble protein of 130 kDa that contains a COOH-terminal R-SNARE motif but lacks a transmembrane anchor. Its R-SNARE motif forms a stable core SNARE complex with syntaxin 1a and SNAP-25. Here we present the crystal structure of this core tomosyn SNARE complex at 2.0-A resolution. It consists of a four-helical bundle very similar to that of the SNARE complex containing synaptobrevin. Most differences are found on the surface, where they prevented tight binding of complexin. Both complexes form with similar rates as assessed by CD spectroscopy. In addition, synaptobrevin cannot displace the tomosyn helix from the tight complex and vice versa, indicating that both SNARE complexes represent end products. Moreover, data bank searches revealed that the R-SNARE motif of tomosyn is highly conserved throughout all eukaryotic kingdoms. This suggests that the formation of a tight SNARE complex is important for the function of tomosyn.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0006887</accession>
					<name>exocytosis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0045202</accession>
					<name>synapse</name>
				</go>
				<go>
					<accession>GO:0031201</accession>
					<name>SNARE complex</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Syntaxin-binding protein 5</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSHGGIEGVKGAASGVVGELARARLALDERGQKLSDLEERTAAMMSSADSFSKHAHEMMLKYK</sequence>
				<length>63</length>
				<uniprot>
					<id>Q9WU70</id>
					<start>1083</start>
					<end>1145</end>
					<coverage>5.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9WU70</id>
					<start>1086</start>
					<end>1145</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1088</region_start>
						<region_end>1142</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-1A</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSHSKQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDTKKAVKYQS</sequence>
				<length>75</length>
				<uniprot>
					<id>P32851</id>
					<start>185</start>
					<end>259</end>
					<coverage>26%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P32851</id>
					<start>186</start>
					<end>259</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>197</region_start>
						<region_end>256</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00804.22</region_id>
						<region_name>Syntaxin</region_name>
						<region_start>30</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>228</region_start>
						<region_end>280</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GSHMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLDRVEEGMNHINQDMKEAEKNLKDLGK</sequence>
				<length>80</length>
				<uniprot>
					<id>P60881</id>
					<start>5</start>
					<end>83</end>
					<coverage>38.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>5</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Macaca mulatta</source_organism>
				<sequence>GSHMASRENEMDENLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQRATKMLG</sequence>
				<length>69</length>
				<uniprot>
					<id>P60881</id>
					<start>141</start>
					<end>204</end>
					<coverage>31.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>141</start>
					<end>204</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>141</region_start>
						<region_end>198</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:15316007). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4410002</accession>
		<general>
			<name>Exocytotic SNARE core complex (Synaptobrevin homolog 1 / SSO1 / Protein transport protein SEC9)</name>
			<pdb_id>3b5n</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>17956869</pmid>
				<authors>Strop P, Kaiser SE, Vrljic M, Brunger AT</authors>
				<title>The structure of the yeast plasma membrane SNARE complex reveals destabilizing water-filled cavities.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2008</year>
				<issue>2</issue>
				<volume>283</volume>
				<pages>1113-9</pages>
				<abstract>SNARE proteins form a complex that leads to membrane fusion between vesicles, organelles, and plasma membrane in all eukaryotic cells. We report the 1.7A resolution structure of the SNARE complex that mediates exocytosis at the plasma membrane in the yeast Saccharomyces cerevisiae. Similar to its neuronal and endosomal homologues, the S. cerevisiae SNARE complex forms a parallel four-helix bundle in the center of which is an ionic layer. The S. cerevisiae SNARE complex exhibits increased helix bending near the ionic layer, contains water-filled cavities in the complex core, and exhibits reduced thermal stability relative to mammalian SNARE complexes. Mutagenesis experiments suggest that the water-filled cavities contribute to the lower stability of the S. cerevisiae complex.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006906</accession>
					<name>vesicle fusion</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0031201</accession>
					<name>SNARE complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains E, F, G, H, I, J, K and L were removed as chains A, B, C and D represent the biologically active tetramer.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>4</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Synaptobrevin homolog 1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>GSRTAELQAEIDDTVGIMRDNINKVAERGERLTSIEDKADNLAVSAQGFKRGANRVRKAMW</sequence>
				<length>61</length>
				<uniprot>
					<id>P31109</id>
					<start>26</start>
					<end>86</end>
					<coverage>52.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P31109</id>
					<start>27</start>
					<end>86</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00957.18</region_id>
						<region_name>Synaptobrevin</region_name>
						<region_start>25</region_start>
						<region_end>113</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein SSO1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>ALAEVQARHQELLKLEKSMAELTQLFNDMEELVIEQQENVDVIDKNVEDAQLDVEQGVGHTDKAVKSAR</sequence>
				<length>69</length>
				<uniprot>
					<id>P32867</id>
					<start>189</start>
					<end>257</end>
					<coverage>23.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P32867</id>
					<start>189</start>
					<end>257</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>190</region_start>
						<region_end>256</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00804.22</region_id>
						<region_name>Syntaxin</region_name>
						<region_start>33</region_start>
						<region_end>226</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>226</region_start>
						<region_end>278</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Protein transport protein SEC9</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>GSIKFTKQSSVASTRNTLKMAQDAERAGMNTLGMLGHQSEQLNNVEGNLDLMKVQNKVADEKVAELKKLQ</sequence>
				<length>70</length>
				<uniprot>
					<id>P40357</id>
					<start>431</start>
					<end>500</end>
					<coverage>10.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P40357</id>
					<start>433</start>
					<end>499</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>433</region_start>
						<region_end>499</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Protein transport protein SEC9</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>GSEMELEIDRNLDQIQQVSNRLKKMALTTGKELDSQQKRLNNIEESTDDLDINLHMNTNRLAGI</sequence>
				<length>64</length>
				<uniprot>
					<id>P40357</id>
					<start>587</start>
					<end>650</end>
					<coverage>9.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P40357</id>
					<start>596</start>
					<end>650</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>596</region_start>
						<region_end>648</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:17956869). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4210003</accession>
		<general>
			<name>Endosomal SNARE core complex (Syntaxin-1A / SNAP25)</name>
			<pdb_id>1jth</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>11533035</pmid>
				<authors>Misura KM, Gonzalez LC, May AP, Scheller RH, Weis WI</authors>
				<title>Crystal structure and biophysical properties of a complex between the N-terminal SNARE region of SNAP25 and syntaxin 1a.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2001</year>
				<issue>44</issue>
				<volume>276</volume>
				<pages>41301-9</pages>
				<abstract>SNARE proteins are required for intracellular membrane fusion. In the neuron, the plasma membrane SNAREs syntaxin 1a and SNAP25 bind to VAMP2 found on neurotransmitter-containing vesicles. These three proteins contain &amp;quot;SNARE regions" that mediate their association into stable tetrameric coiled-coil structures. Syntaxin 1a contributes one such region, designated H3, and SNAP25 contributes two SNARE regions to the fusogenic complex with VAMP2. Syntaxin 1a H3 (syn1aH3) and SNAP25 can form a stable assembly, which can then be bound by VAMP2 to form the full SNARE complex. Here we show that syn1aH3 can also form a stable but kinetically trapped complex with the N-terminal SNARE region of SNAP25 (S25N). The crystal structure of this complex reveals an extended parallel four-helix bundle similar to that of the core SNARE and the syn1aH3-SNAP25 complexes. The inherent ability of syn1aH3 and S25N to associate stably in vitro implies that the intracellular fusion machinery must prevent formation of, or remove, any non-productive complexes. Comparison with the syn1aH3-SNAP25 complex suggests that the linkage of the N- and C-terminal SNAP25 SNARE regions is kinetically advantageous in preventing formation of the non-productive syn1aH3-S25N complex. We also demonstrate that the syn1aH3-S25N complex can be disassembled by alpha-SNAP and N-ethylmaleimide-sensitive factor.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0019904</accession>
					<name>protein domain specific binding</name>
				</go>
				<go>
					<accession>GO:0000149</accession>
					<name>SNARE binding</name>
				</go>
				<go>
					<accession>GO:0017022</accession>
					<name>myosin binding</name>
				</go>
				<go>
					<accession>GO:0047485</accession>
					<name>protein N-terminus binding</name>
				</go>
				<go>
					<accession>GO:0005484</accession>
					<name>SNAP receptor activity</name>
				</go>
				<go>
					<accession>GO:0044325</accession>
					<name>ion channel binding</name>
				</go>
				<go>
					<accession>GO:0048306</accession>
					<name>calcium-dependent protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0031629</accession>
					<name>synaptic vesicle fusion to presynaptic active zone membrane</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0045202</accession>
					<name>synapse</name>
				</go>
				<go>
					<accession>GO:0070033</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex</name>
				</go>
				<go>
					<accession>GO:0043005</accession>
					<name>neuron projection</name>
				</go>
				<go>
					<accession>GO:0043229</accession>
					<name>intracellular organelle</name>
				</go>
				<go>
					<accession>GO:0070032</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex</name>
				</go>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
				<go>
					<accession>GO:0070044</accession>
					<name>synaptobrevin 2-SNAP-25-syntaxin-1a complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric, 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MAEDADMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNLTDLG</sequence>
				<length>82</length>
				<uniprot>
					<id>P60881</id>
					<start>1</start>
					<end>82</end>
					<coverage>39.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>1</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>71</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syntaxin-1A</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>ALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDTKKAVKYQSKARRKKIM</sequence>
				<length>77</length>
				<uniprot>
					<id>P32851</id>
					<start>191</start>
					<end>267</end>
					<coverage>26.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P32851</id>
					<start>191</start>
					<end>267</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>256</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00804.22</region_id>
						<region_name>Syntaxin</region_name>
						<region_start>30</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>228</region_start>
						<region_end>280</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Synaptosomal-associated protein 25</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>MAEDADMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNLTDLG</sequence>
				<length>82</length>
				<uniprot>
					<id>P60881</id>
					<start>1</start>
					<end>82</end>
					<coverage>39.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P60880</id>
					<start>1</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>11</region_start>
						<region_end>77</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Syntaxin-1A</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>ALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAVSDTKKAVKYQSKARRKKIM</sequence>
				<length>77</length>
				<uniprot>
					<id>P32851</id>
					<start>191</start>
					<end>267</end>
					<coverage>26.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P32851</id>
					<start>191</start>
					<end>267</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>196</region_start>
						<region_end>244</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00804.22</region_id>
						<region_name>Syntaxin</region_name>
						<region_start>30</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05739.16</region_id>
						<region_name>SNARE</region_name>
						<region_start>228</region_start>
						<region_end>280</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows the core domain of a SNARE complex (PMID:11533035). SNARE complexes are formed by the parallel arrangement of four protein chains bound by coiled-coil interactions forming a four helix bundle (PMID:9390521). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200010</accession>
		<general>
			<name>CENP-A/histone H4 dimer (human)</name>
			<pdb_id>3nqj</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>20739937</pmid>
				<authors>Sekulic N, Bassett EA, Rogers DJ, Black BE</authors>
				<title>The structure of (CENP-A-H4)(2) reveals physical features that mark centromeres.</title>
				<journal>Nature</journal>
				<year>2010</year>
				<issue>7313</issue>
				<volume>467</volume>
				<pages>347-51</pages>
				<abstract>Centromeres are specified epigenetically, and the histone H3 variant CENP-A is assembled into the chromatin of all active centromeres. Divergence from H3 raises the possibility that CENP-A generates unique chromatin features to mark physically centromere location. Here we report the crystal structure of a subnucleosomal heterotetramer, human (CENP-A-H4)(2), that reveals three distinguishing properties encoded by the residues that comprise the CENP-A targeting domain (CATD; ref. 2): (1) a CENP-A-CENP-A interface that is substantially rotated relative to the H3-H3 interface; (2) a protruding loop L1 of the opposite charge as that on H3; and (3) strong hydrophobic contacts that rigidify the CENP-A-H4 interface. Residues involved in the CENP-A-CENP-A rotation are required for efficient incorporation into centromeric chromatin, indicating specificity for an unconventional nucleosome shape. DNA topological analysis indicates that CENP-A-containing nucleosomes are octameric with conventional left-handed DNA wrapping, in contrast to other recent proposals. Our results indicate that CENP-A marks centromere location by restructuring the nucleosome from within its folded histone core.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0034080</accession>
					<name>CENP-A containing nucleosome assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3-like centromeric protein A</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MLLIRKLPFSRLAREICVKFTRGVDFNWQAQALLALQEAAEAFLVHLFEDAYLLTLHAGRVTLFPKDVQLARRIRGLEEGLG</sequence>
				<length>82</length>
				<uniprot>
					<id>P49450</id>
					<start>59</start>
					<end>140</end>
					<coverage>58.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P49450</id>
					<start>60</start>
					<end>140</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>64</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>123</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>133</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>84</length>
				<uniprot>
					<id>P62805</id>
					<start>20</start>
					<end>103</end>
					<coverage>81.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>21</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>47</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows a dimer adopting the histone fold with Centromere protein A (CENP-A) substituting histone H3 in a classical H3/H4 dimer (PMID:20739937). While CENP-A containing dimers show slight structural differences compared to H3/H4 dimers, the overall dimer and nucleosomal structure (and based on these presumably the folding kinetics) are essentially the same (PMID:22127263). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3an2</pdb_id>
			<pdb_id>3nqu</pdb_id>
			<pdb_id>3r45</pdb_id>
			<pdb_id>3wtp</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210006</accession>
		<general>
			<name>CENP-A/histone H4 dimer (Kluyveromyces lactis)</name>
			<pdb_id>2yfw</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Kluyveromyces lactis</source_organism>
			<publication>
				<pmid>21606327</pmid>
				<authors>Cho US, Harrison SC</authors>
				<title>Recognition of the centromere-specific histone Cse4 by the chaperone Scm3.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2011</year>
				<issue>23</issue>
				<volume>108</volume>
				<pages>9367-71</pages>
				<abstract>A specialized nucleosome is a component of all eukaryotic kinetochores. The core of this nucleosome contains a centromere-specific histone, CENP-A (the Cse4 gene product in budding yeast), instead of the usual H3. Assembly of a centromeric nucleosome depends on a specific chaperone, called Scm3 in yeast and HJURP in higher eukaryotes. We describe here the structure of a complex formed by an N-terminal fragment of Scm3 with the histone-fold domains of Cse4, and H4, all prepared as recombinant proteins derived from the budding yeast Kluyveromyces lactis. The contacts of Scm3 with Cse4 explain its selectivity for the centromere-specific histone; key residues at the interface are conserved in HJURP, indicating a common mechanism for centromeric-histone deposition. We also report the structure of a (Cse4 : H4)(2) heterotetramer; comparison with the structure of the Scm3:Cse4:H4 complex shows that tetramer formation and DNA-binding require displacement of Scm3 from the nucleosome core. The two structures together suggest that specific contacts between the chaperone and Cse4, rather than an altered overall structure of the nucleosome core, determine the selective presence of Cse4 at centromeres.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000786</accession>
					<name>nucleosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G and H were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3-like centromeric protein CSE4</name>
				<source_organism>Kluyveromyces lactis</source_organism>
				<sequence>ALAEIRKYQRSTDLLISRMPFARLVKEVTDQFTTESEPLRWQSMAIMALQEASEAYLVGLLEHTNLLALHAKRITIMRKDMQLARRIRGQFI</sequence>
				<length>92</length>
				<uniprot>
					<id>Q6CTI2</id>
					<start>93</start>
					<end>184</end>
					<coverage>50%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q6CTI2</id>
					<start>93</start>
					<end>184</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>110</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>135</region_start>
						<region_end>162</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>167</region_start>
						<region_end>168</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>170</region_start>
						<region_end>180</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>45</region_start>
						<region_end>180</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Kluyveromyces lactis</source_organism>
				<sequence>MSGRGKGGKGLGKGGAKRHRKILRDNIQGITKPAIRRLARRGGVKRISGLIYEEVRNVLKTFLESVIRDAVTYTEHAKRKTVTSLDVVYALKRQGRTLYGFGG</sequence>
				<length>103</length>
				<uniprot>
					<id>Q6CMU6</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02309</id>
					<start>18</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>19</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The structure shows a dimer adopting the histone fold with Centromere protein A (CENP-A) substituting histone H3 in a classical H3/H4 dimer (PMID:21606327). While CENP-A containing dimers show slight structural differences compared to H3/H4 dimers, the overall dimer and nucleosomal structure (and based on these presumably the folding kinetics) are essentially the same (PMID:22127263). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2yfv</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2200011</accession>
		<general>
			<name>CENP-S/CENP-X dimer (human)</name>
			<pdb_id>4ne3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>24390579</pmid>
				<authors>Zhao Q, Saro D, Sachpatzidis A, Singh TR, Schlingman D, Zheng XF, Mack A, Tsai MS, Mochrie S, Regan L, Meetei AR, Sung P, Xiong Y</authors>
				<title>The MHF complex senses branched DNA by binding a pair of crossover DNA duplexes.</title>
				<journal>Nat Commun</journal>
				<year>2014</year>
				<volume>5</volume>
				<pages>2987</pages>
				<abstract>The conserved MHF1-MHF2 (MHF) complex functions in the activation of the Fanconi anaemia pathway of the DNA damage response, in regulating homologous recombination, and in DNA replication fork maintenance. MHF facilitates the processing of multiple types of branched DNAs by the DNA translocase FANCM. Here we report the crystal structure of a human MHF-DNA complex that reveals the DNA-binding mode of MHF. The structure suggests that MHF prefers branched DNA over double-stranded DNA because it engages two duplex arms. Biochemical analyses verify that MHF preferentially engages DNA forks or various four-way junctions independent of the junction-site structure. Furthermore, genetic experiments provide evidence that the observed DNA-binding interface of MHF is important for cellular resistance to DNA damage. These results offer insights into how the MHF complex recognizes branched DNA and stimulates FANCM activity at such a structure to promote genome maintenance.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0034080</accession>
					<name>CENP-A containing nucleosome assembly</name>
				</go>
				<go>
					<accession>GO:0036297</accession>
					<name>interstrand cross-link repair</name>
				</go>
				<go>
					<accession>GO:0051382</accession>
					<name>kinetochore assembly</name>
				</go>
				<go>
					<accession>GO:0000712</accession>
					<name>resolution of meiotic recombination intermediates</name>
				</go>
				<go>
					<accession>GO:0031297</accession>
					<name>replication fork processing</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
				<go>
					<accession>GO:0031398</accession>
					<name>positive regulation of protein ubiquitination</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000777</accession>
					<name>condensed chromosome kinetochore</name>
				</go>
				<go>
					<accession>GO:0043240</accession>
					<name>Fanconi anaemia nuclear complex</name>
				</go>
				<go>
					<accession>GO:0071821</accession>
					<name>FANCM-MHF complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Centromere protein S</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SYQQRLKAAVHYTVGCLCEEVALDKAMQFSKQTIAAISELTFRQCENFAKDLEMFARHAKRTTINTEDVKLLARRSNSLLKYITDKSEEIAQA</sequence>
				<length>93</length>
				<uniprot>
					<id>Q8N2Z9</id>
					<start>14</start>
					<end>106</end>
					<coverage>67.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8N2Z9</id>
					<start>14</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15630.3</region_id>
						<region_name>CENP-S</region_name>
						<region_start>17</region_start>
						<region_end>92</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Centromere protein X</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SGFRKELVSRLLHLHFKDDKTKVSGDALQLMVELLKVFVVEAAVRGVRQAQAEDALRVDVDQLEKVLPQLLLDF</sequence>
				<length>74</length>
				<uniprot>
					<id>A8MT69</id>
					<start>8</start>
					<end>81</end>
					<coverage>91.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_A8MT69</id>
					<start>8</start>
					<end>81</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09415.7</region_id>
						<region_name>CENP-X</region_name>
						<region_start>12</region_start>
						<region_end>81</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Centromere proteins S and X (CENP-S and CENP-X), also called MHF1 and MHF2 form histone-like heterodimers (PMID:20347428). These dimers further associate with heterodimers formed by CENP-T and CENP-W and these tetrameric structures share a high degree of similarity with canonical histone multimers within the nucleosome (PMID:22304917). CENP-T-W-S-X tetramers - similarly to nucleosomes formed by histones - are able to bind and supercoil DNA (PMID:24234442). Apart from some structural differences leading to different functions (e.g. CENP-T-W-S-X tetramers show a preference for branched DNA as opposed to nucleosomes, PMID:24390579), both the overall and the underlying basic structures of nucleosomes and CENP-T-W-S-X tetramers are essentially the same with both CENP-S/CENP-X and CENP-T/W dimers forming structures nearly identical to that of histone dimers (PMID:20347428 and PMID:19070575). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4dra</pdb_id>
			<pdb_id>4drb</pdb_id>
			<pdb_id>4e44</pdb_id>
			<pdb_id>4e45</pdb_id>
			<pdb_id>4ne5</pdb_id>
			<pdb_id>4ne6</pdb_id>
			<pdb_id>4ndy</pdb_id>
			<pdb_id>4ne1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210007</accession>
		<general>
			<name>CENP-S/CENP-X dimer (Gallus gallus)</name>
			<pdb_id>3b0b</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.15</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>22304917</pmid>
				<authors>Nishino T, Takeuchi K, Gascoigne KE, Suzuki A, Hori T, Oyama T, Morikawa K, Cheeseman IM, Fukagawa T</authors>
				<title>CENP-T-W-S-X forms a unique centromeric chromatin structure with a histone-like fold.</title>
				<journal>Cell</journal>
				<year>2012</year>
				<issue>3</issue>
				<volume>148</volume>
				<pages>487-501</pages>
				<abstract>The multiprotein kinetochore complex must assemble at a specific site on each chromosome to achieve accurate chromosome segregation. Defining the nature of the DNA-protein interactions that specify the position of the kinetochore and provide a scaffold for kinetochore formation remain key goals. Here, we demonstrate that the centromeric histone-fold-containing CENP-T-W and CENP-S-X complexes coassemble to form a stable CENP-T-W-S-X heterotetramer. High-resolution structural analysis of the individual complexes and the heterotetramer reveals similarity to other histone fold-containing complexes including canonical histones within a nucleosome. The CENP-T-W-S-X heterotetramer binds to and supercoils DNA. Mutants designed to compromise heterotetramerization or the DNA-protein contacts around the heterotetramer strongly reduce the DNA binding and supercoiling activities in vitro and compromise kinetochore assembly in vivo. These data suggest that the CENP-T-W-S-X complex forms a unique nucleosome-like structure to generate contacts with DNA, extending the &amp;quot;histone code" beyond canonical nucleosome proteins.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
				<go>
					<accession>GO:0006281</accession>
					<name>DNA repair</name>
				</go>
				<go>
					<accession>GO:0051382</accession>
					<name>kinetochore assembly</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0000777</accession>
					<name>condensed chromosome kinetochore</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were removed as chains A and D represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Centromere protein S</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GSEAAGGEQRELLIQRLRAAVHYTTGCLCQDVAEDKGVLFSKQTVAAISEITFRQCENFARDLEMFARHAKRSTITSEDVKLLARRSNSLLKYITQKSDELASSNME</sequence>
				<length>107</length>
				<uniprot>
					<id>E1BSW7</id>
					<start>2</start>
					<end>106</end>
					<coverage>75.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_E1BSW7</id>
					<start>2</start>
					<end>106</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>88</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15630.3</region_id>
						<region_name>CENP-S</region_name>
						<region_start>14</region_start>
						<region_end>89</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Centromere protein X</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GYEEREGGFRKETVERLLRLHFRDGRTRVNGDALLLMAELLKVFVREAAARAARQAQAEDLEKVDIEHVEKVLPQLLLDFV</sequence>
				<length>81</length>
				<uniprot>
					<id>P0DJH7</id>
					<start>2</start>
					<end>80</end>
					<coverage>98.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0DJH7</id>
					<start>2</start>
					<end>80</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>27</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>66</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09415.7</region_id>
						<region_name>CENP-X</region_name>
						<region_start>10</region_start>
						<region_end>79</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Centromere proteins S and X (CENP-S and CENP-X), also called MHF1 and MHF2 form histone-like heterodimers (PMID:20347428). These dimers further associate with heterodimers formed by CENP-T and CENP-W and these tetrameric structures share a high degree of similarity with canonical histone multimers within the nucleosome (PMID:22304917). CENP-T-W-S-X tetramers - similarly to nucleosomes formed by histones - are able to bind and supercoil DNA (PMID:24234442). Apart from some structural differences leading to different functions (e.g. CENP-T-W-S-X tetramers show a preference for branched DNA as opposed to nucleosomes, PMID:24390579), both the overall and the underlying basic structures of nucleosomes and CENP-T-W-S-X tetramers are essentially the same with both CENP-S/CENP-X and CENP-T/W dimers forming structures nearly identical to that of histone dimers (PMID:20347428 and PMID:19070575). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3vh5</pdb_id>
			<pdb_id>3vh6</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210008</accession>
		<general>
			<name>MHF complex (Saccharomyces cerevisiae)</name>
			<pdb_id>3v9r</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.40</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>22325783</pmid>
				<authors>Yang H, Zhang T, Tao Y, Wu L, Li HT, Zhou JQ, Zhong C, Ding J</authors>
				<title>Saccharomyces cerevisiae MHF complex structurally resembles the histones (H3-H4)₂ heterotetramer and functions as a heterotetramer.</title>
				<journal>Structure</journal>
				<year>2012</year>
				<issue>2</issue>
				<volume>20</volume>
				<pages>364-70</pages>
				<abstract>Fanconi anemia (FA) is a chromosomal instability disorder associated with deficiencies in the Fanconi anemia complementation group (FANC) network. A complex consisting of FANCM-associated histone-fold proteins 1 and 2 (MHF1 and MHF2) has been shown to act cooperatively with FANCM in DNA damage repair in the FA pathway. Here we report the structure of Saccharomyces cerevisiae MHF complex in which MHF1 and MHF2 assume a typical histone fold, and the complex has a heterotetrameric architecture similar to that of the histones (H3-H4)₂ heterotetramer. Loop L2 of MHF1 is probably involved in DNA binding, and loop L3 and helices α2 and α3 of one MHF1 subunit interact with those of the other to form two heterotetramer interfaces. Further genetic data demonstrate that the heterotetramer assembly is essential for the function of the complex in DNA repair. These results provide, to the best of our knowledge, new mechanistic insights into the function of the MHF complex.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006281</accession>
					<name>DNA repair</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0071821</accession>
					<name>FANCM-MHF complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein YOL086W-A</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MNDDEDRAQLKARLWIRVEERLQQVLSSEDIKYTPRFINSLLELAYLQLGEMGSDLQAFARHAGRGVVNKSDLMLYLRKQPDLQERVTQE</sequence>
				<length>90</length>
				<uniprot>
					<id>Q3E835</id>
					<start>1</start>
					<end>90</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q3E835</id>
					<start>1</start>
					<end>90</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>35</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>71</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>83</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15630.3</region_id>
						<region_name>CENP-S</region_name>
						<region_start>8</region_start>
						<region_end>83</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Uncharacterized protein YDL160C-A</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MLSKEALIKILSQNEGGNDMKIADEVVPMIQKYLDIFIDEAVLRSLQSHKDINGERGDKSPLELSHQDLERIVGLLLMDMLEHHHHHH</sequence>
				<length>88</length>
				<uniprot>
					<id>Q3E829</id>
					<start>1</start>
					<end>80</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q3E829</id>
					<start>1</start>
					<end>80</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>23</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>64</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09415.7</region_id>
						<region_name>CENP-X</region_name>
						<region_start>4</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Centromere proteins S and X (CENP-S and CENP-X), also called MHF1 and MHF2 form histone-like heterodimers (MHF complex, PMID:20347428). These dimers further associate with heterodimers formed by CENP-T and CENP-W and these tetrameric structures share a high degree of similarity with canonical histone multimers within the nucleosome (PMID:22304917). CENP-T-W-S-X tetramers - similarly to nucleosomes formed by histones - are able to bind and supercoil DNA (PMID:24234442). Apart from some structural differences leading to different functions (e.g. CENP-T-W-S-X tetramers show a preference for branched DNA as opposed to nucleosomes, PMID:24390579), both the overall and the underlying basic structures of nucleosomes and CENP-T-W-S-X tetramers are essentially the same with both CENP-S/CENP-X and CENP-T/W dimers forming structures nearly identical to that of histone dimers (PMID:20347428 and PMID:19070575). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2210009</accession>
		<general>
			<name>CENP-T/CENP-W dimer (Gallus gallus)</name>
			<pdb_id>3b0c</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>22304917</pmid>
				<authors>Nishino T, Takeuchi K, Gascoigne KE, Suzuki A, Hori T, Oyama T, Morikawa K, Cheeseman IM, Fukagawa T</authors>
				<title>CENP-T-W-S-X forms a unique centromeric chromatin structure with a histone-like fold.</title>
				<journal>Cell</journal>
				<year>2012</year>
				<issue>3</issue>
				<volume>148</volume>
				<pages>487-501</pages>
				<abstract>The multiprotein kinetochore complex must assemble at a specific site on each chromosome to achieve accurate chromosome segregation. Defining the nature of the DNA-protein interactions that specify the position of the kinetochore and provide a scaffold for kinetochore formation remain key goals. Here, we demonstrate that the centromeric histone-fold-containing CENP-T-W and CENP-S-X complexes coassemble to form a stable CENP-T-W-S-X heterotetramer. High-resolution structural analysis of the individual complexes and the heterotetramer reveals similarity to other histone fold-containing complexes including canonical histones within a nucleosome. The CENP-T-W-S-X heterotetramer binds to and supercoils DNA. Mutants designed to compromise heterotetramerization or the DNA-protein contacts around the heterotetramer strongly reduce the DNA binding and supercoiling activities in vitro and compromise kinetochore assembly in vivo. These data suggest that the CENP-T-W-S-X complex forms a unique nucleosome-like structure to generate contacts with DNA, extending the &amp;quot;histone code" beyond canonical nucleosome proteins.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007059</accession>
					<name>chromosome segregation</name>
				</go>
				<go>
					<accession>GO:0051382</accession>
					<name>kinetochore assembly</name>
				</go>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0000777</accession>
					<name>condensed chromosome kinetochore</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>T</id>
				<name>Centromere protein T</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GSTREPEIASSLIKQIFSHYVKTPVTRDAYKIVEKCSERYFKQISSDLEAYSQHAGRKTVEMADVELLMRRQGLVTDKMPLHVLVERHLPLEYRKLLIPIAVSGNKVIPCK</sequence>
				<length>111</length>
				<uniprot>
					<id>F1NPG5</id>
					<start>529</start>
					<end>639</end>
					<coverage>17.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_F1NPG5</id>
					<start>531</start>
					<end>639</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>539</region_start>
						<region_end>549</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>553</region_start>
						<region_end>553</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>555</region_start>
						<region_end>582</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>587</region_start>
						<region_end>588</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>590</region_start>
						<region_end>599</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>604</region_start>
						<region_end>604</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>607</region_start>
						<region_end>607</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>609</region_start>
						<region_end>616</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>619</region_start>
						<region_end>625</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>529</region_start>
						<region_end>631</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>W</id>
				<name>Centromere protein W</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>GRRTVPRGTLRKIIKKHKPHLRLAANTDLLVHLSFLLFLHRLAEEARTNAFENKSKIIKPEHTIAAAKVILKKSRG</sequence>
				<length>76</length>
				<uniprot>
					<id>P0DJH6</id>
					<start>2</start>
					<end>76</end>
					<coverage>98.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0DJH6</id>
					<start>2</start>
					<end>76</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>7</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15510.3</region_id>
						<region_name>CENP-W</region_name>
						<region_start>1</region_start>
						<region_end>76</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Centromere proteins T and W (CENP-T and CENP-W) form histone-like heterodimers (PMID:19070575). These dimers further associate with heterodimers formed by CENP-S and CENP-X and these tetrameric structures share a high degree of similarity with canonical histone multimers within the nucleosome (PMID:22304917). CENP-T-W-S-X tetramers - similarly to nucleosomes formed by histones - are able to bind and supercoil DNA (PMID:24234442). Apart from some structural differences leading to different functions (e.g. CENP-T-W-S-X tetramers show a preference for branched DNA as opposed to nucleosomes, PMID:24390579), both the overall and the underlying basic structures of nucleosomes and CENP-T-W-S-X tetramers are essentially the same with both CENP-S/CENP-X and CENP-T/W dimers forming structures nearly identical to that of histone dimers (PMID:20347428 and PMID:19070575). Histone dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for various histone dimers (PMID:15588829, PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics; however, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3b0d</pdb_id>
			<pdb_id>3vh5</pdb_id>
			<pdb_id>3vh6</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4110008</accession>
		<general>
			<name>Oligomerization domain of Drosophila melanogaster p53</name>
			<pdb_id>2rp4</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Drosophila melanogaster</source_organism>
			<publication>
				<pmid>17581633</pmid>
				<authors>Ou HD, Löhr F, Vogel V, Mäntele W, Dötsch V</authors>
				<title>Structural evolution of C-terminal domains in the p53 family.</title>
				<journal>EMBO J.</journal>
				<year>2007</year>
				<issue>14</issue>
				<volume>26</volume>
				<pages>3463-73</pages>
				<abstract>The tetrameric state of p53, p63, and p73 has been considered one of the hallmarks of this protein family. While the DNA binding domain (DBD) is highly conserved among vertebrates and invertebrates, sequences C-terminal to the DBD are highly divergent. In particular, the oligomerization domain (OD) of the p53 forms of the model organisms Caenorhabditis elegans and Drosophila cannot be identified by sequence analysis. Here, we present the solution structures of their ODs and show that they both differ significantly from each other as well as from human p53. CEP-1 contains a composite domain of an OD and a sterile alpha motif (SAM) domain, and forms dimers instead of tetramers. The Dmp53 structure is characterized by an additional N-terminal beta-strand and a C-terminal helix. Truncation analysis in both domains reveals that the additional structural elements are necessary to stabilize the structure of the OD, suggesting a new function for the SAM domain. Furthermore, these structures show a potential path of evolution from an ancestral dimeric form over a tetrameric form, with additional stabilization elements, to the tetramerization domain of mammalian p53.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0001097</accession>
					<name>TFIIH-class transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0031624</accession>
					<name>ubiquitin conjugating enzyme binding</name>
				</go>
				<go>
					<accession>GO:0001047</accession>
					<name>core promoter binding</name>
				</go>
				<go>
					<accession>GO:0000976</accession>
					<name>transcription regulatory region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0031625</accession>
					<name>ubiquitin protein ligase binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0060785</accession>
					<name>regulation of apoptosis involved in tissue homeostasis</name>
				</go>
				<go>
					<accession>GO:0035234</accession>
					<name>ectopic germ cell programmed cell death</name>
				</go>
				<go>
					<accession>GO:2000685</accession>
					<name>positive regulation of cellular response to X-ray</name>
				</go>
				<go>
					<accession>GO:0006282</accession>
					<name>regulation of DNA repair</name>
				</go>
				<go>
					<accession>GO:0007131</accession>
					<name>reciprocal meiotic recombination</name>
				</go>
				<go>
					<accession>GO:0006919</accession>
					<name>activation of cysteine-type endopeptidase activity involved in apoptotic process</name>
				</go>
				<go>
					<accession>GO:0046533</accession>
					<name>negative regulation of photoreceptor cell differentiation</name>
				</go>
				<go>
					<accession>GO:0042127</accession>
					<name>regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0043568</accession>
					<name>positive regulation of insulin-like growth factor receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:1990248</accession>
					<name>regulation of transcription from RNA polymerase II promoter in response to DNA damage</name>
				</go>
				<go>
					<accession>GO:0042992</accession>
					<name>negative regulation of transcription factor import into nucleus</name>
				</go>
				<go>
					<accession>GO:0071480</accession>
					<name>cellular response to gamma radiation</name>
				</go>
				<go>
					<accession>GO:0043553</accession>
					<name>negative regulation of phosphatidylinositol 3-kinase activity</name>
				</go>
				<go>
					<accession>GO:0009411</accession>
					<name>response to UV</name>
				</go>
				<go>
					<accession>GO:0040015</accession>
					<name>negative regulation of multicellular organism growth</name>
				</go>
				<go>
					<accession>GO:0030330</accession>
					<name>DNA damage response, signal transduction by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0007405</accession>
					<name>neuroblast proliferation</name>
				</go>
				<go>
					<accession>GO:0048477</accession>
					<name>oogenesis</name>
				</go>
				<go>
					<accession>GO:0014016</accession>
					<name>neuroblast differentiation</name>
				</go>
				<go>
					<accession>GO:0042771</accession>
					<name>intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0009267</accession>
					<name>cellular response to starvation</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0040010</accession>
					<name>positive regulation of growth rate</name>
				</go>
				<go>
					<accession>GO:0016239</accession>
					<name>positive regulation of macroautophagy</name>
				</go>
				<go>
					<accession>GO:0090278</accession>
					<name>negative regulation of peptide hormone secretion</name>
				</go>
				<go>
					<accession>GO:0046620</accession>
					<name>regulation of organ growth</name>
				</go>
				<go>
					<accession>GO:0045787</accession>
					<name>positive regulation of cell cycle</name>
				</go>
				<go>
					<accession>GO:0040018</accession>
					<name>positive regulation of multicellular organism growth</name>
				</go>
				<go>
					<accession>GO:0008340</accession>
					<name>determination of adult lifespan</name>
				</go>
				<go>
					<accession>GO:0042246</accession>
					<name>tissue regeneration</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>GH11591p</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>GPLGSDDSAAEWNVSRTPDGDYRLAITCPNKEWLLQSIEGMIKEAAAEVLRNPNQENLRRHANKLLSLKKRAYELP</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9N6D8</id>
					<start>310</start>
					<end>385</end>
					<coverage>19.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9N6D8</id>
					<start>315</start>
					<end>385</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>324</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>330</region_start>
						<region_end>337</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>383</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11619.5</region_id>
						<region_name>P53_C</region_name>
						<region_start>319</region_start>
						<region_end>385</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>GH11591p</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>GPLGSDDSAAEWNVSRTPDGDYRLAITCPNKEWLLQSIEGMIKEAAAEVLRNPNQENLRRHANKLLSLKKRAYELP</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9N6D8</id>
					<start>310</start>
					<end>385</end>
					<coverage>19.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9N6D8</id>
					<start>315</start>
					<end>385</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>325</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>331</region_start>
						<region_end>337</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>383</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11619.5</region_id>
						<region_name>P53_C</region_name>
						<region_start>319</region_start>
						<region_end>385</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>GH11591p</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>GPLGSDDSAAEWNVSRTPDGDYRLAITCPNKEWLLQSIEGMIKEAAAEVLRNPNQENLRRHANKLLSLKKRAYELP</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9N6D8</id>
					<start>310</start>
					<end>385</end>
					<coverage>19.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9N6D8</id>
					<start>315</start>
					<end>385</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>324</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>331</region_start>
						<region_end>337</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>383</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11619.5</region_id>
						<region_name>P53_C</region_name>
						<region_start>319</region_start>
						<region_end>385</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>GH11591p</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>GPLGSDDSAAEWNVSRTPDGDYRLAITCPNKEWLLQSIEGMIKEAAAEVLRNPNQENLRRHANKLLSLKKRAYELP</sequence>
				<length>76</length>
				<uniprot>
					<id>Q9N6D8</id>
					<start>310</start>
					<end>385</end>
					<coverage>19.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9N6D8</id>
					<start>315</start>
					<end>385</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>326</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>330</region_start>
						<region_end>337</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>365</region_start>
						<region_end>383</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11619.5</region_id>
						<region_name>P53_C</region_name>
						<region_start>319</region_start>
						<region_end>385</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>While the C-terminal region of p53 from humans and D. melanogaster do not share a high degree of sequential identity, they are structurally and functionally similar (PMID:10778859). The oligomerization domain (OD) of D. melanogaster p53 (Dmp53) includes the structural elements of that of human p53 exhibiting a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). Human p53 tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028). The main difference between the two p53 variants are the additional structural elements in Dmp53 OD which comprise an additional helix and a beta-strand. The deletion of these structural elements destabilize the oligomer hinting at a suboptimal binding of the core structural elements compared to the human counterpart (PMID:17581633).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2210010</accession>
		<general>
			<name>Bulb-type mannose-binding lectin (Allium sativum)</name>
			<pdb_id>1kj1</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Allium sativum</source_organism>
			<publication>
				<pmid>11856826</pmid>
				<authors>Ramachandraiah G, Chandra NR, Surolia A, Vijayan M</authors>
				<title>Re-refinement using reprocessed data to improve the quality of the structure: a case study involving garlic lectin.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2002</year>
				<issue>Pt 3</issue>
				<volume>58</volume>
				<pages>414-20</pages>
				<abstract>The structure of dimeric garlic lectin was previously determined to an effective resolution of 2.8A using X-ray intensity data processed by the XDS package and refined using X-PLOR [Chandra et al. (1999), J. Mol. Biol. 285, 1157--1168]. Repeated attempts to grow better crystals with a view to improving the definition of the structure did not succeed. The available raw data were then reprocessed using DENZO. The structure was re-refined with both X-PLOR and CNS separately using the reprocessed data, which extended to a resolution of 2.2A. These two sets of refinements and the two sets using the XDS-processed data afforded an opportunity to compare the performance of different data-processing and refinement packages when dealing with data from weakly diffracting crystals. The best results were obtained when CNS was employed for refinement using data processed by DENZO. The quality and the resolution of the map and the definition of the structure improved substantially. In particular, the amino-acid residues at the variable locations in the sequence, and hence the isolectins, could be identified with a high degree of confidence. It could be established that the crystal asymmetric unit contains two identical heterodimers. The new refined structure also provided a better definition of other finer structural details.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0030246</accession>
					<name>carbohydrate binding</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>Chains P and Q were removed as chains A and D represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Heterodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>I lectin (Precursor)</name>
				<source_organism>Allium sativum</source_organism>
				<sequence>RNLLTNGEGLYAGQSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDIWSTGTYK</sequence>
				<length>109</length>
				<uniprot>
					<id>Q38789</id>
					<start>177</start>
					<end>285</end>
					<coverage>36%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q38789</id>
					<start>177</start>
					<end>285</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>179</region_start>
						<region_end>181</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>185</region_start>
						<region_end>187</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>191</region_start>
						<region_end>194</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>197</region_start>
						<region_end>201</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>207</region_start>
						<region_end>211</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>214</region_start>
						<region_end>218</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>230</region_start>
						<region_end>233</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>239</region_start>
						<region_end>242</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>248</region_start>
						<region_end>251</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>262</region_start>
						<region_end>265</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>271</region_start>
						<region_end>274</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>277</region_start>
						<region_end>280</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>185</region_start>
						<region_end>258</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>II lectin (Precursor)</name>
				<source_organism>Allium sativum</source_organism>
				<sequence>RNILMNDEGLYAGQSLDVEPYHLIMQEDCNLVLYDHSTAVWTTNTDIPGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDIWSTNTYK</sequence>
				<length>109</length>
				<uniprot>
					<id>Q38783</id>
					<start>29</start>
					<end>137</end>
					<coverage>70.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q38784</id>
					<start>18</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>49</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>59</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>66</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>103</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>113</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>29</region_start>
						<region_end>111</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The association between the two subunits of mannose-binding lectin from garlic bulbs was shown to be highly reversible and can be defined as a two-state process in which the folded dimer is converted directly into the unfolded monomers (PMID:11401577).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1bwu</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110013</accession>
		<general>
			<name>Bulb-type lectin (Allium sativum)</name>
			<pdb_id>4h3o</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.17</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Allium sativum</source_organism>
			<publication>
				<authors>Kumar, S., Yamini, S., Kumar, J., Kaur, P., Singh, T.P., Dey, S.</authors>
				<title>Crystal structure of a new form of lectin from Allium sativum at 2.17 A resolution</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Homodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Lectin</name>
				<source_organism>Allium sativum</source_organism>
				<sequence>RNILDNNEGLYAGQSLDVEPYHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGSDIWST</sequence>
				<length>105</length>
				<uniprot>
					<id>K4DIE9</id>
					<start>1</start>
					<end>105</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_K4DIE9</id>
					<start>1</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>8</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>72</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>99</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>9</region_start>
						<region_end>83</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Lectin</name>
				<source_organism>Allium sativum</source_organism>
				<sequence>RNILDNNEGLYAGQSLDVEPYHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGSDIWST</sequence>
				<length>105</length>
				<uniprot>
					<id>K4DIE9</id>
					<start>1</start>
					<end>105</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_K4DIE9</id>
					<start>1</start>
					<end>105</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>8</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>21</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>72</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>86</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>95</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>101</region_start>
						<region_end>104</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>9</region_start>
						<region_end>83</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A very closely homologous lectin of the same type from the same organism sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110014</accession>
		<general>
			<name>Mannose-binding lectin (Narcissus pseudonarcissus)</name>
			<pdb_id>3dzw</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Galanthus nivalis</source_organism>
			<publication>
				<authors>Rizkallah, P.J., Ozbey, S., Sauerborn, M.K.</authors>
				<title>Structure of Narcissus pseudonarcissus lectin complex with Mannobiose at 1.7 A resolution, form II</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005537</accession>
					<name>mannose binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain C was generated from chain A using the biomatrix described in the original PDB file. Chain B was removed as chains A and C represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Homodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Mannose-specific lectin</name>
				<source_organism>Galanthus nivalis</source_organism>
				<sequence>DNILYSGETLSPGEFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTNIH</sequence>
				<length>109</length>
				<uniprot>
					<id>P30617</id>
					<start>24</start>
					<end>130</end>
					<coverage>68.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P30617</id>
					<start>24</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>44</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>24</region_start>
						<region_end>128</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Mannose-specific lectin</name>
				<source_organism>Galanthus nivalis</source_organism>
				<sequence>DNILYSGETLSPGEFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTNIH</sequence>
				<length>109</length>
				<uniprot>
					<id>P30617</id>
					<start>24</start>
					<end>130</end>
					<coverage>68.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P30617</id>
					<start>24</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>44</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>24</region_start>
						<region_end>128</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous lectin of the same type sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1jpc</pdb_id>
			<pdb_id>1msa</pdb_id>
			<pdb_id>1niv</pdb_id>
			<pdb_id>1npl</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110015</accession>
		<general>
			<name>Mannose-binding lectin (Polygonatum cyrtonema)</name>
			<pdb_id>3a0e</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Polygonatum cyrtonema</source_organism>
			<publication>
				<pmid>20546901</pmid>
				<authors>Ding J, Bao J, Zhu D, Zhang Y, Wang DC</authors>
				<title>Crystal structures of a novel anti-HIV mannose-binding lectin from Polygonatum cyrtonema Hua with unique ligand-binding property and super-structure.</title>
				<journal>J. Struct. Biol.</journal>
				<year>2010</year>
				<issue>3</issue>
				<volume>171</volume>
				<pages>309-17</pages>
				<abstract>Polygonatum cyrtonema lectin (PCL) is a novel anti-HIV mannose-binding lectin from Galanthus nivalis agglutinin (GNA)-related lectin family. Crystal structures of ligand-free PCL and its complexes with monomannoside and alpha1-3 dimannoside have been determined. The ligand-free PCL is dimeric, with both subunits adopt the beta-prism II fold. PCL subunit binds mannose using a potential bivalent mode instead of the usual trivalent mode, in which carbohydrate-binding site (CBS) I and CBS III adopt the conserved mannose-binding motif of QXDXNXVXY (X is one of any amino acid residues) as observed in other structurally characterized GNA-related lectins, while CBS II adopts a modified motif with residues Gln58 and Asp60, which are critical for mannose-binding, substituted by His58 and Asn60, respectively. As a result, CBS II is unfit for mannose-binding. In the mannoside complexes, ligand-bindings only occur at CBS I which provides the specificity for alpha1-3 dimannoside. CBS II and CBS III are cooperatively occupied by a well-ordered sulfate ion, through which the individual dimers are cross-linked to form a unique super-structure of 3(2) helical lattice. Surveying the sequences of GNA-related lectins revealed that the modified binding motif of CBS II is widely distributed in the Liliaceae family as an intrinsic structural element. There is evidence that other GNA-related lectins will also adopt the similar super-structure as PCL. Thus PCL structure, unique in ligand-binding mode, may represent a novel type of structure of GNA-related lectins. Comparative analyses indicated that the dimer-based super-structure may play a primary role in the anti-HIV property of PCL.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0030246</accession>
					<name>carbohydrate binding</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Homodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Mannose/sialic acid-binding lectin</name>
				<source_organism>Polygonatum cyrtonema</source_organism>
				<sequence>VNSLSSPNSLFTGHSLEVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGSGPA</sequence>
				<length>110</length>
				<uniprot>
					<id>Q8L568</id>
					<start>29</start>
					<end>138</end>
					<coverage>68.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8L568</id>
					<start>29</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>54</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>67</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>103</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>114</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>36</region_start>
						<region_end>134</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Mannose/sialic acid-binding lectin</name>
				<source_organism>Polygonatum cyrtonema</source_organism>
				<sequence>VNSLSSPNSLFTGHSLEVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGSGPA</sequence>
				<length>110</length>
				<uniprot>
					<id>Q8L568</id>
					<start>29</start>
					<end>138</end>
					<coverage>68.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8L568</id>
					<start>29</start>
					<end>138</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>33</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>50</region_start>
						<region_end>54</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>67</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>82</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>91</region_start>
						<region_end>94</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>103</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>114</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>123</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>129</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>36</region_start>
						<region_end>134</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous lectin of the same type sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3a0c</pdb_id>
			<pdb_id>3a0d</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210011</accession>
		<general>
			<name>Tuber agglutinin (Colocasia esculenta)</name>
			<pdb_id>5d5g</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.74</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Colocasia esculenta</source_organism>
			<publication>
				<authors>Biswas, H., Chattopadhyaya, R.</authors>
				<title>Crystal Structure of Colocasia esculenta tuber agglutinin : quarternary interactions and conformational stability</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Heterodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tuber agglutinin</name>
				<source_organism>Colocasia esculenta</source_organism>
				<sequence>LGTNYLLSGQTLDREGHLKNGDFDLVMQDDCNLVLYNGNWQSNTANKGRDCKLTLTDYGELVIKNGDGSTVWRSRAQSVKGNYAAVVHPDGRLVVFGPSVFKIDPWVPG</sequence>
				<length>109</length>
				<uniprot>
					<id>R9RL27</id>
					<start>24</start>
					<end>132</end>
					<coverage>41.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R9RL27</id>
					<start>24</start>
					<end>132</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>56</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>119</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>122</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>26</region_start>
						<region_end>116</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tuber agglutinin</name>
				<source_organism>Colocasia esculenta</source_organism>
				<sequence>NIPFTNNLLFSGQVLYGDGRLTAKSHQLVMQGDCNLVLYGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSSSSSKHGDYVLILRDDGFAVIYGPAIWETSPQ</sequence>
				<length>111</length>
				<uniprot>
					<id>R9RL27</id>
					<start>140</start>
					<end>250</end>
					<coverage>42%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_R9RL27</id>
					<start>140</start>
					<end>250</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>147</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>153</region_start>
						<region_end>155</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>158</region_start>
						<region_end>162</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>165</region_start>
						<region_end>169</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>175</region_start>
						<region_end>178</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>184</region_start>
						<region_end>185</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>196</region_start>
						<region_end>199</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>205</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>214</region_start>
						<region_end>217</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>228</region_start>
						<region_end>231</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>237</region_start>
						<region_end>240</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>243</region_start>
						<region_end>246</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>145</region_start>
						<region_end>248</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous lectin of the same type sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>5d9z</pdb_id>
			<pdb_id>3r0e</pdb_id>
			<pdb_id>5t1x</pdb_id>
			<pdb_id>5t20</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210012</accession>
		<general>
			<name>Neoculin heterodimer (Molineria latifolia)</name>
			<pdb_id>2d04</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.76</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Molineria latifolia</source_organism>
			<publication>
				<pmid>16616933</pmid>
				<authors>Shimizu-Ibuka A, Morita Y, Terada T, Asakura T, Nakajima K, Iwata S, Misaka T, Sorimachi H, Arai S, Abe K</authors>
				<title>Crystal structure of neoculin: insights into its sweetness and taste-modifying activity.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2006</year>
				<issue>1</issue>
				<volume>359</volume>
				<pages>148-58</pages>
				<abstract>Although the majority of sweet compounds are of low molecular mass, several proteins are known to elicit sweet taste responses in humans. The fruit of Curculigo latifolia contains a heterodimeric protein, neoculin, which has both sweetness and a taste-modifying activity that converts sourness to sweetness. Here, we report the crystal structure of neoculin at 2.76A resolution. This is the first well-defined tertiary structure of a taste-modifying protein of this kind. The overall structure is quite similar to those of monocot mannose-binding lectins. However, crucial topological differences are observed in the C-terminal regions of both subunits. In both subunits of neoculin, the C-terminal tails turn up to form loops fixed by inter-subunit disulfide bonds that are not observed in the lectins. Indeed, the corresponding regions of the lectins stretch straight over the surface of another subunit. Such a C-terminal structural feature as is observed in neoculin results in a decrease in subunit-subunit interactions. Moreover, distribution of electrostatic potential on the surface of neoculin is unique and significantly different from those of the lectins, particularly in the basic subunit (NBS). We have found that there is a large cluster composed of six basic residues on the surface of NBS, and speculate that it might be involved in the elicitation of sweetness and/or taste-modifying activity of neoculin. Molecular dynamics simulation based on the crystallography results suggests that neoculin may adopt a widely &amp;quot;open" conformation at acidic pH, while unprotonated neoculin at neutral pH is in a "closed" conformation. Based on these simulations and the generation of a docking model between neoculin and the sweet-taste receptor, T1R2-T1R3, we propose the hypothesis that neoculin is in dynamic equilibrium between open and closed states, and that the addition of an acid shifts the equilibrium to the open state, allowing ligand-receptor interaction.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0030246</accession>
					<name>carbohydrate binding</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G and H were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Heterodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Curculin-2</name>
				<source_organism>Molineria latifolia</source_organism>
				<sequence>DSVLLSGQTLYAGHSLTSGSYTLTIQNNCNLVKYQHGRQIWASDTDGQGSQCRLTLRSDGNLIIYDDNNMVVWGSDCWGNNGTYALVLQQDGLFVIYGPVLWPLGLNGCRSLN</sequence>
				<length>113</length>
				<uniprot>
					<id>Q6F495</id>
					<start>23</start>
					<end>135</end>
					<coverage>71.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q6F495</id>
					<start>23</start>
					<end>135</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>110</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>116</region_start>
						<region_end>119</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>122</region_start>
						<region_end>122</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>125</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>130</region_start>
						<region_end>130</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>23</region_start>
						<region_end>103</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Curculin-1</name>
				<source_organism>Molineria latifolia</source_organism>
				<sequence>DNVLLSGQTLHADHSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSLGPNGCRRVNG</sequence>
				<length>114</length>
				<uniprot>
					<id>P19667</id>
					<start>23</start>
					<end>136</end>
					<coverage>72.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P19667</id>
					<start>23</start>
					<end>136</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>93</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>110</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>116</region_start>
						<region_end>119</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>122</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>131</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>23</region_start>
						<region_end>101</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous protein (bulb-type lectin) sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2dpf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210013</accession>
		<general>
			<name>Mannose-binding lectin (Crocus vernus)</name>
			<pdb_id>3mez</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.94</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Crocus vernus</source_organism>
			<publication>
				<authors>Akrem, A.</authors>
				<title>X-ray structural analysis of a mannose specific lectin from dutch crocus (crocus vernus)</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005537</accession>
					<name>mannose binding</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Heterodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Mannose-specific lectin 3</name>
				<source_organism>Crocus vernus</source_organism>
				<sequence>DNNVLLTGDVIHTDNQLSYESAAFVMQGDCNLVLYNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGPAIWSTPAAA</sequence>
				<length>111</length>
				<uniprot>
					<id>P86626</id>
					<start>1</start>
					<end>111</end>
					<coverage>49.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P86626</id>
					<start>1</start>
					<end>111</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>22</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>32</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>62</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>97</region_start>
						<region_end>100</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>103</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>2</region_start>
						<region_end>108</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Mannose-specific lectin 3</name>
				<source_organism>Crocus vernus</source_organism>
				<sequence>NIPRVRNVLFSSQVMYDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPAVWSTAA</sequence>
				<length>113</length>
				<uniprot>
					<id>P86626</id>
					<start>112</start>
					<end>224</end>
					<coverage>50.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P86626</id>
					<start>112</start>
					<end>224</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>119</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>125</region_start>
						<region_end>127</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>131</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>147</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>156</region_start>
						<region_end>160</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>171</region_start>
						<region_end>174</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>180</region_start>
						<region_end>183</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>189</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>203</region_start>
						<region_end>206</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>212</region_start>
						<region_end>215</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>218</region_start>
						<region_end>221</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>117</region_start>
						<region_end>223</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous protein (bulb-type lectin) sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100009</accession>
		<general>
			<name>Basic HLH/leucine zipper domain of Max</name>
			<pdb_id>1r05</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>15342239</pmid>
				<authors>Sauvé S, Tremblay L, Lavigne P</authors>
				<title>The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2004</year>
				<issue>3</issue>
				<volume>342</volume>
				<pages>813-32</pages>
				<abstract>Basic region-helix1-loop-helix2-leucine zipper (b/H(1)LH(2)/LZ) transcription factors bind specific DNA sequence in their target gene promoters as dimers. Max, a b/H(1)LH(2)/LZ transcription factor, is the obligate heterodimeric partner of the related b/H(1)LH(2)/LZ proteins of the Myc and Mad families. These heterodimers specifically bind E-box DNA sequence (CACGTG) to activate (e.g. c-Myc/Max) and repress (e.g. Mad1/Max) transcription. Max can also homodimerize and bind E-box sequences in c-Myc target gene promoters. While the X-ray structure of the Max b/H(1)LH(2)/LZ/DNA complex and that of others have been reported, the precise sequence of events leading to the reversible and specific binding of these important transcription factors is still largely unknown. In order to provide insights into the DNA binding mechanism, we have solved the NMR solution structure of a covalently homodimerized version of a Max b/H(1)LH(2)/LZ protein with two stabilizing mutations in the LZ, and characterized its backbone dynamics from (15)N spin-relaxation measurements in the absence of DNA. Apart from minor differences in the pitch of the LZ, possibly resulting from the mutations in the construct, we observe that the packing of the helices in the H(1)LH(2) domain is almost identical to that of the two crystal structures, indicating that no important conformational change in these helices occurs upon DNA binding. Conversely to the crystal structures of the DNA complexes, the first 14 residues of the basic region are found to be mostly unfolded while the loop is observed to be flexible. This indicates that these domains undergo conformational changes upon DNA binding. On the other hand, we find the last four residues of the basic region form a persistent helical turn contiguous to H(1). In addition, we provide evidence of the existence of internal motions in the backbone of H(1) that are of larger amplitude and longer time-scale (nanoseconds) than the ones in the H(2) and LZ domain. Most interestingly, we note that conformers in the ensemble of calculated structures have highly conserved basic residues (located in the persistent helical turn of the basic region and in the loop) known to be important for specific binding in a conformation that matches that of the DNA-bound state. These partially prefolded conformers can directly fit into the major groove of DNA and as such are proposed to lie on the pathway leading to the reversible and specific DNA binding. In these conformers, the conserved basic side-chains form a cluster that elevates the local electrostatic potential and could provide the necessary driving force for the generation of the internal motions localized in the H(1) and therefore link structural determinants with the DNA binding function. Overall, our results suggests that the Max homodimeric b/H(1)LH(2)/LZ can rapidly and preferentially bind DNA sequence through transient and partially prefolded states and subsequently, adopt the fully helical bound state in a DNA-assisted mechanism or induced-fit.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003713</accession>
					<name>transcription coactivator activity</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0032403</accession>
					<name>protein complex binding</name>
				</go>
				<go>
					<accession>GO:0000983</accession>
					<name>transcription factor activity, RNA polymerase II core promoter sequence-specific</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006357</accession>
					<name>regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0048678</accession>
					<name>response to axon injury</name>
				</go>
				<go>
					<accession>GO:0006461</accession>
					<name>protein complex assembly</name>
				</go>
				<go>
					<accession>GO:0009267</accession>
					<name>cellular response to starvation</name>
				</go>
				<go>
					<accession>GO:0060041</accession>
					<name>retina development in camera-type eye</name>
				</go>
				<go>
					<accession>GO:0032868</accession>
					<name>response to insulin</name>
				</go>
				<go>
					<accession>GO:0010629</accession>
					<name>negative regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0071375</accession>
					<name>cellular response to peptide hormone stimulus</name>
				</go>
				<go>
					<accession>GO:0051402</accession>
					<name>neuron apoptotic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030425</accession>
					<name>dendrite</name>
				</go>
				<go>
					<accession>GO:0016605</accession>
					<name>PML body</name>
				</go>
				<go>
					<accession>GO:0071339</accession>
					<name>MLL1 complex</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Basic helix-loop-helix (bHLH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein max</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MADKRAHHNALERKRRDHIKDSFHSLRDSVPSLQGEKASRAQILDKATEYIQYMRRKVHTLQQDIDDLKRQNALLEQQVRALEGSGC</sequence>
				<length>87</length>
				<uniprot>
					<id>P61244</id>
					<start>21</start>
					<end>107</end>
					<coverage>54.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P61244</id>
					<start>22</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>62</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>24</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein max</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MADKRAHHNALERKRRDHIKDSFHSLRDSVPSLQGEKASRAQILDKATEYIQYMRRKVHTLQQDIDDLKRQNALLEQQVRALEGSGC</sequence>
				<length>87</length>
				<uniprot>
					<id>P61244</id>
					<start>21</start>
					<end>107</end>
					<coverage>54.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P61244</id>
					<start>22</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>62</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>24</region_start>
						<region_end>75</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Monomeric elements of basic helix-loop-helix domains were shown to be natively unfolded with a pH-dependent premolten globule conformation, as shown by several spectroscopic techniques (NMR, fluorescence, FTIR, and circular dichroism) (PMID:20102160, PMID:8303294).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-110 region described in DisProt entry DP00084 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-110 region described in DisProt entry DP00084 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1nlw</pdb_id>
			<pdb_id>1an2</pdb_id>
			<pdb_id>1hlo</pdb_id>
			<pdb_id>5eyo</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100010</accession>
		<general>
			<name>Transcription factor HES-1 dimer</name>
			<pdb_id>2mh3</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>24403087</pmid>
				<authors>Popovic M, Wienk H, Coglievina M, Boelens R, Pongor S, Pintar A</authors>
				<title>The basic-helix-loop-helix region of the transcriptional repressor HES-1 is preorganized to bind DNA.</title>
				<journal>Proteins</journal>
				<year>2014</year>
				<abstract>HES-1, one of the main downstream effectors in Notch signaling, is a transcriptional repressor of the basic helix-loop-helix (bHLH) family. Using NMR methods, we have determined the structure and dynamics of a recombinant protein, H1H, which includes an N-terminal segment, b1, containing functionally important phosphorylation sites, the basic region b2, required for binding to DNA, and the helix-loop-helix domain (HLH). We show that a proline residue in the sequence divides the protein in two parts, a flexible and disordered N-terminal region including b1 and a structured, mainly helical region comprising b2 and the HLH domain. Binding of H1H to a dsDNA oligonucleotide was monitored through the chemical shift perturbation of backbone amide resonances, and showed that the interaction surface involves not only the b2 segment, but also several residues in the b1 and HLH regions. © Proteins 2014;. © 2014 Wiley Periodicals, Inc.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0042826</accession>
					<name>histone deacetylase binding</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
				<go>
					<accession>GO:0071820</accession>
					<name>N-box binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0051087</accession>
					<name>chaperone binding</name>
				</go>
				<go>
					<accession>GO:0001078</accession>
					<name>transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0035910</accession>
					<name>ascending aorta morphogenesis</name>
				</go>
				<go>
					<accession>GO:0021537</accession>
					<name>telencephalon development</name>
				</go>
				<go>
					<accession>GO:0045977</accession>
					<name>positive regulation of mitotic cell cycle, embryonic</name>
				</go>
				<go>
					<accession>GO:0031016</accession>
					<name>pancreas development</name>
				</go>
				<go>
					<accession>GO:0090162</accession>
					<name>establishment of epithelial cell polarity</name>
				</go>
				<go>
					<accession>GO:0007219</accession>
					<name>Notch signaling pathway</name>
				</go>
				<go>
					<accession>GO:2000978</accession>
					<name>negative regulation of forebrain neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0097084</accession>
					<name>vascular smooth muscle cell development</name>
				</go>
				<go>
					<accession>GO:0061106</accession>
					<name>negative regulation of stomach neuroendocrine cell differentiation</name>
				</go>
				<go>
					<accession>GO:0072012</accession>
					<name>glomerulus vasculature development</name>
				</go>
				<go>
					<accession>GO:0060412</accession>
					<name>ventricular septum morphogenesis</name>
				</go>
				<go>
					<accession>GO:0030901</accession>
					<name>midbrain development</name>
				</go>
				<go>
					<accession>GO:0030324</accession>
					<name>lung development</name>
				</go>
				<go>
					<accession>GO:0048711</accession>
					<name>positive regulation of astrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0021984</accession>
					<name>adenohypophysis development</name>
				</go>
				<go>
					<accession>GO:0061626</accession>
					<name>pharyngeal arch artery morphogenesis</name>
				</go>
				<go>
					<accession>GO:2000737</accession>
					<name>negative regulation of stem cell differentiation</name>
				</go>
				<go>
					<accession>GO:2000227</accession>
					<name>negative regulation of pancreatic A cell differentiation</name>
				</go>
				<go>
					<accession>GO:0021557</accession>
					<name>oculomotor nerve development</name>
				</go>
				<go>
					<accession>GO:0042102</accession>
					<name>positive regulation of T cell proliferation</name>
				</go>
				<go>
					<accession>GO:0016477</accession>
					<name>cell migration</name>
				</go>
				<go>
					<accession>GO:0021861</accession>
					<name>forebrain radial glial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0048715</accession>
					<name>negative regulation of oligodendrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0030513</accession>
					<name>positive regulation of BMP signaling pathway</name>
				</go>
				<go>
					<accession>GO:0003266</accession>
					<name>regulation of secondary heart field cardioblast proliferation</name>
				</go>
				<go>
					<accession>GO:0060253</accession>
					<name>negative regulation of glial cell proliferation</name>
				</go>
				<go>
					<accession>GO:0048538</accession>
					<name>thymus development</name>
				</go>
				<go>
					<accession>GO:0072050</accession>
					<name>S-shaped body morphogenesis</name>
				</go>
				<go>
					<accession>GO:0072049</accession>
					<name>comma-shaped body morphogenesis</name>
				</go>
				<go>
					<accession>GO:0006461</accession>
					<name>protein complex assembly</name>
				</go>
				<go>
					<accession>GO:0045608</accession>
					<name>negative regulation of auditory receptor cell differentiation</name>
				</go>
				<go>
					<accession>GO:0045598</accession>
					<name>regulation of fat cell differentiation</name>
				</go>
				<go>
					<accession>GO:0061009</accession>
					<name>common bile duct development</name>
				</go>
				<go>
					<accession>GO:0060716</accession>
					<name>labyrinthine layer blood vessel development</name>
				</go>
				<go>
					<accession>GO:0046331</accession>
					<name>lateral inhibition</name>
				</go>
				<go>
					<accession>GO:0048469</accession>
					<name>cell maturation</name>
				</go>
				<go>
					<accession>GO:0007224</accession>
					<name>smoothened signaling pathway</name>
				</go>
				<go>
					<accession>GO:0043388</accession>
					<name>positive regulation of DNA binding</name>
				</go>
				<go>
					<accession>GO:0061309</accession>
					<name>cardiac neural crest cell development involved in outflow tract morphogenesis</name>
				</go>
				<go>
					<accession>GO:0060122</accession>
					<name>inner ear receptor stereocilium organization</name>
				</go>
				<go>
					<accession>GO:0045747</accession>
					<name>positive regulation of Notch signaling pathway</name>
				</go>
				<go>
					<accession>GO:0007155</accession>
					<name>cell adhesion</name>
				</go>
				<go>
					<accession>GO:0035019</accession>
					<name>somatic stem cell population maintenance</name>
				</go>
				<go>
					<accession>GO:0048667</accession>
					<name>cell morphogenesis involved in neuron differentiation</name>
				</go>
				<go>
					<accession>GO:1903955</accession>
					<name>positive regulation of protein targeting to mitochondrion</name>
				</go>
				<go>
					<accession>GO:0042668</accession>
					<name>auditory receptor cell fate determination</name>
				</go>
				<go>
					<accession>GO:0050678</accession>
					<name>regulation of epithelial cell proliferation</name>
				</go>
				<go>
					<accession>GO:0042517</accession>
					<name>positive regulation of tyrosine phosphorylation of Stat3 protein</name>
				</go>
				<go>
					<accession>GO:0021575</accession>
					<name>hindbrain morphogenesis</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0072282</accession>
					<name>metanephric nephron tubule morphogenesis</name>
				</go>
				<go>
					<accession>GO:0003143</accession>
					<name>embryonic heart tube morphogenesis</name>
				</go>
				<go>
					<accession>GO:0001889</accession>
					<name>liver development</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0090102</accession>
					<name>cochlea development</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0021558</accession>
					<name>trochlear nerve development</name>
				</go>
				<go>
					<accession>GO:0072141</accession>
					<name>renal interstitial fibroblast development</name>
				</go>
				<go>
					<accession>GO:0097150</accession>
					<name>neuronal stem cell population maintenance</name>
				</go>
				<go>
					<accession>GO:0021555</accession>
					<name>midbrain-hindbrain boundary morphogenesis</name>
				</go>
				<go>
					<accession>GO:0060164</accession>
					<name>regulation of timing of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:2000974</accession>
					<name>negative regulation of pro-B cell differentiation</name>
				</go>
				<go>
					<accession>GO:0060675</accession>
					<name>ureteric bud morphogenesis</name>
				</go>
				<go>
					<accession>GO:0007262</accession>
					<name>STAT protein import into nucleus</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Basic helix-loop-helix (bHLH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcription factor HES-1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKPKTASEHRKSSKPIMEKRRRARINESLSQLKTLILDALKKDSSRHSKLEKADILEMTVKHLRNLQRAQ</sequence>
				<length>70</length>
				<uniprot>
					<id>Q14469</id>
					<start>26</start>
					<end>95</end>
					<coverage>25%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35428</id>
					<start>27</start>
					<end>95</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>71</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>35</region_start>
						<region_end>92</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Transcription factor HES-1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MKPKTASEHRKSSKPIMEKRRRARINESLSQLKTLILDALKKDSSRHSKLEKADILEMTVKHLRNLQRAQ</sequence>
				<length>70</length>
				<uniprot>
					<id>Q14469</id>
					<start>26</start>
					<end>95</end>
					<coverage>25%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35428</id>
					<start>27</start>
					<end>95</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>35</region_start>
						<region_end>92</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Monomeric elements of basic helix-loop-helix domains were shown to be natively unfolded with a pH-dependent premolten globule conformation, as shown by several spectroscopic techniques (NMR, fluorescence, FTIR, and circular dichroism) (PMID:20102160, PMID:8303294).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00010.23) has been experimentally characterized as disordered in DisProt entries DP00084 and DP00672, and IDEAL entry IID00121.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00010.23) has been experimentally characterized as disordered in DisProt entries DP00084 and DP00672, and IDEAL entry IID00121.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100011</accession>
		<general>
			<name>DNA-binding protein inhibitor ID-3</name>
			<pdb_id>2lfh</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<authors>Eletsky, A., Wang, D., Kohan, E., Janjua, H., Acton, T.B., Xiao, R., Everett, J.K., Montelione, G.T., Szyperski, T.</authors>
				<title>Solution NMR Structure of the Helix-loop-Helix Domain of Human ID3 Protein, Northeast Structural Genomics Consortium Target HR3111A</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0019904</accession>
					<name>protein domain specific binding</name>
				</go>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0008134</accession>
					<name>transcription factor binding</name>
				</go>
				<go>
					<accession>GO:1901707</accession>
					<name>leptomycin B binding</name>
				</go>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003714</accession>
					<name>transcription corepressor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042476</accession>
					<name>odontogenesis</name>
				</go>
				<go>
					<accession>GO:0030903</accession>
					<name>notochord development</name>
				</go>
				<go>
					<accession>GO:0006275</accession>
					<name>regulation of DNA replication</name>
				</go>
				<go>
					<accession>GO:0030855</accession>
					<name>epithelial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0009611</accession>
					<name>response to wounding</name>
				</go>
				<go>
					<accession>GO:0007417</accession>
					<name>central nervous system development</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0007507</accession>
					<name>heart development</name>
				</go>
				<go>
					<accession>GO:0043433</accession>
					<name>negative regulation of sequence-specific DNA binding transcription factor activity</name>
				</go>
				<go>
					<accession>GO:0045668</accession>
					<name>negative regulation of osteoblast differentiation</name>
				</go>
				<go>
					<accession>GO:0001656</accession>
					<name>metanephros development</name>
				</go>
				<go>
					<accession>GO:0007623</accession>
					<name>circadian rhythm</name>
				</go>
				<go>
					<accession>GO:0030182</accession>
					<name>neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0043065</accession>
					<name>positive regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0072750</accession>
					<name>cellular response to leptomycin B</name>
				</go>
				<go>
					<accession>GO:0051726</accession>
					<name>regulation of cell cycle</name>
				</go>
				<go>
					<accession>GO:0007517</accession>
					<name>muscle organ development</name>
				</go>
				<go>
					<accession>GO:0045662</accession>
					<name>negative regulation of myoblast differentiation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0015630</accession>
					<name>microtubule cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Basic helix-loop-helix (bHLH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>DNA-binding protein inhibitor ID-3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MGHHHHHHSHMGGGKGPAAEEPLSLLDDMNHCYSRLRELVPGVPRGTQLSQVEILQRVIDYILDLQVV</sequence>
				<length>68</length>
				<uniprot>
					<id>Q02535</id>
					<start>27</start>
					<end>83</end>
					<coverage>47.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P41133</id>
					<start>27</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>43</region_start>
						<region_end>54</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>66</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>40</region_start>
						<region_end>81</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>DNA-binding protein inhibitor ID-3</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MGHHHHHHSHMGGGKGPAAEEPLSLLDDMNHCYSRLRELVPGVPRGTQLSQVEILQRVIDYILDLQVV</sequence>
				<length>68</length>
				<uniprot>
					<id>Q02535</id>
					<start>27</start>
					<end>83</end>
					<coverage>47.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P41133</id>
					<start>27</start>
					<end>83</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>43</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>66</region_start>
						<region_end>81</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>40</region_start>
						<region_end>81</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Monomeric elements of basic helix-loop-helix domains were shown to be natively unfolded with a pH-dependent premolten globule conformation, as shown by several spectroscopic techniques (NMR, fluorescence, FTIR, and circular dichroism) (PMID:20102160, PMID:8303294).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00010.23) has been experimentally characterized as disordered in DisProt entries DP00084 and DP00672, and IDEAL entry IID00121.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>A close homologue sharing the same Pfam domain (PF00010.23) has been experimentally characterized as disordered in DisProt entries DP00084 and DP00672, and IDEAL entry IID00121.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120021</accession>
		<general>
			<name>CesAB chaperone homodimer</name>
			<pdb_id>2lhk</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>22152477</pmid>
				<authors>Chen L, Balabanidou V, Remeta DP, Minetti CA, Portaliou AG, Economou A, Kalodimos CG</authors>
				<title>Structural instability tuning as a regulatory mechanism in protein-protein interactions.</title>
				<journal>Mol. Cell</journal>
				<year>2011</year>
				<issue>5</issue>
				<volume>44</volume>
				<pages>734-44</pages>
				<abstract>Protein-protein interactions mediate a vast number of cellular processes. Here, we present a regulatory mechanism in protein-protein interactions mediated by finely tuned structural instability and coupled with molecular mimicry. We show that a set of type III secretion (TTS) autoinhibited homodimeric chaperones adopt a molten globule-like state that transiently exposes the substrate binding site as a means to become rapidly poised for binding to their cognate protein substrates. Packing defects at the homodimeric interface stimulate binding, whereas correction of these defects results in less labile chaperones that give rise to nonfunctional biological systems. The protein substrates use structural mimicry to offset the weak spots in the chaperones and to counteract their autoinhibitory conformation. This regulatory mechanism of protein activity is evolutionarily conserved among several TSS systems and presents a lucid example of functional advantage conferred upon a biological system by finely tuned structural instability.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>L0052</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MSIVSQTRNKELLDKKIRSEIEAIKKIIAEFDVVKESVNELSEKAKTDPQAAEKLNKLIEGYTYGEERKLYDSALSKIEKLIETLSPARSKSQSTMNQRNRNNRKIV</sequence>
				<length>107</length>
				<uniprot>
					<id>O52124</id>
					<start>1</start>
					<end>107</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O52124</id>
					<start>1</start>
					<end>107</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11439.5</region_id>
						<region_name>T3SchapCesA</region_name>
						<region_start>1</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>L0052</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MSIVSQTRNKELLDKKIRSEIEAIKKIIAEFDVVKESVNELSEKAKTDPQAAEKLNKLIEGYTYGEERKLYDSALSKIEKLIETLSPARSKSQSTMNQRNRNNRKIV</sequence>
				<length>107</length>
				<uniprot>
					<id>O52124</id>
					<start>1</start>
					<end>107</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O52124</id>
					<start>1</start>
					<end>107</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>2</region_start>
						<region_end>4</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>31</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>43</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>72</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11439.5</region_id>
						<region_name>T3SchapCesA</region_name>
						<region_start>1</region_start>
						<region_end>95</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>E. coli CesAB was shown to form a loosely packed four-helix bundle stabilized by coiled-coil interactions that are partially disrupted by packing irregularities. Thus native CesAB adopts a molted globule-like structure even in its dimeric state (PMID:22152477).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2m1n</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120022</accession>
		<general>
			<name>Quorum-sensing antiactivator TraM</name>
			<pdb_id>1rfy</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Rhizobium radiobacter</source_organism>
			<publication>
				<pmid>15186414</pmid>
				<authors>Chen G, Malenkos JW, Cha MR, Fuqua C, Chen L</authors>
				<title>Quorum-sensing antiactivator TraM forms a dimer that dissociates to inhibit TraR.</title>
				<journal>Mol. Microbiol.</journal>
				<year>2004</year>
				<issue>6</issue>
				<volume>52</volume>
				<pages>1641-51</pages>
				<abstract>The quorum-sensing transcriptional activator TraR of Agrobacterium tumefaciens, which controls the replication and conjugal transfer of the tumour-inducing (Ti) virulence plasmid, is inhibited by the TraM antiactivator. The crystal structure of TraM reveals this protein to form a homodimer in which the monomer primarily consists of two long coiled alpha-helices, and one of the helices from each monomer also bundles to form the dimeric interface. The importance of dimerization is addressed by mutational studies in which disruption of the hydrophobic dimer interface leads to aggregation of TraM. Biochemical studies confirm that TraM exists as a homodimer in solution in equilibrium with the monomeric form, and also establish that the TraM-TraR complex is a heterodimer. Thus, the TraM homodimer undergoes dissociation in forming the antiactivation complex. Combined with the structure of TraR (Zhang et al., 2002, Nature 417: 971-974; Vannini et al., 2002, EMBO J 21: 4393-4401), our structural analysis suggests overlapping interactive surfaces in homodimeric TraM with those in the TraM-TraR complex and a mechanism for TraM inhibition on TraR.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0000746</accession>
					<name>conjugation</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain C was generated from chain A using the biomatrix described in the original PDB file. Chain B was removed as chains A and C represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Transcriptional repressor TraM</name>
				<source_organism>Rhizobium radiobacter</source_organism>
				<sequence>MELEDANVTKKVELRPLIGLTRGLPPTDLETITIDAIRTHRRLVEKADELFQALPETYKTGQACGGPQHIRYIEASIEMHAQMSALNTLISILGFIPKVVVN</sequence>
				<length>102</length>
				<uniprot>
					<id>Q57471</id>
					<start>1</start>
					<end>102</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q57471</id>
					<start>1</start>
					<end>102</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09228.7</region_id>
						<region_name>Prok-TraM</region_name>
						<region_start>1</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Transcriptional repressor TraM</name>
				<source_organism>Rhizobium radiobacter</source_organism>
				<sequence>MELEDANVTKKVELRPLIGLTRGLPPTDLETITIDAIRTHRRLVEKADELFQALPETYKTGQACGGPQHIRYIEASIEMHAQMSALNTLISILGFIPKVVVN</sequence>
				<length>102</length>
				<uniprot>
					<id>Q57471</id>
					<start>1</start>
					<end>102</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q57471</id>
					<start>1</start>
					<end>102</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09228.7</region_id>
						<region_name>Prok-TraM</region_name>
						<region_start>1</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>TraM dimers were shown to fold/refold in a single step via a two-state mechanism using thermal unfolding experiments monitored by CD (PMID:16997969).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1upg</pdb_id>
			<pdb_id>1us6</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120023</accession>
		<general>
			<name>Quorum-sensing antiactivator TraM2</name>
			<pdb_id>2hjd</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Rhizobium radiobacter</source_organism>
			<publication>
				<pmid>16997969</pmid>
				<authors>Chen G, Wang C, Fuqua C, Zhang LH, Chen L</authors>
				<title>Crystal structure and mechanism of TraM2, a second quorum-sensing antiactivator of Agrobacterium tumefaciens strain A6.</title>
				<journal>J. Bacteriol.</journal>
				<year>2006</year>
				<issue>23</issue>
				<volume>188</volume>
				<pages>8244-51</pages>
				<abstract>Quorum sensing is a community behavior that bacteria utilize to coordinate a variety of population density-dependent biological functions. In Agrobacterium tumefaciens, quorum sensing regulates the replication and conjugative transfer of the tumor-inducing (Ti) plasmid from pathogenic strains to nonpathogenic derivatives. Most of the quorum-sensing regulatory proteins are encoded within the Ti plasmid. Among these, TraR is a LuxR-type transcription factor playing a key role as the quorum-sensing signal receptor, and TraM is an antiactivator that antagonizes TraR through the formation of a stable oligomeric complex. Recently, a second TraM homologue called TraM2, not encoded on the Ti plasmid of A. tumefaciens A6, was identified, in addition to a copy on the Ti plasmid. In this report, we have characterized TraM2 and its interaction with TraR and solved its crystal structure to 2.1 A. Like TraM, TraM2 folds into a helical bundle and exists as homodimer. TraM2 forms a stable complex (K(d) = 8.6 nM) with TraR in a 1:1 binding ratio, a weaker affinity than that of TraM for TraR. Structural analysis and biochemical studies suggest that protein stability may account for the difference between TraM2 and TraM in their binding affinities to TraR and provide a structural basis for L54 in promoting structural stability of TraM.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Quorum-sensing antiactivator</name>
				<source_organism>Rhizobium radiobacter</source_organism>
				<sequence>MDLKDSVVSDTFELRPVIGLTRGLSSADIETLTANAIRLHRQLLEKADQLFQVLPDDIKIGTAAGGEQHLEYIEAMIEMHAQMSAVNTLVGLLGFIPKVSVN</sequence>
				<length>102</length>
				<uniprot>
					<id>Q20HX4</id>
					<start>1</start>
					<end>102</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q20HX4</id>
					<start>1</start>
					<end>102</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09228.7</region_id>
						<region_name>Prok-TraM</region_name>
						<region_start>1</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Quorum-sensing antiactivator</name>
				<source_organism>Rhizobium radiobacter</source_organism>
				<sequence>MDLKDSVVSDTFELRPVIGLTRGLSSADIETLTANAIRLHRQLLEKADQLFQVLPDDIKIGTAAGGEQHLEYIEAMIEMHAQMSAVNTLVGLLGFIPKVSVN</sequence>
				<length>102</length>
				<uniprot>
					<id>Q20HX4</id>
					<start>1</start>
					<end>102</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q20HX4</id>
					<start>1</start>
					<end>102</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>16</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09228.7</region_id>
						<region_name>Prok-TraM</region_name>
						<region_start>1</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>TraM dimers were shown to fold/refold in a single step via a two-state mechanism using thermal unfolding experiments monitored by CD (PMID:16997969).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF5200001</accession>
		<general>
			<name>The synaptic acetylcholinesterase tetramer assembled around a polyproline-II helix</name>
			<pdb_id>1vzj</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.35</resolution>
			<assembly>heteropentamer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>15526038</pmid>
				<authors>Dvir H, Harel M, Bon S, Liu WQ, Vidal M, Garbay C, Sussman JL, Massoulié J, Silman I</authors>
				<title>The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix.</title>
				<journal>EMBO J.</journal>
				<year>2004</year>
				<issue>22</issue>
				<volume>23</volume>
				<pages>4394-405</pages>
				<abstract>Functional localization of acetylcholinesterase (AChE) in vertebrate muscle and brain depends on interaction of the tryptophan amphiphilic tetramerization (WAT) sequence, at the C-terminus of its major splice variant (T), with a proline-rich attachment domain (PRAD), of the anchoring proteins, collagenous (ColQ) and proline-rich membrane anchor. The crystal structure of the WAT/PRAD complex reveals a novel supercoil structure in which four parallel WAT chains form a left-handed superhelix around an antiparallel left-handed PRAD helix resembling polyproline II. The WAT coiled coils possess a WWW motif making repetitive hydrophobic stacking and hydrogen-bond interactions with the PRAD. The WAT chains are related by an approximately 4-fold screw axis around the PRAD. Each WAT makes similar but unique interactions, consistent with an asymmetric pattern of disulfide linkages between the AChE tetramer subunits and ColQ. The P59Q mutation in ColQ, which causes congenital endplate AChE deficiency, and is located within the PRAD, disrupts crucial WAT-WAT and WAT-PRAD interactions. A model is proposed for the synaptic AChE(T) tetramer.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0001507</accession>
					<name>acetylcholine catabolic process in synaptic cleft</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030054</accession>
					<name>cell junction</name>
				</go>
				<go>
					<accession>GO:0031594</accession>
					<name>neuromuscular junction</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0005605</accession>
					<name>basal lamina</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0043083</accession>
					<name>synaptic cleft</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains E, F, G, H and J were removed as chains A, B, C, D and I represent the biologically relevant oligomer.</note>
				<nr_of_chains>5</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Acetylcholinesterase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL</sequence>
				<length>40</length>
				<uniprot>
					<id>P22303</id>
					<start>575</start>
					<end>614</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22303</id>
					<start>575</start>
					<end>614</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>580</region_start>
						<region_end>594</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>596</region_start>
						<region_end>602</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08674.7</region_id>
						<region_name>AChE_tetra</region_name>
						<region_start>578</region_start>
						<region_end>613</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Acetylcholinesterase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL</sequence>
				<length>40</length>
				<uniprot>
					<id>P22303</id>
					<start>575</start>
					<end>614</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22303</id>
					<start>575</start>
					<end>614</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>576</region_start>
						<region_end>586</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>588</region_start>
						<region_end>594</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>596</region_start>
						<region_end>605</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08674.7</region_id>
						<region_name>AChE_tetra</region_name>
						<region_start>578</region_start>
						<region_end>613</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Acetylcholinesterase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL</sequence>
				<length>40</length>
				<uniprot>
					<id>P22303</id>
					<start>575</start>
					<end>614</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22303</id>
					<start>575</start>
					<end>614</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>576</region_start>
						<region_end>594</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>596</region_start>
						<region_end>606</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08674.7</region_id>
						<region_name>AChE_tetra</region_name>
						<region_start>578</region_start>
						<region_end>613</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Acetylcholinesterase</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL</sequence>
				<length>40</length>
				<uniprot>
					<id>P22303</id>
					<start>575</start>
					<end>614</end>
					<coverage>6.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22303</id>
					<start>575</start>
					<end>614</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>576</region_start>
						<region_end>594</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>596</region_start>
						<region_end>606</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08674.7</region_id>
						<region_name>AChE_tetra</region_name>
						<region_start>578</region_start>
						<region_end>613</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>I</id>
				<name>Acetylcholinesterase collagenic tail peptide</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>LLTPPPPPLFPPPFF</sequence>
				<length>15</length>
				<uniprot>
					<id>Q9Y215</id>
					<start>53</start>
					<end>67</end>
					<coverage>3.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9Y215</id>
					<start>?</start>
					<end>?</end>
				</uniref90>
				<regions>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:15526038). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2140010</accession>
		<general>
			<name>Antitoxin phd dimer (Escherichia virus P1)</name>
			<pdb_id>3hs2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.20</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Enterobacteria phage P1</source_organism>
			<publication>
				<pmid>20603017</pmid>
				<authors>Garcia-Pino A, Balasubramanian S, Wyns L, Gazit E, De Greve H, Magnuson RD, Charlier D, van Nuland NA, Loris R</authors>
				<title>Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity.</title>
				<journal>Cell</journal>
				<year>2010</year>
				<issue>1</issue>
				<volume>142</volume>
				<pages>101-11</pages>
				<abstract>Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G and H were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Phd antitoxin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin phd</name>
				<source_organism>Enterobacteria phage P1</source_organism>
				<sequence>MQSINFRTARGNLSEVLNNVEAGEEVEITRRGREPAVIVSKATFEAYKKAALDAEFAS</sequence>
				<length>58</length>
				<uniprot>
					<id>Q06253</id>
					<start>1</start>
					<end>58</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06253</id>
					<start>1</start>
					<end>58</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>36</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>70</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Antitoxin phd</name>
				<source_organism>Enterobacteria phage P1</source_organism>
				<sequence>MQSINFRTARGNLSEVLNNVEAGEEVEITRRGREPAVIVSKATFEAYKKAALDAEFAS</sequence>
				<length>58</length>
				<uniprot>
					<id>Q06253</id>
					<start>1</start>
					<end>58</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q06253</id>
					<start>1</start>
					<end>58</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>30</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>70</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The dimerization of the prevents host death (phd) antitoxin from Escherichia virus P1 has been shown with differential scanning calorimetry to fit well to a two-state model consisting of a dimer unfolding into monomer species (PMID:20603017).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-73 region described in DisProt entry DP00288 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-73 region described in DisProt entry DP00288 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3k33</pdb_id>
			<pdb_id>3kh2</pdb_id>
			<pdb_id>4zlx</pdb_id>
			<pdb_id>4zm0</pdb_id>
			<pdb_id>4zm2</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120024</accession>
		<general>
			<name>Antitoxin phd dimer (Mycobacterium tuberculosis)</name>
			<pdb_id>3g5o</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Mycobacterium tuberculosis</source_organism>
			<publication>
				<authors>Miallau, L., Chernishof, I., Chiang, J., Arbing, M., Cascio, D., Eisenberg, D.</authors>
				<title>The crystal structure of the toxin-antitoxin complex RelBE2 (Rv2865-2866) from Mycobacterium tuberculosis</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0097351</accession>
					<name>toxin-antitoxin pair type II binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0045927</accession>
					<name>positive regulation of growth</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were removed as chains A and D represent the biologically relevant dimer. Chains A and D were truncated to exclude the regions in contact with chains B and C.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Phd antitoxin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin RelF</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence></sequence>
				<length>0</length>
				<uniprot>
					<id>O33347</id>
					<start>1</start>
					<end>93</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O33347</id>
					<start>1</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>1</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>74</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Antitoxin RelF</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence></sequence>
				<length>0</length>
				<uniprot>
					<id>O33347</id>
					<start>1</start>
					<end>93</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O33347</id>
					<start>1</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>1</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>6</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>26</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02604.16</region_id>
						<region_name>PhdYeFM_antitox</region_name>
						<region_start>1</region_start>
						<region_end>74</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The dimerization of the prevents host death (phd) antitoxin from Escherichia virus P1 has been shown with differential scanning calorimetry to fit well to a two-state model consisting of a dimer unfolding into monomer species (PMID:20603017).</complex_evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>A homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>D</chain_id>
				<support>A homologue sharing the same Pfam domain (PF02604.16) has been experimentally characterized as disordered in DisProt entry DP00288.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120025</accession>
		<general>
			<name>Docking domain A of the erythronolide synthase</name>
			<pdb_id>1pzq</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Saccharopolyspora erythraea</source_organism>
			<publication>
				<pmid>12954331</pmid>
				<authors>Broadhurst RW, Nietlispach D, Wheatcroft MP, Leadlay PF, Weissman KJ</authors>
				<title>The structure of docking domains in modular polyketide synthases.</title>
				<journal>Chem. Biol.</journal>
				<year>2003</year>
				<issue>8</issue>
				<volume>10</volume>
				<pages>723-31</pages>
				<abstract>Polyketides from actinomycete bacteria provide the basis for many valuable medicines, so engineering genes for their biosynthesis to produce variant molecules holds promise for drug discovery. The modular polyketide synthases are particularly amenable to this approach, because each cycle of chain extension is catalyzed by a different module of enzymes, and the modules are arranged within giant multienzyme subunits in the order in which they act. Protein-protein interactions between terminal docking domains of successive multienzymes promote their correct positioning within the assembly line, but because the overall complex is not stable in vitro, the key interactions have not been identified. We present here the NMR solution structure of a 120 residue polypeptide representing a typical pair of such domains, fused at their respective C and N termini: it adopts a stable dimeric structure which reveals the detailed role of these (predominantly helical) domains in docking and dimerization by modular polyketide synthases.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0031177</accession>
					<name>phosphopantetheine binding</name>
				</go>
				<go>
					<accession>GO:0016491</accession>
					<name>oxidoreductase activity</name>
				</go>
				<go>
					<accession>GO:0048037</accession>
					<name>cofactor binding</name>
				</go>
				<go>
					<accession>GO:0047879</accession>
					<name>erythronolide synthase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0055114</accession>
					<name>oxidation-reduction process</name>
				</go>
				<go>
					<accession>GO:0033068</accession>
					<name>macrolide biosynthetic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Erythronolide synthase, modules 3 and 4</name>
				<source_organism>Saccharopolyspora erythraea</source_organism>
				<sequence>GSAASPAVDIGDRLDELEKALEALSAEDGHDDVGQRLESLLRRWNSRRADAPSTSAISED</sequence>
				<length>60</length>
				<uniprot>
					<id>Q03132</id>
					<start>3488</start>
					<end>3547</end>
					<coverage>1.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q03132</id>
					<start>3490</start>
					<end>3547</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3498</region_start>
						<region_end>3511</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3518</region_start>
						<region_end>3536</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09277.8</region_id>
						<region_name>Erythro-docking</region_name>
						<region_start>3490</region_start>
						<region_end>3547</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Erythronolide synthase, modules 3 and 4</name>
				<source_organism>Saccharopolyspora erythraea</source_organism>
				<sequence>GSAASPAVDIGDRLDELEKALEALSAEDGHDDVGQRLESLLRRWNSRRADAPSTSAISED</sequence>
				<length>60</length>
				<uniprot>
					<id>Q03132</id>
					<start>3488</start>
					<end>3547</end>
					<coverage>1.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q03132</id>
					<start>3490</start>
					<end>3547</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3498</region_start>
						<region_end>3511</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3518</region_start>
						<region_end>3536</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09277.8</region_id>
						<region_name>Erythro-docking</region_name>
						<region_start>3490</region_start>
						<region_end>3547</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:12954331). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100012</accession>
		<general>
			<name>Human glutathione S-transferase A1</name>
			<pdb_id>1k3y</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>12211029</pmid>
				<authors>Le Trong I, Stenkamp RE, Ibarra C, Atkins WM, Adman ET</authors>
				<title>1.3-A resolution structure of human glutathione S-transferase with S-hexyl glutathione bound reveals possible extended ligandin binding site.</title>
				<journal>Proteins</journal>
				<year>2002</year>
				<issue>4</issue>
				<volume>48</volume>
				<pages>618-27</pages>
				<abstract>Cytosolic glutathione S-transferases (GSTs) play a critical role in xenobiotic binding and metabolism, as well as in modulation of oxidative stress. Here, the high-resolution X-ray crystal structures of homodimeric human GSTA1-1 in the apo form and in complex with S-hexyl glutathione (two data sets) are reported at 1.8, 1.5, and 1.3A respectively. At this level of resolution, distinct conformations of the alkyl chain of S-hexyl glutathione are observed, reflecting the nonspecific nature of the hydrophobic substrate binding site (H-site). Also, an extensive network of ordered water, including 75 discrete solvent molecules, traverses the open subunit-subunit interface and connects the glutathione binding sites in each subunit. In the highest-resolution structure, three glycerol moieties lie within this network and directly connect the amino termini of the glutathione molecules. A search for ligand binding sites with the docking program Molecular Operating Environment identified the ordered water network binding site, lined mainly with hydrophobic residues, suggesting an extended ligand binding surface for nonsubstrate ligands, the so-called ligandin site. Finally, detailed comparison of the structures reported here with previously published X-ray structures reveal a possible reaction coordinate for ligand-dependent conformational changes in the active site and the C-terminus.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004364</accession>
					<name>glutathione transferase activity</name>
				</go>
				<go>
					<accession>GO:0004602</accession>
					<name>glutathione peroxidase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006749</accession>
					<name>glutathione metabolic process</name>
				</go>
				<go>
					<accession>GO:0098869</accession>
					<name>cellular oxidant detoxification</name>
				</go>
				<go>
					<accession>GO:0043651</accession>
					<name>linoleic acid metabolic process</name>
				</go>
				<go>
					<accession>GO:1901687</accession>
					<name>glutathione derivative biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0030855</accession>
					<name>epithelial cell differentiation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Glutathione S-transferase A1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF</sequence>
				<length>221</length>
				<uniprot>
					<id>P08263</id>
					<start>2</start>
					<end>222</end>
					<coverage>99.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08263</id>
					<start>2</start>
					<end>222</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>6</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>86</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>155</region_start>
						<region_end>170</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>179</region_start>
						<region_end>190</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>198</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>210</region_start>
						<region_end>220</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>5</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00043.22</region_id>
						<region_name>GST_C</region_name>
						<region_start>99</region_start>
						<region_end>192</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Glutathione S-transferase A1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF</sequence>
				<length>221</length>
				<uniprot>
					<id>P08263</id>
					<start>2</start>
					<end>222</end>
					<coverage>99.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08263</id>
					<start>2</start>
					<end>222</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>6</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>25</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>66</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>68</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>86</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>155</region_start>
						<region_end>170</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>179</region_start>
						<region_end>190</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>198</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>210</region_start>
						<region_end>220</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>5</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00043.22</region_id>
						<region_name>GST_C</region_name>
						<region_start>99</region_start>
						<region_end>192</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The urea-induced unfolding/refolding of human glutathione S-transferase A1 dimer has been shown to be a two-state process (PMID:9548764) with the association of disordered monomers forming a structured dimer. While there may be some structuring of the monomers before dimerization, this partial structure does not fully stabilize the protein (PMID:10600132).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1gsd</pdb_id>
			<pdb_id>1gse</pdb_id>
			<pdb_id>1gsf</pdb_id>
			<pdb_id>1guh</pdb_id>
			<pdb_id>1k3l</pdb_id>
			<pdb_id>1k3o</pdb_id>
			<pdb_id>1lbk</pdb_id>
			<pdb_id>1pkw</pdb_id>
			<pdb_id>1pkz</pdb_id>
			<pdb_id>1pl1</pdb_id>
			<pdb_id>1pl2</pdb_id>
			<pdb_id>1usb</pdb_id>
			<pdb_id>1xwg</pdb_id>
			<pdb_id>1ydk</pdb_id>
			<pdb_id>2r3x</pdb_id>
			<pdb_id>2r6k</pdb_id>
			<pdb_id>3i69</pdb_id>
			<pdb_id>3i6a</pdb_id>
			<pdb_id>3ik9</pdb_id>
			<pdb_id>3ktl</pdb_id>
			<pdb_id>3l0h</pdb_id>
			<pdb_id>3q74</pdb_id>
			<pdb_id>3u6v</pdb_id>
			<pdb_id>3zfb</pdb_id>
			<pdb_id>3zfl</pdb_id>
			<pdb_id>4hj2</pdb_id>
			<pdb_id>5jcu</pdb_id>
			<pdb_id>5lcz</pdb_id>
			<pdb_id>5ld0</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2130001</accession>
		<general>
			<name>Archaeal histone hMfB</name>
			<pdb_id>1bfm</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Methanothermus fervidus</source_organism>
			<publication>
				<pmid>8568866</pmid>
				<authors>Starich MR, Sandman K, Reeve JN, Summers MF</authors>
				<title>NMR structure of HMfB from the hyperthermophile, Methanothermus fervidus, confirms that this archaeal protein is a histone.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1996</year>
				<issue>1</issue>
				<volume>255</volume>
				<pages>187-203</pages>
				<abstract>The three-dimensional structure of the recombinant histone rHMfB from Methanothermus fervidus, an archaeon that grows optimally at 83 degrees C, has been determined by nuclear magnetic resonance methods. This is only the third structure of a protein from a hyperthermophilic organism (optimal growth at temperatures above 80 degrees C). Signal assignments were made using a combination of homonuclear-correlated, 15N-double resonance and 15N, 13C triple resonance NMR experiments. Long range dipolar interactions for the symmetric homodimer were identified from two-dimensional 13C-double half-filtered and three-dimensional 13C-filtered NMR data obtained for a heterolabeled-dimer. A family of 33 structures was calculated using DSPACE with a total of 609 NOE-derived interproton distance restraints, including 22 intraresidue, 192 sequential, 300 medium-range (two to five residues), 86 long-range intramolecular (more than five residues) and 112 intermolecular distance restraints. The monomer subunits consist of three alpha-helices, extending from residues Pro4 to Ala15 (helix I), Ser21 to Ala50 (helix II) and Lys56 to Lys68 (helix III), as well as two short segments of beta-strand comprised of residues Arg19 to Ser21 and Thr54 to Ile55. Helices I, II and III contain N-terminal capping boxes, and helices I and II contain C-terminal caps. The structure of the (rHMfB)2 dimer appears very similar to the dimer subunits within the histone core octamer of the chicken nucleosome. The presence of a canonical &amp;quot;histone fold" motif in rHMfB is consistent with the HMf family of archaeal histones and the eukaryal nucleosome core histones having evolved from a common ancestor. The (rHMfB)2 dimer contains several structural features that may impart thermal stability (or non-lability), including two novel hydrophobic "proline Ncaps", four interhelical hydrogen bonds and short N- and C-terminal disordered tails.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046982</accession>
					<name>protein heterodimerization activity</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005694</accession>
					<name>chromosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histone-like complexes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>DNA-binding protein HMf-2</name>
				<source_organism>Methanothermus fervidus</source_organism>
				<sequence>MELPIAPIGRIIKDAGAERVSDDARITLAKILEEMGRDIASEAIKLARHAGRKTIKAEDIELAVRRFKK</sequence>
				<length>69</length>
				<uniprot>
					<id>P19267</id>
					<start>1</start>
					<end>69</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P19267</id>
					<start>1</start>
					<end>69</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>19</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>55</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00808.20</region_id>
						<region_name>CBFD_NFYB_HMF</region_name>
						<region_start>1</region_start>
						<region_end>64</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>DNA-binding protein HMf-2</name>
				<source_organism>Methanothermus fervidus</source_organism>
				<sequence>MELPIAPIGRIIKDAGAERVSDDARITLAKILEEMGRDIASEAIKLARHAGRKTIKAEDIELAVRRFKK</sequence>
				<length>69</length>
				<uniprot>
					<id>P19267</id>
					<start>1</start>
					<end>69</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P19267</id>
					<start>1</start>
					<end>69</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>20</region_start>
						<region_end>20</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00808.20</region_id>
						<region_name>CBFD_NFYB_HMF</region_name>
						<region_start>1</region_start>
						<region_end>64</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The GdmCl-induced unfolding and refolding transitions of the dimer (monitored by stopped-flow far UV CD) provide support for a two-state equilibrium reaction with no populated intermediates. The data sets were well described by the global fits to a two-state model (PMID:15313621).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1a7w</pdb_id>
			<pdb_id>1b6w</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100013</accession>
		<general>
			<name>S100B</name>
			<pdb_id>1uwo</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>9519411</pmid>
				<authors>Smith SP, Shaw GS</authors>
				<title>A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form.</title>
				<journal>Structure</journal>
				<year>1998</year>
				<issue>2</issue>
				<volume>6</volume>
				<pages>211-22</pages>
				<abstract> CONCLUSIONS: The calcium-induced reorientation of calcium-binding site II results in the increased exposure of several hydrophobic residues in helix IV and the linker region. While following the general mechanism of calcium modulatory proteins, whereby a hydrophobic target site is exposed, the &apos;calcium switch' observed in S100B appears to be unique from that of other EF-hand proteins and may provide insights into target specificity among calcium modulatory proteins. RESULTS: The solution structure of calcium-saturated human S100B (Ca(2+)-S100B) has been determined by heteronuclear NMR spectroscopy. Ca(2+)-S100B forms a well defined globular structure comprising four EF-hand calcium-binding sites and an extensive hydrophobic dimer interface. A comparison of Ca(2+)-S100B with apo S100B and Ca(2+)-calbindin D9k indicates that while calcium-binding to S100B results in little change in the site I EF-hand, it induces a backbone reorientation of the N terminus of the site II EF-hand. This reorientation leads to a dramatic change in the position of helix III relative to the other helices. BACKGROUND: S100B is a homodimeric member of the EF-hand calcium-binding protein superfamily. The protein has been implicated in cellular processes such as cell differentiation and growth, plays a role in cytoskeletal structure and function, and may have a role in neuropathological diseases, such as Alzheimers. The effects of S100B are mediated via its interaction with target proteins. While several studies have suggested that this interaction is propagated through a calcium-induced conformational change, leading to the exposure of a hydrophobic region of S100B, the molecular details behind this structural alteration remain unclear.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0050786</accession>
					<name>RAGE receptor binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
				<go>
					<accession>GO:0048156</accession>
					<name>tau protein binding</name>
				</go>
				<go>
					<accession>GO:0048306</accession>
					<name>calcium-dependent protein binding</name>
				</go>
				<go>
					<accession>GO:0044548</accession>
					<name>S100 protein binding</name>
				</go>
				<go>
					<accession>GO:0005509</accession>
					<name>calcium ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045087</accession>
					<name>innate immune response</name>
				</go>
				<go>
					<accession>GO:0008284</accession>
					<name>positive regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0008283</accession>
					<name>cell proliferation</name>
				</go>
				<go>
					<accession>GO:0043123</accession>
					<name>positive regulation of I-kappaB kinase/NF-kappaB signaling</name>
				</go>
				<go>
					<accession>GO:0071456</accession>
					<name>cellular response to hypoxia</name>
				</go>
				<go>
					<accession>GO:0060291</accession>
					<name>long-term synaptic potentiation</name>
				</go>
				<go>
					<accession>GO:2001015</accession>
					<name>negative regulation of skeletal muscle cell differentiation</name>
				</go>
				<go>
					<accession>GO:0007409</accession>
					<name>axonogenesis</name>
				</go>
				<go>
					<accession>GO:0048708</accession>
					<name>astrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0051384</accession>
					<name>response to glucocorticoid</name>
				</go>
				<go>
					<accession>GO:0008360</accession>
					<name>regulation of cell shape</name>
				</go>
				<go>
					<accession>GO:0043065</accession>
					<name>positive regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0051597</accession>
					<name>response to methylmercury</name>
				</go>
				<go>
					<accession>GO:0048168</accession>
					<name>regulation of neuronal synaptic plasticity</name>
				</go>
				<go>
					<accession>GO:0007613</accession>
					<name>memory</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0043025</accession>
					<name>neuronal cell body</name>
				</go>
				<go>
					<accession>GO:0001726</accession>
					<name>ruffle</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0048471</accession>
					<name>perinuclear region of cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein S100-B</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE</sequence>
				<length>91</length>
				<uniprot>
					<id>P04271</id>
					<start>2</start>
					<end>92</end>
					<coverage>98.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04271</id>
					<start>2</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>31</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>68</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>71</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01023.16</region_id>
						<region_name>S_100</region_name>
						<region_start>4</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00036.29</region_id>
						<region_name>EF-hand_1</region_name>
						<region_start>53</region_start>
						<region_end>81</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein S100-B</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE</sequence>
				<length>91</length>
				<uniprot>
					<id>P04271</id>
					<start>2</start>
					<end>92</end>
					<coverage>98.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04271</id>
					<start>2</start>
					<end>92</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>30</region_start>
						<region_end>40</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>62</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>71</region_start>
						<region_end>89</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01023.16</region_id>
						<region_name>S_100</region_name>
						<region_start>4</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00036.29</region_id>
						<region_name>EF-hand_1</region_name>
						<region_start>53</region_start>
						<region_end>81</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>GuHCl-induced denaturation of the S100B protein dimer showed that it follows a two-state unfolding/refolding process (PMID:11888280).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3czt</pdb_id>
			<pdb_id>3d0y</pdb_id>
			<pdb_id>3d10</pdb_id>
			<pdb_id>2h61</pdb_id>
			<pdb_id>3hcm</pdb_id>
			<pdb_id>2m49</pdb_id>
			<pdb_id>1mq1</pdb_id>
			<pdb_id>2pru</pdb_id>
			<pdb_id>4xyn</pdb_id>
			<pdb_id>5csf</pdb_id>
			<pdb_id>5csi</pdb_id>
			<pdb_id>5csj</pdb_id>
			<pdb_id>5csn</pdb_id>
			<pdb_id>5d7f</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110016</accession>
		<general>
			<name>Dynein light chain TcTex-1</name>
			<pdb_id>1ygt</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Drosophila melanogaster</source_organism>
			<publication>
				<pmid>15701632</pmid>
				<authors>Williams JC, Xie H, Hendrickson WA</authors>
				<title>Crystal structure of dynein light chain TcTex-1.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2005</year>
				<issue>23</issue>
				<volume>280</volume>
				<pages>21981-6</pages>
				<abstract>TcTex-1, one of three dynein light chains of the dynein motor complex, has been implicated in targeting and binding cargoes to cytoplasmic dynein for retrograde or apical transport. Interactions between TcTex-1 and a diverse set of proteins such as the dynein intermediate chain, Fyn, DOC2, FIP1, the poliovirus receptor, CD155, and the rhodopsin cytoplasmic tail have been reported; yet, despite the broad range of targets, a consensus binding sequence remains uncertain. Consequently, we have solved the crystal structure of the full-length Drosophila homolog of TcTex-1 to 1.7 A resolution using MAD phasing to gain insight into its function and target specificity. The structure is homodimeric with a domain swapping of beta-strand 2 and has a fold similar to the dynein light chain, LC8. Based on structural alignment, the TcTex-1 and LC8 sequences show no identity, although the root mean square deviation between secondary structural elements is less than 1.6 A. Moreover, the N terminus, which is equivalent to beta-strand 1 in LC8, is splayed out and binds to a crystallographic dimer as an anti-parallel beta-strand at the same position as the neuronal nitric-oxide synthase peptide in the LC8 complex. Similarity to LC8 and comparison to the LC8-neuronal nitricoxide synthase complex suggest that TcTex-1 binds its targets in a similar manner as LC8 and provides insight to the lack of strict sequence identity among the targets for TcTex-1.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0045505</accession>
					<name>dynein intermediate chain binding</name>
				</go>
				<go>
					<accession>GO:0042623</accession>
					<name>ATPase activity, coupled</name>
				</go>
				<go>
					<accession>GO:0051959</accession>
					<name>dynein light intermediate chain binding</name>
				</go>
				<go>
					<accession>GO:0003774</accession>
					<name>motor activity</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0008090</accession>
					<name>retrograde axonal transport</name>
				</go>
				<go>
					<accession>GO:0007286</accession>
					<name>spermatid development</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
				<go>
					<accession>GO:0008340</accession>
					<name>determination of adult lifespan</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:1904115</accession>
					<name>axon cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005874</accession>
					<name>microtubule</name>
				</go>
				<go>
					<accession>GO:0005868</accession>
					<name>cytoplasmic dynein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Dynein light chain Tctex-type</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>MDDSREESQFIVDDVSKTIKEAIETTIGGNAYQHDKVNNWTGQVVENCLTVLTKEQKPYKYIVTAMIMQKNGAGLHTASSCYWNNDTDGSCTVRWENKTMYCIVSVFGLAV</sequence>
				<length>111</length>
				<uniprot>
					<id>Q94524</id>
					<start>1</start>
					<end>111</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q94524</id>
					<start>1</start>
					<end>111</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>34</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>59</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>110</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03645.10</region_id>
						<region_name>Tctex-1</region_name>
						<region_start>14</region_start>
						<region_end>110</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Dynein light chain Tctex-type</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>MDDSREESQFIVDDVSKTIKEAIETTIGGNAYQHDKVNNWTGQVVENCLTVLTKEQKPYKYIVTAMIMQKNGAGLHTASSCYWNNDTDGSCTVRWENKTMYCIVSVFGLAV</sequence>
				<length>111</length>
				<uniprot>
					<id>Q94524</id>
					<start>1</start>
					<end>111</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q94524</id>
					<start>1</start>
					<end>111</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>34</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>59</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>100</region_start>
						<region_end>110</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03645.10</region_id>
						<region_name>Tctex-1</region_name>
						<region_start>14</region_start>
						<region_end>110</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The equilibrium unfolding transition of the dynein light chain TcTex-1 dimer was monitored by intrinsic fluorescence intensity, fluorescence anisotropy, and circular dichroism and was modeled as a two-state mechanism where a folded dimer dissociates to two unfolded monomers without populating thermodynamically stable monomeric or dimeric intermediates (PMID:16734416).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3fm7</pdb_id>
			<pdb_id>2pg1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120026</accession>
		<general>
			<name>Dihydrofolate reductase</name>
			<pdb_id>1cz3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Thermotoga maritima</source_organism>
			<publication>
				<pmid>10731419</pmid>
				<authors>Dams T, Auerbach G, Bader G, Jacob U, Ploom T, Huber R, Jaenicke R</authors>
				<title>The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2000</year>
				<issue>3</issue>
				<volume>297</volume>
				<pages>659-72</pages>
				<abstract>Two high-resolution structures have been obtained for dihydrofolate reductase from the hyperthermophilic bacterium Thermotoga maritima in its unliganded state, and in its ternary complex with the cofactor NADPH and the inhibitor, methotrexate. While the overall fold of the hyperthermophilic enzyme is closely similar to monomeric mesophilic dihydrofolate reductase molecules, its quaternary structure is exceptional, in that T. maritima dihydrofolate reductase forms a highly stable homodimer. Here, the molecular reasons for the high intrinsic stability of the enzyme are elaborated and put in context with the available data on the physical parameters governing the folding reaction. The molecule is extremely rigid, even with respect to structural changes during substrate binding and turnover. Subunit cooperativity can be excluded from structural and biochemical data. Major contributions to the high intrinsic stability of the enzyme result from the formation of the dimer. Within the monomer, only subtle stabilizing interactions are detectable, without clear evidence for any of the typical increments of thermal stabilization commonly reported for hyperthermophilic proteins. The docking of the subunits is optimized with respect to high packing density in the dimer interface, additional salt-bridges and beta-sheets. The enzyme does not show significant structural changes upon binding its coenzyme, NADPH, and the inhibitor, methotrexate. The active-site loop, which is known to play an important role in catalysis in mesophilic dihydrofolate reductase molecules, is rearranged, participating in the association of the subunits; it no longer participates in catalysis.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0050661</accession>
					<name>NADP binding</name>
				</go>
				<go>
					<accession>GO:0004146</accession>
					<name>dihydrofolate reductase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006730</accession>
					<name>one-carbon metabolic process</name>
				</go>
				<go>
					<accession>GO:0006545</accession>
					<name>glycine biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0055114</accession>
					<name>oxidation-reduction process</name>
				</go>
				<go>
					<accession>GO:0009165</accession>
					<name>nucleotide biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0046654</accession>
					<name>tetrahydrofolate biosynthetic process</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Dihydrofolate reductase</name>
				<source_organism>Thermotoga maritima</source_organism>
				<sequence>AKVIFVLAMDVSGKIASSVESWSSFEDRKNFRKITTEIGNVVMGRITFEEIGRPLPERLNVVLTRRPKTSNNPSLVFFNGSPADVVKFLEGKGYERVAVIGGKTVFTEFLREKLVDELFVTVEPYVFGKGIPFFDEFEGYFPLKLLEMRRLNERGTLFLKYSVEKSHR</sequence>
				<length>168</length>
				<uniprot>
					<id>Q60034</id>
					<start>2</start>
					<end>165</end>
					<coverage>97%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q60034</id>
					<start>2</start>
					<end>165</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>83</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>97</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>104</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>126</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>141</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>158</region_start>
						<region_end>164</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00186.16</region_id>
						<region_name>DHFR_1</region_name>
						<region_start>3</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Dihydrofolate reductase</name>
				<source_organism>Thermotoga maritima</source_organism>
				<sequence>AKVIFVLAMDVSGKIASSVESWSSFEDRKNFRKITTEIGNVVMGRITFEEIGRPLPERLNVVLTRRPKTSNNPSLVFFNGSPADVVKFLEGKGYERVAVIGGKTVFTEFLREKLVDELFVTVEPYVFGKGIPFFDEFEGYFPLKLLEMRRLNERGTLFLKYSVEKSHR</sequence>
				<length>168</length>
				<uniprot>
					<id>Q60034</id>
					<start>2</start>
					<end>165</end>
					<coverage>97%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q60034</id>
					<start>2</start>
					<end>165</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>41</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>83</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>97</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>104</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>126</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>141</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>158</region_start>
						<region_end>164</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00186.16</region_id>
						<region_name>DHFR_1</region_name>
						<region_start>3</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The enzyme DHFR from the hyperthermophilic bacterium Thermotoga maritima represents an extremely stable dimer; no isolated structured monomers could be detected in equilibrium or during unfolding. The equilibrium unfolding strictly follows the two-state model for the dimer (PMID:10413491).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1d1g</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4120007</accession>
		<general>
			<name>Type II dihydrofolate reductase</name>
			<pdb_id>2rh2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>0.96</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>18052202</pmid>
				<authors>Krahn JM, Jackson MR, DeRose EF, Howell EE, London RE</authors>
				<title>Crystal structure of a type II dihydrofolate reductase catalytic ternary complex.</title>
				<journal>Biochemistry</journal>
				<year>2007</year>
				<issue>51</issue>
				<volume>46</volume>
				<pages>14878-88</pages>
				<abstract>Type II dihydrofolate reductase (DHFR) is a plasmid-encoded enzyme that confers resistance to bacterial DHFR-targeted antifolate drugs. It forms a symmetric homotetramer with a central pore which functions as the active site. Its unusual structure, which results in a promiscuous binding surface that accommodates either the dihydrofolate (DHF) substrate or the NADPH cofactor, has constituted a significant limitation to efforts to understand its substrate specificity and reaction mechanism. We describe here the first structure of a ternary R67 DHFR.DHF.NADP+ catalytic complex, resolved to 1.26 A. This structure provides the first clear picture of how this enzyme, which lacks the active site carboxyl residue that is ubiquitous in Type I DHFRs, is able to function. In the catalytic complex, the polar backbone atoms of two symmetry-related I68 residues provide recognition motifs that interact with the carboxamide on the nicotinamide ring, and the N3-O4 amide function on the pteridine ring. This set of interactions orients the aromatic rings of substrate and cofactor in a relative endo geometry in which the reactive centers are held in close proximity. Additionally, a central, hydrogen-bonded network consisting of two pairs of Y69-Q67-Q67&apos;-Y69' residues provides an unusually tight interface, which appears to serve as a &amp;quot;molecular clamp" holding the substrates in place in an orientation conducive to hydride transfer. In addition to providing the first clear insight regarding how this extremely unusual enzyme is able to function, the structure of the ternary complex provides general insights into how a mutationally challenged enzyme, i.e., an enzyme whose evolution is restricted to four-residues-at-a-time active site mutations, overcomes this fundamental limitation.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004146</accession>
					<name>dihydrofolate reductase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006730</accession>
					<name>one-carbon metabolic process</name>
				</go>
				<go>
					<accession>GO:0042493</accession>
					<name>response to drug</name>
				</go>
				<go>
					<accession>GO:0031427</accession>
					<name>response to methotrexate</name>
				</go>
				<go>
					<accession>GO:0055114</accession>
					<name>oxidation-reduction process</name>
				</go>
				<go>
					<accession>GO:0046654</accession>
					<name>tetrahydrofolate biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0046677</accession>
					<name>response to antibiotic</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains B, C and D were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homotetrameric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Dihydrofolate reductase type 2</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>VFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN</sequence>
				<length>62</length>
				<uniprot>
					<id>P00383</id>
					<start>17</start>
					<end>78</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00383</id>
					<start>17</start>
					<end>78</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>73</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06442.8</region_id>
						<region_name>DHFR_2</region_name>
						<region_start>1</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Dihydrofolate reductase type 2</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>VFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN</sequence>
				<length>62</length>
				<uniprot>
					<id>P00383</id>
					<start>17</start>
					<end>78</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00383</id>
					<start>17</start>
					<end>78</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>73</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06442.8</region_id>
						<region_name>DHFR_2</region_name>
						<region_start>1</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Dihydrofolate reductase type 2</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>VFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN</sequence>
				<length>62</length>
				<uniprot>
					<id>P00383</id>
					<start>17</start>
					<end>78</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00383</id>
					<start>17</start>
					<end>78</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>73</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06442.8</region_id>
						<region_name>DHFR_2</region_name>
						<region_start>1</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Dihydrofolate reductase type 2</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>VFPSNATFGMGDRVRKKSGAAWQGQIVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN</sequence>
				<length>62</length>
				<uniprot>
					<id>P00383</id>
					<start>17</start>
					<end>78</end>
					<coverage>79.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00383</id>
					<start>17</start>
					<end>78</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>53</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>70</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>73</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF06442.8</region_id>
						<region_name>DHFR_2</region_name>
						<region_start>1</region_start>
						<region_end>78</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Using absorbance, fluorescence, and circular dichroism the unfolding of type II DHFR is protein concentration dependent and  can be described by a two-state model involving native dimer and unfolded monomer (PMID:1932013).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2gqv</pdb_id>
			<pdb_id>2p4t</pdb_id>
			<pdb_id>2rk1</pdb_id>
			<pdb_id>2rk2</pdb_id>
			<pdb_id>3sfm</pdb_id>
			<pdb_id>1vie</pdb_id>
			<pdb_id>1vif</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110017</accession>
		<general>
			<name>Class pi glutathione S-transferase (Sus scrofa)</name>
			<pdb_id>2gsr</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.11</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Sus scrofa</source_organism>
			<publication>
				<pmid>7932743</pmid>
				<authors>Dirr H, Reinemer P, Huber R</authors>
				<title>Refined crystal structure of porcine class Pi glutathione S-transferase (pGST P1-1) at 2.1 A resolution.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1994</year>
				<issue>1</issue>
				<volume>243</volume>
				<pages>72-92</pages>
				<abstract>The crystal structure of class Pi glutathione S-transferase from porcine lung (pGST P1-1) in complex with glutathione sulphonate has been refined at 2.11 A resolution, to a crystallographic R-factor of 16.5% for 21, 165 unique reflections. The refined structure includes 3314 protein atoms, 46 inhibitor (glutathione sulphonate) atoms and 254 water molecules. The model shows good stereochemistry, with root-mean-square deviations from ideal bond lengths and bond angles of 0.011 A and 2.8 degrees, respectively. The estimated root-mean-square co-ordinate error is 0.2 A. The protein is a dimer assembled from identical subunits of 207 amino acid residues. The tertiary structure of the pGST P1 subunit is organized as two domains, the N-terminal domain (domain I, residues 1 to 74) and the larger C-terminal domain (domain II, residues 81 to 207). Glutathione sulphonate, a competitive inhibitor, binds to the G-site region (i.e. the glutathione-binding region) of the active site located on each subunit. Each G-site is, however, structurally dependent of the neighbouring subunit as structural elements forming a fully functional G-site are provided by both subunits, with domain I as the major supporting framework. A number of direct and water-mediated polar interactions are involved in sequestering the glutathione analogue at the G-site. The extended conformation assumed by the enzyme-bound inhibitor as well as the strategic interactions between inhibitor and protein, closely resemble those observed for the physiological substrate, reduced glutathione bound at the active site of class Mu glutathione S-transferase 3-3. Hydrogen bonding between the sulphonyl moiety of the inhibitor and the hydroxyl group of an evolutionary conserved tyrosine residue, Tyr7, provides the first direct structural evidence for a catalytic protein group in glutathione S-transferases that is involved in the activation of the substrate glutathione. The catalytic role for Tyr7 has subsequently been confirmed by mutagenesis and kinetic studies. Comparison of the known crystal structures for class Pi, class Mu and class Alpha isoenzymes, indicates that the cytosolic glutathione S-transferases share a common fold and that the structural features for catalysis are similar.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004364</accession>
					<name>glutathione transferase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0008152</accession>
					<name>metabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005739</accession>
					<name>mitochondrion</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Glutathione S-transferase P</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>PPYTITYFPVRGRCEAMRMLLADQDQSWKEEVVTMETWPPLKPSCLFRQLPKFQDGDLTLYQSNAILRHLGRSFGLYGKDQKEAALVDMVNDGVEDLRCKYATLIYTNYEAGKEKYVKELPEHLKPFETLLSQNQGGQAFVVGSQISFADYNLLDLLRIHQVLNPSCLDAFPLLSAYVARLSARPKIKAFLASPEHVNRPINGNGKQ</sequence>
				<length>207</length>
				<uniprot>
					<id>P80031</id>
					<start>1</start>
					<end>206</end>
					<coverage>99.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80031</id>
					<start>1</start>
					<end>206</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>7</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>15</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>107</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>109</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>135</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>148</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>167</region_start>
						<region_end>170</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>172</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>185</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>194</region_start>
						<region_end>197</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>3</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF14497.3</region_id>
						<region_name>GST_C_3</region_name>
						<region_start>95</region_start>
						<region_end>194</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Glutathione S-transferase P</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>PPYTITYFPVRGRCEAMRMLLADQDQSWKEEVVTMETWPPLKPSCLFRQLPKFQDGDLTLYQSNAILRHLGRSFGLYGKDQKEAALVDMVNDGVEDLRCKYATLIYTNYEAGKEKYVKELPEHLKPFETLLSQNQGGQAFVVGSQISFADYNLLDLLRIHQVLNPSCLDAFPLLSAYVARLSARPKIKAFLASPEHVNRPINGNGKQ</sequence>
				<length>207</length>
				<uniprot>
					<id>P80031</id>
					<start>1</start>
					<end>206</end>
					<coverage>99.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80031</id>
					<start>1</start>
					<end>206</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>7</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>29</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>38</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>52</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>58</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>135</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>148</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>172</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>185</region_start>
						<region_end>192</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>194</region_start>
						<region_end>197</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>3</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF14497.3</region_id>
						<region_name>GST_C_3</region_name>
						<region_start>95</region_start>
						<region_end>194</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Guanidine hydrochloride and urea induced denaturation of the dimer is well described by a two-state model involving significant populations of only the folded dimer and unfolded monomer. Neither a folded, active monomeric form nor stable unfolding intermediates were detected (PMID:1930226).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110018</accession>
		<general>
			<name>Glutathione S-transferase (Schistosoma japonicum)</name>
			<pdb_id>4wr4</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Schistosoma japonicum</source_organism>
			<publication>
				<pmid>25985257</pmid>
				<authors>Ohtake K, Yamaguchi A, Mukai T, Kashimura H, Hirano N, Haruki M, Kohashi S, Yamagishi K, Murayama K, Tomabechi Y, Itagaki T, Akasaka R, Kawazoe M, Takemoto C, Shirouzu M, Yokoyama S, Sakamoto K</authors>
				<title>Protein stabilization utilizing a redefined codon.</title>
				<journal>Sci Rep</journal>
				<year>2015</year>
				<volume>5</volume>
				<pages>9762</pages>
				<abstract>Recent advances have fundamentally changed the ways in which synthetic amino acids are incorporated into proteins, enabling their efficient and multiple-site incorporation, in addition to the 20 canonical amino acids. This development provides opportunities for fresh approaches toward addressing fundamental problems in bioengineering. In the present study, we showed that the structural stability of proteins can be enhanced by integrating bulky halogenated amino acids at multiple selected sites. Glutathione S-transferase was thus stabilized significantly (by 5.2 and 5.6 kcal/mol) with 3-chloro- and 3-bromo-l-tyrosines, respectively, incorporated at seven selected sites. X-ray crystallographic analyses revealed that the bulky halogen moieties filled internal spaces within the molecules, and formed non-canonical stabilizing interactions with the neighboring residues. This new mechanism for protein stabilization is quite simple and applicable to a wide range of proteins, as demonstrated by the rapid stabilization of the industrially relevant azoreductase.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004364</accession>
					<name>glutathione transferase activity</name>
				</go>
			</molecular_function>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Glutathione S-transferase class-mu 26 kDa isozyme</name>
				<source_organism>Schistosoma japonicum</source_organism>
				<sequence>MASMTGGQQMGRDPGANSGVTKNSYSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKSD</sequence>
				<length>244</length>
				<uniprot>
					<id>P08515</id>
					<start>2</start>
					<end>217</end>
					<coverage>99.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08515</id>
					<start>2</start>
					<end>217</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>5</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>72</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>120</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>148</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>151</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>156</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>165</region_start>
						<region_end>172</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>181</region_start>
						<region_end>191</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>194</region_start>
						<region_end>200</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>3</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF14497.3</region_id>
						<region_name>GST_C_3</region_name>
						<region_start>100</region_start>
						<region_end>196</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Glutathione S-transferase class-mu 26 kDa isozyme</name>
				<source_organism>Schistosoma japonicum</source_organism>
				<sequence>MASMTGGQQMGRDPGANSGVTKNSYSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKSD</sequence>
				<length>244</length>
				<uniprot>
					<id>P08515</id>
					<start>2</start>
					<end>217</end>
					<coverage>99.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08515</id>
					<start>2</start>
					<end>217</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>5</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>13</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>31</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>41</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>61</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>68</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>72</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>120</region_start>
						<region_end>141</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>148</region_start>
						<region_end>148</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>151</region_start>
						<region_end>151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>156</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>165</region_start>
						<region_end>172</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>181</region_start>
						<region_end>191</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>194</region_start>
						<region_end>200</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02798.17</region_id>
						<region_name>GST_N</region_name>
						<region_start>3</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF14497.3</region_id>
						<region_name>GST_C_3</region_name>
						<region_start>100</region_start>
						<region_end>196</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Data of the urea- and temperature-induced unfolding of the dimer indicate the absence of thermodynamically stable intermediates and that the unfolding/refolding transition is a two-state process involving folded native dimer and unfolded monomer. Thermograms obtained by differential scanning microcalorimetry also fitted a two-state unfolding transition model (PMID:9041642).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1b8x</pdb_id>
			<pdb_id>1bg5</pdb_id>
			<pdb_id>1dug</pdb_id>
			<pdb_id>1gne</pdb_id>
			<pdb_id>1gta</pdb_id>
			<pdb_id>1gtb</pdb_id>
			<pdb_id>1m99</pdb_id>
			<pdb_id>1m9a</pdb_id>
			<pdb_id>1m9b</pdb_id>
			<pdb_id>1u87</pdb_id>
			<pdb_id>1u88</pdb_id>
			<pdb_id>1ua5</pdb_id>
			<pdb_id>1y6e</pdb_id>
			<pdb_id>3crt</pdb_id>
			<pdb_id>3cru</pdb_id>
			<pdb_id>3d0z</pdb_id>
			<pdb_id>3qmz</pdb_id>
			<pdb_id>4ai6</pdb_id>
			<pdb_id>4akg</pdb_id>
			<pdb_id>4akh</pdb_id>
			<pdb_id>4aki</pdb_id>
			<pdb_id>4ecb</pdb_id>
			<pdb_id>4ecc</pdb_id>
			<pdb_id>4wr5</pdb_id>
			<pdb_id>5gzz</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210014</accession>
		<general>
			<name>Monellin</name>
			<pdb_id>1krl</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.90</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Dioscoreophyllum cumminsii</source_organism>
			<publication>
				<pmid>9878408</pmid>
				<authors>Hung LW, Kohmura M, Ariyoshi Y, Kim SH</authors>
				<title>Structural differences in D and L-monellin in the crystals of racemic mixture.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1999</year>
				<issue>1</issue>
				<volume>285</volume>
				<pages>311-21</pages>
				<abstract>The racemic mixture of synthetic d and l-monellin has been crystallized, and its structure has been determined by X-ray crystallography at 1.9 A resolution. The crystal structure consists of two d and two l-monellin molecules in the P1 unit cell with a pseudo-centrosymmetrical arrangement. The final structure reveals small but significant structural differences between d and l-monellin in the same crystal. Possible reasons for these differences and their implications are discussed.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Monellin chain A</name>
				<source_organism>Dioscoreophyllum cumminsii</source_organism>
				<sequence>REIKGYEYQLYVYASDKLFRADISEDYKTRGRKLLRFNGPVPPP</sequence>
				<length>44</length>
				<uniprot>
					<id>P02881</id>
					<start>2</start>
					<end>45</end>
					<coverage>97.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02881</id>
					<start>2</start>
					<end>45</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>6</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>18</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09200.7</region_id>
						<region_name>Monellin</region_name>
						<region_start>2</region_start>
						<region_end>44</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Monellin chain B</name>
				<source_organism>Dioscoreophyllum cumminsii</source_organism>
				<sequence>GEWEIIDIGPFTQNLGKFAVDEENKIGQYGRLTFNKVIRPCMKKTIYEEN</sequence>
				<length>50</length>
				<uniprot>
					<id>P02882</id>
					<start>1</start>
					<end>50</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02882</id>
					<start>1</start>
					<end>50</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>6</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>34</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09200.7</region_id>
						<region_name>Monellin</region_name>
						<region_start>1</region_start>
						<region_end>40</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The two chains of monellin have been shown to be unstructured prior to assembly of the dimer. While the native dimeric structure is reached through various competing pathways entailing different intermediates, these partially structured states can only arise after the encounter complex has been formed (PMID:22542529).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3mon</pdb_id>
			<pdb_id>4mon</pdb_id>
			<pdb_id>3pxm</pdb_id>
			<pdb_id>3pyj</pdb_id>
			<pdb_id>3q2p</pdb_id>
			<pdb_id>5lc6</pdb_id>
			<pdb_id>5lc7</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120027</accession>
		<general>
			<name>Bacterial antitoxin CcdA</name>
			<pdb_id>2adl</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>17007877</pmid>
				<authors>Madl T, Van Melderen L, Mine N, Respondek M, Oberer M, Keller W, Khatai L, Zangger K</authors>
				<title>Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2006</year>
				<issue>2</issue>
				<volume>364</volume>
				<pages>170-85</pages>
				<abstract>Toxin-antitoxin systems are highly abundant in plasmids and bacterial chromosomes. They ensure plasmid maintenance by killing bacteria that have lost the plasmid. Their expression is autoregulated at the level of transcription. Here, we present the solution structure of CcdA, the antitoxin of the ccd system, as a free protein (16.7 kDa) and in complex with its cognate DNA (25.3 kDa). CcdA is composed of two distinct and independent domains: the N-terminal domain, responsible for DNA binding, which establishes a new family of the ribbon-helix-helix fold and the C-terminal region, which is responsible for the interaction with the toxin CcdB. The C-terminal domain is intrinsically unstructured and forms a tight complex with the toxin. We show that CcdA specifically recognizes a 6 bp palindromic DNA sequence within the operator-promoter (OP) region of the ccd operon and binds to DNA by insertion of the positively charged N-terminal beta-sheet into the major groove. The binding of up to three CcdA dimers to a 33mer DNA of its operator-promoter region was studied by NMR spectroscopy, isothermal titration calorimetry and single point mutation. The highly flexible C-terminal region of free CcdA explains its susceptibility to proteolysis by the Lon ATP-dependent protease.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin CcdA</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MKQRITVTVDSDSYQLLKAYDVNISGLVSTTMQNEARRLRAERWKVENQEGMVEVARFIEMNGSFADENKDW</sequence>
				<length>72</length>
				<uniprot>
					<id>P62552</id>
					<start>1</start>
					<end>72</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62553</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07362.9</region_id>
						<region_name>CcdA</region_name>
						<region_start>2</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Antitoxin CcdA</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MKQRITVTVDSDSYQLLKAYDVNISGLVSTTMQNEARRLRAERWKVENQEGMVEVARFIEMNGSFADENKDW</sequence>
				<length>72</length>
				<uniprot>
					<id>P62552</id>
					<start>1</start>
					<end>72</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62553</id>
					<start>1</start>
					<end>72</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>18</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07362.9</region_id>
						<region_name>CcdA</region_name>
						<region_start>2</region_start>
						<region_end>72</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:17007877). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2adn</pdb_id>
			<pdb_id>2h3a</pdb_id>
			<pdb_id>2h3c</pdb_id>
			<pdb_id>3g7z</pdb_id>
			<pdb_id>3hpw</pdb_id>
			<pdb_id>3tcj</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF6110001</accession>
		<general>
			<name>Nucleoside diphosphate kinase (Dictyostelium discoideum)</name>
			<pdb_id>1npk</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homohexamer</assembly>
			<source_organism>Dictyostelium discoideum</source_organism>
			<publication>
				<pmid>7966307</pmid>
				<authors>Moréra S, LeBras G, Lascu I, Lacombe ML, Véron M, Janin J</authors>
				<title>Refined X-ray structure of Dictyostelium discoideum nucleoside diphosphate kinase at 1.8 A resolution.</title>
				<journal>J. Mol. Biol.</journal>
				<year>1994</year>
				<issue>5</issue>
				<volume>243</volume>
				<pages>873-90</pages>
				<abstract>The X-ray structure of the nucleoside diphosphate kinase (NDP kinase) from Dictyostelium discoideum has been refined at 1.8 A resolution from a hexagonal crystal form with a 17 kDa monomer in its asymmetric unit. The atomic model was derived from the previously determined structure of a point mutant of the protein. It contains 150 amino acid residues out of 155, and 95 solvent molecules. The R-factor is 0.196 and the estimated accuracy of the average atomic position, 0.25 A. The Dictyostelium structure is described in detail and compared to those of Drosophila and Myxococcus xanthus NDP kinases. The protein is a hexamer with D3 symmetry. Residues 8 to 138 of each subunit form a globular alpha/beta domain. The four-stranded beta-sheet is antiparallel; its topology is different from other phosphate transfer enzymes, and also from the HPr protein which, like NDP kinase, carries a phosphorylated histidine. The same topology is nevertheless found in several other proteins that bind mononucleotides, RNA or DNA. Strand connections in NDP kinase involve alpha-helices and a 20-residue segment called the Kpn loop. The beta-sheet is regular except for a beta-bulge in edge strand beta 2 and a gamma-turn at residue Ile120 just preceding strand beta 4. The latter may induce strain in the main chain near the active site His122. The alpha 1 beta 2 motif participates in forming dimers within the hexamer, helices alpha 1 and alpha 3, the Kpn loop and C terminus, in forming trimers. The subunit fold and dimer interactions found in Dictyostelium are conserved in other NDP kinases. Trimer interactions probably occur in all eukaryotic enzymes. They are absent in the bacterial Myxococcus xanthus enzyme which is a tetramer, even though the subunit structure is very similar. In Dictyostelium, contacts between Kpn loops near the 3-fold axis block access to a central cavity lined with polar residues and filled with well-defined solvent molecules. Biochemical data on point mutants highlight the contribution of the Kpn loop to protein stability. In Myxococcus, the Kpn loops are on the tetramer surface and their sequence is poorly conserved. Yet, their conformation is maintained and they make a similar contribution to the substrate binding site.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0004550</accession>
					<name>nucleoside diphosphate kinase activity</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006414</accession>
					<name>translational elongation</name>
				</go>
				<go>
					<accession>GO:0009617</accession>
					<name>response to bacterium</name>
				</go>
				<go>
					<accession>GO:0007186</accession>
					<name>G-protein coupled receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0048550</accession>
					<name>negative regulation of pinocytosis</name>
				</go>
				<go>
					<accession>GO:0006187</accession>
					<name>dGTP biosynthetic process from dGDP</name>
				</go>
				<go>
					<accession>GO:0006228</accession>
					<name>UTP biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0006183</accession>
					<name>GTP biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0006241</accession>
					<name>CTP biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0045920</accession>
					<name>negative regulation of exocytosis</name>
				</go>
				<go>
					<accession>GO:0006186</accession>
					<name>dGDP phosphorylation</name>
				</go>
				<go>
					<accession>GO:0016049</accession>
					<name>cell growth</name>
				</go>
				<go>
					<accession>GO:0050765</accession>
					<name>negative regulation of phagocytosis</name>
				</go>
				<go>
					<accession>GO:0030036</accession>
					<name>actin cytoskeleton organization</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005840</accession>
					<name>ribosome</name>
				</go>
				<go>
					<accession>GO:0030141</accession>
					<name>secretory granule</name>
				</go>
				<go>
					<accession>GO:0005856</accession>
					<name>cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0045335</accession>
					<name>phagocytic vesicle</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B, C, D, E and F were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>6</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homohexameric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Nucleoside diphosphate kinase, cytosolic</name>
				<source_organism>Dictyostelium discoideum</source_organism>
				<sequence>STNKVNKERTFLAVKPDGVARGLVGEIIARYEKKGFVLVGLKQLVPTKDLAESHYAEHKERPFFGGLVSFITSGPVVAMVFEGKGVVASARLMIGVTNPLASAPGSIRGDFGVDVGRNIIHGSDSVESANREIALWFKPEELLTEVKPNPNLYE</sequence>
				<length>154</length>
				<uniprot>
					<id>P22887</id>
					<start>2</start>
					<end>155</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22887</id>
					<start>2</start>
					<end>155</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>10</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>35</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>38</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>59</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>72</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>77</region_start>
						<region_end>83</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>87</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>115</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>118</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>127</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>140</region_start>
						<region_end>142</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00334.16</region_id>
						<region_name>NDK</region_name>
						<region_start>9</region_start>
						<region_end>143</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The hexameric NDP kinase from Dictyostelium discoideum displays one single, irreversible differential scanning calorimetry peak (Tm=62Â°C) over a broad protein concentration, indicating a single step denaturation. However, the P105G substitution, which affects a loop implicated in subunit contacts, yields a protein that reversibly dissociates to folded monomers at 38Â°C before the irreversible denaturation occurs (Tm=47Â°C). These data indicate a âcouplingâ of the quaternary structure with the tertiary structure in the wild-type, but not in the mutated protein (PMID:8663370).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1b4s</pdb_id>
			<pdb_id>1b99</pdb_id>
			<pdb_id>1bux</pdb_id>
			<pdb_id>1f3f</pdb_id>
			<pdb_id>1f6t</pdb_id>
			<pdb_id>1hhq</pdb_id>
			<pdb_id>1hiy</pdb_id>
			<pdb_id>1hlw</pdb_id>
			<pdb_id>1kdn</pdb_id>
			<pdb_id>1leo</pdb_id>
			<pdb_id>1lwx</pdb_id>
			<pdb_id>1mn7</pdb_id>
			<pdb_id>1mn9</pdb_id>
			<pdb_id>1ncl</pdb_id>
			<pdb_id>1ndc</pdb_id>
			<pdb_id>1ndk</pdb_id>
			<pdb_id>1ndp</pdb_id>
			<pdb_id>1nsp</pdb_id>
			<pdb_id>1pae</pdb_id>
			<pdb_id>1s5z</pdb_id>
			<pdb_id>2bef</pdb_id>
			<pdb_id>3fkb</pdb_id>
			<pdb_id>4c6a</pdb_id>
			<pdb_id>4cp5</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100014</accession>
		<general>
			<name>Superoxide dismutase (SOD)</name>
			<pdb_id>2c9v</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.07</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>16406071</pmid>
				<authors>Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, Hasnain SS</authors>
				<title>Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2006</year>
				<issue>5</issue>
				<volume>356</volume>
				<pages>1152-62</pages>
				<abstract>Human Cu-Zn superoxide dismutase (SOD1) protects cells from the effects of oxidative stress. Mutations in SOD1 are linked to the familial form of amyotrophic lateral sclerosis. Several hypotheses for their toxicity involve the mis-metallation of the enzyme. We present atomic-resolution crystal structures and biophysical data for human SOD1 in three metallation states: Zn-Zn, Cu-Zn and as-isolated. These data represent the first atomic-resolution structures for human SOD1, the first structure of a reduced SOD1, and the first structure of a fully Zn-substituted SOD1 enzyme. Recombinantly expressed as-isolated SOD1 contains a mixture of Zn and Cu at the Cu-binding site. The Zn-Zn structure appears to be at least as stable as the correctly (Cu-Zn) metallated enzyme. These data raise the possibility that in a cellular environment with low availability of free copper, Zn-Zn may be the preferred metallation state of SOD1 prior to its interaction with the copper chaperone.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004784</accession>
					<name>superoxide dismutase activity</name>
				</go>
				<go>
					<accession>GO:0008270</accession>
					<name>zinc ion binding</name>
				</go>
				<go>
					<accession>GO:0051087</accession>
					<name>chaperone binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0030346</accession>
					<name>protein phosphatase 2B binding</name>
				</go>
				<go>
					<accession>GO:0005507</accession>
					<name>copper ion binding</name>
				</go>
				<go>
					<accession>GO:0048365</accession>
					<name>Rac GTPase binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0046688</accession>
					<name>response to copper ion</name>
				</go>
				<go>
					<accession>GO:0007605</accession>
					<name>sensory perception of sound</name>
				</go>
				<go>
					<accession>GO:0001890</accession>
					<name>placenta development</name>
				</go>
				<go>
					<accession>GO:0043087</accession>
					<name>regulation of GTPase activity</name>
				</go>
				<go>
					<accession>GO:0071318</accession>
					<name>cellular response to ATP</name>
				</go>
				<go>
					<accession>GO:0000187</accession>
					<name>activation of MAPK activity</name>
				</go>
				<go>
					<accession>GO:0048678</accession>
					<name>response to axon injury</name>
				</go>
				<go>
					<accession>GO:0045471</accession>
					<name>response to ethanol</name>
				</go>
				<go>
					<accession>GO:0050665</accession>
					<name>hydrogen peroxide biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0032287</accession>
					<name>peripheral nervous system myelin maintenance</name>
				</go>
				<go>
					<accession>GO:0060052</accession>
					<name>neurofilament cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0034465</accession>
					<name>response to carbon monoxide</name>
				</go>
				<go>
					<accession>GO:0040014</accession>
					<name>regulation of multicellular organism growth</name>
				</go>
				<go>
					<accession>GO:0006879</accession>
					<name>cellular iron ion homeostasis</name>
				</go>
				<go>
					<accession>GO:0046677</accession>
					<name>response to antibiotic</name>
				</go>
				<go>
					<accession>GO:0008217</accession>
					<name>regulation of blood pressure</name>
				</go>
				<go>
					<accession>GO:0032930</accession>
					<name>positive regulation of superoxide anion generation</name>
				</go>
				<go>
					<accession>GO:0046620</accession>
					<name>regulation of organ growth</name>
				</go>
				<go>
					<accession>GO:0001895</accession>
					<name>retina homeostasis</name>
				</go>
				<go>
					<accession>GO:0007283</accession>
					<name>spermatogenesis</name>
				</go>
				<go>
					<accession>GO:0008089</accession>
					<name>anterograde axonal transport</name>
				</go>
				<go>
					<accession>GO:0007569</accession>
					<name>cell aging</name>
				</go>
				<go>
					<accession>GO:0035865</accession>
					<name>cellular response to potassium ion</name>
				</go>
				<go>
					<accession>GO:0007566</accession>
					<name>embryo implantation</name>
				</go>
				<go>
					<accession>GO:0060047</accession>
					<name>heart contraction</name>
				</go>
				<go>
					<accession>GO:0060088</accession>
					<name>auditory receptor cell stereocilium organization</name>
				</go>
				<go>
					<accession>GO:0051881</accession>
					<name>regulation of mitochondrial membrane potential</name>
				</go>
				<go>
					<accession>GO:0002262</accession>
					<name>myeloid cell homeostasis</name>
				</go>
				<go>
					<accession>GO:0009408</accession>
					<name>response to heat</name>
				</go>
				<go>
					<accession>GO:0001975</accession>
					<name>response to amphetamine</name>
				</go>
				<go>
					<accession>GO:0006749</accession>
					<name>glutathione metabolic process</name>
				</go>
				<go>
					<accession>GO:0033081</accession>
					<name>regulation of T cell differentiation in thymus</name>
				</go>
				<go>
					<accession>GO:0060087</accession>
					<name>relaxation of vascular smooth muscle</name>
				</go>
				<go>
					<accession>GO:0055114</accession>
					<name>oxidation-reduction process</name>
				</go>
				<go>
					<accession>GO:0001541</accession>
					<name>ovarian follicle development</name>
				</go>
				<go>
					<accession>GO:0043524</accession>
					<name>negative regulation of neuron apoptotic process</name>
				</go>
				<go>
					<accession>GO:0097332</accession>
					<name>response to antipsychotic drug</name>
				</go>
				<go>
					<accession>GO:0019430</accession>
					<name>removal of superoxide radicals</name>
				</go>
				<go>
					<accession>GO:1902177</accession>
					<name>positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0007626</accession>
					<name>locomotory behavior</name>
				</go>
				<go>
					<accession>GO:0046716</accession>
					<name>muscle cell cellular homeostasis</name>
				</go>
				<go>
					<accession>GO:0019226</accession>
					<name>transmission of nerve impulse</name>
				</go>
				<go>
					<accession>GO:0002576</accession>
					<name>platelet degranulation</name>
				</go>
				<go>
					<accession>GO:0071276</accession>
					<name>cellular response to cadmium ion</name>
				</go>
				<go>
					<accession>GO:0048538</accession>
					<name>thymus development</name>
				</go>
				<go>
					<accession>GO:0008090</accession>
					<name>retrograde axonal transport</name>
				</go>
				<go>
					<accession>GO:0042554</accession>
					<name>superoxide anion generation</name>
				</go>
				<go>
					<accession>GO:0042542</accession>
					<name>response to hydrogen peroxide</name>
				</go>
				<go>
					<accession>GO:0001819</accession>
					<name>positive regulation of cytokine production</name>
				</go>
				<go>
					<accession>GO:0031667</accession>
					<name>response to nutrient levels</name>
				</go>
				<go>
					<accession>GO:0045541</accession>
					<name>negative regulation of cholesterol biosynthetic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:1904115</accession>
					<name>axon cytoplasm</name>
				</go>
				<go>
					<accession>GO:0031012</accession>
					<name>extracellular matrix</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0032839</accession>
					<name>dendrite cytoplasm</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
				<go>
					<accession>GO:0005777</accession>
					<name>peroxisome</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0043209</accession>
					<name>myelin sheath</name>
				</go>
				<go>
					<accession>GO:0005758</accession>
					<name>mitochondrial intermembrane space</name>
				</go>
				<go>
					<accession>GO:0005764</accession>
					<name>lysosome</name>
				</go>
				<go>
					<accession>GO:0005759</accession>
					<name>mitochondrial matrix</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005615</accession>
					<name>extracellular space</name>
				</go>
				<go>
					<accession>GO:0031045</accession>
					<name>dense core granule</name>
				</go>
				<go>
					<accession>GO:0043025</accession>
					<name>neuronal cell body</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Superoxide dismutase [Cu-Zn]</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ</sequence>
				<length>153</length>
				<uniprot>
					<id>P00441</id>
					<start>2</start>
					<end>154</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00441</id>
					<start>2</start>
					<end>154</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>3</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>30</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>42</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>96</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>109</region_start>
						<region_end>111</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>133</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>144</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>151</region_start>
						<region_end>152</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00080.17</region_id>
						<region_name>Sod_Cu</region_name>
						<region_start>9</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Superoxide dismutase [Cu-Zn]</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ</sequence>
				<length>153</length>
				<uniprot>
					<id>P00441</id>
					<start>2</start>
					<end>154</end>
					<coverage>99.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P00441</id>
					<start>2</start>
					<end>154</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>15</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>30</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>42</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>61</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>64</region_start>
						<region_end>64</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>96</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>106</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>112</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>117</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>135</region_start>
						<region_end>138</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>144</region_start>
						<region_end>149</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>151</region_start>
						<region_end>152</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00080.17</region_id>
						<region_name>Sod_Cu</region_name>
						<region_start>9</region_start>
						<region_end>150</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>CD measurements and a global analysis decomposition of the time-resolved fluorescence decay over denaturant concentration shows the presence of an intermediate in the unfolding of human SOD by guanidinium hydrochloride. Considering previous measurements of partially denatured HSOD as a function of protein concentration (PMID:1510915), these results strongly suggest that the unfolding intermediate is a monomer that displays a molten globule state (PMID:8298055).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1azv</pdb_id>
			<pdb_id>1ba9</pdb_id>
			<pdb_id>1dsw</pdb_id>
			<pdb_id>1fun</pdb_id>
			<pdb_id>1hl4</pdb_id>
			<pdb_id>1hl5</pdb_id>
			<pdb_id>1kmg</pdb_id>
			<pdb_id>1l3n</pdb_id>
			<pdb_id>1mfm</pdb_id>
			<pdb_id>1n18</pdb_id>
			<pdb_id>1n19</pdb_id>
			<pdb_id>1oez</pdb_id>
			<pdb_id>1ozt</pdb_id>
			<pdb_id>1ozu</pdb_id>
			<pdb_id>1p1v</pdb_id>
			<pdb_id>1ptz</pdb_id>
			<pdb_id>1pu0</pdb_id>
			<pdb_id>1rk7</pdb_id>
			<pdb_id>1sos</pdb_id>
			<pdb_id>1spd</pdb_id>
			<pdb_id>1uxl</pdb_id>
			<pdb_id>1uxm</pdb_id>
			<pdb_id>2af2</pdb_id>
			<pdb_id>2c9s</pdb_id>
			<pdb_id>2c9u</pdb_id>
			<pdb_id>2gbt</pdb_id>
			<pdb_id>2gbu</pdb_id>
			<pdb_id>2gbv</pdb_id>
			<pdb_id>2lu5</pdb_id>
			<pdb_id>2mp3</pdb_id>
			<pdb_id>2nnx</pdb_id>
			<pdb_id>2r27</pdb_id>
			<pdb_id>2v0a</pdb_id>
			<pdb_id>2vr6</pdb_id>
			<pdb_id>2vr7</pdb_id>
			<pdb_id>2vr8</pdb_id>
			<pdb_id>2wko</pdb_id>
			<pdb_id>2wyt</pdb_id>
			<pdb_id>2wyz</pdb_id>
			<pdb_id>2wz0</pdb_id>
			<pdb_id>2wz5</pdb_id>
			<pdb_id>2wz6</pdb_id>
			<pdb_id>2xjk</pdb_id>
			<pdb_id>2xjl</pdb_id>
			<pdb_id>2zkw</pdb_id>
			<pdb_id>2zkx</pdb_id>
			<pdb_id>2zky</pdb_id>
			<pdb_id>3cqp</pdb_id>
			<pdb_id>3cqq</pdb_id>
			<pdb_id>3ecu</pdb_id>
			<pdb_id>3ecv</pdb_id>
			<pdb_id>3ecw</pdb_id>
			<pdb_id>3gqf</pdb_id>
			<pdb_id>3gtv</pdb_id>
			<pdb_id>3gzo</pdb_id>
			<pdb_id>3gzp</pdb_id>
			<pdb_id>3gzq</pdb_id>
			<pdb_id>3h2p</pdb_id>
			<pdb_id>3h2q</pdb_id>
			<pdb_id>3hff</pdb_id>
			<pdb_id>3k91</pdb_id>
			<pdb_id>3kh3</pdb_id>
			<pdb_id>3kh4</pdb_id>
			<pdb_id>3ltv</pdb_id>
			<pdb_id>3qqd</pdb_id>
			<pdb_id>3re0</pdb_id>
			<pdb_id>3t5w</pdb_id>
			<pdb_id>4a7g</pdb_id>
			<pdb_id>4a7q</pdb_id>
			<pdb_id>4a7s</pdb_id>
			<pdb_id>4a7t</pdb_id>
			<pdb_id>4a7u</pdb_id>
			<pdb_id>4a7v</pdb_id>
			<pdb_id>4b3e</pdb_id>
			<pdb_id>4bcy</pdb_id>
			<pdb_id>4bcz</pdb_id>
			<pdb_id>4bd4</pdb_id>
			<pdb_id>4ff9</pdb_id>
			<pdb_id>4mcm</pdb_id>
			<pdb_id>4mcn</pdb_id>
			<pdb_id>4nin</pdb_id>
			<pdb_id>4nio</pdb_id>
			<pdb_id>4nip</pdb_id>
			<pdb_id>4oh2</pdb_id>
			<pdb_id>4sod</pdb_id>
			<pdb_id>4xcr</pdb_id>
			<pdb_id>5dli</pdb_id>
			<pdb_id>2nam</pdb_id>
			<pdb_id>5j0f</pdb_id>
			<pdb_id>5j0g</pdb_id>
			<pdb_id>5k02</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120028</accession>
		<general>
			<name>Subtilisin inhibitor (SSI)</name>
			<pdb_id>3ssi</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Streptomyces albogriseolus</source_organism>
			<publication>
				<authors>Suzuki, T.</authors>
				<title>Structural Modulation of the Protein Proteinase Inhibitor Ssi (Streptomyces Subtilisin Inhibitor)</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004867</accession>
					<name>serine-type endopeptidase inhibitor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010951</accession>
					<name>negative regulation of endopeptidase activity</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Subtilisin inhibitor</name>
				<source_organism>Streptomyces albogriseolus</source_organism>
				<sequence>DAPSALYAPSALVLTVGKGVSATTAAPERAVTLTCAPGPSGTHPAAGSACADLAAVGGDLNALTRGEDVMCPMVYDPVLLTVDGVWQGKRVSYERVFSNECEMNAHGSSVFAF</sequence>
				<length>113</length>
				<uniprot>
					<id>P01006</id>
					<start>32</start>
					<end>144</end>
					<coverage>78.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01006</id>
					<start>32</start>
					<end>144</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>42</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>96</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>109</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>131</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00720.14</region_id>
						<region_name>SSI</region_name>
						<region_start>39</region_start>
						<region_end>130</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Subtilisin inhibitor</name>
				<source_organism>Streptomyces albogriseolus</source_organism>
				<sequence>DAPSALYAPSALVLTVGKGVSATTAAPERAVTLTCAPGPSGTHPAAGSACADLAAVGGDLNALTRGEDVMCPMVYDPVLLTVDGVWQGKRVSYERVFSNECEMNAHGSSVFAF</sequence>
				<length>113</length>
				<uniprot>
					<id>P01006</id>
					<start>32</start>
					<end>144</end>
					<coverage>78.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01006</id>
					<start>32</start>
					<end>144</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>42</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>60</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>71</region_start>
						<region_end>71</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>96</region_start>
						<region_end>96</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>109</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>120</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>131</region_start>
						<region_end>134</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>137</region_start>
						<region_end>137</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00720.14</region_id>
						<region_name>SSI</region_name>
						<region_start>39</region_start>
						<region_end>130</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The thermal unfolding of SSI has been studied by differential scanning calorimetry (DSC). The DSC data show that dimeric SSI remains dimeric as the temperature is raised until it unfolds and that it then dissociates during the unfolding process (PMID:7030385).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2sic</pdb_id>
			<pdb_id>3sic</pdb_id>
			<pdb_id>5sic</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110019</accession>
		<general>
			<name>4-aminobutyrate aminotransferase</name>
			<pdb_id>1ohv</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Sus scrofa</source_organism>
			<publication>
				<pmid>14534310</pmid>
				<authors>Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, Silverman RB, Schirmer T</authors>
				<title>Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2004</year>
				<issue>1</issue>
				<volume>279</volume>
				<pages>363-73</pages>
				<abstract>Gamma-aminobutyric acid aminotransferase (GABA-AT) is a pyridoxal 5&apos;-phosphate-dependent enzyme responsible for the degradation of the inhibitory neurotransmitter GABA. GABA-AT is a validated target for antiepilepsy drugs because its selective inhibition raises GABA concentrations in brain. The antiepilepsy drug, gamma-vinyl-GABA (vigabatrin) has been investigated in the past by various biochemical methods and resulted in several proposals for its mechanisms of inactivation. In this study we solved and compared the crystal structures of pig liver GABA-AT in its native form (to 2.3-A resolution) and in complex with vigabatrin as well as with the close analogue gamma-ethynyl-GABA (to 2.3 and 2.8 A, respectively). Both inactivators form a covalent ternary adduct with the active site Lys-329 and the pyridoxal 5'-phosphate (PLP) cofactor. The crystal structures provide direct support for specific inactivation mechanisms proposed earlier on the basis of radio-labeling experiments. The reactivity of GABA-AT crystals with the two GABA analogues was also investigated by polarized absorption microspectrophotometry. The spectral data are discussed in relation to the proposed mechanism. Intriguingly, all three structures revealed a [2Fe-2S] cluster of yet unknown function at the center of the dimeric molecule in the vicinity of the PLP cofactors.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0032145</accession>
					<name>succinate-semialdehyde dehydrogenase binding</name>
				</go>
				<go>
					<accession>GO:0003867</accession>
					<name>4-aminobutyrate transaminase activity</name>
				</go>
				<go>
					<accession>GO:0051537</accession>
					<name>2 iron, 2 sulfur cluster binding</name>
				</go>
				<go>
					<accession>GO:0030170</accession>
					<name>pyridoxal phosphate binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0047298</accession>
					<name>(S)-3-amino-2-methylpropionate transaminase activity</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0042135</accession>
					<name>neurotransmitter catabolic process</name>
				</go>
				<go>
					<accession>GO:0048148</accession>
					<name>behavioral response to cocaine</name>
				</go>
				<go>
					<accession>GO:0009450</accession>
					<name>gamma-aminobutyric acid catabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005759</accession>
					<name>mitochondrial matrix</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0032144</accession>
					<name>4-aminobutyrate transaminase complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically active dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>4-aminobutyrate aminotransferase, mitochondrial</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>SQAAAKVDVEFDYDGPLMKTEVPGPRSRELMKQLNIIQNAEAVHFFCNYEESRGNYLVDVDGNRMLDLYSQISSIPIGYSHPALVKLVQQPQNVSTFINRPALGILPPENFVEKLRESLLSVAPKGMSQLITMACGSCSNENAFKTIFMWYRSKERGQSAFSKEELETCMINQAPGCPDYSILSFMGAFHGRTMGCLATTHSKAIHKIDIPSFDWPIAPFPRLKYPLEEFVKENQQEEARCLEEVEDLIVKYRKKKKTVAGIIVEPIQSEGGDNHASDDFFRKLRDISRKHGCAFLVDEVQTGGGSTGKFWAHEHWGLDDPADVMTFSKKMMTGGFFHKEEFRPNAPYRIFNTWLGDPSKNLLLAEVINIIKREDLLSNAAHAGKVLLTGLLDLQARYPQFISRVRGRGTFCSFDTPDESIRNKLISIARNKGVMLGGCGDKSIRFRPTLVFRDHHAHLFLNIFSDILADFK</sequence>
				<length>472</length>
				<uniprot>
					<id>P80147</id>
					<start>39</start>
					<end>499</end>
					<coverage>92.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80147</id>
					<start>39</start>
					<end>499</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>92</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>98</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>107</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>110</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>119</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>139</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>147</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>157</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>164</region_start>
						<region_end>184</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>191</region_start>
						<region_end>198</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>209</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>222</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>232</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>245</region_start>
						<region_end>246</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>255</region_start>
						<region_end>257</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>259</region_start>
						<region_end>282</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>287</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>296</region_start>
						<region_end>296</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>302</region_start>
						<region_end>302</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>306</region_start>
						<region_end>318</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>326</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>344</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>352</region_start>
						<region_end>355</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>357</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>362</region_start>
						<region_end>366</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>368</region_start>
						<region_end>370</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>401</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>404</region_start>
						<region_end>425</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>431</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>439</region_start>
						<region_end>443</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>447</region_start>
						<region_end>459</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>462</region_start>
						<region_end>463</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>465</region_start>
						<region_end>467</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>471</region_start>
						<region_end>474</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>482</region_start>
						<region_end>497</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00202.18</region_id>
						<region_name>Aminotran_3</region_name>
						<region_start>65</region_start>
						<region_end>496</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>4-aminobutyrate aminotransferase, mitochondrial</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>SQAAAKVDVEFDYDGPLMKTEVPGPRSRELMKQLNIIQNAEAVHFFCNYEESRGNYLVDVDGNRMLDLYSQISSIPIGYSHPALVKLVQQPQNVSTFINRPALGILPPENFVEKLRESLLSVAPKGMSQLITMACGSCSNENAFKTIFMWYRSKERGQSAFSKEELETCMINQAPGCPDYSILSFMGAFHGRTMGCLATTHSKAIHKIDIPSFDWPIAPFPRLKYPLEEFVKENQQEEARCLEEVEDLIVKYRKKKKTVAGIIVEPIQSEGGDNHASDDFFRKLRDISRKHGCAFLVDEVQTGGGSTGKFWAHEHWGLDDPADVMTFSKKMMTGGFFHKEEFRPNAPYRIFNTWLGDPSKNLLLAEVINIIKREDLLSNAAHAGKVLLTGLLDLQARYPQFISRVRGRGTFCSFDTPDESIRNKLISIARNKGVMLGGCGDKSIRFRPTLVFRDHHAHLFLNIFSDILADFK</sequence>
				<length>472</length>
				<uniprot>
					<id>P80147</id>
					<start>39</start>
					<end>499</end>
					<coverage>92.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P80147</id>
					<start>39</start>
					<end>499</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>53</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>75</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>84</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>92</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>98</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>107</region_start>
						<region_end>107</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>110</region_start>
						<region_end>117</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>119</region_start>
						<region_end>126</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>136</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>139</region_start>
						<region_end>145</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>147</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>157</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>164</region_start>
						<region_end>184</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>191</region_start>
						<region_end>198</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>209</region_start>
						<region_end>213</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>222</region_start>
						<region_end>227</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>232</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>245</region_start>
						<region_end>246</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>255</region_start>
						<region_end>257</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>259</region_start>
						<region_end>282</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>287</region_start>
						<region_end>292</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>296</region_start>
						<region_end>296</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>302</region_start>
						<region_end>302</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>306</region_start>
						<region_end>318</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>322</region_start>
						<region_end>326</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>340</region_start>
						<region_end>344</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>352</region_start>
						<region_end>355</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>357</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>362</region_start>
						<region_end>366</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>368</region_start>
						<region_end>370</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>401</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>404</region_start>
						<region_end>425</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>431</region_start>
						<region_end>436</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>439</region_start>
						<region_end>443</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>447</region_start>
						<region_end>459</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>462</region_start>
						<region_end>463</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>465</region_start>
						<region_end>467</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>471</region_start>
						<region_end>473</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>482</region_start>
						<region_end>497</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00202.18</region_id>
						<region_name>Aminotran_3</region_name>
						<region_start>65</region_start>
						<region_end>496</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The unfolding of pig liver 4-aminobutyrate aminotransferase by urea has been investigated at equilibrium. Unfolding of the enzyme was monitored by circular dichroism and fluorescence spectroscopy. The steepness of the fluorescence and CD changes between 2 and 8 M urea, and the lack of any discernible plateau suggests that unfolding of the protein is a cooperative process. The unfolding of 4-aminobutyrate aminotransferase as a function of urea concentration was monitored by fluorescence measurements of the tryptophanyl residues. The kinetic results indicate that the aminotransferase unfolds in a single kinetic phase (PMID:8075151).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ohw</pdb_id>
			<pdb_id>1ohy</pdb_id>
			<pdb_id>4y0d</pdb_id>
			<pdb_id>4y0h</pdb_id>
			<pdb_id>4y0i</pdb_id>
			<pdb_id>4zsw</pdb_id>
			<pdb_id>4zsy</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140011</accession>
		<general>
			<name>Dimeric Mnt repressor</name>
			<pdb_id>1mnt</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Enterobacteria phage P22</source_organism>
			<publication>
				<pmid>7999761</pmid>
				<authors>Burgering MJ, Boelens R, Gilbert DE, Breg JN, Knight KL, Sauer RT, Kaptein R</authors>
				<title>Solution structure of dimeric Mnt repressor (1-76).</title>
				<journal>Biochemistry</journal>
				<year>1994</year>
				<issue>50</issue>
				<volume>33</volume>
				<pages>15036-45</pages>
				<abstract>Wild-type Mnt repressor of Salmonella bacteriophage P22 is a tetrameric protein of 82 residues per monomer. A C-terminal deletion mutant of the repressor denoted Mnt (1-76) is a dimer in solution. The structure of this dimer has been determined using NMR. The NMR assignments of the majority of the 1H, 15N, and 13C resonances were obtained using 2D and triple-resonance 3D techniques. Elements of secondary structure were identified on the basis of characteristic sequential and medium range NOEs. For the structure determination more than 1000 NOEs per monomer were obtained, and structures were generated using distance geometry and restrained simulated annealing calculations. The discrimination of intra- vs intermonomer NOEs was based upon the observation of intersubunit NOEs in [15N,13C] double half-filtered NOESY experiments. The N-terminal part of Mnt (residues 1-44), which shows a 40% sequence homology with the Arc repressor, has a similar secondary and tertiary structure. Mnt (1-76) continues with a loop region of irregular structure, a third alpha-helix, and a random coil C-terminal peptide. Analysis of the secondary structure NOEs, the exchange rates, and the backbone chemical shifts suggests that the carboxy-terminal third helix is less stable than the remainder of the protein, but the observation of intersubunit NOEs for this part of the protein enables the positioning of this helix. The rsmd&apos;s between the backbone atoms of the N-terminal part of the Mnt repressor (residues 5-43, 5'-43') and the Arc repressor is 1.58 A, and between this region and the corresponding part of the MetJ repressor 1.43 A.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>ARDDPHFNFRMPMEVREKLKFRAEANGRSMNSELLQIVQDALSKPSPVTGYRNDAERLADEQSELVKKMVFDTLKD</sequence>
				<length>76</length>
				<uniprot>
					<id>P03049</id>
					<start>2</start>
					<end>77</end>
					<coverage>91.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>2</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>11</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>24</region_start>
						<region_end>27</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03869.11</region_id>
						<region_name>Arc</region_name>
						<region_start>2</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Regulatory protein mnt</name>
				<source_organism>Enterobacteria phage P22</source_organism>
				<sequence>ARDDPHFNFRMPMEVREKLKFRAEANGRSMNSELLQIVQDALSKPSPVTGYRNDAERLADEQSELVKKMVFDTLKD</sequence>
				<length>76</length>
				<uniprot>
					<id>P03049</id>
					<start>2</start>
					<end>77</end>
					<coverage>91.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03049</id>
					<start>2</start>
					<end>77</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>7</region_start>
						<region_end>9</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>56</region_start>
						<region_end>63</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03869.11</region_id>
						<region_name>Arc</region_name>
						<region_start>2</region_start>
						<region_end>51</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11423.5</region_id>
						<region_name>Repressor_Mnt</region_name>
						<region_start>53</region_start>
						<region_end>80</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The Mnt repressor shows a high degree of sequential and structural similarity with the Arc and MetJ repressors (PMID:7999761). Both of these close homologues of Mnt repressor have been shown to adopt a stable structure only via dimerization (PMID:8110744, PMID:1390748)</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2140012</accession>
		<general>
			<name>Dimeric serine proteinase from Semliki Forest virus core protein</name>
			<pdb_id>1vcq</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.10</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Semliki forest virus</source_organism>
			<publication>
				<pmid>9094737</pmid>
				<authors>Choi HK, Lu G, Lee S, Wengler G, Rossmann MG</authors>
				<title>Structure of Semliki Forest virus core protein.</title>
				<journal>Proteins</journal>
				<year>1997</year>
				<issue>3</issue>
				<volume>27</volume>
				<pages>345-59</pages>
				<abstract>Alphaviruses are enveloped, insect-borne viruses, which contains a positive-sense RNA genome. The protein capsid is surrounded by a lipid membrane, which is penetrated by glycoprotein spikes. The structure of the Sindbis virus (SINV) (the type virus) core protein (SCP) was previously determined and found to have a chymotrypsin-like structure. SCP is a serine proteinase which cleaves itself from a polyprotein. Semliki Forest virus (SFV) is among the most distantly related alphaviruses to SINV. Similar to SCP, autocatalysis is inhibited in SFCP after cleavage of the polyprotein by leaving the carboxy-terminal tryptophan in the specificity pocket. The structures of two different crystal forms (I and II) of SFV core protein (SFCP) have been determined to 3.0 A and 3.3 A resolution, respectively. The SFCP monomer backbone structure is very similar to that of SCP. The dimeric association between monomers, A and B, found in two different crystal forms of SCP is also present in both crystal forms of SFCP. However, a third monomer, C, occurs in SFCP crystal form I. While monomers A and B make a tail-to-tail dimer contact, monomers B and C make a head-to-head dimer contact. A hydrophobic pocket on the surface of the capsid protein, the proposed site of binding of the E2 glycoprotein, has large conformational differences with respect to SCP and, in contrast to SCP, is found devoid of bound peptide. In particular, Tyr184 is pointing out of the hydrophobic pocket in SFCP, whereas the equivalent tyrosine in SCP is pointing into the pocket. The conformation of Tyr184, found in SFCP, is consistent with its availability for iodination, as observed in the homologous SINV cores. This suggests, by comparison with SCP, that E2 binding to cores causes major conformational changes, including the burial of Tyr184, which would stabilize the intact virus on budding from an infected cell. The head-to-tail contacts found in the pentameric and hexameric associations within the virion utilize in the same monomer surface regions as found in the crystalline dimer interfaces.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0004252</accession>
					<name>serine-type endopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0005198</accession>
					<name>structural molecule activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
				<go>
					<accession>GO:0006508</accession>
					<name>proteolysis</name>
				</go>
				<go>
					<accession>GO:0019068</accession>
					<name>virion assembly</name>
				</go>
				<go>
					<accession>GO:0075512</accession>
					<name>clathrin-mediated endocytosis of virus by host cell</name>
				</go>
				<go>
					<accession>GO:0019062</accession>
					<name>virion attachment to host cell</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0039619</accession>
					<name>T=4 icosahedral viral capsid</name>
				</go>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0020002</accession>
					<name>host cell plasma membrane</name>
				</go>
				<go>
					<accession>GO:0044174</accession>
					<name>host cell endosome</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Homooligomeric enzymes</class>
				<subclass>Homodimeric enzymes</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Structural polyprotein</name>
				<source_organism>Semliki forest virus</source_organism>
				<sequence>CIFEVKHEGKVTGYACLVGDKVMKPAHVKGVIDNADLAKLAFKKSSKYDLECAQIPVHMRSDASKYTHEKPEGHYNWHHGAVQYSGGRFTIPTGAGKPGDSGRPIFDNKGRVVAIVLGGANEGSRTALSVVTWNKDMVTRVTPEGSEEW</sequence>
				<length>149</length>
				<uniprot>
					<id>P03315</id>
					<start>119</start>
					<end>267</end>
					<coverage>11.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03315</id>
					<start>119</start>
					<end>267</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>125</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>140</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>143</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>149</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>153</region_start>
						<region_end>156</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>161</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>172</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>175</region_start>
						<region_end>180</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>182</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>184</region_start>
						<region_end>184</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>191</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>198</region_start>
						<region_end>202</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>207</region_start>
						<region_end>210</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>222</region_start>
						<region_end>224</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>230</region_start>
						<region_end>240</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>243</region_start>
						<region_end>251</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>256</region_start>
						<region_end>259</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00944.16</region_id>
						<region_name>Peptidase_S3</region_name>
						<region_start>112</region_start>
						<region_end>268</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Structural polyprotein</name>
				<source_organism>Semliki forest virus</source_organism>
				<sequence>CIFEVKHEGKVTGYACLVGDKVMKPAHVKGVIDNADLAKLAFKKSSKYDLECAQIPVHMRSDASKYTHEKPEGHYNWHHGAVQYSGGRFTIPTGAGKPGDSGRPIFDNKGRVVAIVLGGANEGSRTALSVVTWNKDMVTRVTPEGSEEW</sequence>
				<length>149</length>
				<uniprot>
					<id>P03315</id>
					<start>119</start>
					<end>267</end>
					<coverage>11.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03315</id>
					<start>119</start>
					<end>267</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>121</region_start>
						<region_end>125</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>128</region_start>
						<region_end>133</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>135</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>139</region_start>
						<region_end>140</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>149</region_start>
						<region_end>150</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>153</region_start>
						<region_end>156</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>163</region_start>
						<region_end>163</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>168</region_start>
						<region_end>168</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>171</region_start>
						<region_end>172</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>175</region_start>
						<region_end>180</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>182</region_start>
						<region_end>182</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>184</region_start>
						<region_end>184</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>191</region_start>
						<region_end>195</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>198</region_start>
						<region_end>202</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>207</region_start>
						<region_end>210</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>222</region_start>
						<region_end>224</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>230</region_start>
						<region_end>240</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>243</region_start>
						<region_end>251</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>256</region_start>
						<region_end>259</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>264</region_start>
						<region_end>264</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00944.16</region_id>
						<region_name>Peptidase_S3</region_name>
						<region_start>112</region_start>
						<region_end>268</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 119-260 region described in DisProt entry DP00999 covers 95.3% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 119-260 region described in DisProt entry DP00999 covers 95.3% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1dyl</pdb_id>
			<pdb_id>1vcp</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140013</accession>
		<general>
			<name>Influenza A NEP M1-binding domain</name>
			<pdb_id>1pd3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Influenza A virus</source_organism>
			<publication>
				<pmid>12970177</pmid>
				<authors>Akarsu H, Burmeister WP, Petosa C, Petit I, Müller CW, Ruigrok RW, Baudin F</authors>
				<title>Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2).</title>
				<journal>EMBO J.</journal>
				<year>2003</year>
				<issue>18</issue>
				<volume>22</volume>
				<pages>4646-55</pages>
				<abstract>During influenza virus infection, viral ribonucleoproteins (vRNPs) are replicated in the nucleus and must be exported to the cytoplasm before assembling into mature viral particles. Nuclear export is mediated by the cellular protein Crm1 and putatively by the viral protein NEP/NS2. Proteolytic cleavage of NEP defines an N-terminal domain which mediates RanGTP-dependent binding to Crm1 and a C-terminal domain which binds to the viral matrix protein M1. The 2.6 A crystal structure of the C-terminal domain reveals an amphipathic helical hairpin which dimerizes as a four-helix bundle. The NEP-M1 interaction involves two critical epitopes: an exposed tryptophan (Trp78) surrounded by a cluster of glutamate residues on NEP, and the basic nuclear localization signal (NLS) of M1. Implications for vRNP export are discussed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006405</accession>
					<name>RNA export from nucleus</name>
				</go>
				<go>
					<accession>GO:0019072</accession>
					<name>viral genome packaging</name>
				</go>
				<go>
					<accession>GO:0019083</accession>
					<name>viral transcription</name>
				</go>
				<go>
					<accession>GO:0019061</accession>
					<name>uncoating of virus</name>
				</go>
				<go>
					<accession>GO:0019065</accession>
					<name>receptor-mediated endocytosis of virus by host cell</name>
				</go>
				<go>
					<accession>GO:0019064</accession>
					<name>fusion of virus membrane with host plasma membrane</name>
				</go>
				<go>
					<accession>GO:0039675</accession>
					<name>exit of virus from host cell nucleus through nuclear pore</name>
				</go>
				<go>
					<accession>GO:0019062</accession>
					<name>virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0046761</accession>
					<name>viral budding from plasma membrane</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030666</accession>
					<name>endocytic vesicle membrane</name>
				</go>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0031904</accession>
					<name>endosome lumen</name>
				</go>
				<go>
					<accession>GO:0019012</accession>
					<name>virion</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric, forming a 4-helix bundle)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Nuclear export protein</name>
				<source_organism>Influenza A virus</source_organism>
				<sequence>QNRNGKWREQLGQKFEEIRWLIEEVRHRLKITENSFEQITFMQALQLLLEVEQEIRTF</sequence>
				<length>58</length>
				<uniprot>
					<id>P03508</id>
					<start>59</start>
					<end>116</end>
					<coverage>47.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03506</id>
					<start>59</start>
					<end>116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>64</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>115</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00601.16</region_id>
						<region_name>Flu_NS2</region_name>
						<region_start>28</region_start>
						<region_end>121</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Nuclear export protein</name>
				<source_organism>Influenza A virus</source_organism>
				<sequence>QNRNGKWREQLGQKFEEIRWLIEEVRHRLKITENSFEQITFMQALQLLLEVEQEIRTF</sequence>
				<length>58</length>
				<uniprot>
					<id>P03508</id>
					<start>59</start>
					<end>116</end>
					<coverage>47.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03506</id>
					<start>59</start>
					<end>116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>65</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>114</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00601.16</region_id>
						<region_name>Flu_NS2</region_name>
						<region_start>28</region_start>
						<region_end>121</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-121 region described in DisProt entry DP00871 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-121 region described in DisProt entry DP00871 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120029</accession>
		<general>
			<name>SinR dimerization domain</name>
			<pdb_id>2yal</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.27</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Bacillus subtilis</source_organism>
			<publication>
				<pmid>21708175</pmid>
				<authors>Colledge VL, Fogg MJ, Levdikov VM, Leech A, Dodson EJ, Wilkinson AJ</authors>
				<title>Structure and organisation of SinR, the master regulator of biofilm formation in Bacillus subtilis.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2011</year>
				<issue>3</issue>
				<volume>411</volume>
				<pages>597-613</pages>
				<abstract>sinR encodes a tetrameric repressor of genes required for biofilm formation in Bacillus subtilis. sinI, which is transcribed under Spo0A control, encodes a dimeric protein that binds to SinR to form a SinR-SinI heterodimer in which the DNA-binding functions of SinR are abrogated and repression of biofilm genes is relieved. The heterodimer-forming surface comprises residues conserved between SinR and SinI. Each forms a pair of α-helices that hook together to form an intermolecular four-helix bundle. Here, we are interested in the assembly of the SinR tetramer and its binding to DNA. Size-exclusion chromatography with multi-angle laser light scattering and crystallographic analysis reveal that a DNA-binding fragment of SinR (residues 1-69) is a monomer, while a SinI-binding fragment (residues 74-111) is a tetramer arranged as a dimer of dimers. The SinR(74-111) chain forms two α-helices with the organisation of the dimer similar to that observed in the SinR-SinI complex. The tetramer is formed through interactions of residues at the C-termini of the four chains. A model of the intact SinR tetramer in which the DNA binding domains surround the tetramerisation core was built. Fluorescence anisotropy and surface plasmon resonance experiments showed that SinR binds to an oligonucleotide duplex, 5&apos;-TTTGTTCTCTAAAGAGAACTTA-3', containing a pair of SinR consensus sequences in inverted orientation with a K(d) of 300 nM. The implications of these data for promoter binding and the curious quaternary structural transitions of SinR upon binding to (i) SinI and (ii) the SinR-like protein SlrR, which &amp;quot;repurposes" SinR as a repressor of autolysin and motility genes, are discussed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0010629</accession>
					<name>negative regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0030435</accession>
					<name>sporulation resulting in formation of a cellular spore</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>HTH-type transcriptional regulator SinR</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>GPAIDSEWEKLVRDAMTSGVSKKQFREFLDYQKWRKSQKEE</sequence>
				<length>41</length>
				<uniprot>
					<id>P06533</id>
					<start>71</start>
					<end>111</end>
					<coverage>36.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06533</id>
					<start>74</start>
					<end>111</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>76</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>94</region_start>
						<region_end>107</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08671.7</region_id>
						<region_name>SinI</region_name>
						<region_start>74</region_start>
						<region_end>101</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>HTH-type transcriptional regulator SinR</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>GPAIDSEWEKLVRDAMTSGVSKKQFREFLDYQKWRKSQKEE</sequence>
				<length>41</length>
				<uniprot>
					<id>P06533</id>
					<start>71</start>
					<end>111</end>
					<coverage>36.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06533</id>
					<start>74</start>
					<end>111</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>77</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08671.7</region_id>
						<region_name>SinI</region_name>
						<region_start>74</region_start>
						<region_end>101</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The C-terminal dimerization regions of SirR is highly mobile evading structure determination by X-ray (PMID:23430750).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The C-terminal dimerization regions of SirR is highly mobile evading structure determination by X-ray (PMID:23430750).</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3zkc</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110020</accession>
		<general>
			<name>The mid-region of tropomyosin</name>
			<pdb_id>2b9c</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Bos taurus</source_organism>
			<publication>
				<pmid>16365313</pmid>
				<authors>Brown JH, Zhou Z, Reshetnikova L, Robinson H, Yammani RD, Tobacman LS, Cohen C</authors>
				<title>Structure of the mid-region of tropomyosin: bending and binding sites for actin.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2005</year>
				<issue>52</issue>
				<volume>102</volume>
				<pages>18878-83</pages>
				<abstract>Tropomyosin is a two-chain alpha-helical coiled coil whose periodic interactions with the F-actin helix are critical for thin filament stabilization and the regulation of muscle contraction. Here we deduce the mechanical and chemical basis of these interactions from the 2.3-A-resolution crystal structure of the middle three of tropomyosin&apos;s seven periods. Geometrically specific bends of the coiled coil, produced by clusters of core alanines, and variable bends about gaps in the core, produced by isolated alanines, occur along the molecule. The crystal packing is notable in signifying that the functionally important fifth period includes an especially favorable protein-binding site, comprising an unusual apolar patch on the surface together with surrounding charged residues. Based on these and other results, we have constructed a specific model of the thin filament, with the N-terminal halves of each period (i.e., the so-called &amp;quot;alpha zones") of tropomyosin axially aligned with subdomain 3 of each monomer in F-actin.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003779</accession>
					<name>actin binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005856</accession>
					<name>cytoskeleton</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tropomyosin alpha-1 chain</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>MNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEELKTVTNNLKSLEDKVEELLSKNYHLENEVARLKKLVGE</sequence>
				<length>147</length>
				<uniprot>
					<id>Q5KR49</id>
					<start>88</start>
					<end>225</end>
					<coverage>48.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09493</id>
					<start>88</start>
					<end>225</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>103</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>123</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>125</region_start>
						<region_end>209</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>214</region_start>
						<region_end>225</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00261.17</region_id>
						<region_name>Tropomyosin</region_name>
						<region_start>48</region_start>
						<region_end>284</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tropomyosin alpha-1 chain</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>MNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEELKTVTNNLKSLEDKVEELLSKNYHLENEVARLKKLVGE</sequence>
				<length>147</length>
				<uniprot>
					<id>Q5KR49</id>
					<start>88</start>
					<end>225</end>
					<coverage>48.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09493</id>
					<start>88</start>
					<end>225</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>100</region_start>
						<region_end>143</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>145</region_start>
						<region_end>225</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00261.17</region_id>
						<region_name>Tropomyosin</region_name>
						<region_start>48</region_start>
						<region_end>284</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16365313). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2d3e</pdb_id>
			<pdb_id>2efr</pdb_id>
			<pdb_id>2efs</pdb_id>
			<pdb_id>2tma</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120030</accession>
		<general>
			<name>Antitoxin RelB</name>
			<pdb_id>2k29</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>18501926</pmid>
				<authors>Li GY, Zhang Y, Inouye M, Ikura M</authors>
				<title>Structural mechanism of transcriptional autorepression of the Escherichia coli RelB/RelE antitoxin/toxin module.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2008</year>
				<issue>1</issue>
				<volume>380</volume>
				<pages>107-19</pages>
				<abstract>The Escherichia coli chromosomal relBE operon encodes a toxin-antitoxin system, which is autoregulated by its protein products, RelB and RelE. RelB acts as a transcriptional repressor and RelE functions as a cofactor to enhance the repressor activity of RelB. Here, we present the NMR-derived structure of a RelB dimer and show that a RelB dimer recognizes a hexad repeat in the palindromic operator region through a ribbon-helix-helix motif. Our biochemical data show that two weakly associated RelB dimers bind to the adjacent repeats in the 3&apos;-site of the operator (O(R)) at a moderate affinity (K(d), approximately 10(-5) M). However, in the presence of RelE, a RelB tetramer binds two distinct binding sites within the operator region, each with an enhanced affinity (K(d), approximately 10(-6) M for the low-affinity site, O(L), and 10(-8) M for the high-affinity site, O(R)). We propose that the enhanced affinity for the operator element is mediated by a cooperative DNA binding by a pair of RelB dimers and that the interaction between RelB dimers is strongly augmented by the presence of the cognate toxin RelE.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Antitoxin RelB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GSHMGSINLRIDDELKARSYAALEKMGVTPSEALRLMLEYIADNERLPFKQTL</sequence>
				<length>53</length>
				<uniprot>
					<id>P0C079</id>
					<start>1</start>
					<end>50</end>
					<coverage>63.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0C079</id>
					<start>1</start>
					<end>50</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04221.9</region_id>
						<region_name>RelB</region_name>
						<region_start>1</region_start>
						<region_end>79</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Antitoxin RelB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GSHMGSINLRIDDELKARSYAALEKMGVTPSEALRLMLEYIADNERLPFKQTL</sequence>
				<length>53</length>
				<uniprot>
					<id>P0C079</id>
					<start>1</start>
					<end>50</end>
					<coverage>63.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P0C079</id>
					<start>1</start>
					<end>50</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>2</region_start>
						<region_end>8</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>10</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF04221.9</region_id>
						<region_name>RelB</region_name>
						<region_start>1</region_start>
						<region_end>79</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:18501926). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4fxe</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2140014</accession>
		<general>
			<name>Dimerization domain of the rabies virus phosphoprotein </name>
			<pdb_id>3l32</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.50</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Rabies virus</source_organism>
			<publication>
				<pmid>20089657</pmid>
				<authors>Ivanov I, Crépin T, Jamin M, Ruigrok RW</authors>
				<title>Structure of the dimerization domain of the rabies virus phosphoprotein.</title>
				<journal>J. Virol.</journal>
				<year>2010</year>
				<issue>7</issue>
				<volume>84</volume>
				<pages>3707-10</pages>
				<abstract>The crystal structure of the dimerization domain of rabies virus phosphoprotein was determined. The monomer consists of two alpha-helices that make a helical hairpin held together mainly by hydrophobic interactions. The monomer has a hydrophilic and a hydrophobic face, and in the dimer two monomers pack together through their hydrophobic surfaces. This structure is very different from the dimerization domain of the vesicular stomatitis virus phosphoprotein and also from the tetramerization domain of the Sendai virus phosphoprotein, suggesting that oligomerization is conserved but not structure.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003968</accession>
					<name>RNA-directed RNA polymerase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0039564</accession>
					<name>suppression by virus of host STAT2 activity</name>
				</go>
				<go>
					<accession>GO:0019083</accession>
					<name>viral transcription</name>
				</go>
				<go>
					<accession>GO:0046718</accession>
					<name>viral entry into host cell</name>
				</go>
				<go>
					<accession>GO:0039502</accession>
					<name>suppression by virus of host type I interferon-mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0001172</accession>
					<name>transcription, RNA-templated</name>
				</go>
				<go>
					<accession>GO:0075521</accession>
					<name>microtubule-dependent intracellular transport of viral material towards nucleus</name>
				</go>
				<go>
					<accession>GO:0039563</accession>
					<name>suppression by virus of host STAT1 activity</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
				<go>
					<accession>GO:0019012</accession>
					<name>virion</name>
				</go>
				<go>
					<accession>GO:0030430</accession>
					<name>host cell cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Phosphoprotein</name>
				<source_organism>Rabies virus</source_organism>
				<sequence>MNLLFQSYLDNVGVQIVRQMRSGERFLKIWSQTVEEIVSYVTVNF</sequence>
				<length>45</length>
				<uniprot>
					<id>Q0GBY3</id>
					<start>89</start>
					<end>133</end>
					<coverage>15.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22363</id>
					<start>90</start>
					<end>133</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>108</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03012.11</region_id>
						<region_name>PP_M1</region_name>
						<region_start>1</region_start>
						<region_end>296</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Phosphoprotein</name>
				<source_organism>Rabies virus</source_organism>
				<sequence>MNLLFQSYLDNVGVQIVRQMRSGERFLKIWSQTVEEIVSYVTVNF</sequence>
				<length>45</length>
				<uniprot>
					<id>Q0GBY3</id>
					<start>89</start>
					<end>133</end>
					<coverage>15.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P22363</id>
					<start>90</start>
					<end>133</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>91</region_start>
						<region_end>109</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>132</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03012.11</region_id>
						<region_name>PP_M1</region_name>
						<region_start>1</region_start>
						<region_end>296</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The C-terminal dimerization region of SirR is highly mobile evading structure determination by X-ray (PDB:3oa1).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The C-terminal dimerization region of SirR is highly mobile evading structure determination by X-ray (PDB:3oa1).</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2140015</accession>
		<general>
			<name>Capsid protein C fragment from dengue virus capsid protein</name>
			<pdb_id>1r6r</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Dengue virus type 2</source_organism>
			<publication>
				<pmid>14993605</pmid>
				<authors>Ma L, Jones CT, Groesch TD, Kuhn RJ, Post CB</authors>
				<title>Solution structure of dengue virus capsid protein reveals another fold.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2004</year>
				<issue>10</issue>
				<volume>101</volume>
				<pages>3414-9</pages>
				<abstract>Dengue virus is responsible for approximately 50-100 million infections, resulting in nearly 24,000 deaths annually. The capsid (C) protein of dengue virus is essential for specific encapsidation of the RNA genome, but little structural information on the C protein is available. We report the solution structure of the 200-residue homodimer of dengue 2 C protein. The structure provides, to our knowledge, the first 3D picture of a flavivirus C protein and identifies a fold that includes a large dimerization surface contributed by two pairs of helices, one of which has characteristics of a coiled-coil. NMR structure determination involved a secondary structure sorting approach to facilitate assignment of the intersubunit nuclear Overhauser effect interactions. The dimer of dengue C protein has an unusually high net charge, and the structure reveals an asymmetric distribution of basic residues over the surface of the protein. Nearly half of the basic residues lie along one face of the dimer. In contrast, the conserved hydrophobic region forms an extensive apolar surface at a dimer interface on the opposite side of the molecule. We propose a model for the interaction of dengue C protein with RNA and the viral membrane that is based on the asymmetric charge distribution of the protein and is consistent with previously reported results.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008026</accession>
					<name>ATP-dependent helicase activity</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0003725</accession>
					<name>double-stranded RNA binding</name>
				</go>
				<go>
					<accession>GO:0004482</accession>
					<name>mRNA (guanine-N7-)-methyltransferase activity</name>
				</go>
				<go>
					<accession>GO:0003968</accession>
					<name>RNA-directed RNA polymerase activity</name>
				</go>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0070008</accession>
					<name>serine-type exopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0003724</accession>
					<name>RNA helicase activity</name>
				</go>
				<go>
					<accession>GO:0004483</accession>
					<name>mRNA (nucleoside-2'-O-)-methyltransferase activity</name>
				</go>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0004252</accession>
					<name>serine-type endopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0005198</accession>
					<name>structural molecule activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006508</accession>
					<name>proteolysis</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0036265</accession>
					<name>RNA (guanine-N7)-methylation</name>
				</go>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
				<go>
					<accession>GO:0039502</accession>
					<name>suppression by virus of host type I interferon-mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0006370</accession>
					<name>7-methylguanosine mRNA capping</name>
				</go>
				<go>
					<accession>GO:0039564</accession>
					<name>suppression by virus of host STAT2 activity</name>
				</go>
				<go>
					<accession>GO:0001172</accession>
					<name>transcription, RNA-templated</name>
				</go>
				<go>
					<accession>GO:0039694</accession>
					<name>viral RNA genome replication</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0075512</accession>
					<name>clathrin-mediated endocytosis of virus by host cell</name>
				</go>
				<go>
					<accession>GO:0019062</accession>
					<name>virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0080009</accession>
					<name>mRNA methylation</name>
				</go>
				<go>
					<accession>GO:0039520</accession>
					<name>induction by virus of host autophagy</name>
				</go>
				<go>
					<accession>GO:0039574</accession>
					<name>suppression by virus of host TYK2 activity</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
				<go>
					<accession>GO:0044167</accession>
					<name>host cell endoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0019028</accession>
					<name>viral capsid</name>
				</go>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Genome polyprotein</name>
				<source_organism>Dengue virus type 2</source_organism>
				<sequence>MNDQRKKARNTPFNMLKRERNRVSTVQQLTKRFSLGMLQGRGPLKLFMALVAFLRFLTIPPTAGILKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR</sequence>
				<length>100</length>
				<uniprot>
					<id>P12823</id>
					<start>1</start>
					<end>100</end>
					<coverage>3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P29991</id>
					<start>1</start>
					<end>100</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>5</region_start>
						<region_end>118</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Genome polyprotein</name>
				<source_organism>Dengue virus type 2</source_organism>
				<sequence>MNDQRKKARNTPFNMLKRERNRVSTVQQLTKRFSLGMLQGRGPLKLFMALVAFLRFLTIPPTAGILKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR</sequence>
				<length>100</length>
				<uniprot>
					<id>P12823</id>
					<start>1</start>
					<end>100</end>
					<coverage>3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P29991</id>
					<start>1</start>
					<end>100</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>32</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>75</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>5</region_start>
						<region_end>118</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-100 region described in DisProt entry DP00876 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-100 region described in DisProt entry DP00876 covers 100% of a close homologue of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110021</accession>
		<general>
			<name>ID2 HLH homodimer</name>
			<pdb_id>4aya</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Sus scrofa</source_organism>
			<publication>
				<pmid>23119064</pmid>
				<authors>Wong MV, Jiang S, Palasingam P, Kolatkar PR</authors>
				<title>A Divalent Ion Is Crucial in the Structure and Dominant-Negative Function of ID Proteins, a Class of Helix-Loop-Helix Transcription Regulators.</title>
				<journal>PLoS ONE</journal>
				<year>2012</year>
				<issue>10</issue>
				<volume>7</volume>
				<pages>e48591</pages>
				<abstract>Inhibitors of DNA binding and differentiation (ID) proteins, a dominant-negative group of helix-loop-helix (HLH) transcription regulators, are well-characterized key players in cellular fate determination during development in mammals as well as Drosophila. Although not oncogenes themselves, their upregulation by various oncogenic proteins (such as Ras, Myc) and their inhibitory effects on cell cycle proteins (such as pRb) hint at their possible roles in tumorigenesis. Furthermore, their potency as inhibitors of cellular differentiation, through their heterodimerization with subsequent inactivation of the ubiquitous E proteins, suggest possible novel roles in engineering induced pluripotent stem cells (iPSCs). We present the high-resolution 2.1Å crystal structure of ID2 (HLH domain), coupled with novel biochemical insights in the presence of a divalent ion, possibly calcium (Ca2+), in the loop of ID proteins, which appear to be crucial for the structure and activity of ID proteins. These new insights will pave the way for new rational drug designs, in addition to current synthetic peptide options, against this potent player in tumorigenesis as well as more efficient ways for stem cells reprogramming.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0044325</accession>
					<name>ion channel binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045777</accession>
					<name>positive regulation of blood pressure</name>
				</go>
				<go>
					<accession>GO:0045648</accession>
					<name>positive regulation of erythrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0045893</accession>
					<name>positive regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0048541</accession>
					<name>Peyer's patch development</name>
				</go>
				<go>
					<accession>GO:0021772</accession>
					<name>olfactory bulb development</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0014003</accession>
					<name>oligodendrocyte development</name>
				</go>
				<go>
					<accession>GO:0060612</accession>
					<name>adipose tissue development</name>
				</go>
				<go>
					<accession>GO:0061031</accession>
					<name>endodermal digestive tract morphogenesis</name>
				</go>
				<go>
					<accession>GO:0048557</accession>
					<name>embryonic digestive tract morphogenesis</name>
				</go>
				<go>
					<accession>GO:0048469</accession>
					<name>cell maturation</name>
				</go>
				<go>
					<accession>GO:0003166</accession>
					<name>bundle of His development</name>
				</go>
				<go>
					<accession>GO:0032922</accession>
					<name>circadian regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0048667</accession>
					<name>cell morphogenesis involved in neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0045665</accession>
					<name>negative regulation of neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0045475</accession>
					<name>locomotor rhythm</name>
				</go>
				<go>
					<accession>GO:2000045</accession>
					<name>regulation of G1/S transition of mitotic cell cycle</name>
				</go>
				<go>
					<accession>GO:0071285</accession>
					<name>cellular response to lithium ion</name>
				</go>
				<go>
					<accession>GO:0019216</accession>
					<name>regulation of lipid metabolic process</name>
				</go>
				<go>
					<accession>GO:0048663</accession>
					<name>neuron fate commitment</name>
				</go>
				<go>
					<accession>GO:0061030</accession>
					<name>epithelial cell differentiation involved in mammary gland alveolus development</name>
				</go>
				<go>
					<accession>GO:0090398</accession>
					<name>cellular senescence</name>
				</go>
				<go>
					<accession>GO:0043153</accession>
					<name>entrainment of circadian clock by photoperiod</name>
				</go>
				<go>
					<accession>GO:0048715</accession>
					<name>negative regulation of oligodendrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0043353</accession>
					<name>enucleate erythrocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0071158</accession>
					<name>positive regulation of cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0048661</accession>
					<name>positive regulation of smooth muscle cell proliferation</name>
				</go>
				<go>
					<accession>GO:0001966</accession>
					<name>thigmotaxis</name>
				</go>
				<go>
					<accession>GO:0043392</accession>
					<name>negative regulation of DNA binding</name>
				</go>
				<go>
					<accession>GO:0045600</accession>
					<name>positive regulation of fat cell differentiation</name>
				</go>
				<go>
					<accession>GO:2000178</accession>
					<name>negative regulation of neural precursor cell proliferation</name>
				</go>
				<go>
					<accession>GO:0001656</accession>
					<name>metanephros development</name>
				</go>
				<go>
					<accession>GO:0033598</accession>
					<name>mammary gland epithelial cell proliferation</name>
				</go>
				<go>
					<accession>GO:0045668</accession>
					<name>negative regulation of osteoblast differentiation</name>
				</go>
				<go>
					<accession>GO:0008344</accession>
					<name>adult locomotory behavior</name>
				</go>
				<go>
					<accession>GO:0045651</accession>
					<name>positive regulation of macrophage differentiation</name>
				</go>
				<go>
					<accession>GO:0001779</accession>
					<name>natural killer cell differentiation</name>
				</go>
				<go>
					<accession>GO:0003149</accession>
					<name>membranous septum morphogenesis</name>
				</go>
				<go>
					<accession>GO:0043433</accession>
					<name>negative regulation of sequence-specific DNA binding transcription factor activity</name>
				</go>
				<go>
					<accession>GO:0045578</accession>
					<name>negative regulation of B cell differentiation</name>
				</go>
				<go>
					<accession>GO:0048711</accession>
					<name>positive regulation of astrocyte differentiation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
				<go>
					<accession>GO:0005813</accession>
					<name>centrosome</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Basic helix-loop-helix (bHLH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>DNA-binding protein inhibitor ID-2</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>GMKAFSPVRSVRKNSLSDHSLGISRSKTPVDDPMSLLYNMNDCYSKLKELVPSIPQNKKVSKMEILQHVIDYILDLQIALDSHLKPSFLVQSGDIAS</sequence>
				<length>97</length>
				<uniprot>
					<id>Q2VIU1</id>
					<start>1</start>
					<end>82</end>
					<coverage>61.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P41136</id>
					<start>1</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>35</region_start>
						<region_end>76</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>DNA-binding protein inhibitor ID-2</name>
				<source_organism>Sus scrofa</source_organism>
				<sequence>GMKAFSPVRSVRKNSLSDHSLGISRSKTPVDDPMSLLYNMNDCYSKLKELVPSIPQNKKVSKMEILQHVIDYILDLQIALDSHLKPSFLVQSGDIAS</sequence>
				<length>97</length>
				<uniprot>
					<id>Q2VIU1</id>
					<start>1</start>
					<end>82</end>
					<coverage>61.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P41136</id>
					<start>1</start>
					<end>82</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>61</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>35</region_start>
						<region_end>76</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Monomeric elements of basic helix-loop-helix domains were shown to be natively unfolded with a pH-dependent premolten globule conformation, as shown by several spectroscopic techniques (NMR, fluorescence, FTIR, and circular dichroism) (PMID:20102160, PMID:8303294).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110022</accession>
		<general>
			<name>Cobra venom nerve growth factor (NGF)</name>
			<pdb_id>4ec7</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Naja atra</source_organism>
			<publication>
				<pmid>22649032</pmid>
				<authors>Tong Q, Wang F, Zhou HZ, Sun HL, Song H, Shu YY, Gong Y, Zhang WT, Cai TX, Yang FQ, Tang J, Jiang T</authors>
				<title>Structural and functional insights into lipid-bound nerve growth factors.</title>
				<journal>FASEB J.</journal>
				<year>2012</year>
				<issue>9</issue>
				<volume>26</volume>
				<pages>3811-21</pages>
				<abstract>Nerve growth factor (NGF) is a dimeric molecule that modulates the survival, proliferation, and differentiation of nervous cells and is also known to act on cells of the immune system and endocrine system. NGFs extracted from mouse submaxillary gland and cobra venom have different immunological behaviors, yet the underlying mechanism remains unclear. Here we report the crystal structure of the NGF purified from Chinese cobra Naja naja atra (cNGF), which unexpectedly reveals a 2-tailed lipid molecule that is embedded between the two protomers of the NGF homodimer. In addition, crystallographic analysis indicated that the purified mouse NGF(mNGF) is free from lipid but can bind lysophosphatidylserine (lyso-PS) in the same pocket as cNGF. Bioassays indicated that the binding of lipid molecules to cNGF and mNGF are essential for their mast cell activation activity and abates their p75(NTR) binding capacity. Taken together, these results suggest a new mechanism for the regulation of the function of NGF.-Tong, Q., Wang, F., Zhou, H.-Z., Sun, H.-L., Song, H., Shu, Y.-Y., Gong, Y., Zhang, W.-T., Cai, T.-X., Yang, F.-Q., Tang, J., Jiang, T. Structural and functional insights into lipid-bound nerve growth factors.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008083</accession>
					<name>growth factor activity</name>
				</go>
				<go>
					<accession>GO:0008191</accession>
					<name>metalloendopeptidase inhibitor activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010951</accession>
					<name>negative regulation of endopeptidase activity</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>NGF-like proteins</class>
				<subclass>Homodimeric NGF-like proteins</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Venom nerve growth factor</name>
				<source_organism>Naja atra</source_organism>
				<sequence>EDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKEYFFETKCKNPNPEPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIETACVCVITKKKGN</sequence>
				<length>116</length>
				<uniprot>
					<id>P61898</id>
					<start>1</start>
					<end>116</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P61898</id>
					<start>1</start>
					<end>116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>11</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>42</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>45</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>62</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>74</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>112</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>6</region_start>
						<region_end>115</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Venom nerve growth factor</name>
				<source_organism>Naja atra</source_organism>
				<sequence>EDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKEYFFETKCKNPNPEPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIETACVCVITKKKGN</sequence>
				<length>116</length>
				<uniprot>
					<id>P61898</id>
					<start>1</start>
					<end>116</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P61898</id>
					<start>1</start>
					<end>116</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>11</region_start>
						<region_end>12</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>16</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>25</region_start>
						<region_end>28</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>33</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>39</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>62</region_start>
						<region_end>62</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>65</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>69</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>76</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>110</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00243.15</region_id>
						<region_name>NGF</region_name>
						<region_start>6</region_start>
						<region_end>115</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Various dimeric members of neurotrophic factors (including human/mouse nerve growth factor, human brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5)) have been shown to fold and dimerize at the same time via a two-state process (PMID:8161524). While the members of this family show a significant variance in sequence, they adopt a highly similar structure upon binding and behave almost identically in unfolding/refolding experiments. Thus the two-state folding/binding nature seems to be a hallmark of NGF and closely related proteins.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120031</accession>
		<general>
			<name>SopB dimerization domain</name>
			<pdb_id>3kz5</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.58</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>20236989</pmid>
				<authors>Schumacher MA, Piro KM, Xu W</authors>
				<title>Insight into F plasmid DNA segregation revealed by structures of SopB and SopB-DNA complexes.</title>
				<journal>Nucleic Acids Res.</journal>
				<year>2010</year>
				<issue>13</issue>
				<volume>38</volume>
				<pages>4514-26</pages>
				<abstract>Accurate DNA segregation is essential for genome transmission. Segregation of the prototypical F plasmid requires the centromere-binding protein SopB, the NTPase SopA and the sopC centromere. SopB displays an intriguing range of DNA-binding properties essential for partition; it binds sopC to form a partition complex, which recruits SopA, and it also coats DNA to prevent non-specific SopA-DNA interactions, which inhibits SopA polymerization. To understand the myriad functions of SopB, we determined a series of SopB-DNA crystal structures. SopB does not distort its DNA site and our data suggest that SopB-sopC forms an extended rather than wrapped partition complex with the SopA-interacting domains aligned on one face. SopB is a multidomain protein, which like P1 ParB contains an all-helical DNA-binding domain that is flexibly attached to a compact (beta(3)-alpha)(2) dimer-domain. Unlike P1 ParB, the SopB dimer-domain does not bind DNA. Moreover, SopB contains a unique secondary dimerization motif that bridges between DNA duplexes. Both specific and non-specific SopB-DNA bridging structures were observed. This DNA-linking function suggests a novel mechanism for in trans DNA spreading by SopB, explaining how it might mask DNA to prevent DNA-mediated inhibition of SopA polymerization.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0030541</accession>
					<name>plasmid partitioning</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain A was removed as chains B and E represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>B</id>
				<name>Protein SopB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GSHMSSRHQFAPGATVLYKGDKMVLNLDRSRVPTECIEKIEAILKELEKPAP</sequence>
				<length>52</length>
				<uniprot>
					<id>P62558</id>
					<start>272</start>
					<end>323</end>
					<coverage>16.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62559</id>
					<start>279</start>
					<end>323</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>279</region_start>
						<region_end>282</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>285</region_start>
						<region_end>290</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>293</region_start>
						<region_end>299</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>305</region_start>
						<region_end>318</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Protein SopB</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>GSHMSSRHQFAPGATVLYKGDKMVLNLDRSRVPTECIEKIEAILKELEKPAP</sequence>
				<length>52</length>
				<uniprot>
					<id>P62558</id>
					<start>272</start>
					<end>323</end>
					<coverage>16.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62559</id>
					<start>279</start>
					<end>323</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>279</region_start>
						<region_end>282</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>285</region_start>
						<region_end>290</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>293</region_start>
						<region_end>299</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>305</region_start>
						<region_end>318</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The C-terminal dimerization region of SopB is highly mobile evading structure determination by X-ray (PMID:20236989).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>E</chain_id>
				<support>The C-terminal dimerization region of SopB is highly mobile evading structure determination by X-ray (PMID:20236989).</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110023</accession>
		<general>
			<name>Basic HLH/leucine zipper domain of apo MITF</name>
			<pdb_id>4ath</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.95</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Mus musculus</source_organism>
			<publication>
				<pmid>23207919</pmid>
				<authors>Pogenberg V, Ogmundsdóttir MH, Bergsteinsdóttir K, Schepsky A, Phung B, Deineko V, Milewski M, Steingrímsson E, Wilmanns M</authors>
				<title>Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF.</title>
				<journal>Genes Dev.</journal>
				<year>2012</year>
				<issue>23</issue>
				<volume>26</volume>
				<pages>2647-58</pages>
				<abstract>Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and an important oncogene in melanoma. MITF heterodimeric assembly with related basic helix-loop-helix leucine zipper transcription factors is highly restricted, and its binding profile to cognate DNA sequences is distinct. Here, we determined the crystal structure of MITF in its apo conformation and in the presence of two related DNA response elements, the E-box and M-box. In addition, we investigated mouse and human Mitf mutations to dissect the functional significance of structural features. Owing to an unusual three-residue shift in the leucine zipper register, the MITF homodimer shows a marked kink in one of the two zipper helices to allow an out-of-register assembly. Removal of this insertion relieves restricted heterodimerization by MITF and permits assembly with the transcription factor MAX. Binding of MITF to the M-box motif is mediated by an unusual nonpolar interaction by Ile212, a residue that is mutated in mice and humans with Waardenburg syndrome. As several related transcription factors have low affinity for the M-box sequence, our analysis unravels how these proteins discriminate between similar target sequences. Our data provide a rational basis for targeting MITF in the treatment of important hereditary diseases and cancer.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0000978</accession>
					<name>RNA polymerase II core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003705</accession>
					<name>transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0000979</accession>
					<name>RNA polymerase II core promoter sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0030318</accession>
					<name>melanocyte differentiation</name>
				</go>
				<go>
					<accession>GO:0006461</accession>
					<name>protein complex assembly</name>
				</go>
				<go>
					<accession>GO:0044336</accession>
					<name>canonical Wnt signaling pathway involved in negative regulation of apoptotic process</name>
				</go>
				<go>
					<accession>GO:0046849</accession>
					<name>bone remodeling</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:2000144</accession>
					<name>positive regulation of DNA-templated transcription, initiation</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0045165</accession>
					<name>cell fate commitment</name>
				</go>
				<go>
					<accession>GO:0045670</accession>
					<name>regulation of osteoclast differentiation</name>
				</go>
				<go>
					<accession>GO:0097531</accession>
					<name>mast cell migration</name>
				</go>
				<go>
					<accession>GO:0030316</accession>
					<name>osteoclast differentiation</name>
				</go>
				<go>
					<accession>GO:0043010</accession>
					<name>camera-type eye development</name>
				</go>
				<go>
					<accession>GO:0042127</accession>
					<name>regulation of cell proliferation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
				<go>
					<accession>GO:0043234</accession>
					<name>protein complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Basic helix-loop-helix (bHLH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Microphthalmia-associated transcription factor</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GAMRFNINDRIKELGTLIPKSNDPDMRWNKGTILKASVDYIRKLQREQQRAKDLENRQKKLEHANRHLLLRVQELEMQARAHG</sequence>
				<length>83</length>
				<uniprot>
					<id>Q08874</id>
					<start>321</start>
					<end>403</end>
					<coverage>15.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75030</id>
					<start>324</start>
					<end>403</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>325</region_start>
						<region_end>338</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>352</region_start>
						<region_end>368</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>370</region_start>
						<region_end>396</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>398</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>312</region_start>
						<region_end>365</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Microphthalmia-associated transcription factor</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>GAMRFNINDRIKELGTLIPKSNDPDMRWNKGTILKASVDYIRKLQREQQRAKDLENRQKKLEHANRHLLLRVQELEMQARAHG</sequence>
				<length>83</length>
				<uniprot>
					<id>Q08874</id>
					<start>321</start>
					<end>403</end>
					<coverage>15.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O75030</id>
					<start>324</start>
					<end>403</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>324</region_start>
						<region_end>338</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>352</region_start>
						<region_end>396</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>398</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00010.23</region_id>
						<region_name>HLH</region_name>
						<region_start>312</region_start>
						<region_end>365</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Monomeric elements of basic helix-loop-helix domains were shown to be natively unfolded with a pH-dependent premolten globule conformation, as shown by several spectroscopic techniques (NMR, fluorescence, FTIR, and circular dichroism) (PMID:20102160, PMID:8303294).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4ati</pdb_id>
			<pdb_id>4atk</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF3100003</accession>
		<general>
			<name>Vimentin coil 1B fragment (trimeric)</name>
			<pdb_id>4ypc</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.44</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>26795465</pmid>
				<authors>Chernyatina AA, Hess JF, Guzenko D, Voss JC, Strelkov SV</authors>
				<title>How to Study Intermediate Filaments in Atomic Detail.</title>
				<journal>Meth. Enzymol.</journal>
				<year>2016</year>
				<volume>568</volume>
				<pages>3-33</pages>
				<abstract>Studies of the intermediate filament (IF) structure are a prerequisite of understanding their function. In addition, the structural information is indispensable if one wishes to gain a mechanistic view on the disease-related mutations in the IFs. Over the years, considerable progress has been made on the atomic structure of the elementary building block of all IFs, the coiled-coil dimer. Here, we discuss the approaches, methods and practices that have contributed to this advance. With abundant genetic information on hand, bioinformatics approaches give important insights into the dimer structure, including the head and tail regions poorly assessable experimentally. At the same time, the most important contribution has been provided by X-ray crystallography. Following the &amp;quot;divide-and-conquer" approach, many fragments from several IF proteins could be crystallized and resolved to atomic resolution. We will systematically cover the main procedures of these crystallographic studies, suggest ways to maximize their efficiency, and also discuss the possible pitfalls and limitations. In addition, electron paramagnetic resonance with site-directed spin labeling was another method providing a major impact toward the understanding of the IF structure. Upon placing the spin labels into specific positions within the full-length protein, one can evaluate the proximity of the labels and their mobility. This makes it possible to make conclusions about the dimer structure in the coiled-coil region and beyond, as well as to explore the dimer-dimer contacts.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008022</accession>
					<name>protein C-terminus binding</name>
				</go>
				<go>
					<accession>GO:0005212</accession>
					<name>structural constituent of eye lens</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0097110</accession>
					<name>scaffold protein binding</name>
				</go>
				<go>
					<accession>GO:0005200</accession>
					<name>structural constituent of cytoskeleton</name>
				</go>
				<go>
					<accession>GO:1990254</accession>
					<name>keratin filament binding</name>
				</go>
				<go>
					<accession>GO:0003725</accession>
					<name>double-stranded RNA binding</name>
				</go>
				<go>
					<accession>GO:0001948</accession>
					<name>glycoprotein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0060020</accession>
					<name>Bergmann glial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0010977</accession>
					<name>negative regulation of neuron projection development</name>
				</go>
				<go>
					<accession>GO:0070307</accession>
					<name>lens fiber cell development</name>
				</go>
				<go>
					<accession>GO:0030049</accession>
					<name>muscle filament sliding</name>
				</go>
				<go>
					<accession>GO:0045109</accession>
					<name>intermediate filament organization</name>
				</go>
				<go>
					<accession>GO:0060395</accession>
					<name>SMAD protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0010628</accession>
					<name>positive regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0016032</accession>
					<name>viral process</name>
				</go>
				<go>
					<accession>GO:0014002</accession>
					<name>astrocyte development</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005882</accession>
					<name>intermediate filament</name>
				</go>
				<go>
					<accession>GO:0031012</accession>
					<name>extracellular matrix</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0031252</accession>
					<name>cell leading edge</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005777</accession>
					<name>peroxisome</name>
				</go>
				<go>
					<accession>GO:0043005</accession>
					<name>neuron projection</name>
				</go>
				<go>
					<accession>GO:0005925</accession>
					<name>focal adhesion</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vimentin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>VDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQ</sequence>
				<length>83</length>
				<uniprot>
					<id>P08670</id>
					<start>161</start>
					<end>243</end>
					<coverage>17.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08670</id>
					<start>161</start>
					<end>243</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>167</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00038.18</region_id>
						<region_name>Filament</region_name>
						<region_start>102</region_start>
						<region_end>410</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Vimentin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>VDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQ</sequence>
				<length>83</length>
				<uniprot>
					<id>P08670</id>
					<start>161</start>
					<end>243</end>
					<coverage>17.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08670</id>
					<start>161</start>
					<end>243</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>167</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00038.18</region_id>
						<region_name>Filament</region_name>
						<region_start>102</region_start>
						<region_end>410</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Vimentin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>VDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQ</sequence>
				<length>83</length>
				<uniprot>
					<id>P08670</id>
					<start>161</start>
					<end>243</end>
					<coverage>17.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08670</id>
					<start>161</start>
					<end>243</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>167</region_start>
						<region_end>235</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00038.18</region_id>
						<region_name>Filament</region_name>
						<region_start>102</region_start>
						<region_end>410</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:26795465). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4yv3</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2130002</accession>
		<general>
			<name>Methionyl-tRNA synthetase from Pyrococcus abyssi</name>
			<pdb_id>1mkh</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.01</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Pyrococcus abyssi</source_organism>
			<publication>
				<pmid>12390027</pmid>
				<authors>Crepin T, Schmitt E, Blanquet S, Mechulam Y</authors>
				<title>Structure and function of the C-terminal domain of methionyl-tRNA synthetase.</title>
				<journal>Biochemistry</journal>
				<year>2002</year>
				<issue>43</issue>
				<volume>41</volume>
				<pages>13003-11</pages>
				<abstract>The minimal polypeptide supporting full methionyl-tRNA synthetase (MetRS) activity is composed of four domains: a catalytic Rossmann fold, a connective peptide, a KMSKS domain, and a C-terminal alpha helix bundle domain. The minimal MetRS behaves as a monomer. In several species, MetRS is a homodimer because of a C-terminal domain appended to the core polypeptide. Upon truncation of this C-terminal domain, subunits dissociate irreversibly. Here, the C-terminal domain of dimeric MetRS from Pyrococcus abyssi was isolated and studied. It displays nonspecific tRNA-binding properties and has a crystalline structure closely resembling that of Trbp111, a dimeric tRNA-binding protein found in many bacteria and archaea. The obtained 3D model was used to direct mutations against dimerization of Escherichia coli MetRS. Comparison of the resulting mutants to native and C-truncated MetRS shows that the presence of the appended C-domain improves tRNA(Met) binding affinity. However, dimer formation is required to evidence the gain in affinity.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0000049</accession>
					<name>tRNA binding</name>
				</go>
				<go>
					<accession>GO:0004825</accession>
					<name>methionine-tRNA ligase activity</name>
				</go>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006431</accession>
					<name>methionyl-tRNA aminoacylation</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrix described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Methionine--tRNA ligase</name>
				<source_organism>Pyrococcus abyssi</source_organism>
				<sequence>MYVKFDDFAKLDLRVGKIIEVKDHPNADKLYVVKVDLGDEVRTLVAGLKKYYKPEELLNRYVVVVANLEPKKLRGIGSQGMLLAADDGERVALLMPDKEVKLGAKVR</sequence>
				<length>107</length>
				<uniprot>
					<id>Q9V011</id>
					<start>616</start>
					<end>722</end>
					<coverage>14.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9V011</id>
					<start>616</start>
					<end>722</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>618</region_start>
						<region_end>618</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>620</region_start>
						<region_end>624</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>628</region_start>
						<region_end>638</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>646</region_start>
						<region_end>651</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>656</region_start>
						<region_end>661</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>669</region_start>
						<region_end>672</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>676</region_start>
						<region_end>680</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>683</region_start>
						<region_end>683</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>686</region_start>
						<region_end>687</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>692</region_start>
						<region_end>693</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>697</region_start>
						<region_end>697</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>699</region_start>
						<region_end>701</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>706</region_start>
						<region_end>711</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>720</region_start>
						<region_end>721</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01588.17</region_id>
						<region_name>tRNA_bind</region_name>
						<region_start>628</region_start>
						<region_end>720</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Methionine--tRNA ligase</name>
				<source_organism>Pyrococcus abyssi</source_organism>
				<sequence>MYVKFDDFAKLDLRVGKIIEVKDHPNADKLYVVKVDLGDEVRTLVAGLKKYYKPEELLNRYVVVVANLEPKKLRGIGSQGMLLAADDGERVALLMPDKEVKLGAKVR</sequence>
				<length>107</length>
				<uniprot>
					<id>Q9V011</id>
					<start>616</start>
					<end>722</end>
					<coverage>14.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9V011</id>
					<start>616</start>
					<end>722</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>618</region_start>
						<region_end>618</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>620</region_start>
						<region_end>624</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>628</region_start>
						<region_end>638</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>646</region_start>
						<region_end>651</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>656</region_start>
						<region_end>661</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>669</region_start>
						<region_end>672</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>676</region_start>
						<region_end>680</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>683</region_start>
						<region_end>683</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>686</region_start>
						<region_end>687</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>692</region_start>
						<region_end>693</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>697</region_start>
						<region_end>697</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>699</region_start>
						<region_end>701</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>706</region_start>
						<region_end>711</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>720</region_start>
						<region_end>721</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01588.17</region_id>
						<region_name>tRNA_bind</region_name>
						<region_start>628</region_start>
						<region_end>720</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The C-terminal dimerization region of methionyl-tRNA synthetase is highly mobile evading structure determination by X-ray (PMID:14992601).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The C-terminal dimerization region of methionyl-tRNA synthetase is highly mobile evading structure determination by X-ray (PMID:14992601).</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2220002</accession>
		<general>
			<name>PE25-PPE41 heterodimer from M. tuberculosis</name>
			<pdb_id>4w4k</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.95</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Mycobacterium tuberculosis</source_organism>
			<publication>
				<pmid>25275011</pmid>
				<authors>Ekiert DC, Cox JS</authors>
				<title>Structure of a PE-PPE-EspG complex from Mycobacterium tuberculosis reveals molecular specificity of ESX protein secretion.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2014</year>
				<abstract>Nearly 10% of the coding capacity of the Mycobacterium tuberculosis genome is devoted to two highly expanded and enigmatic protein families called PE and PPE, some of which are important virulence/immunogenicity factors and are secreted during infection via a unique alternative secretory system termed &amp;quot;type VII." How PE-PPE proteins function during infection and how they are translocated to the bacterial surface through the five distinct type VII secretion systems [ESAT-6 secretion system (ESX)] of M. tuberculosis is poorly understood. Here, we report the crystal structure of a PE-PPE heterodimer bound to ESX secretion-associated protein G (EspG), which adopts a novel fold. This PE-PPE-EspG complex, along with structures of two additional EspGs, suggests that EspG acts as an adaptor that recognizes specific PE-PPE protein complexes via extensive interactions with PPE domains, and delivers them to ESX machinery for secretion. Surprisingly, secretion of most PE-PPE proteins in M. tuberculosis is likely mediated by EspG from the ESX-5 system, underscoring the importance of ESX-5 in mycobacterial pathogenesis. Moreover, our results indicate that PE-PPE domains function as cis-acting targeting sequences that are read out by EspGs, revealing the molecular specificity for secretion through distinct ESX pathways.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>PE family protein</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MHHHHHHENLYFQTNPEALTVAATEVRRIRDRAIQSDAQVAPMTTAVRPPAADLVSEKAATFLVEYARKYRQTIAAAAVVLEEFAHALTTGADKYATAEADNIKTFS</sequence>
				<length>107</length>
				<uniprot>
					<id>A0A0H3LBR3</id>
					<start>5</start>
					<end>98</end>
					<coverage>94.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_UPI0005092AC7</id>
					<start>1</start>
					<end>107</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>9</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>46</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00934.17</region_id>
						<region_name>PE</region_name>
						<region_start>1</region_start>
						<region_end>93</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>PPE family protein</name>
				<source_organism>Mycobacterium tuberculosis</source_organism>
				<sequence>MHFEAYPPEVNSANIYAGPGPDSMLAAARAWRSLDVEMTAVQRSFNRTLLSLMDAWAGPVVMQLMEAAKPFVRWLTDLCVQLSEVERQIHEIVRAYEWAHHDMVPLAQIYNNRAERQILIDNNALGQFTAQIADLDQEYDDFWDEDGEVMRDYRLRVSDALSKLTPWKAPPPIA</sequence>
				<length>174</length>
				<uniprot>
					<id>A0A0H3LBN6</id>
					<start>1</start>
					<end>174</end>
					<coverage>89.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q79FE1</id>
					<start>1</start>
					<end>174</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>5</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>22</region_start>
						<region_end>53</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>69</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>106</region_start>
						<region_end>121</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>129</region_start>
						<region_end>161</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00823.16</region_id>
						<region_name>PPE</region_name>
						<region_start>5</region_start>
						<region_end>161</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Both proteins involved in the interaction evade successful expression, purification and crystallization in their monomeric form, owing to the fact that both proteins are disordered and are extremely susceptible to degradation (PMID:16690741).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2g38</pdb_id>
			<pdb_id>4w4l</pdb_id>
			<pdb_id>4kxr</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100015</accession>
		<general>
			<name>Vimentin coil 1B fragment (dimeric)</name>
			<pdb_id>3ssu</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.60</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>22869704</pmid>
				<authors>Chernyatina AA, Nicolet S, Aebi U, Herrmann H, Strelkov SV</authors>
				<title>Atomic structure of the vimentin central α-helical domain and its implications for intermediate filament assembly.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2012</year>
				<issue>34</issue>
				<volume>109</volume>
				<pages>13620-5</pages>
				<abstract>Together with actin filaments and microtubules, intermediate filaments (IFs) are the basic cytoskeletal components of metazoan cells. Over 80 human diseases have been linked to mutations in various IF proteins to date. However, the filament structure is far from being resolved at the atomic level, which hampers rational understanding of IF pathologies. The elementary building block of all IF proteins is a dimer consisting of an α-helical coiled-coil (CC) &amp;quot;rod" domain flanked by the flexible head and tail domains. Here we present three crystal structures of overlapping human vimentin fragments that comprise the first half of its rod domain. Given the previously solved fragments, a nearly complete atomic structure of the vimentin rod has become available. It consists of three α-helical segments (coils 1A, 1B, and 2) interconnected by linkers (L1 and L12). Most of the CC structure has a left-handed twist with heptad repeats, but both coil 1B and coil 2 also exhibit untwisted, parallel stretches with hendecad repeats. In the crystal structure, linker L1 was found to be α-helical without being involved in the CC formation. The available data allow us to construct an atomic model of the antiparallel tetramer representing the second level of vimentin assembly. Although the presence of the nonhelical head domains is essential for proper tetramer stabilization, the precise alignment of the dimers forming the tetramer appears to depend on the complementarity of their surface charge distribution patterns, while the structural plasticity of linker L1 and coil 1A plays a role in the subsequent IF assembly process.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008022</accession>
					<name>protein C-terminus binding</name>
				</go>
				<go>
					<accession>GO:0005212</accession>
					<name>structural constituent of eye lens</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0097110</accession>
					<name>scaffold protein binding</name>
				</go>
				<go>
					<accession>GO:0005200</accession>
					<name>structural constituent of cytoskeleton</name>
				</go>
				<go>
					<accession>GO:1990254</accession>
					<name>keratin filament binding</name>
				</go>
				<go>
					<accession>GO:0003725</accession>
					<name>double-stranded RNA binding</name>
				</go>
				<go>
					<accession>GO:0001948</accession>
					<name>glycoprotein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0060020</accession>
					<name>Bergmann glial cell differentiation</name>
				</go>
				<go>
					<accession>GO:0010977</accession>
					<name>negative regulation of neuron projection development</name>
				</go>
				<go>
					<accession>GO:0070307</accession>
					<name>lens fiber cell development</name>
				</go>
				<go>
					<accession>GO:0030049</accession>
					<name>muscle filament sliding</name>
				</go>
				<go>
					<accession>GO:0045109</accession>
					<name>intermediate filament organization</name>
				</go>
				<go>
					<accession>GO:0060395</accession>
					<name>SMAD protein signal transduction</name>
				</go>
				<go>
					<accession>GO:0010628</accession>
					<name>positive regulation of gene expression</name>
				</go>
				<go>
					<accession>GO:0016032</accession>
					<name>viral process</name>
				</go>
				<go>
					<accession>GO:0014002</accession>
					<name>astrocyte development</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005882</accession>
					<name>intermediate filament</name>
				</go>
				<go>
					<accession>GO:0031012</accession>
					<name>extracellular matrix</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0031252</accession>
					<name>cell leading edge</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005777</accession>
					<name>peroxisome</name>
				</go>
				<go>
					<accession>GO:0043005</accession>
					<name>neuron projection</name>
				</go>
				<go>
					<accession>GO:0005925</accession>
					<name>focal adhesion</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Vimentin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKL</sequence>
				<length>93</length>
				<uniprot>
					<id>P08670</id>
					<start>97</start>
					<end>189</end>
					<coverage>20%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08670</id>
					<start>99</start>
					<end>189</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>145</region_start>
						<region_end>187</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00038.18</region_id>
						<region_name>Filament</region_name>
						<region_start>102</region_start>
						<region_end>410</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Vimentin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKL</sequence>
				<length>93</length>
				<uniprot>
					<id>P08670</id>
					<start>97</start>
					<end>189</end>
					<coverage>20%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P08670</id>
					<start>99</start>
					<end>189</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>150</region_start>
						<region_end>186</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00038.18</region_id>
						<region_name>Filament</region_name>
						<region_start>102</region_start>
						<region_end>410</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:22869704). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3s4r</pdb_id>
			<pdb_id>3g1e</pdb_id>
			<pdb_id>3swk</pdb_id>
			<pdb_id>3uf1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2100016</accession>
		<general>
			<name>TRIM25 coiled-coil</name>
			<pdb_id>4cfg</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.80</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<authors>James, L.</authors>
				<title>Structure of the Trim25 Coiled-Coil</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>E3 ubiquitin/ISG15 ligase TRIM25</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MAELCPLAEELSCSICLEPFKEPVTTPCGHNFCGSCLNETWAVQGSPYLCPQCRAVYQARPQLHKNTVLCNVVEQFLQADLAREPPADVWTPPARASAPSPNAQVACDHCLKEAAVKTCLVCMASFCQEHLQPHFDSPAFQDHPLQPPVRDLLRRKCSQHNRLREFFCPEHSECICHICLVEHKTCSPASLSQASADLEATLRHKLTVMYSQINGASRALDDVRNRQQDVRMTANRKVEQLQQEYTEMKALLDASETTSTRKIKEEEKRVNSQFDTIYQILLKKKSEIQTLKEEIEQSLTKRDEFEFLEKASKLRGISTQPVYIPEVELNHKLIKGIHQSTIDLKNELKQCIGRLQEPTPSSGDPGEHDPASTHKSTRPVKKVSKEEKKSKKPPPVPALPSKLPTFGAPEQLVDLKQAGLEAAAKATSSHPNSTSLKAKVLETFLAKSRPELLEYYIKVILDYNTAHNKVALSECYTVASVAEMPQNYRPHPQRFTYCSQVLGLHCYKKGIHYWEVELQKNNFCGVGICYGSMNRQGPESRLGRNSASWCVEWFNTKISAWHNNVEKTLPSTKATRVGVLLNCDHGFVIFFAVADKVHLMYKFRVDFTEALYPAFWVFSAGATLSICSPK</sequence>
				<length>630</length>
				<uniprot>
					<id>Q14258</id>
					<start>194</start>
					<end>357</end>
					<coverage>26%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q14258</id>
					<start>194</start>
					<end>357</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>195</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>210</region_start>
						<region_end>231</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>233</region_start>
						<region_end>247</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>249</region_start>
						<region_end>304</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>307</region_start>
						<region_end>317</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>334</region_start>
						<region_end>357</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>E3 ubiquitin/ISG15 ligase TRIM25</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MAELCPLAEELSCSICLEPFKEPVTTPCGHNFCGSCLNETWAVQGSPYLCPQCRAVYQARPQLHKNTVLCNVVEQFLQADLAREPPADVWTPPARASAPSPNAQVACDHCLKEAAVKTCLVCMASFCQEHLQPHFDSPAFQDHPLQPPVRDLLRRKCSQHNRLREFFCPEHSECICHICLVEHKTCSPASLSQASADLEATLRHKLTVMYSQINGASRALDDVRNRQQDVRMTANRKVEQLQQEYTEMKALLDASETTSTRKIKEEEKRVNSQFDTIYQILLKKKSEIQTLKEEIEQSLTKRDEFEFLEKASKLRGISTQPVYIPEVELNHKLIKGIHQSTIDLKNELKQCIGRLQEPTPSSGDPGEHDPASTHKSTRPVKKVSKEEKKSKKPPPVPALPSKLPTFGAPEQLVDLKQAGLEAAAKATSSHPNSTSLKAKVLETFLAKSRPELLEYYIKVILDYNTAHNKVALSECYTVASVAEMPQNYRPHPQRFTYCSQVLGLHCYKKGIHYWEVELQKNNFCGVGICYGSMNRQGPESRLGRNSASWCVEWFNTKISAWHNNVEKTLPSTKATRVGVLLNCDHGFVIFFAVADKVHLMYKFRVDFTEALYPAFWVFSAGATLSICSPK</sequence>
				<length>630</length>
				<uniprot>
					<id>Q14258</id>
					<start>194</start>
					<end>357</end>
					<coverage>26%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q14258</id>
					<start>194</start>
					<end>357</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>197</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>210</region_start>
						<region_end>231</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>233</region_start>
						<region_end>247</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>249</region_start>
						<region_end>303</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>308</region_start>
						<region_end>318</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>334</region_start>
						<region_end>356</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:24550273). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4ltb</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4200001</accession>
		<general>
			<name>OPTN:TBK1 complex</name>
			<pdb_id>5eof</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.05</resolution>
			<assembly>heterotetramer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>27620379</pmid>
				<authors>Li F, Xie X, Wang Y, Liu J, Cheng X, Guo Y, Gong Y, Hu S, Pan L</authors>
				<title>Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins.</title>
				<journal>Nat Commun</journal>
				<year>2016</year>
				<volume>7</volume>
				<pages>12708</pages>
				<abstract>Optineurin is an important autophagy receptor involved in several selective autophagy processes, during which its function is regulated by TBK1. Mutations of optineurin and TBK1 are both associated with neurodegenerative diseases. However, the mechanistic basis underlying the specific interaction between optineurin and TBK1 is still elusive. Here we determine the crystal structures of optineurin/TBK1 complex and the related NAP1/TBK1 complex, uncovering the detailed molecular mechanism governing the optineurin and TBK1 interaction, and revealing a general binding mode between TBK1 and its associated adaptor proteins. In addition, we demonstrate that the glaucoma-associated optineurin E50K mutation not only enhances the interaction between optineurin and TBK1 but also alters the oligomeric state of optineurin, and the ALS-related TBK1 E696K mutation specifically disrupts the optineurin/TBK1 complex formation but has little effect on the NAP1/TBK1 complex. Thus, our study provides mechanistic insights into those currently known disease-causing optineurin and TBK1 mutations found in patients.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Optineurin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPGSHLAHPNLDTFTPEELLQQMKELLTENHQLKEAMKLNNQAMKGRFEELSAWTEKQKEERQFFEIQSKEAKERLMALSHE</sequence>
				<length>82</length>
				<uniprot>
					<id>Q96CV9</id>
					<start>26</start>
					<end>103</end>
					<coverage>13.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q96CV9</id>
					<start>26</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11577.5</region_id>
						<region_name>NEMO</region_name>
						<region_start>37</region_start>
						<region_end>104</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Optineurin</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPGSHLAHPNLDTFTPEELLQQMKELLTENHQLKEAMKLNNQAMKGRFEELSAWTEKQKEERQFFEIQSKEAKERLMALSHE</sequence>
				<length>82</length>
				<uniprot>
					<id>Q96CV9</id>
					<start>26</start>
					<end>103</end>
					<coverage>13.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q96CV9</id>
					<start>26</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>37</region_start>
						<region_end>101</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF11577.5</region_id>
						<region_name>NEMO</region_name>
						<region_start>37</region_start>
						<region_end>104</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Serine/threonine-protein kinase TBK1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPGSYPSSNTLVEMTLGMKKLKEEMEGVVKELAENNHILERFGSLTMDGGLRNVDCL</sequence>
				<length>57</length>
				<uniprot>
					<id>Q9UHD2</id>
					<start>677</start>
					<end>729</end>
					<coverage>7.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9UHD2</id>
					<start>677</start>
					<end>729</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>680</region_start>
						<region_end>714</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Serine/threonine-protein kinase TBK1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GPGSYPSSNTLVEMTLGMKKLKEEMEGVVKELAENNHILERFGSLTMDGGLRNVDCL</sequence>
				<length>57</length>
				<uniprot>
					<id>Q9UHD2</id>
					<start>677</start>
					<end>729</end>
					<coverage>7.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9UHD2</id>
					<start>677</start>
					<end>729</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>680</region_start>
						<region_end>718</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:27620379). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>5eoa</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4200002</accession>
		<general>
			<name>p63/p73 hetero-tetramerization domain (human)</name>
			<pdb_id>2nb1</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterotetramer (dimer of dimers)</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>27716744</pmid>
				<authors>Gebel J, Luh LM, Coutandin D, Osterburg C, Löhr F, Schäfer B, Frombach AS, Sumyk M, Buchner L, Krojer T, Salah E, Mathea S, Güntert P, Knapp S, Dötsch V</authors>
				<title>Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.</title>
				<journal>Cell Death Differ.</journal>
				<year>2016</year>
				<abstract>Members of the p53 tumor-suppressor family are expressed as multiple isoforms. Isoforms with an N-terminal transactivation domain are transcriptionally active, while those ones lacking this domain often inhibit the transcriptional activity of other family members. In squamous cell carcinomas, the high expression level of ΔNp63α inhibits the tumor-suppressor function of TAp73β. This can in principle be due to blocking of the promoter or by direct interaction between both proteins. p63 and p73 can hetero-oligomerize through their tetramerization domains and a hetero-tetramer consisting of two p63 and two p73 molecules is thermodynamically more stable than both homo-tetramers. Here we show that cells expressing both p63 and p73 exist in mouse epidermis and hair follicle and that hetero-tetramer complexes can be detected by immunoprecipitation in differentiating keratinocytes. Through structure determination of the hetero-tetramer, we reveal why this hetero-tetramer is the thermodynamically preferred species. We have created mutants that exclusively form either hetero-tetramers or homo-tetramers, allowing to investigate the function of these p63/p73 hetero-tetramers. Using these tools, we show that inhibition of TAp73β in squamous cell carcinomas is due to promoter squelching and not direct interaction.Cell Death and Differentiation advance online publication, 7 October 2016; doi:10.1038/cdd.2016.83.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0043565</accession>
					<name>sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003684</accession>
					<name>damaged DNA binding</name>
				</go>
				<go>
					<accession>GO:0001077</accession>
					<name>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</name>
				</go>
				<go>
					<accession>GO:0002039</accession>
					<name>p53 binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0003682</accession>
					<name>chromatin binding</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
				<go>
					<accession>GO:0044212</accession>
					<name>transcription regulatory region DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:1901796</accession>
					<name>regulation of signal transduction by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0006978</accession>
					<name>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</name>
				</go>
				<go>
					<accession>GO:1900740</accession>
					<name>positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway</name>
				</go>
				<go>
					<accession>GO:0042771</accession>
					<name>intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</name>
				</go>
				<go>
					<accession>GO:0010332</accession>
					<name>response to gamma radiation</name>
				</go>
				<go>
					<accession>GO:0010165</accession>
					<name>response to X-ray</name>
				</go>
				<go>
					<accession>GO:0034644</accession>
					<name>cellular response to UV</name>
				</go>
				<go>
					<accession>GO:0051262</accession>
					<name>protein tetramerization</name>
				</go>
				<go>
					<accession>GO:0031571</accession>
					<name>mitotic G1 DNA damage checkpoint</name>
				</go>
				<go>
					<accession>GO:0006366</accession>
					<name>transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005739</accession>
					<name>mitochondrion</name>
				</go>
				<go>
					<accession>GO:0005667</accession>
					<name>transcription factor complex</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005654</accession>
					<name>nucleoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SDDELLYLPVRGRETYEMLLEIKESLELMQYLPQHTIETYRQQQQQQHQHLLQKQTSIQS</sequence>
				<length>60</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>397</start>
					<end>455</end>
					<coverage>8.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>397</start>
					<end>455</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>401</region_start>
						<region_end>401</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>404</region_start>
						<region_end>405</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>430</region_start>
						<region_end>445</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRKNFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>351</start>
					<end>398</end>
					<coverage>7.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>398</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>355</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>380</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>384</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Tumor protein 63</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SDDELLYLPVRGRETYEMLLEIKESLELMQYLPQHTIETYRQQQQQQHQHLLQKQTSIQS</sequence>
				<length>60</length>
				<uniprot>
					<id>Q9H3D4</id>
					<start>397</start>
					<end>455</end>
					<coverage>8.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9H3D4</id>
					<start>397</start>
					<end>455</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>401</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>405</region_start>
						<region_end>405</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>408</region_start>
						<region_end>426</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>430</region_start>
						<region_end>445</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>391</region_start>
						<region_end>431</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Tumor protein p73</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEDTYYLQVRGRKNFEILMKLKESLELMELVPQPLVDSYRQQQQLLQR</sequence>
				<length>50</length>
				<uniprot>
					<id>O15350</id>
					<start>351</start>
					<end>398</end>
					<coverage>7.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O15350</id>
					<start>351</start>
					<end>398</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>355</region_start>
						<region_end>359</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>362</region_start>
						<region_end>380</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>384</region_start>
						<region_end>389</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>345</region_start>
						<region_end>384</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>p63 and p73 are members of the p53 protein family. The tetramerization region of p53, p63 and p73 are closely homologous to each other, having very similar sequences, structures and biological functions (PMID:25185827, PMID:18289041, PMID:20379196), all containing the same Pfam domain (PF07710). The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200012</accession>
		<general>
			<name>Leukemia Fusion Target AF9 in complex with AF4</name>
			<pdb_id>2lm0</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>23260655</pmid>
				<authors>Leach BI, Kuntimaddi A, Schmidt CR, Cierpicki T, Johnson SA, Bushweller JH</authors>
				<title>Leukemia Fusion Target AF9 Is an Intrinsically Disordered Transcriptional Regulator that Recruits Multiple Partners via Coupled Folding and Binding.</title>
				<journal>Structure</journal>
				<year>2012</year>
				<abstract>Mixed lineage leukemia (MLL) fusion proteins cause oncogenic transformation of hematopoietic cells by constitutive recruitment of elongation factors to HOX promoters, resulting in overexpression of target genes. The structural basis of transactivation by MLL fusion partners remains undetermined. We show that the ANC1 homology domain (AHD) of AF9, one of the most common MLL translocation partners, is intrinsically disordered and recruits multiple transcription factors through coupled folding and binding. We determined the structure of the AF9 AHD in complex with the elongation factor AF4 and show that aliphatic residues, which are conserved in each of the AF9 binding partners, form an integral part of the hydrophobic core of the complex. Nuclear magnetic resonance relaxation measurements show that AF9 retains significant dynamic behavior which may facilitate exchange between disordered partners. We propose that AF9 functions as a signaling hub that regulates transcription through dynamic recruitment of cofactors in normal hematopoiesis and in acute leukemia.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chain A has been split into two chains to reflect the real biological assembly. The newly generated chain A corresponds to residues 738-779, while chain B corresponds to residues 1490-1568. Linker residues and expression tags were removed.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>AF4/FMR2 family member 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>RLPLPLRDTKLLSPLRDTPPPQSLMVKITLDLLSRIPQPPGKPMG</sequence>
				<length>45</length>
				<uniprot>
					<id>P51825</id>
					<start>738</start>
					<end>779</end>
					<coverage>3.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P51825</id>
					<start>738</start>
					<end>779</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>763</region_start>
						<region_end>764</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF05110.10</region_id>
						<region_name>AF-4</region_name>
						<region_start>8</region_start>
						<region_end>1207</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein AF-9</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SDKQIKNGECDKAYLDELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTTVRKLQSYLETSGTS</sequence>
				<length>79</length>
				<uniprot>
					<id>P42568</id>
					<start>490</start>
					<end>568</end>
					<coverage>13.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P42568</id>
					<start>490</start>
					<end>568</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>504</region_start>
						<region_end>515</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>523</region_start>
						<region_end>531</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>536</region_start>
						<region_end>538</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>543</region_start>
						<region_end>545</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>552</region_start>
						<region_end>561</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>AF9 is an intrinsically disordered protein, which binds competing disordered partners, most notably AF4, Dot1L, BCoR and hPC3. The two interacting protein regions undergo mutual synergistic folding (PMID:23260655).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200013</accession>
		<general>
			<name>Leukemia Fusion Target AF9 in complex with hPC3</name>
			<pdb_id>2n4q</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<authors>Kuntimaddi, A., Leach, B.I., Bushweller, J.H.</authors>
				<title>Solution NMR Structure of CBX8 in complex with AF9 (CBX8-AF9)</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Chromobox protein homolog 8</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>TQGGRPSLIARIPVARILGDPEEE</sequence>
				<length>24</length>
				<uniprot>
					<id>Q9HC52</id>
					<start>327</start>
					<end>349</end>
					<coverage>5.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9HC52</id>
					<start>327</start>
					<end>349</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>334</region_start>
						<region_end>336</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>339</region_start>
						<region_end>342</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Protein AF-9</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MDKAYLDELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTTVRKLQSYLETSGTS</sequence>
				<length>70</length>
				<uniprot>
					<id>P42568</id>
					<start>500</start>
					<end>568</end>
					<coverage>12.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P42568</id>
					<start>500</start>
					<end>568</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>501</region_start>
						<region_end>514</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>520</region_start>
						<region_end>532</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>537</region_start>
						<region_end>539</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>542</region_start>
						<region_end>546</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>552</region_start>
						<region_end>563</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>AF9 is an intrinsically disordered protein, which binds competing disordered partners, most notably AF4, Dot1L, BCoR and hPC3. The two interacting protein regions undergo mutual synergistic folding (PMID:23260655).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200014</accession>
		<general>
			<name>Leukemia Fusion Target AF9 in complex with Dot1L</name>
			<pdb_id>2mv7</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>25921540</pmid>
				<authors>Kuntimaddi A, Achille NJ, Thorpe J, Lokken AA, Singh R, Hemenway CS, Adli M, Zeleznik-Le NJ, Bushweller JH</authors>
				<title>Degree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation Potential.</title>
				<journal>Cell Rep</journal>
				<year>2015</year>
				<issue>5</issue>
				<volume>11</volume>
				<pages>808-20</pages>
				<abstract>The MLL gene is a common target of chromosomal translocations found in human leukemia. MLL-fusion leukemia has a consistently poor outcome. One of the most common translocation partners is AF9 (MLLT3). MLL-AF9 recruits DOT1L, a histone 3 lysine 79 methyltransferase (H3K79me1/me2/me3), leading to aberrant gene transcription. We show that DOT1L has three AF9 binding sites and present the nuclear magnetic resonance (NMR) solution structure of a DOT1L-AF9 complex. We generate structure-guided point mutations and find that they have graded effects on recruitment of DOT1L to MLL-AF9. Chromatin immunoprecipitation sequencing (ChIP-seq) analyses of H3K79me2 and H3K79me3 show that graded reduction of the DOT1L interaction with MLL-AF9 results in differential loss of H3K79me2 and me3 at MLL-AF9 target genes. Furthermore, the degree of DOT1L recruitment is linked to the level of MLL-AF9 hematopoietic transformation.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Protein AF-9</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>DKAYLDELVELHRRLMTLRERHILQQIVNLIEETGHFHITNTTFDFDLCSLDKTTVRKLQSYLETSGTS</sequence>
				<length>69</length>
				<uniprot>
					<id>P42568</id>
					<start>500</start>
					<end>568</end>
					<coverage>12.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P42568</id>
					<start>500</start>
					<end>568</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>501</region_start>
						<region_end>516</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>520</region_start>
						<region_end>533</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>537</region_start>
						<region_end>539</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>542</region_start>
						<region_end>546</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>547</region_start>
						<region_end>549</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>552</region_start>
						<region_end>562</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone-lysine N-methyltransferase, H3 lysine-79 specific</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>TNKLPVSIPLASVVLPSRAERARST</sequence>
				<length>25</length>
				<uniprot>
					<id>Q8TEK3</id>
					<start>876</start>
					<end>900</end>
					<coverage>1.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q8TEK3</id>
					<start>877</start>
					<end>900</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>880</region_start>
						<region_end>882</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>AF9 is an intrinsically disordered protein, which binds competing disordered partners, most notably AF4, Dot1L, BCoR and hPC3. The two interacting protein regions undergo mutual synergistic folding (PMID:23260655).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF3140002</accession>
		<general>
			<name>SARS-Coronavirus HR2 Domain (prefusion, trimeric form)</name>
			<pdb_id>2fxp</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotrimer</assembly>
			<source_organism>Human SARS coronavirus</source_organism>
			<publication>
				<pmid>16507566</pmid>
				<authors>Hakansson-McReynolds S, Jiang S, Rong L, Caffrey M</authors>
				<title>Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.</title>
				<journal>J. Biol. Chem.</journal>
				<year>2006</year>
				<issue>17</issue>
				<volume>281</volume>
				<pages>11965-71</pages>
				<abstract>The envelope glycoprotein, termed the spike protein, of severe acute respiratory syndrome coronavirus (SARS-CoV) is known to mediate viral entry. Similar to other class 1 viral fusion proteins, the heptad repeat regions of SARS-CoV spike are thought to undergo conformational changes from a prefusion form to a subsequent post-fusion form that enables fusion of the viral and host membranes. Recently, the structure of a post-fusion form of SARS-CoV spike, which consists of isolated domains of heptad repeats 1 and 2 (HR1 and HR2), has been determined by x-ray crystallography. To date there is no structural information for the prefusion conformations of SARS-CoV HR1 and HR2. In this work we present the NMR structure of the HR2 domain (residues 1141-1193) from SARS-CoV (termed S2-HR2) in the presence of the co-solvent trifluoroethanol. We find that in the absence of HR1, S2-HR2 forms a coiled coil symmetric trimer with a complex molecular mass of 18 kDa. The S2-HR2 structure, which is the first example of the prefusion form of coronavirus envelope, supports the current model of viral membrane fusion and gives insight into the design of structure-based antagonists of SARS.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046789</accession>
					<name>host cell surface receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0009405</accession>
					<name>pathogenesis</name>
				</go>
				<go>
					<accession>GO:0046813</accession>
					<name>receptor-mediated virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0044173</accession>
					<name>host cell endoplasmic reticulum-Golgi intermediate compartment membrane</name>
				</go>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0020002</accession>
					<name>host cell plasma membrane</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>GSHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>55</length>
				<uniprot>
					<id>P59594</id>
					<start>1139</start>
					<end>1193</end>
					<coverage>4.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1140</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1148</region_start>
						<region_end>1151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1155</region_start>
						<region_end>1185</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>GSHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>55</length>
				<uniprot>
					<id>P59594</id>
					<start>1139</start>
					<end>1193</end>
					<coverage>4.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1140</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1148</region_start>
						<region_end>1151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1155</region_start>
						<region_end>1185</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>GSHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>55</length>
				<uniprot>
					<id>P59594</id>
					<start>1139</start>
					<end>1193</end>
					<coverage>4.4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1140</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1148</region_start>
						<region_end>1151</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1155</region_start>
						<region_end>1185</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16507566). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF3100004</accession>
		<general>
			<name>C-terminal coiled coil domain of Transient receptor potential (TRP) channel subfamily P member 2</name>
			<pdb_id>3hrn</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.90</resolution>
			<assembly>homotrimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>19556541</pmid>
				<authors>Yu Y, Ulbrich MH, Li MH, Buraei Z, Chen XZ, Ong AC, Tong L, Isacoff EY, Yang J</authors>
				<title>Structural and molecular basis of the assembly of the TRPP2/PKD1 complex.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2009</year>
				<issue>28</issue>
				<volume>106</volume>
				<pages>11558-63</pages>
				<abstract>Mutations in PKD1 and TRPP2 account for nearly all cases of autosomal dominant polycystic kidney disease (ADPKD). These 2 proteins form a receptor/ion channel complex on the cell surface. Using a combination of biochemistry, crystallography, and a single-molecule method to determine the subunit composition of proteins in the plasma membrane of live cells, we find that this complex contains 3 TRPP2 and 1 PKD1. A newly identified coiled-coil domain in the C terminus of TRPP2 is critical for the formation of this complex. This coiled-coil domain forms a homotrimer, in both solution and crystal structure, and binds to a single coiled-coil domain in the C terminus of PKD1. Mutations that disrupt the TRPP2 coiled-coil domain trimer abolish the assembly of both the full-length TRPP2 trimer and the TRPP2/PKD1 complex and diminish the surface expression of both proteins. These results have significant implications for the assembly, regulation, and function of the TRPP2/PKD1 complex and the pathogenic mechanism of some ADPKD-producing mutations.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0048763</accession>
					<name>calcium-induced calcium release activity</name>
				</go>
				<go>
					<accession>GO:0005102</accession>
					<name>receptor binding</name>
				</go>
				<go>
					<accession>GO:0005245</accession>
					<name>voltage-gated calcium channel activity</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0051371</accession>
					<name>muscle alpha-actinin binding</name>
				</go>
				<go>
					<accession>GO:0043398</accession>
					<name>HLH domain binding</name>
				</go>
				<go>
					<accession>GO:0051219</accession>
					<name>phosphoprotein binding</name>
				</go>
				<go>
					<accession>GO:0044325</accession>
					<name>ion channel binding</name>
				</go>
				<go>
					<accession>GO:0005509</accession>
					<name>calcium ion binding</name>
				</go>
				<go>
					<accession>GO:0005248</accession>
					<name>voltage-gated sodium channel activity</name>
				</go>
				<go>
					<accession>GO:0051117</accession>
					<name>ATPase binding</name>
				</go>
				<go>
					<accession>GO:0005267</accession>
					<name>potassium channel activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0001892</accession>
					<name>embryonic placenta development</name>
				</go>
				<go>
					<accession>GO:0060078</accession>
					<name>regulation of postsynaptic membrane potential</name>
				</go>
				<go>
					<accession>GO:0031659</accession>
					<name>positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle</name>
				</go>
				<go>
					<accession>GO:0072235</accession>
					<name>metanephric distal tubule development</name>
				</go>
				<go>
					<accession>GO:0021510</accession>
					<name>spinal cord development</name>
				</go>
				<go>
					<accession>GO:0045944</accession>
					<name>positive regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0071464</accession>
					<name>cellular response to hydrostatic pressure</name>
				</go>
				<go>
					<accession>GO:0003127</accession>
					<name>detection of nodal flow</name>
				</go>
				<go>
					<accession>GO:0034614</accession>
					<name>cellular response to reactive oxygen species</name>
				</go>
				<go>
					<accession>GO:0051209</accession>
					<name>release of sequestered calcium ion into cytosol</name>
				</go>
				<go>
					<accession>GO:0072218</accession>
					<name>metanephric ascending thin limb development</name>
				</go>
				<go>
					<accession>GO:0072219</accession>
					<name>metanephric cortical collecting duct development</name>
				</go>
				<go>
					<accession>GO:0035904</accession>
					<name>aorta development</name>
				</go>
				<go>
					<accession>GO:0071805</accession>
					<name>potassium ion transmembrane transport</name>
				</go>
				<go>
					<accession>GO:0060674</accession>
					<name>placenta blood vessel development</name>
				</go>
				<go>
					<accession>GO:0021915</accession>
					<name>neural tube development</name>
				</go>
				<go>
					<accession>GO:0035502</accession>
					<name>metanephric part of ureteric bud development</name>
				</go>
				<go>
					<accession>GO:0007050</accession>
					<name>cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0001658</accession>
					<name>branching involved in ureteric bud morphogenesis</name>
				</go>
				<go>
					<accession>GO:0031587</accession>
					<name>positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity</name>
				</go>
				<go>
					<accession>GO:0035725</accession>
					<name>sodium ion transmembrane transport</name>
				</go>
				<go>
					<accession>GO:0071470</accession>
					<name>cellular response to osmotic stress</name>
				</go>
				<go>
					<accession>GO:0072284</accession>
					<name>metanephric S-shaped body morphogenesis</name>
				</go>
				<go>
					<accession>GO:0007259</accession>
					<name>JAK-STAT cascade</name>
				</go>
				<go>
					<accession>GO:0071498</accession>
					<name>cellular response to fluid shear stress</name>
				</go>
				<go>
					<accession>GO:0072177</accession>
					<name>mesonephric duct development</name>
				</go>
				<go>
					<accession>GO:0045429</accession>
					<name>positive regulation of nitric oxide biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0061441</accession>
					<name>renal artery morphogenesis</name>
				</go>
				<go>
					<accession>GO:0071910</accession>
					<name>determination of liver left/right asymmetry</name>
				</go>
				<go>
					<accession>GO:0071158</accession>
					<name>positive regulation of cell cycle arrest</name>
				</go>
				<go>
					<accession>GO:0001947</accession>
					<name>heart looping</name>
				</go>
				<go>
					<accession>GO:0060315</accession>
					<name>negative regulation of ryanodine-sensitive calcium-release channel activity</name>
				</go>
				<go>
					<accession>GO:0072214</accession>
					<name>metanephric cortex development</name>
				</go>
				<go>
					<accession>GO:2000134</accession>
					<name>negative regulation of G1/S transition of mitotic cell cycle</name>
				</go>
				<go>
					<accession>GO:0042994</accession>
					<name>cytoplasmic sequestering of transcription factor</name>
				</go>
				<go>
					<accession>GO:0008285</accession>
					<name>negative regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0050982</accession>
					<name>detection of mechanical stimulus</name>
				</go>
				<go>
					<accession>GO:0030814</accession>
					<name>regulation of cAMP metabolic process</name>
				</go>
				<go>
					<accession>GO:0072075</accession>
					<name>metanephric mesenchyme development</name>
				</go>
				<go>
					<accession>GO:0072208</accession>
					<name>metanephric smooth muscle tissue development</name>
				</go>
				<go>
					<accession>GO:0051298</accession>
					<name>centrosome duplication</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0002133</accession>
					<name>polycystin complex</name>
				</go>
				<go>
					<accession>GO:0030027</accession>
					<name>lamellipodium</name>
				</go>
				<go>
					<accession>GO:0036064</accession>
					<name>ciliary basal body</name>
				</go>
				<go>
					<accession>GO:0031512</accession>
					<name>motile primary cilium</name>
				</go>
				<go>
					<accession>GO:0009925</accession>
					<name>basal plasma membrane</name>
				</go>
				<go>
					<accession>GO:0071458</accession>
					<name>integral component of cytoplasmic side of endoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0005911</accession>
					<name>cell-cell junction</name>
				</go>
				<go>
					<accession>GO:0071556</accession>
					<name>integral component of lumenal side of endoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0031513</accession>
					<name>nonmotile primary cilium</name>
				</go>
				<go>
					<accession>GO:0045180</accession>
					<name>basal cortex</name>
				</go>
				<go>
					<accession>GO:0060170</accession>
					<name>ciliary membrane</name>
				</go>
				<go>
					<accession>GO:0072686</accession>
					<name>mitotic spindle</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0005887</accession>
					<name>integral component of plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains B and C were generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>3</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (trimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Polycystin-2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MGVSYEEFQVLVRRVDRMEHSIGSIVSKIDAVIVKLEIMERAKLKRREVLGRLLDGVAEDERLG</sequence>
				<length>64</length>
				<uniprot>
					<id>Q13563</id>
					<start>832</start>
					<end>895</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q13563</id>
					<start>833</start>
					<end>895</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>836</region_start>
						<region_end>894</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Polycystin-2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MGVSYEEFQVLVRRVDRMEHSIGSIVSKIDAVIVKLEIMERAKLKRREVLGRLLDGVAEDERLG</sequence>
				<length>64</length>
				<uniprot>
					<id>Q13563</id>
					<start>832</start>
					<end>895</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q13563</id>
					<start>833</start>
					<end>895</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>836</region_start>
						<region_end>894</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Polycystin-2</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>MGVSYEEFQVLVRRVDRMEHSIGSIVSKIDAVIVKLEIMERAKLKRREVLGRLLDGVAEDERLG</sequence>
				<length>64</length>
				<uniprot>
					<id>Q13563</id>
					<start>832</start>
					<end>895</end>
					<coverage>6.6%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q13563</id>
					<start>833</start>
					<end>895</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>836</region_start>
						<region_end>894</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:19556541). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3hro</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110024</accession>
		<general>
			<name>L27 domain complex (D. melanogaster)</name>
			<pdb_id>4rp3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.36</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Drosophila melanogaster</source_organism>
			<publication>
				<authors>Ghosh, A., Ramagopal, U., Ahmed, A., Bhoshle, R., Seidel, R., Stead, M., Toro, R., Almo, S.C.</authors>
				<title>Crystal Structure of the L27 Domain of Discs Large 1 (target ID NYSGRC-010766) from Drosophila melanogaster bound to a potassium ion (space group P212121)</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004871</accession>
					<name>signal transducer activity</name>
				</go>
				<go>
					<accession>GO:0005154</accession>
					<name>epidermal growth factor receptor binding</name>
				</go>
				<go>
					<accession>GO:0005198</accession>
					<name>structural molecule activity</name>
				</go>
				<go>
					<accession>GO:0004385</accession>
					<name>guanylate kinase activity</name>
				</go>
				<go>
					<accession>GO:0035255</accession>
					<name>ionotropic glutamate receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0045167</accession>
					<name>asymmetric protein localization involved in cell fate determination</name>
				</go>
				<go>
					<accession>GO:0042058</accession>
					<name>regulation of epidermal growth factor receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0007165</accession>
					<name>signal transduction</name>
				</go>
				<go>
					<accession>GO:0045475</accession>
					<name>locomotor rhythm</name>
				</go>
				<go>
					<accession>GO:0001708</accession>
					<name>cell fate specification</name>
				</go>
				<go>
					<accession>GO:0045196</accession>
					<name>establishment or maintenance of neuroblast polarity</name>
				</go>
				<go>
					<accession>GO:0008049</accession>
					<name>male courtship behavior</name>
				</go>
				<go>
					<accession>GO:0045887</accession>
					<name>positive regulation of synaptic growth at neuromuscular junction</name>
				</go>
				<go>
					<accession>GO:0001738</accession>
					<name>morphogenesis of a polarized epithelium</name>
				</go>
				<go>
					<accession>GO:0007155</accession>
					<name>cell adhesion</name>
				</go>
				<go>
					<accession>GO:0046956</accession>
					<name>positive phototaxis</name>
				</go>
				<go>
					<accession>GO:0007268</accession>
					<name>synaptic transmission</name>
				</go>
				<go>
					<accession>GO:0019991</accession>
					<name>septate junction assembly</name>
				</go>
				<go>
					<accession>GO:0000122</accession>
					<name>negative regulation of transcription from RNA polymerase II promoter</name>
				</go>
				<go>
					<accession>GO:0030714</accession>
					<name>anterior/posterior axis specification, follicular epithelium</name>
				</go>
				<go>
					<accession>GO:0045197</accession>
					<name>establishment or maintenance of epithelial cell apical/basal polarity</name>
				</go>
				<go>
					<accession>GO:0030710</accession>
					<name>regulation of border follicle cell delamination</name>
				</go>
				<go>
					<accession>GO:0000132</accession>
					<name>establishment of mitotic spindle orientation</name>
				</go>
				<go>
					<accession>GO:0008285</accession>
					<name>negative regulation of cell proliferation</name>
				</go>
				<go>
					<accession>GO:0045175</accession>
					<name>basal protein localization</name>
				</go>
				<go>
					<accession>GO:0010906</accession>
					<name>regulation of glucose metabolic process</name>
				</go>
				<go>
					<accession>GO:0008593</accession>
					<name>regulation of Notch signaling pathway</name>
				</go>
				<go>
					<accession>GO:0043113</accession>
					<name>receptor clustering</name>
				</go>
				<go>
					<accession>GO:0007391</accession>
					<name>dorsal closure</name>
				</go>
				<go>
					<accession>GO:0046710</accession>
					<name>GDP metabolic process</name>
				</go>
				<go>
					<accession>GO:0097120</accession>
					<name>receptor localization to synapse</name>
				</go>
				<go>
					<accession>GO:0016336</accession>
					<name>establishment or maintenance of polarity of larval imaginal disc epithelium</name>
				</go>
				<go>
					<accession>GO:0046425</accession>
					<name>regulation of JAK-STAT cascade</name>
				</go>
				<go>
					<accession>GO:0007318</accession>
					<name>pole plasm protein localization</name>
				</go>
				<go>
					<accession>GO:0042332</accession>
					<name>gravitaxis</name>
				</go>
				<go>
					<accession>GO:0051124</accession>
					<name>synaptic growth at neuromuscular junction</name>
				</go>
				<go>
					<accession>GO:0046037</accession>
					<name>GMP metabolic process</name>
				</go>
				<go>
					<accession>GO:0060581</accession>
					<name>cell fate commitment involved in pattern specification</name>
				</go>
				<go>
					<accession>GO:0016332</accession>
					<name>establishment or maintenance of polarity of embryonic epithelium</name>
				</go>
				<go>
					<accession>GO:0051726</accession>
					<name>regulation of cell cycle</name>
				</go>
				<go>
					<accession>GO:0019233</accession>
					<name>sensory perception of pain</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0014069</accession>
					<name>postsynaptic density</name>
				</go>
				<go>
					<accession>GO:0016327</accession>
					<name>apicolateral plasma membrane</name>
				</go>
				<go>
					<accession>GO:0016328</accession>
					<name>lateral plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005920</accession>
					<name>smooth septate junction</name>
				</go>
				<go>
					<accession>GO:0061176</accession>
					<name>type Ib terminal bouton</name>
				</go>
				<go>
					<accession>GO:0016323</accession>
					<name>basolateral plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005856</accession>
					<name>cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0048471</accession>
					<name>perinuclear region of cytoplasm</name>
				</go>
				<go>
					<accession>GO:0045179</accession>
					<name>apical cortex</name>
				</go>
				<go>
					<accession>GO:0045211</accession>
					<name>postsynaptic membrane</name>
				</go>
				<go>
					<accession>GO:0031594</accession>
					<name>neuromuscular junction</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>L27 domains</class>
				<subclass>L27_1 type</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Disks large 1 tumor suppressor protein</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>SMPVKKQEAHRALELLEDYHARLSEPQDRALRIAIERVIRIFKSRLFQALLDIQEFYELTLLDDSKSIQQKTAETLQIATKWEKDGQAVKIADFIKSS</sequence>
				<length>98</length>
				<uniprot>
					<id>P31007</id>
					<start>1</start>
					<end>97</end>
					<coverage>10%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P31007</id>
					<start>1</start>
					<end>97</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>87</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09058.7</region_id>
						<region_name>L27_1</region_name>
						<region_start>4</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Disks large 1 tumor suppressor protein</name>
				<source_organism>Drosophila melanogaster</source_organism>
				<sequence>SMPVKKQEAHRALELLEDYHARLSEPQDRALRIAIERVIRIFKSRLFQALLDIQEFYELTLLDDSKSIQQKTAETLQIATKWEKDGQAVKIADFIKSS</sequence>
				<length>98</length>
				<uniprot>
					<id>P31007</id>
					<start>1</start>
					<end>97</end>
					<coverage>10%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P31007</id>
					<start>1</start>
					<end>97</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>8</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>60</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>88</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF09058.7</region_id>
						<region_name>L27_1</region_name>
						<region_start>4</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form half of a heterotetrameric L27 complex (a dimer of dimers) (PMID:16147993). L27 complexes formed by Lin-2 and Lin-7 proteins were shown to function as obligate heterodimers/tetramers undergoing a cooperative unfolding transition. Circular dichroism studies reveal that the individual monomers are largely unfolded outside the complex form (PMID:12110687).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4rp4</pdb_id>
			<pdb_id>4rp5</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110025</accession>
		<general>
			<name>Tropomyosin dimer (Gallus gallus)</name>
			<pdb_id>1ic2</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Gallus gallus</source_organism>
			<publication>
				<pmid>11438684</pmid>
				<authors>Brown JH, Kim KH, Jun G, Greenfield NJ, Dominguez R, Volkmann N, Hitchcock-DeGregori SE, Cohen C</authors>
				<title>Deciphering the design of the tropomyosin molecule.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2001</year>
				<issue>15</issue>
				<volume>98</volume>
				<pages>8496-501</pages>
				<abstract>The crystal structure at 2.0-A resolution of an 81-residue N-terminal fragment of muscle alpha-tropomyosin reveals a parallel two-stranded alpha-helical coiled-coil structure with a remarkable core. The high alanine content of the molecule is clustered into short regions where the local 2-fold symmetry is broken by a small (approximately 1.2-A) axial staggering of the helices. The joining of these regions with neighboring segments, where the helices are in axial register, gives rise to specific bends in the molecular axis. We observe such bends to be widely distributed in two-stranded alpha-helical coiled-coil proteins. This asymmetric design in a dimer of identical (or highly similar) sequences allows the tropomyosin molecule to adopt multiple bent conformations. The seven alanine clusters in the core of the complete molecule (which spans seven monomers of the actin helix) promote the semiflexible winding of the tropomyosin filament necessary for its regulatory role in muscle contraction.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003779</accession>
					<name>actin binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
				<go>
					<accession>GO:0005856</accession>
					<name>cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Tropomyosin alpha-1 chain</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEERSKQLEDELVALQKKLKGTEDELDKYSESLKDAQEKLELADKKATDC</sequence>
				<length>81</length>
				<uniprot>
					<id>P04268</id>
					<start>1</start>
					<end>81</end>
					<coverage>28.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09493</id>
					<start>1</start>
					<end>81</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>77</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00261.17</region_id>
						<region_name>Tropomyosin</region_name>
						<region_start>48</region_start>
						<region_end>284</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tropomyosin alpha-1 chain</name>
				<source_organism>Gallus gallus</source_organism>
				<sequence>MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEERSKQLEDELVALQKKLKGTEDELDKYSESLKDAQEKLELADKKATDC</sequence>
				<length>81</length>
				<uniprot>
					<id>P04268</id>
					<start>1</start>
					<end>81</end>
					<coverage>28.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09493</id>
					<start>1</start>
					<end>81</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00261.17</region_id>
						<region_name>Tropomyosin</region_name>
						<region_start>48</region_start>
						<region_end>284</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:11438684). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3mtu</pdb_id>
			<pdb_id>3u1a</pdb_id>
			<pdb_id>3u1c</pdb_id>
			<pdb_id>1c1g</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110026</accession>
		<general>
			<name>N-Terminal dimerization domain Lis1</name>
			<pdb_id>1uuj</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.75</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<pmid>15274919</pmid>
				<authors>Kim MH, Cooper DR, Oleksy A, Devedjiev Y, Derewenda U, Reiner O, Otlewski J, Derewenda ZS</authors>
				<title>The structure of the N-terminal domain of the product of the lissencephaly gene Lis1 and its functional implications.</title>
				<journal>Structure</journal>
				<year>2004</year>
				<issue>6</issue>
				<volume>12</volume>
				<pages>987-98</pages>
				<abstract>Mutations in the Lis1 gene result in lissencephaly (smooth brain), a debilitating developmental syndrome caused by the impaired ability of postmitotic neurons to migrate to their correct destination in the cerebral cortex. Sequence similarities suggest that the LIS1 protein contains a C-terminal seven-blade beta-propeller domain, while the structure of the N-terminal fragment includes the LisH (Lis-homology) motif, a pattern found in over 100 eukaryotic proteins with a hitherto unknown function. We present the 1.75 A resolution crystal structure of the N-terminal domain of mouse LIS1, and we show that the LisH motif is a novel, thermodynamically very stable dimerization domain. The structure explains the molecular basis of a low severity form of lissencephaly.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0008017</accession>
					<name>microtubule binding</name>
				</go>
				<go>
					<accession>GO:0042803</accession>
					<name>protein homodimerization activity</name>
				</go>
				<go>
					<accession>GO:0051219</accession>
					<name>phosphoprotein binding</name>
				</go>
				<go>
					<accession>GO:0045505</accession>
					<name>dynein intermediate chain binding</name>
				</go>
				<go>
					<accession>GO:0047179</accession>
					<name>platelet-activating factor acetyltransferase activity</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0007268</accession>
					<name>synaptic transmission</name>
				</go>
				<go>
					<accession>GO:0050885</accession>
					<name>neuromuscular process controlling balance</name>
				</go>
				<go>
					<accession>GO:0042249</accession>
					<name>establishment of planar polarity of embryonic epithelium</name>
				</go>
				<go>
					<accession>GO:0090102</accession>
					<name>cochlea development</name>
				</go>
				<go>
					<accession>GO:0051081</accession>
					<name>nuclear envelope disassembly</name>
				</go>
				<go>
					<accession>GO:0045773</accession>
					<name>positive regulation of axon extension</name>
				</go>
				<go>
					<accession>GO:0021819</accession>
					<name>layer formation in cerebral cortex</name>
				</go>
				<go>
					<accession>GO:0061003</accession>
					<name>positive regulation of dendritic spine morphogenesis</name>
				</go>
				<go>
					<accession>GO:0001961</accession>
					<name>positive regulation of cytokine-mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0001667</accession>
					<name>ameboidal-type cell migration</name>
				</go>
				<go>
					<accession>GO:0007405</accession>
					<name>neuroblast proliferation</name>
				</go>
				<go>
					<accession>GO:0017145</accession>
					<name>stem cell division</name>
				</go>
				<go>
					<accession>GO:0045931</accession>
					<name>positive regulation of mitotic cell cycle</name>
				</go>
				<go>
					<accession>GO:0090176</accession>
					<name>microtubule cytoskeleton organization involved in establishment of planar polarity</name>
				</go>
				<go>
					<accession>GO:0043622</accession>
					<name>cortical microtubule organization</name>
				</go>
				<go>
					<accession>GO:0046329</accession>
					<name>negative regulation of JNK cascade</name>
				</go>
				<go>
					<accession>GO:0030036</accession>
					<name>actin cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0040019</accession>
					<name>positive regulation of embryonic development</name>
				</go>
				<go>
					<accession>GO:0007097</accession>
					<name>nuclear migration</name>
				</go>
				<go>
					<accession>GO:0001675</accession>
					<name>acrosome assembly</name>
				</go>
				<go>
					<accession>GO:0043087</accession>
					<name>regulation of GTPase activity</name>
				</go>
				<go>
					<accession>GO:0051660</accession>
					<name>establishment of centrosome localization</name>
				</go>
				<go>
					<accession>GO:0048854</accession>
					<name>brain morphogenesis</name>
				</go>
				<go>
					<accession>GO:0008090</accession>
					<name>retrograde axonal transport</name>
				</go>
				<go>
					<accession>GO:0021540</accession>
					<name>corpus callosum morphogenesis</name>
				</go>
				<go>
					<accession>GO:0016042</accession>
					<name>lipid catabolic process</name>
				</go>
				<go>
					<accession>GO:0021895</accession>
					<name>cerebral cortex neuron differentiation</name>
				</go>
				<go>
					<accession>GO:0021766</accession>
					<name>hippocampus development</name>
				</go>
				<go>
					<accession>GO:0019226</accession>
					<name>transmission of nerve impulse</name>
				</go>
				<go>
					<accession>GO:2000574</accession>
					<name>regulation of microtubule motor activity</name>
				</go>
				<go>
					<accession>GO:0000132</accession>
					<name>establishment of mitotic spindle orientation</name>
				</go>
				<go>
					<accession>GO:0009306</accession>
					<name>protein secretion</name>
				</go>
				<go>
					<accession>GO:0007611</accession>
					<name>learning or memory</name>
				</go>
				<go>
					<accession>GO:0010977</accession>
					<name>negative regulation of neuron projection development</name>
				</go>
				<go>
					<accession>GO:0070507</accession>
					<name>regulation of microtubule cytoskeleton organization</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
				<go>
					<accession>GO:0031023</accession>
					<name>microtubule organizing center organization</name>
				</go>
				<go>
					<accession>GO:0001764</accession>
					<name>neuron migration</name>
				</go>
				<go>
					<accession>GO:0047496</accession>
					<name>vesicle transport along microtubule</name>
				</go>
				<go>
					<accession>GO:0008344</accession>
					<name>adult locomotory behavior</name>
				</go>
				<go>
					<accession>GO:0036035</accession>
					<name>osteoclast development</name>
				</go>
				<go>
					<accession>GO:0060117</accession>
					<name>auditory receptor cell development</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0031512</accession>
					<name>motile primary cilium</name>
				</go>
				<go>
					<accession>GO:0005813</accession>
					<name>centrosome</name>
				</go>
				<go>
					<accession>GO:0031965</accession>
					<name>nuclear membrane</name>
				</go>
				<go>
					<accession>GO:0031252</accession>
					<name>cell leading edge</name>
				</go>
				<go>
					<accession>GO:0000235</accession>
					<name>astral microtubule</name>
				</go>
				<go>
					<accession>GO:1904115</accession>
					<name>axon cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005938</accession>
					<name>cell cortex</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005871</accession>
					<name>kinesin complex</name>
				</go>
				<go>
					<accession>GO:0043025</accession>
					<name>neuronal cell body</name>
				</go>
				<go>
					<accession>GO:0030426</accession>
					<name>growth cone</name>
				</go>
				<go>
					<accession>GO:0048471</accession>
					<name>perinuclear region of cytoplasm</name>
				</go>
				<go>
					<accession>GO:0000776</accession>
					<name>kinetochore</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Platelet-activating factor acetylhydrolase IB subunit alpha</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GAMVLSQRQRDELNRAIADYLRSNGYEEAYSVFKKEAELDMNEELDKKYAGLLEKKWTSVIRLQKKVMELESKLNEAKEEFTSGGPLG</sequence>
				<length>88</length>
				<uniprot>
					<id>P63004</id>
					<start>1</start>
					<end>86</end>
					<coverage>21%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P63005</id>
					<start>1</start>
					<end>86</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08513.8</region_id>
						<region_name>LisH</region_name>
						<region_start>9</region_start>
						<region_end>35</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Platelet-activating factor acetylhydrolase IB subunit alpha</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>GAMVLSQRQRDELNRAIADYLRSNGYEEAYSVFKKEAELDMNEELDKKYAGLLEKKWTSVIRLQKKVMELESKLNEAKEEFTSGGPLG</sequence>
				<length>88</length>
				<uniprot>
					<id>P63004</id>
					<start>1</start>
					<end>86</end>
					<coverage>21%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P63005</id>
					<start>1</start>
					<end>86</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>5</region_start>
						<region_end>21</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>25</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>65</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>67</region_start>
						<region_end>75</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF08513.8</region_id>
						<region_name>LisH</region_name>
						<region_start>9</region_start>
						<region_end>35</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Lis1 was shown to be a dimer under native conditions. Monitoring the chemically induced unfolding of the protein by fluorescence and by circular dichroism revealed that the reaction follows a single and coincident transition.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110027</accession>
		<general>
			<name>Mannose-binding lectin (Hyacinthoides hispanica)</name>
			<pdb_id>1b2p</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Hyacinthoides hispanica</source_organism>
			<publication>
				<pmid>10393293</pmid>
				<authors>Wood SD, Wright LM, Reynolds CD, Rizkallah PJ, Allen AK, Peumans WJ, Van Damme EJ</authors>
				<title>Structure of the native (unligated) mannose-specific bulb lectin from Scilla campanulata (bluebell) at 1.7 A resolution.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>1999</year>
				<issue>Pt 7</issue>
				<volume>55</volume>
				<pages>1264-72</pages>
				<abstract>The X-ray crystal structure of native Scilla campanulata agglutinin, a mannose-specific lectin from bluebell bulbs and a member of the Liliaceae family, has been determined by molecular replacement and refined to an R value of 0.186 at 1.7 A resolution. The lectin crystallizes in space group P21212 with unit-cell parameters a = 70. 42, b = 92.95, c = 46.64 A. The unit cell contains eight protein molecules of Mr = 13143 Da (119 amino-acid residues). The asymmetric unit comprises two chemically identical molecules, A and B, related by a non-crystallographic twofold axis perpendicular to c. This dimer further associates by crystallographic twofold symmetry to form a tetramer. The fold of the polypeptide backbone closely resembles that found in the lectins from Galanthus nivalis (snowdrop) and Hippeastrum (amaryllis) and contains a threefold symmetric beta-prism made up of three antiparallel four-stranded beta-sheets. Each of the four-stranded beta-sheets (I, II and III) possesses a potential saccharide-binding site containing conserved residues; however, site II has two mutations relative to sites I and III which may prevent ligation at this site. Our study provides the first accurate and detailed description of a native (unligated) structure from this superfamily of mannose-specific bulb lectins and will allow comparisons with a number of lectin-saccharide complexes which have already been determined or are currently under investigation.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Bulb-type lectin domain</class>
				<subclass>Homodimeric lectin</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Lectin SCAman (Fragment)</name>
				<source_organism>Hyacinthoides hispanica</source_organism>
				<sequence>NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALWATQTVR</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9ZP49</id>
					<start>22</start>
					<end>140</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9ZP49</id>
					<start>22</start>
					<end>140</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>24</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>103</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>116</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>126</region_start>
						<region_end>130</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>35</region_start>
						<region_end>112</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Lectin SCAman (Fragment)</name>
				<source_organism>Hyacinthoides hispanica</source_organism>
				<sequence>NNIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALWATQTVR</sequence>
				<length>119</length>
				<uniprot>
					<id>Q9ZP49</id>
					<start>22</start>
					<end>140</end>
					<coverage>76.8%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q9ZP49</id>
					<start>22</start>
					<end>140</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>24</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>37</region_start>
						<region_end>39</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>51</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>63</region_start>
						<region_end>67</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>70</region_start>
						<region_end>74</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>85</region_start>
						<region_end>88</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>94</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>103</region_start>
						<region_end>106</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>116</region_start>
						<region_end>120</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>126</region_start>
						<region_end>130</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>132</region_start>
						<region_end>135</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01453.21</region_id>
						<region_name>B_lectin</region_name>
						<region_start>35</region_start>
						<region_end>112</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>A closely homologous lectin of the same type sharing a high degree of sequence and structural similarity has been shown to follow a two-state folding process (PMID:11401577).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2110028</accession>
		<general>
			<name>Dimerization domain of the type I alpha regulatory subunit of protein kinase A</name>
			<pdb_id>2ezw</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Bos taurus</source_organism>
			<publication>
				<pmid>12860132</pmid>
				<authors>Banky P, Roy M, Newlon MG, Morikis D, Haste NM, Taylor SS, Jennings PA</authors>
				<title>Related protein-protein interaction modules present drastically different surface topographies despite a conserved helical platform.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2003</year>
				<issue>5</issue>
				<volume>330</volume>
				<pages>1117-29</pages>
				<abstract>The subcellular localization of cAMP-dependent protein kinase (PKA) occurs through interaction with A-Kinase Anchoring Proteins (AKAPs). AKAPs bind to the PKA regulatory subunit dimer of both type Ialpha and type IIalpha (RIalpha and RIIalpha). RIalpha and RIIalpha display characteristic localization within different cell types, which is maintained by interaction of AKAPs with the N-terminal dimerization and docking domain (D/D) of the respective regulatory subunit. Previously, we reported the solution structure of RIIa D/D module, both free and bound to AKAPs. We have now solved the solution structure of the dimerization and docking domain of the type Ialpha regulatory dimer subunit (RIalpha D/D). RIalpha D/D is a compact docking module, with unusual interchain disulfide bonds that help maintain the AKAP interaction surface. In contrast to the shallow hydrophobic groove for AKAP binding across the surface of the RIIalpha D/D dimeric interface, the RIalpha D/D module presents a deep cleft for proposed AKAP binding. RIalpha and RIIalpha D/D interaction modules present drastically differing dimeric topographies, despite a conserved X-type four-helix bundle structure.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0031625</accession>
					<name>ubiquitin protein ligase binding</name>
				</go>
				<go>
					<accession>GO:0004862</accession>
					<name>cAMP-dependent protein kinase inhibitor activity</name>
				</go>
				<go>
					<accession>GO:0034236</accession>
					<name>protein kinase A catalytic subunit binding</name>
				</go>
				<go>
					<accession>GO:0008603</accession>
					<name>cAMP-dependent protein kinase regulator activity</name>
				</go>
				<go>
					<accession>GO:0030552</accession>
					<name>cAMP binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:2000480</accession>
					<name>negative regulation of cAMP-dependent protein kinase activity</name>
				</go>
				<go>
					<accession>GO:0060038</accession>
					<name>cardiac muscle cell proliferation</name>
				</go>
				<go>
					<accession>GO:0046007</accession>
					<name>negative regulation of activated T cell proliferation</name>
				</go>
				<go>
					<accession>GO:0001707</accession>
					<name>mesoderm formation</name>
				</go>
				<go>
					<accession>GO:0045214</accession>
					<name>sarcomere organization</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0044853</accession>
					<name>plasma membrane raft</name>
				</go>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0031588</accession>
					<name>nucleotide-activated protein kinase complex</name>
				</go>
				<go>
					<accession>GO:0031594</accession>
					<name>neuromuscular junction</name>
				</go>
				<go>
					<accession>GO:0001772</accession>
					<name>immunological synapse</name>
				</go>
				<go>
					<accession>GO:0005952</accession>
					<name>cAMP-dependent protein kinase complex</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>cAMP-dependent protein kinase type I-alpha regulatory subunit</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>SLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFEKLEKEEAK</sequence>
				<length>50</length>
				<uniprot>
					<id>P00514</id>
					<start>13</start>
					<end>62</end>
					<coverage>13.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P10644</id>
					<start>14</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02197.14</region_id>
						<region_name>RIIa</region_name>
						<region_start>24</region_start>
						<region_end>61</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>cAMP-dependent protein kinase type I-alpha regulatory subunit</name>
				<source_organism>Bos taurus</source_organism>
				<sequence>SLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFEKLEKEEAK</sequence>
				<length>50</length>
				<uniprot>
					<id>P00514</id>
					<start>13</start>
					<end>62</end>
					<coverage>13.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P10644</id>
					<start>14</start>
					<end>63</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>14</region_start>
						<region_end>17</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF02197.14</region_id>
						<region_name>RIIa</region_name>
						<region_start>24</region_start>
						<region_end>61</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The N-terminal dimerization region of RIalpha is highly mobile evading structure determination by X-ray (PMID:24316401).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The N-terminal dimerization region of RIalpha is highly mobile evading structure determination by X-ray (PMID:24316401).</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3im3</pdb_id>
			<pdb_id>3im4</pdb_id>
			<pdb_id>5hvz</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2110029</accession>
		<general>
			<name>Coiled Coil Domain of Pawr</name>
			<pdb_id>5fiy</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.00</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Rattus norvegicus</source_organism>
			<publication>
				<authors>Tiruttani Subhramanyam, U.K., Kubicek, J., Eidhoff, U.B., Labahn, J.</authors>
				<title>The Structure of Coiled Coil Domain of Pawr</title>
				<journal>To be published</journal>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F and G were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>PRKC apoptosis WT1 regulator protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>ASWSHPQFEKAGFSRHNRDTSAPANFASSSTLEKRIEDLEKEVLRERQENLRLTRLMQDKEEMIGKLKEEIDLLNRDLDDMEDENEQLKQENKTLLKVVGQLTR</sequence>
				<length>104</length>
				<uniprot>
					<id>Q62627</id>
					<start>240</start>
					<end>332</end>
					<coverage>28%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q62627</id>
					<start>240</start>
					<end>332</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>257</region_start>
						<region_end>284</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>286</region_start>
						<region_end>290</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>292</region_start>
						<region_end>308</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>310</region_start>
						<region_end>331</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>PRKC apoptosis WT1 regulator protein</name>
				<source_organism>Rattus norvegicus</source_organism>
				<sequence>ASWSHPQFEKAGFSRHNRDTSAPANFASSSTLEKRIEDLEKEVLRERQENLRLTRLMQDKEEMIGKLKEEIDLLNRDLDDMEDENEQLKQENKTLLKVVGQLTR</sequence>
				<length>104</length>
				<uniprot>
					<id>Q62627</id>
					<start>240</start>
					<end>332</end>
					<coverage>28%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q62627</id>
					<start>240</start>
					<end>332</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>257</region_start>
						<region_end>284</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>286</region_start>
						<region_end>290</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>292</region_start>
						<region_end>308</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>310</region_start>
						<region_end>332</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions. Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF4110009</accession>
		<general>
			<name>p53/p73-b homo-tetramerization domain (Ciona intestinalis)</name>
			<pdb_id>2mw4</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homotetramer (dimer of dimers)</assembly>
			<source_organism>Ciona intestinalis</source_organism>
			<publication>
				<pmid>26473758</pmid>
				<authors>Heering J, Jonker HR, Löhr F, Schwalbe H, Dötsch V</authors>
				<title>Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain.</title>
				<journal>Protein Sci.</journal>
				<year>2015</year>
				<abstract>Most members of the p53 family of transcription factors form tetramers. Responsible for determining the oligomeric state is a short oligomerization domain consisting of one β-strand and one α-helix. With the exception of human p53 all other family members investigated so far contain a second α-helix as part of their tetramerization domain. Here we have used NMR spectroscopy to characterize the oligomerization domains of the two p53-like proteins from the tunicate Ciona intestinalis, representing the closest living relative of vertebrates. Structure determination reveals for one of the two proteins a new type of packing of this second α-helix on the core domain that was not predicted based on the sequence, while the other protein does not form a second helix despite the presence of crucial residues that are conserved in all other family members that form a second helix. By mutational analysis we identify a proline as well as large hydrophobic residues in the hinge region between both helices as the crucial determinant for the formation of a second helix. This article is protected by copyright. All rights reserved.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>p53 tetramerization</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Uncharacterized protein</name>
				<source_organism>Ciona intestinalis</source_organism>
				<sequence>SDGDVVYTLNIRGKRKFEKVKEYKEALDLLDYVQPDVKKACCQRNQI</sequence>
				<length>47</length>
				<uniprot>
					<id>F6SSG7</id>
					<start>374</start>
					<end>419</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_F6SSG7</id>
					<start>374</start>
					<end>419</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>378</region_start>
						<region_end>384</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>407</region_start>
						<region_end>414</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>367</region_start>
						<region_end>408</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Uncharacterized protein</name>
				<source_organism>Ciona intestinalis</source_organism>
				<sequence>SDGDVVYTLNIRGKRKFEKVKEYKEALDLLDYVQPDVKKACCQRNQI</sequence>
				<length>47</length>
				<uniprot>
					<id>F6SSG7</id>
					<start>374</start>
					<end>419</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_F6SSG7</id>
					<start>374</start>
					<end>419</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>378</region_start>
						<region_end>384</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>407</region_start>
						<region_end>417</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>367</region_start>
						<region_end>408</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Uncharacterized protein</name>
				<source_organism>Ciona intestinalis</source_organism>
				<sequence>SDGDVVYTLNIRGKRKFEKVKEYKEALDLLDYVQPDVKKACCQRNQI</sequence>
				<length>47</length>
				<uniprot>
					<id>F6SSG7</id>
					<start>374</start>
					<end>419</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_F6SSG7</id>
					<start>374</start>
					<end>419</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>378</region_start>
						<region_end>384</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>407</region_start>
						<region_end>414</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>367</region_start>
						<region_end>408</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Uncharacterized protein</name>
				<source_organism>Ciona intestinalis</source_organism>
				<sequence>SDGDVVYTLNIRGKRKFEKVKEYKEALDLLDYVQPDVKKACCQRNQI</sequence>
				<length>47</length>
				<uniprot>
					<id>F6SSG7</id>
					<start>374</start>
					<end>419</end>
					<coverage>11%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_F6SSG7</id>
					<start>374</start>
					<end>419</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>378</region_start>
						<region_end>384</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>386</region_start>
						<region_end>402</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>407</region_start>
						<region_end>414</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF07710.8</region_id>
						<region_name>P53_tetramer</region_name>
						<region_start>367</region_start>
						<region_end>408</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>p53, p63, p73 and their homologues are all members of the p53 protein family. The tetramerization region of p53, p63 and p73 are closely homologous to each other, having very similar sequences, structures and biological functions (PMID:25185827, PMID:18289041, PMID:20379196), all containing the same Pfam domain (PF07710). The tetramerization domain of p53 exhibits a four-helix bundle structure bound by hydrophobic and electrostatic interactions (PMID:8023159). The tetramer is formed as a dimer of dimers and follows a two state folding and binding process, demonstrated in several chemical and thermal denaturation/refolding experiments (PMID:9582268, PMID:18410249, PMID:19913028).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF6240001</accession>
		<general>
			<name>Human respiratory syncytial virus fusion protein core</name>
			<pdb_id>1g2c</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.30</resolution>
			<assembly>heterohexamer</assembly>
			<source_organism>Human respiratory syncytial virus A</source_organism>
			<publication>
				<pmid>11106388</pmid>
				<authors>Zhao X, Singh M, Malashkevich VN, Kim PS</authors>
				<title>Structural characterization of the human respiratory syncytial virus fusion protein core.</title>
				<journal>Proc. Natl. Acad. Sci. U.S.A.</journal>
				<year>2000</year>
				<issue>26</issue>
				<volume>97</volume>
				<pages>14172-7</pages>
				<abstract>Human respiratory syncytial virus (HRSV) is a major cause of a number of severe respiratory diseases, including bronchiolitis and pneumonia, in infants and young children. The HRSV F protein, a glycoprotein essential for viral entry, is a primary target for vaccine and drug development. Two heptad-repeat regions within the HRSV F sequence were predicted by the computer program learncoil-vmf. These regions are thought to form trimer-of-hairpins-like structures, similar to those found in the fusion proteins of several enveloped viruses. The hairpin structure likely brings the viral and cellular membranes into close apposition, thereby facilitating membrane fusion and subsequent viral entry. Here, we show that peptides, denoted HR-N and HR-C, corresponding to the heptad-repeat regions from the N-terminal and C-terminal segments of the HRSV F protein, respectively, form a stable alpha-helical trimer of heterodimers. The HRSV N/C complex was crystallized and its x-ray structure was determined at 2.3-A resolution. As anticipated, the complex is a six-helix bundle in which the HR-N peptides form a three-stranded, central coiled coil, and the HR-C peptides pack in an antiparallel manner into hydrophobic grooves on the coiled-coil surface. There is remarkable structural similarity between the HRSV N/C complex and the fusion protein core of other viruses, including HIV-1 gp41. In addition, earlier work has shown that HRSV HR-C peptides, like the HIV-1 gp41 C peptides, inhibit viral infection. Thus, drug discovery and vaccine development strategies aimed at inhibiting viral entry by blocking hairpin formation may be applied to the inhibition of HRSV.</abstract>
			</publication>
		</general>
		<function>
			<biological_process>
				<go>
					<accession>GO:0019064</accession>
					<name>fusion of virus membrane with host plasma membrane</name>
				</go>
				<go>
					<accession>GO:0060141</accession>
					<name>positive regulation of syncytium formation by virus</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0020002</accession>
					<name>host cell plasma membrane</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W and X were removed as chains A, B, C, D, E and F represent the biologically relevant dimer.</note>
				<nr_of_chains>6</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (hexameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>LHLEGEVNKIKSALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQLLPIVNK</sequence>
				<length>52</length>
				<uniprot>
					<id>P11209</id>
					<start>158</start>
					<end>209</end>
					<coverage>9.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>158</start>
					<end>209</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>161</region_start>
						<region_end>164</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>166</region_start>
						<region_end>208</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG</sequence>
				<length>43</length>
				<uniprot>
					<id>P11209</id>
					<start>477</start>
					<end>519</end>
					<coverage>7.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>477</start>
					<end>519</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>485</region_start>
						<region_end>513</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>LHLEGEVNKIKSALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQLLPIVNK</sequence>
				<length>52</length>
				<uniprot>
					<id>P11209</id>
					<start>158</start>
					<end>209</end>
					<coverage>9.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>158</start>
					<end>209</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>161</region_start>
						<region_end>206</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG</sequence>
				<length>43</length>
				<uniprot>
					<id>P11209</id>
					<start>477</start>
					<end>519</end>
					<coverage>7.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>477</start>
					<end>519</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>487</region_start>
						<region_end>514</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>LHLEGEVNKIKSALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQLLPIVNK</sequence>
				<length>52</length>
				<uniprot>
					<id>P11209</id>
					<start>158</start>
					<end>209</end>
					<coverage>9.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>158</start>
					<end>209</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>161</region_start>
						<region_end>206</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Fusion glycoprotein F0</name>
				<source_organism>Human respiratory syncytial virus A</source_organism>
				<sequence>FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG</sequence>
				<length>43</length>
				<uniprot>
					<id>P11209</id>
					<start>477</start>
					<end>519</end>
					<coverage>7.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P03420</id>
					<start>477</start>
					<end>519</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>485</region_start>
						<region_end>514</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00523.15</region_id>
						<region_name>Fusion_gly</region_name>
						<region_start>29</region_start>
						<region_end>541</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:11106388). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>3kpe</pdb_id>
			<pdb_id>3rrr</pdb_id>
			<pdb_id>3rrt</pdb_id>
			<pdb_id>4jhw</pdb_id>
			<pdb_id>4zyp</pdb_id>
			<pdb_id>5j3d</pdb_id>
			<pdb_id>5toj</pdb_id>
			<pdb_id>5tok</pdb_id>
			<pdb_id>5u68</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4140003</accession>
		<general>
			<name>Measles virus phosphoprotein tetramerization domain</name>
			<pdb_id>4bhv</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Measles virus</source_organism>
			<publication>
				<pmid>24914970</pmid>
				<authors>Blocquel D, Habchi J, Durand E, Sevajol M, Ferron F, Erales J, Papageorgiou N, Longhi S</authors>
				<title>Coiled-coil deformations in crystal structures: the measles virus phosphoprotein multimerization domain as an illustrative example.</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2014</year>
				<issue>Pt 6</issue>
				<volume>70</volume>
				<pages>1589-603</pages>
				<abstract>The structures of two constructs of the measles virus (MeV) phosphoprotein (P) multimerization domain (PMD) are reported and are compared with a third structure published recently by another group [Communie et al. (2013), J. Virol. 87, 7166-7169]. Although the three structures all have a tetrameric and parallel coiled-coil arrangement, structural comparison unveiled considerable differences in the quaternary structure and unveiled that the three structures suffer from significant structural deformation induced by intermolecular interactions within the crystal. These results show that crystal packing can bias conclusions about function and mechanism based on analysis of a single crystal structure, and they challenge to some extent the assumption according to which coiled-coil structures can be reliably predicted from the amino-acid sequence. Structural comparison also highlighted significant differences in the extent of disorder in the C-terminal region of each monomer. The differential flexibility of the C-terminal region is also supported by size-exclusion chromatography and small-angle X-ray scattering studies, which showed that MeV PMD exists in solution as a dynamic equilibrium between two tetramers of different compaction. Finally, the possible functional implications of the flexibility of the C-terminal region of PMD are discussed.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003968</accession>
					<name>RNA-directed RNA polymerase activity</name>
				</go>
				<go>
					<accession>GO:0003723</accession>
					<name>RNA binding</name>
				</go>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0001172</accession>
					<name>transcription, RNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0019079</accession>
					<name>viral genome replication</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Phosphoprotein</name>
				<source_organism>Measles virus</source_organism>
				<sequence>MGDHYDDELFSDVQDIKTALAKIHEDNQKIISKLESLLLLKGEVESIKKQINRQNISIHHHHHH</sequence>
				<length>64</length>
				<uniprot>
					<id>P03422</id>
					<start>304</start>
					<end>360</end>
					<coverage>11.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35974</id>
					<start>304</start>
					<end>360</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>342</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03210.10</region_id>
						<region_name>Paramyx_P_V_C</region_name>
						<region_start>324</region_start>
						<region_end>502</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Phosphoprotein</name>
				<source_organism>Measles virus</source_organism>
				<sequence>MGDHYDDELFSDVQDIKTALAKIHEDNQKIISKLESLLLLKGEVESIKKQINRQNISIHHHHHH</sequence>
				<length>64</length>
				<uniprot>
					<id>P03422</id>
					<start>304</start>
					<end>360</end>
					<coverage>11.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35974</id>
					<start>304</start>
					<end>360</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>311</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03210.10</region_id>
						<region_name>Paramyx_P_V_C</region_name>
						<region_start>324</region_start>
						<region_end>502</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Phosphoprotein</name>
				<source_organism>Measles virus</source_organism>
				<sequence>MGDHYDDELFSDVQDIKTALAKIHEDNQKIISKLESLLLLKGEVESIKKQINRQNISIHHHHHH</sequence>
				<length>64</length>
				<uniprot>
					<id>P03422</id>
					<start>304</start>
					<end>360</end>
					<coverage>11.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35974</id>
					<start>304</start>
					<end>360</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>342</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03210.10</region_id>
						<region_name>Paramyx_P_V_C</region_name>
						<region_start>324</region_start>
						<region_end>502</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Phosphoprotein</name>
				<source_organism>Measles virus</source_organism>
				<sequence>MGDHYDDELFSDVQDIKTALAKIHEDNQKIISKLESLLLLKGEVESIKKQINRQNISIHHHHHH</sequence>
				<length>64</length>
				<uniprot>
					<id>P03422</id>
					<start>304</start>
					<end>360</end>
					<coverage>11.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P35974</id>
					<start>304</start>
					<end>360</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>309</region_start>
						<region_end>340</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>342</region_start>
						<region_end>360</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03210.10</region_id>
						<region_name>Paramyx_P_V_C</region_name>
						<region_start>324</region_start>
						<region_end>502</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:23576502). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4c5q</pdb_id>
			<pdb_id>3zdo</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4140004</accession>
		<general>
			<name>Core (C) protein from West Nile Virus</name>
			<pdb_id>1sfk</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.20</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Kunjin virus</source_organism>
			<publication>
				<pmid>15242592</pmid>
				<authors>Dokland T, Walsh M, Mackenzie JM, Khromykh AA, Ee KH, Wang S</authors>
				<title>West Nile virus core protein; tetramer structure and ribbon formation.</title>
				<journal>Structure</journal>
				<year>2004</year>
				<issue>7</issue>
				<volume>12</volume>
				<pages>1157-63</pages>
				<abstract>We have determined the crystal structure of the core (C) protein from the Kunjin subtype of West Nile virus (WNV), closely related to the NY99 strain of WNV, currently a major health threat in the U.S. WNV is a member of the Flaviviridae family of enveloped RNA viruses that contains many important human pathogens. The C protein is associated with the RNA genome and forms the internal core which is surrounded by the envelope in the virion. The C protein structure contains four alpha helices and forms dimers that are organized into tetramers. The tetramers form extended filamentous ribbons resembling the stacked alpha helices seen in HEAT protein structures.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005198</accession>
					<name>structural molecule activity</name>
				</go>
				<go>
					<accession>GO:0004252</accession>
					<name>serine-type endopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0005524</accession>
					<name>ATP binding</name>
				</go>
				<go>
					<accession>GO:0004483</accession>
					<name>mRNA (nucleoside-2'-O-)-methyltransferase activity</name>
				</go>
				<go>
					<accession>GO:0003724</accession>
					<name>RNA helicase activity</name>
				</go>
				<go>
					<accession>GO:0046983</accession>
					<name>protein dimerization activity</name>
				</go>
				<go>
					<accession>GO:0070008</accession>
					<name>serine-type exopeptidase activity</name>
				</go>
				<go>
					<accession>GO:0003968</accession>
					<name>RNA-directed RNA polymerase activity</name>
				</go>
				<go>
					<accession>GO:0003725</accession>
					<name>double-stranded RNA binding</name>
				</go>
				<go>
					<accession>GO:0004482</accession>
					<name>mRNA (guanine-N7-)-methyltransferase activity</name>
				</go>
				<go>
					<accession>GO:0008026</accession>
					<name>ATP-dependent helicase activity</name>
				</go>
				<go>
					<accession>GO:0046872</accession>
					<name>metal ion binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0080009</accession>
					<name>mRNA methylation</name>
				</go>
				<go>
					<accession>GO:0039574</accession>
					<name>suppression by virus of host TYK2 activity</name>
				</go>
				<go>
					<accession>GO:0039520</accession>
					<name>induction by virus of host autophagy</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0039694</accession>
					<name>viral RNA genome replication</name>
				</go>
				<go>
					<accession>GO:0019062</accession>
					<name>virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0075512</accession>
					<name>clathrin-mediated endocytosis of virus by host cell</name>
				</go>
				<go>
					<accession>GO:0039576</accession>
					<name>suppression by virus of host JAK1 activity</name>
				</go>
				<go>
					<accession>GO:0001172</accession>
					<name>transcription, RNA-templated</name>
				</go>
				<go>
					<accession>GO:0006370</accession>
					<name>7-methylguanosine mRNA capping</name>
				</go>
				<go>
					<accession>GO:0039502</accession>
					<name>suppression by virus of host type I interferon-mediated signaling pathway</name>
				</go>
				<go>
					<accession>GO:0036265</accession>
					<name>RNA (guanine-N7)-methylation</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006508</accession>
					<name>proteolysis</name>
				</go>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005576</accession>
					<name>extracellular region</name>
				</go>
				<go>
					<accession>GO:0019028</accession>
					<name>viral capsid</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
				<go>
					<accession>GO:0044167</accession>
					<name>host cell endoplasmic reticulum membrane</name>
				</go>
				<go>
					<accession>GO:0042025</accession>
					<name>host cell nucleus</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains E, F, G and H were removed as chains A, B, C and D represent the biologically relevant dimer.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Genome polyprotein</name>
				<source_organism>Kunjin virus</source_organism>
				<sequence>RVLSLTGLKRAMLSLIDGRGPTRFVLALLAFFRFTAIAPTRAVLDRWRSVNKQTAMKHLLSFKKELGTLTSAINRR</sequence>
				<length>76</length>
				<uniprot>
					<id>P14335</id>
					<start>23</start>
					<end>98</end>
					<coverage>2.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06935</id>
					<start>23</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>6</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Genome polyprotein</name>
				<source_organism>Kunjin virus</source_organism>
				<sequence>RVLSLTGLKRAMLSLIDGRGPTRFVLALLAFFRFTAIAPTRAVLDRWRSVNKQTAMKHLLSFKKELGTLTSAINRR</sequence>
				<length>76</length>
				<uniprot>
					<id>P14335</id>
					<start>23</start>
					<end>98</end>
					<coverage>2.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06935</id>
					<start>23</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>6</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Genome polyprotein</name>
				<source_organism>Kunjin virus</source_organism>
				<sequence>RVLSLTGLKRAMLSLIDGRGPTRFVLALLAFFRFTAIAPTRAVLDRWRSVNKQTAMKHLLSFKKELGTLTSAINRR</sequence>
				<length>76</length>
				<uniprot>
					<id>P14335</id>
					<start>23</start>
					<end>98</end>
					<coverage>2.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06935</id>
					<start>23</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>31</region_start>
						<region_end>37</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>6</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Genome polyprotein</name>
				<source_organism>Kunjin virus</source_organism>
				<sequence>RVLSLTGLKRAMLSLIDGRGPTRFVLALLAFFRFTAIAPTRAVLDRWRSVNKQTAMKHLLSFKKELGTLTSAINRR</sequence>
				<length>76</length>
				<uniprot>
					<id>P14335</id>
					<start>23</start>
					<end>98</end>
					<coverage>2.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06935</id>
					<start>23</start>
					<end>98</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>44</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>63</region_start>
						<region_end>69</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>74</region_start>
						<region_end>95</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01003.16</region_id>
						<region_name>Flavi_capsid</region_name>
						<region_start>6</region_start>
						<region_end>123</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The 1-105 region described in DisProt entry DP00673 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The 1-105 region described in DisProt entry DP00673 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>C</chain_id>
				<support>The 1-105 region described in DisProt entry DP00673 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>D</chain_id>
				<support>The 1-105 region described in DisProt entry DP00673 covers 100% of the sequence present in the structure.</support>
			</chain_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100017</accession>
		<general>
			<name>C-terminal domain of the end-binding protein 1 (EB1)</name>
			<pdb_id>1wu9</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.54</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>15616574</pmid>
				<authors>Honnappa S, John CM, Kostrewa D, Winkler FK, Steinmetz MO</authors>
				<title>Structural insights into the EB1-APC interaction.</title>
				<journal>EMBO J.</journal>
				<year>2005</year>
				<issue>2</issue>
				<volume>24</volume>
				<pages>261-9</pages>
				<abstract>EB1 proteins bind to microtubule ends where they act in concert with other components, including the adenomatous polyposis coli (APC) tumor suppressor, to regulate the microtubule filament system. We find that EB1 is a stable dimer with a parallel coiled coil and show that dimerization is essential for the formation of its C-terminal domain (EB1-C). The crystal structure of EB1-C reveals a highly conserved surface patch with a deep hydrophobic cavity at its center. EB1-C binds two copies of an APC-derived C-terminal peptide (C-APCp1) with equal 5 microM affinity. The conserved APC Ile2805-Pro2806 sequence motif serves as an anchor for the interaction of C-APCp1 with the hydrophobic cavity of EB1-C. Phosphorylation of the conserved Cdc2 site Ser2789-Lys2792 in C-APCp1 reduces binding four-fold, indicating that the interaction APC-EB1 is post-translationally regulated in cells. Our findings provide a basis for understanding the dynamic crosstalk of EB1 proteins with their molecular targets in eukaryotic organisms.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0044822</accession>
					<name>poly(A) RNA binding</name>
				</go>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
				<go>
					<accession>GO:0098641</accession>
					<name>cadherin binding involved in cell-cell adhesion</name>
				</go>
				<go>
					<accession>GO:0008022</accession>
					<name>protein C-terminus binding</name>
				</go>
				<go>
					<accession>GO:0051010</accession>
					<name>microtubule plus-end binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0031115</accession>
					<name>negative regulation of microtubule polymerization</name>
				</go>
				<go>
					<accession>GO:0007062</accession>
					<name>sister chromatid cohesion</name>
				</go>
				<go>
					<accession>GO:0035372</accession>
					<name>protein localization to microtubule</name>
				</go>
				<go>
					<accession>GO:0008283</accession>
					<name>cell proliferation</name>
				</go>
				<go>
					<accession>GO:1903033</accession>
					<name>positive regulation of microtubule plus-end binding</name>
				</go>
				<go>
					<accession>GO:0051301</accession>
					<name>cell division</name>
				</go>
				<go>
					<accession>GO:1904527</accession>
					<name>negative regulation of microtubule binding</name>
				</go>
				<go>
					<accession>GO:0007067</accession>
					<name>mitotic nuclear division</name>
				</go>
				<go>
					<accession>GO:0000086</accession>
					<name>G2/M transition of mitotic cell cycle</name>
				</go>
				<go>
					<accession>GO:0098609</accession>
					<name>cell-cell adhesion</name>
				</go>
				<go>
					<accession>GO:0030335</accession>
					<name>positive regulation of cell migration</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0030981</accession>
					<name>cortical microtubule cytoskeleton</name>
				</go>
				<go>
					<accession>GO:0005829</accession>
					<name>cytosol</name>
				</go>
				<go>
					<accession>GO:0005913</accession>
					<name>cell-cell adherens junction</name>
				</go>
				<go>
					<accession>GO:0035371</accession>
					<name>microtubule plus-end</name>
				</go>
				<go>
					<accession>GO:0005813</accession>
					<name>centrosome</name>
				</go>
				<go>
					<accession>GO:0005794</accession>
					<name>Golgi apparatus</name>
				</go>
				<go>
					<accession>GO:0031253</accession>
					<name>cell projection membrane</name>
				</go>
				<go>
					<accession>GO:0005881</accession>
					<name>cytoplasmic microtubule</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (dimeric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Microtubule-associated protein RP/EB family member 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEAAELMQQVNVLKLTVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPDEGGPQEEQEEY</sequence>
				<length>80</length>
				<uniprot>
					<id>Q15691</id>
					<start>189</start>
					<end>268</end>
					<coverage>29.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q15691</id>
					<start>189</start>
					<end>268</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>230</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>237</region_start>
						<region_end>247</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03271.14</region_id>
						<region_name>EB1</region_name>
						<region_start>210</region_start>
						<region_end>248</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Microtubule-associated protein RP/EB family member 1</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSDEAAELMQQVNVLKLTVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPDEGGPQEEQEEY</sequence>
				<length>80</length>
				<uniprot>
					<id>Q15691</id>
					<start>189</start>
					<end>268</end>
					<coverage>29.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q15691</id>
					<start>189</start>
					<end>268</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>192</region_start>
						<region_end>230</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>237</region_start>
						<region_end>249</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>251</region_start>
						<region_end>253</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03271.14</region_id>
						<region_name>EB1</region_name>
						<region_start>210</region_start>
						<region_end>248</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>EB1 is a stable dimer with a parallel coiled coil and show that dimerization is essential for the formation of its C-terminal domain (EB1-C) (PMID:15616574).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1txq</pdb_id>
			<pdb_id>1yib</pdb_id>
			<pdb_id>1yig</pdb_id>
			<pdb_id>2hkq</pdb_id>
			<pdb_id>2hl5</pdb_id>
			<pdb_id>2r8u</pdb_id>
			<pdb_id>3gjo</pdb_id>
			<pdb_id>3tq7</pdb_id>
			<pdb_id>4xa3</pdb_id>
			<pdb_id>4xa6</pdb_id>
			<pdb_id>5jv3</pdb_id>
			<pdb_id>5jvm</pdb_id>
			<pdb_id>5jvp</pdb_id>
			<pdb_id>5jvr</pdb_id>
			<pdb_id>5jvs</pdb_id>
			<pdb_id>5jvu</pdb_id>
			<pdb_id>5jx1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF6140001</accession>
		<general>
			<name>SARS-Coronavirus HR2 Domain (post-fusion, hexameric form)</name>
			<pdb_id>1zv8</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.94</resolution>
			<assembly>homohexamer</assembly>
			<source_organism>Human SARS coronavirus</source_organism>
			<publication>
				<pmid>16698550</pmid>
				<authors>Deng Y, Liu J, Zheng Q, Yong W, Lu M</authors>
				<title>Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein.</title>
				<journal>Structure</journal>
				<year>2006</year>
				<issue>5</issue>
				<volume>14</volume>
				<pages>889-99</pages>
				<abstract>Entry of SARS coronavirus into its target cell requires large-scale structural transitions in the viral spike (S) glycoprotein in order to induce fusion of the virus and cell membranes. Here we describe the identification and crystal structures of four distinct alpha-helical domains derived from the highly conserved heptad-repeat (HR) regions of the S2 fusion subunit. The four domains are an antiparallel four-stranded coiled coil, a parallel trimeric coiled coil, a four-helix bundle, and a six-helix bundle that is likely the final fusogenic form of the protein. When considered together, the structural and thermodynamic features of the four domains suggest a possible mechanism whereby the HR regions, initially sequestered in the native S glycoprotein spike, are released and refold sequentially to promote membrane fusion. Our results provide a structural framework for understanding the control of membrane fusion and should guide efforts to intervene in the SARS coronavirus entry process.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046789</accession>
					<name>host cell surface receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
				<go>
					<accession>GO:0046813</accession>
					<name>receptor-mediated virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0009405</accession>
					<name>pathogenesis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0020002</accession>
					<name>host cell plasma membrane</name>
				</go>
				<go>
					<accession>GO:0044173</accession>
					<name>host cell endoplasmic reticulum-Golgi intermediate compartment membrane</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains G, H, I, J, K and L were removed as chains A, B, C, D, E and F represent the biologically relevant hexamer.</note>
				<nr_of_chains>6</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS</sequence>
				<length>50</length>
				<uniprot>
					<id>P59594</id>
					<start>901</start>
					<end>950</end>
					<coverage>4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>901</start>
					<end>950</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>902</region_start>
						<region_end>948</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL</sequence>
				<length>36</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1185</end>
					<coverage>2.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1185</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1162</region_start>
						<region_end>1178</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS</sequence>
				<length>50</length>
				<uniprot>
					<id>P59594</id>
					<start>901</start>
					<end>950</end>
					<coverage>4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>901</start>
					<end>950</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>903</region_start>
						<region_end>946</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL</sequence>
				<length>36</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1185</end>
					<coverage>2.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1185</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1162</region_start>
						<region_end>1178</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>E</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>NQKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS</sequence>
				<length>50</length>
				<uniprot>
					<id>P59594</id>
					<start>901</start>
					<end>950</end>
					<coverage>4%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>901</start>
					<end>950</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>902</region_start>
						<region_end>948</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL</sequence>
				<length>36</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1185</end>
					<coverage>2.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1185</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1162</region_start>
						<region_end>1178</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16698550). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2beq</pdb_id>
			<pdb_id>2bez</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120032</accession>
		<general>
			<name>BenM DNA binding domain dimer</name>
			<pdb_id>3m1e</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.80</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Acinetobacter baylyi</source_organism>
			<publication>
				<authors>Alanazi, A., Neidle, E.L., Momany, C.</authors>
				<title>Crystal structure of the unbound LysR-type transcriptional regulator BenM DNA binding domain</title>
				<journal>Acta Crystallogr. D Biol. Crystallogr.</journal>
				<year>2013</year>
				<pages>-</pages>
				<abstract></abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0003700</accession>
					<name>transcription factor activity, sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0003677</accession>
					<name>DNA binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0019439</accession>
					<name>aromatic compound catabolic process</name>
				</go>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chain B was generated from chain A using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>HTH-type transcriptional regulator BenM</name>
				<source_organism>Acinetobacter baylyi</source_organism>
				<sequence>MELRHLRYFVAVVEEQSFTKAADKLCIAQPPLSRQIQNLEEELGIQLLERGSRPVKTTPEGHFFYQYAIKLLSNVDQMVSMTKRIASGHHHHHH</sequence>
				<length>94</length>
				<uniprot>
					<id>O68014</id>
					<start>1</start>
					<end>94</end>
					<coverage>30.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O68014</id>
					<start>1</start>
					<end>87</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>48</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00126.24</region_id>
						<region_name>HTH_1</region_name>
						<region_start>3</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>HTH-type transcriptional regulator BenM</name>
				<source_organism>Acinetobacter baylyi</source_organism>
				<sequence>MELRHLRYFVAVVEEQSFTKAADKLCIAQPPLSRQIQNLEEELGIQLLERGSRPVKTTPEGHFFYQYAIKLLSNVDQMVSMTKRIASGHHHHHH</sequence>
				<length>94</length>
				<uniprot>
					<id>O68014</id>
					<start>1</start>
					<end>94</end>
					<coverage>30.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_O68014</id>
					<start>1</start>
					<end>87</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>3</region_start>
						<region_end>15</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>43</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>48</region_start>
						<region_end>48</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>57</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>59</region_start>
						<region_end>86</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00126.24</region_id>
						<region_name>HTH_1</region_name>
						<region_start>3</region_start>
						<region_end>62</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The N-terminal dimerization regions of BenM is highly mobile evading structure determination by X-ray (PMID:19400783).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The N-terminal dimerization regions of BenM is highly mobile evading structure determination by X-ray (PMID:19400783).</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4ihs</pdb_id>
			<pdb_id>4iht</pdb_id>
			<pdb_id>3k1m</pdb_id>
			<pdb_id>3k1n</pdb_id>
			<pdb_id>3k1p</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2210015</accession>
		<general>
			<name>H2A-H2B histone dimer (S. cerevisiae), containing histone variants H2A.2 and H2B.1</name>
			<pdb_id>4kud</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>3.20</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Saccharomyces cerevisiae</source_organism>
			<publication>
				<pmid>23934152</pmid>
				<authors>Yang D, Fang Q, Wang M, Ren R, Wang H, He M, Sun Y, Yang N, Xu RM</authors>
				<title>Nα-acetylated Sir3 stabilizes the conformation of a nucleosome-binding loop in the BAH domain.</title>
				<journal>Nat. Struct. Mol. Biol.</journal>
				<year>2013</year>
				<abstract>In Saccharomyces cerevisiae, acetylation of the Sir3 N terminus is important for transcriptional silencing. This covalent modification promotes the binding of the Sir3 BAH domain to the nucleosome, but a mechanistic understanding of this phenomenon is lacking. By X-ray crystallography, we show here that the acetylated N terminus of Sir3 does not interact with the nucleosome directly. Instead, it stabilizes a nucleosome-binding loop in the BAH domain.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I, J, K and L have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A.2</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MAGGKGGKAGSAAKASQSRSAKAGLTFPVGRVHRLLRRGNYAQRIGSGAPVYLTAVLEYLAAEILELAGNAARDNKKTRIIPRHLQLAIRNDDELNKLLGNVTIAQGGVLPNIHQNLLPKKSAKTAKASQEL</sequence>
				<length>132</length>
				<uniprot>
					<id>P04912</id>
					<start>1</start>
					<end>132</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04911</id>
					<start>1</start>
					<end>132</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>19</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>38</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>44</region_start>
						<region_end>45</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>49</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>79</region_start>
						<region_end>80</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>82</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>93</region_start>
						<region_end>98</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>4</region_start>
						<region_end>92</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>93</region_start>
						<region_end>127</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B.1</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MSAKAEKKPASKAPAEKKPAAKKTSTSTDGKKRSKARKETYSSYIYKVLKQTHPDTGISQKSMSILNSFVNDIFERIATEASKLAAYNKKSTISAREIQTAVRLILPGELAKHAVSEGTRAVTKYSSSTQA</sequence>
				<length>131</length>
				<uniprot>
					<id>P02293</id>
					<start>1</start>
					<end>131</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P02293</id>
					<start>1</start>
					<end>131</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>42</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>57</region_start>
						<region_end>58</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>60</region_start>
						<region_end>87</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>92</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>95</region_start>
						<region_end>105</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>108</region_start>
						<region_end>128</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>105</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>4wnn</pdb_id>
			<pdb_id>5bt1</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2120033</accession>
		<general>
			<name>E. coli proline utilization A (PutA) DNA-binding domain</name>
			<pdb_id>2ay0</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.10</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Escherichia coli</source_organism>
			<publication>
				<pmid>17001030</pmid>
				<authors>Larson JD, Jenkins JL, Schuermann JP, Zhou Y, Becker DF, Tanner JJ</authors>
				<title>Crystal structures of the DNA-binding domain of Escherichia coli proline utilization A flavoprotein and analysis of the role of Lys9 in DNA recognition.</title>
				<journal>Protein Sci.</journal>
				<year>2006</year>
				<issue>11</issue>
				<volume>15</volume>
				<pages>2630-41</pages>
				<abstract>PutA (proline utilization A) from Escherichia coli is a 1320-amino-acid residue protein that is both a bifunctional proline catabolic enzyme and an autogenous transcriptional repressor. Here, we report the first crystal structure of a PutA DNA-binding domain along with functional analysis of a mutant PutA defective in DNA binding. Crystals were grown using a polypeptide corresponding to residues 1-52 of E. coli PutA (PutA52). The 2.1 Angstrom resolution structure of PutA52 mutant Lys9Met was determined using Se-Met MAD phasing, and the structure of native PutA52 was solved at 1.9 Angstrom resolution using molecular replacement. Residues 3-46 form a ribbon-helix-helix (RHH) substructure, thus establishing PutA as the largest protein to contain an RHH domain. The PutA RHH domain forms the intertwined dimer with tightly packed hydrophobic core that is characteristic of the RHH family. The structures were used to examine the three-dimensional context of residues conserved in PutA RHH domains. Homology modeling suggests that Lys9 and Thr5 contact DNA bases through the major groove, while Arg15, Thr28, and His30 may interact with the phosphate backbone. Lys9 is shown to be essential for specific recognition of put control DNA using gel shift analysis of the Lys9Met mutant of full-length PutA. Lys9 is disordered in the PutA52 structure, which implies an induced-fit binding mechanism in which the side chain of Lys9 becomes ordered through interaction with DNA. These results provide new insights into the structural basis of DNA recognition by PutA and reveal three-dimensional structural details of the PutA dimer interface.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0004657</accession>
					<name>proline dehydrogenase activity</name>
				</go>
				<go>
					<accession>GO:0000986</accession>
					<name>bacterial-type RNA polymerase core promoter proximal region sequence-specific DNA binding</name>
				</go>
				<go>
					<accession>GO:0050660</accession>
					<name>flavin adenine dinucleotide binding</name>
				</go>
				<go>
					<accession>GO:0003842</accession>
					<name>1-pyrroline-5-carboxylate dehydrogenase activity</name>
				</go>
				<go>
					<accession>GO:0004029</accession>
					<name>aldehyde dehydrogenase (NAD) activity</name>
				</go>
				<go>
					<accession>GO:0001141</accession>
					<name>transcriptional repressor activity, bacterial-type RNA polymerase core promoter proximal region sequence-specific binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0010133</accession>
					<name>proline catabolic process to glutamate</name>
				</go>
				<go>
					<accession>GO:0006561</accession>
					<name>proline biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0055114</accession>
					<name>oxidation-reduction process</name>
				</go>
				<go>
					<accession>GO:0045892</accession>
					<name>negative regulation of transcription, DNA-templated</name>
				</go>
				<go>
					<accession>GO:0006351</accession>
					<name>transcription, DNA-templated</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0009898</accession>
					<name>cytoplasmic side of plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E and F were removed as chains A and B represent the biologically relevant dimer.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Bifunctional protein PutA</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MGTTTMGVMLDDATRERIKSAATRIDRTPHWLIKQAIFSYLEQLENSDTLPEHHHHHH</sequence>
				<length>58</length>
				<uniprot>
					<id>P09546</id>
					<start>1</start>
					<end>52</end>
					<coverage>3.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09546</id>
					<start>1</start>
					<end>52</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>24</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>43</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Bifunctional protein PutA</name>
				<source_organism>Escherichia coli</source_organism>
				<sequence>MGTTTMGVMLDDATRERIKSAATRIDRTPHWLIKQAIFSYLEQLENSDTLPEHHHHHH</sequence>
				<length>58</length>
				<uniprot>
					<id>P09546</id>
					<start>1</start>
					<end>52</end>
					<coverage>3.9%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P09546</id>
					<start>1</start>
					<end>52</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>4</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>29</region_start>
						<region_end>43</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:17001030). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
		<related_structures>
			<pdb_id>2gpe</pdb_id>
			<pdb_id>2rbf</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF4140005</accession>
		<general>
			<name>SARS-Coronavirus HR2 Domain (post-fusion, tetrameric form)</name>
			<pdb_id>1zv7</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>1.70</resolution>
			<assembly>homotetramer</assembly>
			<source_organism>Human SARS coronavirus</source_organism>
			<publication>
				<pmid>16698550</pmid>
				<authors>Deng Y, Liu J, Zheng Q, Yong W, Lu M</authors>
				<title>Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein.</title>
				<journal>Structure</journal>
				<year>2006</year>
				<issue>5</issue>
				<volume>14</volume>
				<pages>889-99</pages>
				<abstract>Entry of SARS coronavirus into its target cell requires large-scale structural transitions in the viral spike (S) glycoprotein in order to induce fusion of the virus and cell membranes. Here we describe the identification and crystal structures of four distinct alpha-helical domains derived from the highly conserved heptad-repeat (HR) regions of the S2 fusion subunit. The four domains are an antiparallel four-stranded coiled coil, a parallel trimeric coiled coil, a four-helix bundle, and a six-helix bundle that is likely the final fusogenic form of the protein. When considered together, the structural and thermodynamic features of the four domains suggest a possible mechanism whereby the HR regions, initially sequestered in the native S glycoprotein spike, are released and refold sequentially to promote membrane fusion. Our results provide a structural framework for understanding the control of membrane fusion and should guide efforts to intervene in the SARS coronavirus entry process.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0046789</accession>
					<name>host cell surface receptor binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0046813</accession>
					<name>receptor-mediated virion attachment to host cell</name>
				</go>
				<go>
					<accession>GO:0039654</accession>
					<name>fusion of virus membrane with host endosome membrane</name>
				</go>
				<go>
					<accession>GO:0009405</accession>
					<name>pathogenesis</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0044173</accession>
					<name>host cell endoplasmic reticulum-Golgi intermediate compartment membrane</name>
				</go>
				<go>
					<accession>GO:0019031</accession>
					<name>viral envelope</name>
				</go>
				<go>
					<accession>GO:0020002</accession>
					<name>host cell plasma membrane</name>
				</go>
				<go>
					<accession>GO:0055036</accession>
					<name>virion membrane</name>
				</go>
				<go>
					<accession>GO:0016021</accession>
					<name>integral component of membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>Chains C and D were generated from chains A and B, respectively, using the biomatrices described in the original PDB file.</note>
				<nr_of_chains>4</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Coils and zippers</class>
				<subclass>Coiled coil (tetrameric)</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>44</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1193</end>
					<coverage>3.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1151</region_start>
						<region_end>1186</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>44</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1193</end>
					<coverage>3.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1154</region_start>
						<region_end>1184</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>C</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>44</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1193</end>
					<coverage>3.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1151</region_start>
						<region_end>1186</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Spike glycoprotein</name>
				<source_organism>Human SARS coronavirus</source_organism>
				<sequence>DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK</sequence>
				<length>44</length>
				<uniprot>
					<id>P59594</id>
					<start>1150</start>
					<end>1193</end>
					<coverage>3.5%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P59594</id>
					<start>1150</start>
					<end>1193</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>1154</region_start>
						<region_end>1184</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01601.13</region_id>
						<region_name>Corona_S2</region_name>
						<region_start>648</region_start>
						<region_end>1252</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The subunits in the structure are bound via coiled coil interactions (PMID:16698550). Coiled coils are highly versatile folding units (PMID:11166216), where the formation of the structure and the interaction between subunits is almost ubiquitously linked. This cooperative nature of binding and folding that results in a two-step process has been demonstrated for coiled coils with varying oligomeric state from dimers (PMID:9811815) and trimers (PMID:10933510) up to heptamers (PMID:17030805). While the interaction and folding are linked, in certain cases there can be significant residual structure before association (PMID:8401212). However, these residual structural elements usually encompass 1-2 turns of helices that serve as a 'nucleation site' driving interaction and helix formation (zipping up) (PMID:17438295), thus even in these cases monomeric coiled coil subunits cannot be considered to have a stable structure.</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200015</accession>
		<general>
			<name>H2A-H2B histone dimer (human), containing histone variants H2A type 1-A and H2B type 1-J</name>
			<pdb_id>5gt0</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.82</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>27992841</pmid>
				<authors>Padavattan S, Thiruselvam V, Shinagawa T, Hasegawa K, Kumasaka T, Ishii S, Kumarevel T</authors>
				<title>Structural analyses of the nucleosome complexes with human testis-specific histone variants, hTh2a and hTh2b.</title>
				<journal>Biophys. Chem.</journal>
				<year>2017</year>
				<volume>221</volume>
				<pages>41-48</pages>
				<abstract>Th2a and Th2b are the testis-specific histone variants highly expressed during spermatogenesis. Approximately 4% of the genome is retained in nucleosomes in mature human sperm, which is enriched at loci of developmental importance. Our recent studies revealed that the mouse histone variant homologs TH2a and TH2b are involved in reprogramming. In the present work, we report three nucleosome structures (NCPs) with human testis-specific histone variants hTh2a and hTh2b, [hGcH (hTh2a-hTh2b-H3-H4), hGcHV1 (hTh2a-H2b-H3-H4) and hGcHV2 (H2a-hTh2b-H3-H4)] and a 146-base pair (bp) duplex DNA fragment at ~3.0Å resolutions. These crystal structures revealed two major changes within the nucleosomes, either with hTh2a, hTh2b or both variants, as compared to the canonical counterpart. First, the H-bonding interactions between the L1-L1&apos; interfaces mediated by the hTh2a/hTh2a' L1-loops are lost. Second, the histone dimer-DNA contacts are considerably reduced, and these changes are localized around ±31 to 35-bp from the nucleosome entry/exit sites. Thus, the modified functional residues at the N- and C-terminal ends of histone variants are responsible for the observed structural changes and regulate the gene expression through specific structural alterations in the chromatin by modulating the chromatin-associated binding proteins.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A type 1-A</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SGRGKQGGKARAKSKSRSSRAGLQFPVGRIHRLLRKGNYAERIGAGAPVYLAAVLEYLTAEILELAGNASRDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTESHHHKAQSK</sequence>
				<length>130</length>
				<uniprot>
					<id>Q96QV6</id>
					<start>2</start>
					<end>131</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P04908</id>
					<start>2</start>
					<end>131</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>92</region_start>
						<region_end>126</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 1-C/E/F/G/I</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>125</length>
				<uniprot>
					<id>P62807</id>
					<start>2</start>
					<end>126</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62807</id>
					<start>2</start>
					<end>126</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>39</region_start>
						<region_end>49</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>54</region_start>
						<region_end>55</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>57</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>89</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>102</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>105</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>102</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200016</accession>
		<general>
			<name>H2A-H2B histone dimer (human), containing histone variants H2A type 1-D and H2B type 1-A</name>
			<pdb_id>5gt3</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.91</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>27992841</pmid>
				<authors>Padavattan S, Thiruselvam V, Shinagawa T, Hasegawa K, Kumasaka T, Ishii S, Kumarevel T</authors>
				<title>Structural analyses of the nucleosome complexes with human testis-specific histone variants, hTh2a and hTh2b.</title>
				<journal>Biophys. Chem.</journal>
				<year>2017</year>
				<volume>221</volume>
				<pages>41-48</pages>
				<abstract>Th2a and Th2b are the testis-specific histone variants highly expressed during spermatogenesis. Approximately 4% of the genome is retained in nucleosomes in mature human sperm, which is enriched at loci of developmental importance. Our recent studies revealed that the mouse histone variant homologs TH2a and TH2b are involved in reprogramming. In the present work, we report three nucleosome structures (NCPs) with human testis-specific histone variants hTh2a and hTh2b, [hGcH (hTh2a-hTh2b-H3-H4), hGcHV1 (hTh2a-H2b-H3-H4) and hGcHV2 (H2a-hTh2b-H3-H4)] and a 146-base pair (bp) duplex DNA fragment at ~3.0Å resolutions. These crystal structures revealed two major changes within the nucleosomes, either with hTh2a, hTh2b or both variants, as compared to the canonical counterpart. First, the H-bonding interactions between the L1-L1&apos; interfaces mediated by the hTh2a/hTh2a' L1-loops are lost. Second, the histone dimer-DNA contacts are considerably reduced, and these changes are localized around ±31 to 35-bp from the nucleosome entry/exit sites. Thus, the modified functional residues at the N- and C-terminal ends of histone variants are responsible for the observed structural changes and regulate the gene expression through specific structural alterations in the chromatin by modulating the chromatin-associated binding proteins.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains C and D.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>C</id>
				<name>Histone H2A type 1-D</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYSERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTESHHKAKGK</sequence>
				<length>129</length>
				<uniprot>
					<id>P20671</id>
					<start>2</start>
					<end>130</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P20671</id>
					<start>2</start>
					<end>130</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>18</region_start>
						<region_end>22</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>36</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>44</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>47</region_start>
						<region_end>73</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>78</region_start>
						<region_end>79</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>81</region_start>
						<region_end>90</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>92</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>114</region_start>
						<region_end>116</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF16211.2</region_id>
						<region_name>Histone_H2A_C</region_name>
						<region_start>92</region_start>
						<region_end>126</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>D</id>
				<name>Histone H2B type 1-A</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>PEVSSKGATISKKGFKKAVVKTQKKEGKKRKRTRKESYSIYIYKVLKQVHPDTGISSKAMSIMNSFVTDIFERIASEASRLAHYSKRSTISSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK</sequence>
				<length>126</length>
				<uniprot>
					<id>Q96A08</id>
					<start>2</start>
					<end>127</end>
					<coverage>99.2%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P70696</id>
					<start>2</start>
					<end>127</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>40</region_start>
						<region_end>50</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>55</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>58</region_start>
						<region_end>85</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>90</region_start>
						<region_end>91</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>93</region_start>
						<region_end>103</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>106</region_start>
						<region_end>124</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>2</region_start>
						<region_end>103</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200017</accession>
		<general>
			<name>H3-H4 histone dimer (human), containing histone variant H3.3C</name>
			<pdb_id>4z5t</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.80</resolution>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>26779285</pmid>
				<authors>Urahama T, Harada A, Maehara K, Horikoshi N, Sato K, Sato Y, Shiraishi K, Sugino N, Osakabe A, Tachiwana H, Kagawa W, Kimura H, Ohkawa Y, Kurumizaka H</authors>
				<title>Histone H3.5 forms an unstable nucleosome and accumulates around transcription start sites in human testis.</title>
				<journal>Epigenetics Chromatin</journal>
				<year>2016</year>
				<volume>9</volume>
				<pages>2</pages>
				<abstract> CONCLUSIONS: We performed comprehensive studies of H3.5, and found the instability of the H3.5 nucleosome and the accumulation of H3.5 protein around TSSs in human testis. The unstable H3.5 nucleosome may function in the chromatin dynamics around the TSSs, during spermatogenesis. RESULTS: We found that the H3.5 nucleosome is less stable than the H3.3 nucleosome. The crystal structure of the H3.5 nucleosome showed that the H3.5-specific Leu103 residue, which corresponds to the H3.3 Phe104 residue, reduces the hydrophobic interaction with histone H4. Mutational analyses revealed that the H3.5-specific Leu103 residue is responsible for the instability of the H3.5 nucleosome, both in vitro and in living cells. The H3.5 protein was present in human seminiferous tubules, but little to none was found in mature sperm. A chromatin immunoprecipitation coupled with sequencing analysis revealed that H3.5 accumulated around transcription start sites (TSSs) in testicular cells. BACKGROUND: Human histone H3.5 is a non-allelic H3 variant evolutionally derived from H3.3. The H3.5 mRNA is highly expressed in human testis. However, the function of H3.5 has remained poorly understood.</abstract>
			</publication>
		</general>
		<function>
		</function>
		<macromolecules>
			<general>
				<note>Chains C, D, E, F, G, H, I and J have been removed to highlight the basic interaction that forms the histone dimer composed of chains A and B.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Histone-like interactions</class>
				<subclass>Histones</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Histone H3.3C</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMARTKQTARKSTGGKAPRKQLATKAARKSTPSTCGVKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFNTDLRFQSAAVGALQEASEAYLVGLLEDTNLCAIHAKRVTIMPKDIQLARRIRGERA</sequence>
				<length>138</length>
				<uniprot>
					<id>Q6NXT2</id>
					<start>1</start>
					<end>135</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q6NXT2</id>
					<start>1</start>
					<end>135</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>45</region_start>
						<region_end>56</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>64</region_start>
						<region_end>78</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>83</region_start>
						<region_end>84</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>86</region_start>
						<region_end>113</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>118</region_start>
						<region_end>119</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>121</region_start>
						<region_end>131</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF00125.21</region_id>
						<region_name>Histone</region_name>
						<region_start>1</region_start>
						<region_end>131</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Histone H4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>GSHMSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG</sequence>
				<length>106</length>
				<uniprot>
					<id>P62805</id>
					<start>1</start>
					<end>103</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P62805</id>
					<start>1</start>
					<end>103</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>26</region_start>
						<region_end>29</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>32</region_start>
						<region_end>41</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>46</region_start>
						<region_end>47</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>76</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>81</region_start>
						<region_end>82</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>93</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF15511.3</region_id>
						<region_name>CENP-T_C</region_name>
						<region_start>18</region_start>
						<region_end>99</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Histones form parts of the nucleosome particle by dimerization and subsequent multimerization (PMID:1946434). The dimer contains both histone subunits in a highly intertwined conformation reflecting the possible domain-swapped origins of the structure (PMID:17391511). Accordingly, this dimerization has been experimentally characterized to be coupled to the structure formation of both interacting partners (PMID:12779337); this synergistic folding has been shown separately for H2A-H2B dimers (PMID:15588829) and H3-H4 dimers as well (PMID:15096635). Histones containing various types of monomeric subunits can exhibit varying stability and folding kinetics. E.g. in the case of H3-H4 histones, the dimerization is a complex process with the two monomers first adopting an intermediate state upon encounter and then reaching the classical histone fold through restructurization (PMID:12779337). However, independent of composition and folding kinetics, all histones appear to fold in a cooperative fashion that is coupled to binding (PMID:11669650).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2120034</accession>
		<general>
			<name>Bacillus subtilis antitoxin MazE</name>
			<pdb_id>4me7</pdb_id>
			<exp_method>X-ray</exp_method>
			<resolution>2.92</resolution>
			<assembly>homodimer</assembly>
			<source_organism>Bacillus subtilis</source_organism>
			<publication>
				<pmid>24120662</pmid>
				<authors>Simanshu DK, Yamaguchi Y, Park JH, Inouye M, Patel DJ</authors>
				<title>Structural Basis of mRNA Recognition and Cleavage by Toxin MazF and Its Regulation by Antitoxin MazE in Bacillus subtilis.</title>
				<journal>Mol. Cell</journal>
				<year>2013</year>
				<abstract>MazF is an mRNA interferase, which, upon activation during stress conditions, cleaves mRNAs in a sequence-specific manner, resulting in cellular growth arrest. During normal growth conditions, the MazF toxin is inactivated through binding to its cognate antitoxin, MazE. How MazF specifically recognizes its mRNA target and carries out cleavage and how the formation of the MazE-MazF complex inactivates MazF remain unclear. We present crystal structures of MazF in complex with mRNA substrate and antitoxin MazE in Bacillus subtilis. The structure of MazF in complex with uncleavable UUdUACAUAA RNA substrate defines the molecular basis underlying the sequence-specific recognition of UACAU and the role of residues involved in the cleavage through site-specific mutational studies. The structure of the heterohexameric (MazF)2-(MazE)2-(MazF)2 complex in Bacillus subtilis, supplemented by mutational data, demonstrates that the positioning of the C-terminal helical segment of MazE within the RNA-binding channel of the MazF dimer prevents mRNA binding and cleavage by MazF.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0042802</accession>
					<name>identical protein binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0006355</accession>
					<name>regulation of transcription, DNA-templated</name>
				</go>
			</biological_process>
		</function>
		<macromolecules>
			<general>
				<note>Chains A, B, C and D were removed and chains E and F were truncated to include residues 6-52 and 7-52, respectively, to highlight the dimeric interaction.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Ribbon-helix-helix (RHH)</subclass>
			</general>
			<chain>
				<id>E</id>
				<name>Antitoxin EndoAI</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>SMSESSARTEMKISLPENLVAELDGVAMREKRSRNELISQAVRAYVSERTTRHNRDLMRRGYMEMAKINLNISSEAHFAECEAETTVERLVSGG</sequence>
				<length>94</length>
				<uniprot>
					<id>P96621</id>
					<start>1</start>
					<end>93</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P96621</id>
					<start>1</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>11</region_start>
						<region_end>14</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>35</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01402.18</region_id>
						<region_name>RHH_1</region_name>
						<region_start>11</region_start>
						<region_end>47</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>F</id>
				<name>Antitoxin EndoAI</name>
				<source_organism>Bacillus subtilis</source_organism>
				<sequence>SMSESSARTEMKISLPENLVAELDGVAMREKRSRNELISQAVRAYVSERTTRHNRDLMRRGYMEMAKINLNISSEAHFAECEAETTVERLVSGG</sequence>
				<length>94</length>
				<uniprot>
					<id>P96621</id>
					<start>1</start>
					<end>93</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P96621</id>
					<start>1</start>
					<end>93</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>9</region_start>
						<region_end>13</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>17</region_start>
						<region_end>26</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>28</region_start>
						<region_end>31</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>35</region_start>
						<region_end>52</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01402.18</region_id>
						<region_name>RHH_1</region_name>
						<region_start>11</region_start>
						<region_end>47</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting chains form a ribbon-helix-helix (RHH) structure (PMID:17007877). These structures in general have been described with the two monomers adopting a stable conformation upon the interaction (PMID:17676053). The hydrophobic core stabilizing the complex is formed by both interactors and is thus absent prior to the interaction (PMID:25713077).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2100018</accession>
		<general>
			<name>Dimeric cytoplasmic domain of syndecan-4</name>
			<pdb_id>1ejp</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>homodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>11456484</pmid>
				<authors>Shin J, Lee W, Lee D, Koo BK, Han I, Lim Y, Woods A, Couchman JR, Oh ES</authors>
				<title>Solution structure of the dimeric cytoplasmic domain of syndecan-4.</title>
				<journal>Biochemistry</journal>
				<year>2001</year>
				<issue>29</issue>
				<volume>40</volume>
				<pages>8471-8</pages>
				<abstract>The syndecans, transmembrane proteoglycans which are involved in the organization of cytoskeleton and/or actin microfilaments, have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions. Since previous studies indicate that the function of the syndecan-4 cytoplasmic domain is dependent on its oligomeric status, the conformation of the syndecan-4 cytoplasmic domain itself is important in the understanding of its biological roles. Gel filtration results show that the syndecan-4 cytoplasmic domain (4L) itself forms a dimer stabilized by ionic interactions between peptides at physiological pH. Commensurately, the NMR structures demonstrate that syndecan-4L is a compact intertwined dimer with a symmetric clamp shape in the central variable V region with a root-mean-square deviation between backbone atom coordinates of 0.95 A for residues Leu(186)-Ala(195). The molecular surface of the 4L dimer is highly positively charged. In addition, no intersubunit NOEs in membrane proximal amino acid resides (C1 region) have been observed, demonstrating that the C1 region is mostly unstructured in the syndecan-4L dimer. Interestingly, two parallel strands of 4L form a cavity in the center of the dimeric twist similar to our previously reported 4V structure. The overall topology of the central variable region within the 4L structure is very similar to that of 4V complexed with the phosphatidylinositol 4,5-bisphosphate; however, the intersubunit interaction mode is affected by the presence of C1 and C2 regions. Therefore, we propose that although the 4V region in the full cytoplasmic domain has a tendency for strong peptide--peptide interaction, it may not be enough to overcome the repulsion of the C1 regions of syndecan-4L.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0070053</accession>
					<name>thrombospondin receptor activity</name>
				</go>
				<go>
					<accession>GO:0001968</accession>
					<name>fibronectin binding</name>
				</go>
				<go>
					<accession>GO:0005080</accession>
					<name>protein kinase C binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0051496</accession>
					<name>positive regulation of stress fiber assembly</name>
				</go>
				<go>
					<accession>GO:1903543</accession>
					<name>positive regulation of exosomal secretion</name>
				</go>
				<go>
					<accession>GO:0042060</accession>
					<name>wound healing</name>
				</go>
				<go>
					<accession>GO:0051894</accession>
					<name>positive regulation of focal adhesion assembly</name>
				</go>
				<go>
					<accession>GO:0045860</accession>
					<name>positive regulation of protein kinase activity</name>
				</go>
				<go>
					<accession>GO:0016477</accession>
					<name>cell migration</name>
				</go>
				<go>
					<accession>GO:0001523</accession>
					<name>retinoid metabolic process</name>
				</go>
				<go>
					<accession>GO:0001843</accession>
					<name>neural tube closure</name>
				</go>
				<go>
					<accession>GO:1903553</accession>
					<name>positive regulation of extracellular exosome assembly</name>
				</go>
				<go>
					<accession>GO:0006024</accession>
					<name>glycosaminoglycan biosynthetic process</name>
				</go>
				<go>
					<accession>GO:0060122</accession>
					<name>inner ear receptor stereocilium organization</name>
				</go>
				<go>
					<accession>GO:0010762</accession>
					<name>regulation of fibroblast migration</name>
				</go>
				<go>
					<accession>GO:0007165</accession>
					<name>signal transduction</name>
				</go>
				<go>
					<accession>GO:0001657</accession>
					<name>ureteric bud development</name>
				</go>
				<go>
					<accession>GO:0006027</accession>
					<name>glycosaminoglycan catabolic process</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0005887</accession>
					<name>integral component of plasma membrane</name>
				</go>
				<go>
					<accession>GO:0070062</accession>
					<name>extracellular exosome</name>
				</go>
				<go>
					<accession>GO:0045121</accession>
					<name>membrane raft</name>
				</go>
				<go>
					<accession>GO:0005796</accession>
					<name>Golgi lumen</name>
				</go>
				<go>
					<accession>GO:0005925</accession>
					<name>focal adhesion</name>
				</go>
				<go>
					<accession>GO:0043034</accession>
					<name>costamere</name>
				</go>
				<go>
					<accession>GO:0009986</accession>
					<name>cell surface</name>
				</go>
				<go>
					<accession>GO:0043202</accession>
					<name>lysosomal lumen</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>1</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Syndecan-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>RMKKKDEGSYDLGKKPIYKKAPTNEFYA</sequence>
				<length>28</length>
				<uniprot>
					<id>P31431</id>
					<start>171</start>
					<end>198</end>
					<coverage>14.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P31431</id>
					<start>171</start>
					<end>198</end>
				</uniref90>
				<regions>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01034.17</region_id>
						<region_name>Syndecan</region_name>
						<region_start>139</region_start>
						<region_end>196</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Syndecan-4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>RMKKKDEGSYDLGKKPIYKKAPTNEFYA</sequence>
				<length>28</length>
				<uniprot>
					<id>P31431</id>
					<start>171</start>
					<end>198</end>
					<coverage>14.1%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P31431</id>
					<start>171</start>
					<end>198</end>
				</uniref90>
				<regions>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01034.17</region_id>
						<region_name>Syndecan</region_name>
						<region_start>139</region_start>
						<region_end>196</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<chain_evidence>
				<chain_id>A</chain_id>
				<support>The cytoplasmic domain of Syndecan-4 has been shown to adopt a stable structure upon binding to a partner protein (either through binding to an ordered domain PMID:16533050 or through dimerization PMID:11456484).</support>
			</chain_evidence>
			<chain_evidence>
				<chain_id>B</chain_id>
				<support>The cytoplasmic domain of Syndecan-4 has been shown to adopt a stable structure upon binding to a partner protein (either through binding to an ordered domain PMID:16533050 or through dimerization PMID:11456484).</support>
			</chain_evidence>
		</evidence>
		<related_structures>
			<pdb_id>1ejq</pdb_id>
		</related_structures>
	</entry>
	<entry>
		<accession>MF2211003</accession>
		<general>
			<name>Yeast elongin C in complex with a von Hippel-Lindau peptide</name>
			<pdb_id>1hv2</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Saccharomyces cerevisiae / Mus musculus</source_organism>
			<publication>
				<pmid>11545595</pmid>
				<authors>Botuyan MV, Mer G, Yi GS, Koth CM, Case DA, Edwards AM, Chazin WJ, Arrowsmith CH</authors>
				<title>Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.</title>
				<journal>J. Mol. Biol.</journal>
				<year>2001</year>
				<issue>1</issue>
				<volume>312</volume>
				<pages>177-86</pages>
				<abstract>Elongin is a transcription elongation factor that stimulates the rate of elongation by suppressing transient pausing by RNA polymerase II at many sites along the DNA. It is heterotrimeric in mammals, consisting of elongins A, B and C subunits, and bears overall similarity to a class of E3 ubiquitin ligases known as SCF (Skp1-Cdc53 (cullin)-F-box) complexes. A subcomplex of elongins B and C is a target for negative regulation by the von Hippel-Lindau (VHL) tumor-suppressor protein. Elongin C from Saccharomyces cerevisiae, Elc1, exhibits high sequence similarity to mammalian elongin C. Using NMR spectroscopy we have determined the three-dimensional structure of Elc1 in complex with a human VHL peptide, VHL(157-171), representing the major Elc1 binding site. The bound VHL peptide is entirely helical. Elc1 utilizes two C-terminal helices and an intervening loop to form a binding groove that fits VHL(157-171). Chemical shift perturbation and dynamics analyses reveal that a global conformational change accompanies Elc1/VHL(157-171) complex formation. Moreover, the disappearance of conformational exchange phenomena on the microsecond to millisecond time scale within Elc1 upon VHL peptide binding suggests a role for slow internal motions in ligand recognition.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0005515</accession>
					<name>protein binding</name>
				</go>
			</molecular_function>
			<cellular_component>
				<go>
					<accession>GO:0005737</accession>
					<name>cytoplasm</name>
				</go>
				<go>
					<accession>GO:0005634</accession>
					<name>nucleus</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>Elongin-C</name>
				<source_organism>Saccharomyces cerevisiae</source_organism>
				<sequence>MSQDFVTLVSKDDKEYEISRSAAMISPTLKAMIEGPFRESKGRIELKQFDSHILEKAVEYLNYNLKYSGVSEDDDEIPEFEIPTEMSLELLLAADYLSI</sequence>
				<length>99</length>
				<uniprot>
					<id>Q03071</id>
					<start>1</start>
					<end>99</end>
					<coverage>100%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_Q03071</id>
					<start>1</start>
					<end>99</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>5</region_start>
						<region_end>10</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>14</region_start>
						<region_end>19</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>20</region_start>
						<region_end>23</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>27</region_start>
						<region_end>34</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>beta</region_name>
						<region_start>43</region_start>
						<region_end>46</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>51</region_start>
						<region_end>70</region_end>
					</region>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>84</region_start>
						<region_end>97</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF03931.12</region_id>
						<region_name>Skp1_POZ</region_name>
						<region_start>4</region_start>
						<region_end>66</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Von Hippel-Lindau disease tumor suppressor</name>
				<source_organism>Mus musculus</source_organism>
				<sequence>TLKERCLQVVRSLVK</sequence>
				<length>15</length>
				<uniprot>
					<id>P40338</id>
					<start>123</start>
					<end>137</end>
					<coverage>8.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P40338</id>
					<start>123</start>
					<end>137</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>124</region_start>
						<region_end>136</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF01847.13</region_id>
						<region_name>VHL</region_name>
						<region_start>27</region_start>
						<region_end>172</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>Both elongin C and the interacting region of VHL are dynamically unstable in isolation and only adopt a stable conformation upon interaction (PMID:11545595).</complex_evidence>
		</evidence>
	</entry>
	<entry>
		<accession>MF2200018</accession>
		<general>
			<name>T-cell surface glycoprotein CD4 and proto-oncogene tyrosine-protein kinase LCK fragments</name>
			<pdb_id>1q68</pdb_id>
			<exp_method>NMR</exp_method>
			<assembly>heterodimer</assembly>
			<source_organism>Homo sapiens</source_organism>
			<publication>
				<pmid>14500983</pmid>
				<authors>Kim PW, Sun ZY, Blacklow SC, Wagner G, Eck MJ</authors>
				<title>A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8.</title>
				<journal>Science</journal>
				<year>2003</year>
				<issue>5640</issue>
				<volume>301</volume>
				<pages>1725-8</pages>
				<abstract>The T cell coreceptors CD4 and CD8 both associate via their cytoplasmic tails with the N-terminus of the Src-family tyrosine kinase Lck. These interactions require zinc and are critical for T cell development and activation. We examined the folding and solution structures of ternary CD4-Lck-Zn2+ and CD8alpha-Lck-Zn2+ complexes. The coreceptor tails and the Lck N-terminus are unstructured in isolation but assemble in the presence of zinc to form compactly folded heterodimeric domains. The cofolded complexes have similar &amp;quot;zinc clasp" cores that are augmented by distinct structural elements. A dileucine motif required for clathrin-mediated endocytosis of CD4 is masked by Lck.</abstract>
			</publication>
		</general>
		<function>
			<molecular_function>
				<go>
					<accession>GO:0001948</accession>
					<name>glycoprotein binding</name>
				</go>
				<go>
					<accession>GO:0019901</accession>
					<name>protein kinase binding</name>
				</go>
			</molecular_function>
			<biological_process>
				<go>
					<accession>GO:0030217</accession>
					<name>T cell differentiation</name>
				</go>
				<go>
					<accession>GO:0050852</accession>
					<name>T cell receptor signaling pathway</name>
				</go>
				<go>
					<accession>GO:0031295</accession>
					<name>T cell costimulation</name>
				</go>
				<go>
					<accession>GO:0050690</accession>
					<name>regulation of defense response to virus by virus</name>
				</go>
				<go>
					<accession>GO:0016032</accession>
					<name>viral process</name>
				</go>
				<go>
					<accession>GO:0007169</accession>
					<name>transmembrane receptor protein tyrosine kinase signaling pathway</name>
				</go>
			</biological_process>
			<cellular_component>
				<go>
					<accession>GO:0045121</accession>
					<name>membrane raft</name>
				</go>
				<go>
					<accession>GO:0005886</accession>
					<name>plasma membrane</name>
				</go>
			</cellular_component>
		</function>
		<macromolecules>
			<general>
				<note>No modifications of the original PDB file. Chain identifiers are identical with the PDB's identifiers.</note>
				<nr_of_chains>2</nr_of_chains>
				<nr_of_unique_protein_segments>2</nr_of_unique_protein_segments>
				<class>Other</class>
				<subclass>Other</subclass>
			</general>
			<chain>
				<id>A</id>
				<name>T-cell surface glycoprotein CD4</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>RCRHRRRQAERLSQIKRLLSEKKTCQCPHRFQKTCSPI</sequence>
				<length>38</length>
				<uniprot>
					<id>P01730</id>
					<start>421</start>
					<end>458</end>
					<coverage>8.3%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P01730</id>
					<start>421</start>
					<end>458</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>431</region_start>
						<region_end>440</region_end>
					</region>
					<region>
						<region_type>pfam</region_type>
						<region_id>PF12104.5</region_id>
						<region_name>Tcell_CD4_C</region_name>
						<region_start>426</region_start>
						<region_end>453</region_end>
					</region>
				</regions>
			</chain>
			<chain>
				<id>B</id>
				<name>Tyrosine-protein kinase Lck</name>
				<source_organism>Homo sapiens</source_organism>
				<sequence>SHPEDDWLENIDVCENCHYPIVPLDGKGT</sequence>
				<length>29</length>
				<uniprot>
					<id>P06239</id>
					<start>7</start>
					<end>35</end>
					<coverage>5.7%</coverage>
				</uniprot>
				<uniref90>
					<id>UniRef90_P06239</id>
					<start>7</start>
					<end>35</end>
				</uniref90>
				<regions>
					<region>
						<region_type>secondary structure</region_type>
						<region_name>helix</region_name>
						<region_start>12</region_start>
						<region_end>15</region_end>
					</region>
				</regions>
			</chain>
		</macromolecules>
		<evidence>
			<complex_evidence>The interacting regions of CD4 and Lck were shown using NMR to undergo cooperative folding as a result of the binding (PMID:14500983).</complex_evidence>
		</evidence>
	</entry>
</database>
